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Persons working for VKM, either as appointed members of the Committee or as ad hoc 
experts, do this by virtue of their scientific expertise, not as representatives for their 
employers. The Civil Services Act instructions on legal competence apply for all work 
prepared by VKM. 
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The present benefit and risk assessment of breastmilk and contaminants in breastmilk was 
initiated by the Norwegian Scientific Committee for Food Safety (VKM). The overall 
objective is to provide a balanced assessment of the benefits of breastmilk against the possible 
risks from exposure to contaminants in breastmilk with focus on Norwegian conditions. The 
aim is to contribute to a foundation for decision-makers when providing recommendations on 
the length of exclusive and partial breastfeeding. 
The composition of breastmilk is tailored for the needs of the newborn. Provided that the 
nutritional needs of the mother are met during pregnancy and breastfeeding, breastmilk covers 
all the nutritional requirements of the infant the first months of life, with the exception of 
vitamin D. Breastmilk also contains a number of specialised components, including growth 
factors, factors with anti-microbial and anti-inflammatory properties and selected 
immunological components which boost the maturation of the infant’s immune system. Infant 
formula fulfils the infant’s established nutritional needs, but does not provide the specific 
protective factors which are present only in breastmilk. 
However, studies over the last four decades have shown that polluting chemicals have 
accumulated in the environment, biomagnified in the food chain, are in our bodies, and 
consequently in breastmilk. The levels of lipid-soluble persistent contaminants in the foetus, 
the newborn child and in breastmilk largely reflect the amount of these in the mother’s body.  
Thus, breastmilk contains nutrients and protective immunological factors which have a 
positive effect on infant health, but may also contain contaminants. Particularly lipid-soluble 
and persistent contaminants accumulate in the infant during breastfeeding. This has 
contributed to a debate among experts agreeing that breastfeeding is beneficial, but discussing 
the advisable length of breastfeeding.  
 
Breastfeeding in Norway 
Breastfeeding prevalence is higher in Norway than in most European countries. 80% of the 
infants are breastfed at 6 months of age and 46% at 12 months. Mean breastfeeding duration 
is about 10 months.  
Norwegian health authorities recommend that infants are exclusively breastfed for 6 months 
with a total duration of at least 12 months. However, only a minority of Norwegian mothers 
breastfeed exclusively for the recommended 6 months. The prevalence of exclusive 
breastfeeding declines rapidly from 3 months onwards with only 9% being exclusively 
breastfed at 6 months.  
Mean breastmilk consumption in exclusively breastfed infants increases from approximately 
700 ml/day at age 1 month to 850 ml/day at age 6 months. The amount of breastmilk provided 
to the child is not very different between the partially and exclusively breastfed infants during 
the first 4 months. From 7 months, breastmilk consumption in partially breastfed infants may 
be about 500 ml/day.  
There are a few conditions where breastfeeding is contraindicated. Among these are some 
metabolic disorders, infections and use of certain pharmaceuticals. 
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Nutrients and immunological components in breastmilk 
The positive health effects of breastmilk relates to nutritious as well as immunological 
properties.  
An infant who is exclusively breastfed for the first 6 months of life has, provided adequate 
nutrition of the mother, all the nutritional needs covered with the exception of vitamin D. 
Therefore, worldwide, the recommended daily intake of nutrients for infants is derived from 
the nutrient concentrations in breastmilk multiplied with the average intake of breastmilk.  
The composition of nutrients in breastmilk varies by stage of lactation, the time of day and 
during a given feeding. The concentration of some nutrients also varies according to the 
mother’s diet. The energy content of breastmilk varies, but has been estimated to be about 700 
kcal/L. The content of proteins and carbohydrates is relatively stable, while the fat content has 
large variations. The fatty acid composition and concentrations of most vitamins reflect the 
maternal intake, while the concentrations of most minerals are not affected by the maternal 
diet, except for selenium and iodine.  
Breastmilk has protective properties. It contains a number of specialised components, 
including factors with anti-microbial and anti-inflammatory properties as well as constituents 
boosting the maturation of the infant’s immune system. This benefits health in childhood and 
most likely also later in life. The milk antibodies are targeted against potential pathogens and 
other antigens to which the mother has been exposed. Moreover, maturation of the infant’s 
immune system is influenced by contact with the immune-modulating factors in breastmilk as 
well as dietary and microbial constituents in the infant’s gut. Different components in 
breastmilk facilitate the establishment of a beneficial intestinal microbiota, which is important 
for induction of a balanced mucosal immune system. Through all these mechanisms, 
breastfeeding represents an ingenious immunologic integration of mother and child.  
 
Nutrients in infant formula 
If breastfeeding is not possible or if there is a need for more milk in addition to breastmilk, 
infant formula is recommended until the child is 12 months of age.  
Infant formula fulfills the infant´s established nutritional needs, but does not provide maternal 
antibodies and innate defence factors or immunity-promoting components. The majority of 
the infant formulas on the Norwegian market are cow’s milk-based. 
Data from a national dietary survey among infants (Spedkost, 2006) showed that at 6 months 
of age, 43% of the infants in Norway had been introduced to infant formula, and 36% used it 
regularly. At 1 year of age, 43% of the infants received infant formula regularly.  
Infant formulas in Norway are subject to EU regulations that cover the composition, labelling, 
marketing and distribution of the product. The regulations give minimum and maximum 
limits for nutrients for infant formulas and include some of the provisions of the WHO Code1.  
 
Contaminants and exogenous microbes in breastmilk and infant formula   
Breastmilk, as a reflection of the mother’s body, contains low concentrations of a mixture of 
different contaminants. Only the most prevalent contaminants in breastmilk have been 
                                                 
1International Code of marketing of Breast-Milk substitutes. 
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determined chemically and even fewer have been studied in humans with regard to impact on 
early life health.  
The main focus of the present benefit and risk assessment of breastmilk are contaminants 
which are included in the Stockholm convention on Persistent Organic Pollutants (POPs)2. 
They can be divided into the three main groups; pesticides (DDT and HCB), other 
halogenated organic pollutants (dioxins and dioxin-like PCBs, non dioxin-like PCBs, 
brominated flame retardants (PBDE), perfluorinated compounds (PFOS/PFOA)) and heavy 
metals (lead, mercury and cadmium). 
In the identification and characterisation of negative health effects, combined exposures to 
multiple contaminants3 from breastmilk have to some extent been taken into consideration, as 
several of the cohorts have been investigating the impact on health outcomes of PCBs and 
dioxins in combination with DDT or HCB and some in combination with mercury. 
Additionally, it should be noted that the contaminants studied may be considered as markers 
for the combined exposure of multiple contaminants, since their occurrences are often 
correlated. 
Metal concentrations in both breastmilk and infant formula (e.g. mercury and lead) are 
generally low and not at levels associated with concern.  
Due to national and international restrictions and bans on use, the levels of dioxins, PCBs, and 
pesticides (like DDTs and HCB) have declined substantially (more than 60%) in the 
environment and in humans the last three decades. Compared to DDTs, HCB, dioxins and 
PCBs, the concentration of PBDEs in breastmilk in Norway increased until approximately 
year 2000, after which a decline has been observed. The fluorinated surfactants PFOS and 
PFOA have shown a similar time trend as the PBDEs. 
There are limited Norwegian data on levels of persistent organic pollutants in infant formula, 
but the levels reported are generally much lower than in breastmilk. 
Some contaminants which do not accumulate in the food chain may also be relevant in both 
breastmilk and infant formula. Substances from food packaging materials, e.g. phthalates, 
may be present in both breastmilk and infant formula, as well as process-generated substances 
such as acrylamide, PAHs, furan and 3-MDCP. The hormone active substance bisphenol A 
(BPA) used in plastic has recently been banned in infant feeding bottles in EU and Norway. 
Occurrence data in breastmilk and infant formula for these substances in Norway are scarce.  
The main difference between the contaminants in breastmilk and those provided by infant 
formula or bottle-feeding is that breastmilk generally contains higher levels of persistent 
organic pollutants, while most of the unwanted substances imposed by infant formula and 
bottle-feeding have a shorter half-life.  
Infant formula may contain microbial contamination of concern, which may lead to diarrhea 
and in severe cases bacteraemia and meningitis. Cronobacter spp. (formerly Enterobacter 
sakazakii) is a rare cause of invasive infection with high death rates in newborn infants. 
Possible outbreak from microbiological hazards in infant formula itself or due to 
                                                 
2The Stockholm Convention (SC) on Persistent Organic Pollutants (POPs) is a global treaty administered by the 
United Nations Environment Programme (UNEP) to protect human health and the environment from chemicals, 
and first entered into force in 2004 (Stockholm Convention on POPs 2004 http://www.chm.pops.int). The 
criteria for being included in SC are persistence, bioaccumulation, potential for long-range transport, and adverse 
effects. 
3In popular terms often referred to as the “cocktail effect”. 
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contaminated water is an issue in developing countries, but no such outbreaks have been 
registered in Norway.  
 
Methodological approach to this benefits and risk assessment 
The benefit assessment is based on positive health effects reported in systematic reviews and 
meta-analyses published within the last 10 years. This implies that VKM has not conducted 
its own specific literature search to reveal the epidemiological studies that have examined 
positive health effects of breastmilk, but summarises and discusses the health outcomes 
described in the included systematic reviews and meta-analyses4. 
In addition, some other reviews or single studies of high quality have been included if recent 
publications of relevance to the benefit assessment have appeared, or the above described 
reviews and meta-analyses have not commented on diseases/conditions of interest. In the 
VKM conclusions, most emphasis has been put on two recent systematic reviews; one from 
Nordic Nutrition Recommendations (2013) and one from WHO (2013).  
As a basis for the risk assessment to identify and characterise possible negative effects of 
contaminants in breastmilk, a full scale systematic literature search for single studies 
investigating such effects associated with exposure to contaminants in breastmilk was 
conducted. 
It was set as an absolute inclusion criterion that the studies should provide good breastfeeding 
data and be able to differentiate effects of postnatal exposure from prenatal exposure. 
The systematic literature search resulted in 46 studies which were rated for quality (A-B-C) 
according to a predefined set of criteria. Of these, no studies were categorised as A, while 24 
studies qualified for category B. The category C-studies were not considered further. The 
negative health effects of contaminants in breastmilk in this report are thus based on 24 
papers from 10 cohorts conducted in seven different countries (USA, Canada, Faroe Isles, 
Spain, Germany, the Netherlands and Slovakia). No such data on impact on infant and child 
health of exposure to contaminants via breastmilk was available from Norway. Only the 




There are several methods in use for grading evidence in systematic literature reviews. The 
grading of evidence used in this benefit and risk assessment is similar to the grading system 
used by the World Cancer Research Fund (WCRF) in the report Food, Nutrition, Physical 
Activity and the prevention of Cancer: a global perspective from 2007. 
 
 
                                                 
4The included systematic reviews and meta-analyses are: Breast-feeding: A Commentary by the ESPGHAN 
Committee on Nutrition (including a previous WHO-report from 2007, and two other systematic reviews from 
2005 and 2007). The influence of maternal, fetal and child nutrition on the development of chronic disease in 
later life from the Scientific Advisory Committee on Nutrition in UK from 2011. Breastfeeding, introduction of 
other foods and effects on health: A systematic literature review for the 5th Nordic Nutrition Recommendations 
from 2013. Long-term effects of breastfeeding: A systematic review from WHO also from 2013. 
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• Limited – suggestive 
• Limited – no conclusion 
 
When grading the evidence of the literature on positive health effects associated with 
breastmilk, VKM has graded the sum of the work by others, some of whom have not graded 
their results and some using grading, but various grading systems. An element of “best 
judgement” is thus unavoidable from our side, as there to our knowledge are no international 
guidelines for grading on the basis of reviews and meta-analyses. 
 
Breastfeeding data in meta-analyses and reviews for positive health effects 
Few of the meta-analyses, reviews or single studies used as a basis for the benefit assessment 
enabled differentiation of health benefits of breastmilk in a long-term dose-dependent manner. 
Although some of the studies support conclusions that prolonged and exclusive breastfeeding 
up to 6 months of age stimulates protective effects better than shorter duration, the optimal 
length of exclusive and total duration of breastfeeding remains to be settled. 
 
Norwegian contaminant exposure estimates and tolerable intake levels 
Exposure estimates for Norwegian infants were done for PCB-153, DDE, HCB, dioxins and 
dl-PCBs. These compounds were the only contaminants where sufficient occurrence data in 
Norwegian breastmilk were available. Furthermore, these compounds were investigated in the 
included studies on possible negative health effects associated with contaminants in 
breastmilk.  
The cumulative amounts pr kg body weight were estimated by combining contaminant 
concentrations in breastmilk from Norwegian women with mean consumption of breastmilk, 
mean fat concentration in breastmilk and the mean body weight in children. 
In general, the risks from exposure to contaminants have been assessed by international risk 
assessment bodies such as the Joint FAO/WHO Expert Committee on Food Additives 
(JECFA) or European Food Safety Authority (EFSA). Tolerable intakes have been set for 
some contaminants (e.g. dioxins and dl-PCBs (dioxin-like PCBs)), DDE, HCB and some 
fluorinated compounds).  
For other contaminants, EFSA could not establish tolerable intakes due to lack of data (e.g. 
PBDEs and ndl-PCBs (non dioxin-like PCBs)). However, VKM has previously used a 
guidance value and used this for sum of six ndl-PCBs. 
As long as the exposure from breastmilk is below tolerable intakes, exposure in infants is 
considered not to be of concern. It is important to note that tolerable intake values are values 
presumed to be safe. They are not equivalent to levels above which negative health effects are 
                                                 
5More detailed criteria given in section 10.1. 
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likely to occur. Safety margins are incorporated in the values, and exceeding the tolerable 
intake merely results in a reduced safety margin.  
The exposure estimates indicate that the DDE and HCB exposure via breastmilk to infants is 
lower than the tolerable daily intakes (TDIs). The guidance value for ndl-PCBs is based on 
maternal exposure in cohorts were the infants were breastfed. Exposure estimations in 
Norwegian women indicate that at least 95% of Norwegian infants are exposed to ndl-PCBs 
below a level which can be considered tolerable.  
Exceeding the tolerable intake in infants does not necessarily imply that the concentration in 
the infant body reaches a level of concern, and therefore the tolerable intakes of dioxins and 
dl-PCBs are not directly applicable for infants. The tolerable intake of dioxins and dl-PCBs 
has been set to ensure that the contaminant concentration in the mother (the maternal whole 
body concentration, expressed per kg body weight) is below the highest concentration that is 
considered safe to the foetus. This is the body concentration associated with intake similar to 
the tolerable intake. Due to the rapid growth of the infant a dilution of contaminants takes 
place with a slower increase in body concentration.  
The dietary intake of dioxins and dl-PCBs, as recently estimated in the Norwegian MoBa 
cohort, was below the tolerable weekly intake (TWI6) for more than 97% of the participating 
pregnant women. This indicates a low risk associated with prenatal exposure among infants in 
Norway. 
 
Contaminant exposure in Norwegian infants in comparison with infants in included 
cohorts addressing negative health effects 
The Norwegian levels of PCB-153 and DDE in breastmilk are substantially lower than in 
most of the cohorts included in the risk part of the assessment. However, Norwegian mothers 
continue partial breastfeeding longer than women in most of the studies addressing negative 
health effects. Even when being breastfed for 2 years, the accumulated amount of 
contaminants in Norwegian children will not reach the maximum  levels of the included 
cohorts. Furthermore, the highest body concentration in Norwegian infants is reached later in 
infancy in comparison with the included cohorts. 
 
Additional considerations 
The present benefit and risk assessment has included studies that have separated measures of 
pre- and postnatal exposure and associations with the health outcomes. Effects from prenatal 
exposure can be assessed by e.g. investigating association between infant and/or maternal 
exposure levels at birth and health outcomes later in life. However, if postnatal exposure is 
also of importance, it may influence the associations with prenatal exposure. Further, 
associations between postnatal exposure and health outcome may also be influenced by 
prenatal exposure. Although such influence can be adjusted for in statistical analyses, residual 
influence cannot be ruled out. Focusing on studies separating associations with pre-and 
postnatal exposure was in view of VKM the best approach available for this benefit and risk 
assessment. 
Many of the studies on negative effects on neurodevelopment included in the present 
assessment found an association between prenatal contaminant exposure7 and increased risk – 
                                                 
6The TWI for dioxins and dl-PCBs is 14 pg TEQ/kg body weight/week. 
7Mostly twice or more than current Norwegian exposure. 
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an effect not observed by postnatal exposure. Hence, assuming equal sensitivity in the pre- 
and postnatal period is probably a conservative approach which most likely overestimates the 
risk when the highest body concentration is reached as late in infancy as 12 months, as in 
Norway.  
 
Benefit and risk assessment by health outcome 
The literature grading forms the basis of the benefit and risk assessment. Furthermore, the 
evaluation of the benefits and possible risks related to breastmilk is based on Norwegian data 
on prevalence of breastfeeding and concentrations of persistent organic pollutants in 
breastmilk.  
The health outcomes described in the included papers for positive and negative health effects 
are related to the following diseases or conditions: 
• Neurodevelopment 
• Immune response-associated diseases including infections, asthma/wheezing and 
allergy, coeliac disease, inflammatory bowel disease (Crohn’s disease and ulcerative 
colitis) and type 1 diabetes. 
• Growth, overweight and obesity 
• Outcomes related to the metabolic syndrome such as blood-pressure, serum-
cholesterol, type 2 diabetes and cardiovascular disease 
• Malignant diseases (cancer) 
• Sudden infant death syndrome 
• Thyroid parameters 
• Sexual maturation 
The VKM conclusions are organised according to health outcomes, starting with those 
outcomes that have been studied from both a benefit and risk point of view. 
 
Neurodevelopment - IQ and cognitive development 
Based on systematic reviews and meta-analyses published within the last 10 years, VKM 
finds that the evidence is convincing for an enhancing effect of breastmilk on 
neurodevelopment. The optimal length of exclusive and partial breastfeeding which 
stimulates the positive effect remains to be settled. 
The grading of the scientific evidence for negative health effects from persistent organic 
pollutants in breastmilk on neurodevelopment is based on seven cohorts, with findings of 
increased risk in three cohorts (Dutch, German and Canadian cohorts). The findings were 
transient in the Dutch and German cohorts, whereas no follow up study from the Canadian 
cohort was available. 
The evidence is limited suggestive for a negative effect from persistent organic pollutants in 
breastmilk on neurodevelopment at exposure levels in these cohorts. The length of exclusive 
and partial breastfeeding associated with the transient negative effects in some studies 
remains to be settled. As to mercury, this compound was only investigated in one cohort and 
VKM concludes that the evidence for an effect of exposure from breastmilk is limited and no 
conclusion can be drawn. 
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A specific confounder challenge for interpretation of studies on neurodevelopment was the 
lack of HOME score measurements. HOME score measurements were used in 7 of the 14 
papers investigating associations between POP’s in breastmilk and neurodevelopment, 
including the two papers which reported transient findings. 
The estimated cumulative amounts per kg body weight of contaminants in infants in the 
Dutch, German and Canadian cohorts were higher than currently in Norway, both prenatally, 
early postnatally and at 1 year of age. Even with a breastfeeding duration of 2 years, the 
cumulative amounts of contaminants in Norwegian infants will not reach similar peak levels 
as the infants in the included cohorts. Furthermore, the highest cumulative amount received 
by present-day Norwegian infants is reached later in infancy than in infants in the included 
cohorts. Taking the methodological challenges and the additional considerations into account, 
the following conclusion is drawn: 
VKM concludes that the benefits of breastmilk clearly outweigh the possible risk of 
impaired neurodevelopment from contaminants in breastmilk.  
 
Immune response-associated diseases  
Based on recent systematic reviews and meta-analyses, VKM finds that the grading of the 
evidence on the benefit side is convincing for a protective effect of breastmilk on infections, 
at least as long as the child is breastfed.  
The evidence is limited and no conclusion can be drawn for a possible protective effect of 
breastmilk on asthma and wheezing, allergies and atopic dermatitis. 
The grading of the scientific evidence for negative health effects from persistent organic 
pollutants in breastmilk on immune response-associated diseases is based on four cohorts, 
with findings of increased risk in three cohorts (Faroe Island 3, Dutch and Slovakian cohorts). 
The evidence is considered limited and no conclusion can be drawn for a negative effect from 
persistent organic pollutants in breastmilk on thymus weight, vaccine antibody titre, 
respiratory infections, asthma and wheezing. VKM notes that although the evidence is limited 
and inconclusive, this is mainly due to the scarcity of studies and disparate endpoint 
measurements. All studies investigating immunological endpoints reported some effect. 
In the risk assessment of immune response-associated diseases other than infections, a major 
challenge was the heterogeneity within each main group of outcomes, e.g. immune response- 
or allergy-related diseases, where all five papers included in reality measured widely different 
outcomes, and different parameters of similar outcomes. 
The Faroe 3 cohort had approximately 9-fold higher concentrations of PCBs than the present-
day Norwegian levels. The Slovakian and Dutch cohorts had about 3 to 4 times higher mean 
breastmilk levels than the present levels in Norway. In the INMA (Menorca) cohort DDE was 
addressed, and the mean levels were 100-fold higher than in Norway. 
The estimated cumulative amount per kg body weight of contaminants in infants in the 
Faroese, Slovakian and Dutch cohorts were higher than current Norwegian levels, both 
prenatally, early postnatally and at 1 year of age. Even with a breastfeeding duration of 2 
years, the cumulative amounts of contaminants in Norwegian infants will not reach similar 
peak levels as the infants in the included cohorts. Furthermore, the highest cumulative level in 
present-day Norwegian infants is reached later in infancy than in infants in the included 
cohorts. 
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Four of the five studies investigating association between persistent organic pollutants in 
breastmilk and immunological parameters also found an association between prenatal 
contaminant exposure and immune response-associated diseases. The nervous- and immune 
systems undergo substantial development after birth, and have been assumed to be sensitive to 
chemical exposures also in the postnatal period. In the absence of knowledge, a conservative 
approach would be to assume that the infant is as sensitive as the foetus. 
 
Taking the methodological challenges and the additional considerations into account, the 
following conclusion is drawn: 
VKM concludes that the benefits of breastmilk in terms of defence against infections 
clearly outweigh the possible risk of reduced resistance to infections from contaminants 
in breastmilk, at least as long as the child is breastfed. 
No conclusion can be drawn on other immune response-associated diseases due to 
inconclusive results on the benefit side and few and disperse studies on the risk side. 
 
Growth, overweight and obesity 
Based on recent systematic reviews and meta-analyses, VKM finds that the evidence is 
convincing for a protective effect of breastmilk on risk of overweight and obesity in 
childhood. The optimal length of exclusive and partial breastfeeding associated with the 
reduction in risk remains to be settled. 
Grading the evidence on the risk side, VKM concludes that the evidence is limited and no 
conclusion can be drawn for a possible association between persistent organic pollutants in 
breastmilk and impaired growth in children. The grading of the scientific evidence for 
negative health effects from persistent organic pollutants in breastmilk on growth was based 
on three cohorts, with negative findings in one, pointing towards reduced (and not increased) 
weight with increasing PCB exposure (Faroe Island 2). Infants in the Faroese cohorts have 
historically had substantially higher levels of contaminants in blood both at birth as well as 
early and late in the nursing period in comparison with Norwegian infants. 
Taking the methodological challenges and the additional considerations into account, the 
following conclusion is drawn: 
VKM concludes that the reduced risk of overweight and obesity associated with 




VKM concludes that the evidence for association between postnatal exposure to 
contaminants and parameters related to thyroid hormones is very limited and no 
conclusion can be drawn. 
 
Type 1 and 2 diabetes, high blood pressure, Crohn’s disease, ulcerative colitis, coeliac 
disease, childhood cancer and sudden infant death syndrome  
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VKM concludes that the evidence is probable for a protective effect of breastmilk on later 
risk of type 1 diabetes, type 2 diabetes and high blood pressure. The optimal length of 
exclusive or partial breastfeeding which protects remains to be settled. 
VKM concludes that the evidence is limited suggestive for a protective effect of breastmilk on 
the risk of Crohn’s disease, ulcerative colitis, coeliac disease, childhood cancer and sudden 
infant death syndrome.  
No studies investigating these health outcomes in relation to contaminants in breastmilk were 
identified. 
 
Overall conclusions on benefit and risk assessment of breastmilk to infant health in 
Norway 
Taking the present-day levels of contaminants in breastmilk and the long duration of 
breastfeeding (12 months) in Norway into account, VKM concludes that:  
• The benefits of breastmilk clearly outweigh the possible risk of impaired 
neurodevelopment from contaminants in breastmilk.  
• The benefits of breastmilk in terms of defence against infections clearly outweigh the 
possible risk of reduced resistance to infections from contaminants in breastmilk, at 
least as long as the child is breastfed. 
• The reduced risk of overweight and obesity associated with breastfeeding clearly 
outweighs the possible risk presented by contaminants in breastmilk. 
• As regards the beneficial effects of breastmilk on risk of type 1 and type 2 diabetes 
and high blood pressure, the evidence suggests a probable beneficial effect later in 
life. There are no studies investigating these health outcomes in relation to 
contaminants in breastmilk. 
• No conclusion can be drawn on other immune response-associated diseases due to 
inconclusive results on the benefit side and few and disperse studies on the risk side. 
 
Following a comprehensive assessment of scientific literature on the positive health 
effects of breastmilk and concentrations in breastmilk of compounds representing 
possible health hazards, and given current knowledge about concentrations of 
contaminants in Norwegian breastmilk and breastfeeding duration in Norway, VKM 
concludes that the benefits associated with breastmilk clearly outweigh the risk 
presented by current levels of contaminants in breastmilk. This conclusion is not 
affected by whether a child is exclusively or partially breastfed up to the age of 6 months 
and partially breastfed up to 12 months of age. 
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Denne nytte- og risikovurderingen av morsmelk og miljøgifter i morsmelk ble initiert av 
Vitenskapskomiteen for mattrygghet (VKM). Det overordnede målet er å gi en balansert 
vurdering av fordelene ved morsmelk opp mot potensielle risikoer ved eksponering for 
miljøgifter i morsmelk, med fokus på norske forhold.  Hensikten er å bidra til et grunnlag for 
beslutningstakere som gir anbefalinger om lengde på fullamming og delamming. 
Sammensetningen av morsmelk er tilpasset den nyfødtes behov. Forutsatt at mor har dekket 
sine ernæringsbehov under svangerskapet og i ammeperioden, dekker morsmelk alle de 
ernæringsmessige behovene barnet har de første månedene, med unntak av vitamin D. 
Morsmelk inneholder også en rekke spesialiserte komponenter som vekstfaktorer og 
substanser med antimikrobielle og antiinflammatoriske egenskaper samt spesielle 
immunologiske komponenter som stimulerer modningen av barnets eget immunsystem. 
Morsmelkerstatning dekker de etablerte ernæringsmessige behovene, men inneholder ikke de 
spesialiserte beskyttelsesfaktorene som bare finnes i morsmelken. 
Studier de siste fire tiårene har vist at fordi forurensende kjemikalier akkumulert i miljøet 
oppkonsentreres i næringskjeden, så finnes de også i våre kropper - spesielt i fettrikt vev, og 
dermed også i morsmelk. Nivåene av fettløselige, tungt nedbrytbare kontaminanter i fosteret, 
det nyfødte barnet og i morsmelken gjenspeiler i stor grad den akkumulerte mengden av disse 
kontaminantene i mors kropp. 
Dette innebærer at morsmelk i tillegg til næringsstoffer og beskyttende immunologiske 
faktorer som har en positiv effekt på spedbarns helse, også kan inneholde kontaminanter. 
Særlig de fettløselige, tungt nedbrytbare kontaminantene akkumuleres hos barnet under 
amming. Dette er bakgrunnen for en debatt blant eksperter om anbefalt ammelengde, til tross 
for allment bred enighet om at amming er gunstig for barnet. 
 
Amming i Norge 
Ammeforekomsten er høyere i Norge enn i de fleste andre europeiske land. Undersøkelser 
viser at 80 % av barna blir ammet ved seks måneders alder og 46 % ved 12 måneder. 
Gjennomsnittlig ammelengde er ca. ti måneder. 
Norske helsemyndigheter anbefaler at spedbarn fullammes i seks måneder og ammes videre 
til barnet er minst ett år. Imidlertid viser det seg at kun et mindretall av norske mødre 
fullammer i seks måneder. Andelen av barn som fullammes avtar raskt fra tre måneder og 
oppover, og ved seks måneder er det kun 9 % av barna som fullammes. 
Det gjennomsnittlige inntaket av morsmelk hos et spedbarn som fullammes øker fra ca. 700 
ml per dag ved en måneds alder til ca. 850 ml per dag ved seks måneder. Studier viser at 
inntak av morsmelk ikke er veldig forskjellig mellom barn som fullammes og barn som 
delammes de første fire månedene. Fra syv måneders alder og oppover er det gjennomsnittlige 
morsmelkinntaket estimert til å være ca. 500 ml per dag. 
Amming anbefales ikke dersom mor har visse særskilte metabolske sykdommer eller 
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Næringsstoffer og immunologiske komponenter i morsmelk 
De positive helseeffektene av morsmelk er særlig knyttet til morsmelkens innhold av 
næringsstoffer og immunologiske komponenter.   
Forutsatt at mor har dekket sine ernæringsmessige behov, vil et spedbarn som fullammes de 
første seks månedene av livet ha alle de etablerte ernæringsmessige behovene dekket, med 
unntak av vitamin D. På verdensbasis er det derfor slik at anbefalt daglig inntak av 
næringsstoffer for spedbarn tar utgangspunkt i konsentrasjonene av de ulike næringsstoffene i 
morsmelk, multiplisert med det gjennomsnittlige morsmelkinntaket. 
Sammensetningen av næringsstoffer i morsmelk varierer avhengig av laktasjonsfase, tid på 
dagen og i løpet av selve ammingen. Enkelte av næringsstoffene varierer også med mors 
kosthold. Energiinnholdet i morsmelk varierer, men har blitt anslått til å være ca. 700 kcal per 
liter. Innholdet av proteiner og karbohydrater er relativt stabilt, mens det er store variasjoner i 
fettinnholdet. Fettsyresammensetning og konsentrasjon av de fleste vitaminene reflekterer 
mors inntak, mens konsentrasjoner av mineraler stort sett ikke påvirkes av mors kosthold, 
med unntak av selen og jod. 
Morsmelken bidrar med stoffer som har beskyttende egenskaper i barnet. Den inneholder en 
rekke spesialiserte immunologiske komponenter, inkludert faktorer med antimikrobielle og 
antiinflammatoriske egenskaper, så vel som substanser som stimulerer modningen av barnets 
eget immunsystem. Disse egenskapene er ikke bare positive for helsen i barndommen, men 
mest sannsynlig også senere i livet. Antistoffer i morsmelken er rettet mot potensielle 
patogener og antigener som mor har vært eksponert for. I tillegg blir modningen av barnets 
immunsystem påvirket av immunmodulerende faktorer i morsmelk og av komponenter fra 
stedegne bakterier og matrester i barnets tarm. Ulike substanser i morsmelk fremmer 
etableringen av en gunstig tarmflora (mikrobiota) hos barnet, noe som er viktig for induksjon 
av et balansert immunsystem både i slimhinnen og ellers i kroppen (immunologisk 
homeostase). Gjennom alle disse mekanismene representerer morsmelk og amming en 
enestående immunologisk integrering av mor og barn. 
 
Næringsstoffer i morsmelkerstatning 
Hvis amming ikke kan gjennomføres, eller dersom det er behov for mer melk i tillegg til 
morsmelk, anbefales morsmelkerstatning til barnet er 12 måneder. 
Morsmelkerstatning dekker spedbarnets etablerte ernæringsmessige behov, men tilfører ikke 
barnet morens antistoffer og naturlige forsvarsfaktorer og heller ikke de andre komponentene 
i morsmelken som stimulerer barnets immunsystem. De fleste morsmelkerstatningene på det 
norske markedet er kumelksbaserte. 
Data fra en nasjonal kostholdsundersøkelse blant spedbarn (Spedkost, 2006-2007) viste at ved 
seks måneders alder har 43 % av norske spedbarn blitt introdusert til morsmelkerstatning og 
36 % brukte morsmelkerstatning som drikke. Ved ett års alder brukte 43 % av norske 
spedbarn morsmelkerstatning jevnlig. 
Morsmelkerstatninger i Norge er underlagt EUs regelverk som dekker sammensetning, 
merking, markedsføring og distribusjon av produktet. Forskrift for morsmelkerstatning gir 
minimums- og maksimumsgrenser for næringsstoffer og inkluderer flere av bestemmelsene i 
WHO-koden8. 
                                                 
8Internasjonal kode for markedsføring av morsmelkerstatninger. 
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Kontaminanter og eksogene mikrober i morsmelk og morsmelkerstatning 
Morsmelken gjenspeiler mors konsentrasjoner av kontaminanter og inneholder derfor lave 
konsentrasjoner av forskjellige forurensninger. Bare de vanligste miljøgiftene er analysert i 
morsmelk, og enda færre er blitt studert i mennesker med hensyn til helseeffekter i spedbarn 
og barn. 
I denne nytte- og risikovurdering av morsmelk har hovedfokuset vært på kontaminanter som 
er inkludert i Stockholmkonvensjonen om tungt nedbrytbare organiske miljøgifter (POPs)9. 
De kan deles inn i tre hovedgrupper: plantevernmidler (DDT og HCB), andre halogenerte 
organiske miljøgifter (dioksiner og dioksinliknende PCB, ikke-dioksinliknende PCB, 
bromerte flammehemmere (PBDE), perfluorerte forbindelser (PFOS / PFOA)) og 
tungmetaller (bly, kvikksølv og kadmium). 
Ved identifisering og karakterisering av negative helseeffekter er kombinerte eksponeringer 
fra flere kontaminanter10 i morsmelk til en viss grad tatt hensyn til, da det i flere av de 
inkluderte kohortene er undersøkt helseeffekter av PCB og dioksiner i kombinasjon med DDT 
eller HCB, og noen i kombinasjon med kvikksølv. I tillegg bør det bemerkes at de 
kontaminantene som er undersøkt kan anses som markører for en kombinert effekt av flere 
kontaminanter, ettersom forekomsten av flere kontaminanter som regel er korrelert. 
Konsentrasjonen av metaller i både morsmelk og morsmelkerstatning (for eksempel kvikksølv 
og bly) er generelt lav, og nivåene gir generelt sett ikke grunnlag for bekymring 
På grunn av nasjonale og internasjonale restriksjoner og forbud mot bruk, har nivåene av 
dioksiner, PCB og plantevernmidler (som DDT og HCB) falt betydelig (mer enn 60 %) i 
miljøet og i mennesker de siste tre tiårene. I motsetning til nivåene for dioksiner, PCB, DDT 
og HCB, så økte konsentrasjonen av PBDE i morsmelk i Norge fram til ca. år 2000, hvoretter 
en nedgang er observert. De perfluorerte forbindelsene PFOS og PFOA, som brukes blant 
annet til overflatebehandling, har vist en lignende tidstrend som PBDE. 
Det finnes begrenset med norske data om nivåer av tungt nedbrytbare organiske miljøgifter i 
morsmelkerstatning, men de rapporterte nivåene er generelt mye lavere enn i morsmelk. 
Noen forurensninger som ikke akkumuleres i næringskjeden kan også være relevante både i 
morsmelk og i morsmelkerstatning. Stoffer som finnes i matemballasje, for eksempel ftalater, 
kan være til stede både i morsmelk og morsmelkerstatning. Det samme gjelder for 
prosessfremkalte stoffer som akrylamid, PAH, furan og 3-MDCP. Det hormonaktive stoffet 
bisfenol A (BPA), som brukes i plast, har nylig blitt forbudt i tåteflasker i EU og i Norge. 
Forekomstdata i morsmelk og morsmelkerstatning for disse stoffene finnes ikke i Norge. 
Den største forskjellen mellom kontaminanter i morsmelk og de som tilføres barnet via 
morsmelkerstatning eller flaske, er generelt at morsmelk inneholder høyere nivåer av tungt 
nedbrytbare organiske miljøgifter, mens de fleste av de uønskede stoffene i 
morsmelkerstatning og flaske har en kortere halveringstid. 
Morsmelkerstatning kan inneholde uønskede mikroorganismer som kan gi barnet diaré, 
og i alvorlige tilfeller bakteriemi og meningitt. Cronobacter spp. (tidligere Enterobacter 
sakazakii) er en sjelden årsak til invasiv infeksjon med høy dødelighet hos nyfødte spedbarn. 
                                                 
9Stockholmkonvensjonen (SC) for tungt nedbrytbare organiske miljøgifter er en global avtale som administreres 
av FNs miljøprogram (UNEP) for å beskytte menneskers helse og miljøet mot kjemikalier. 
Stockholmkonvensjonen trådte i kraft første gang i 2004 (Stockholmkonvensjonen om organiske miljøgifter 
2004 http://www.chm.pops.int). Kriteriene for å bli inkludert i SC er persistens, bioakkumulering, potensiale for 
spredning over store avstander, og alvorlige helseeffekter. 
10Populært kalt «cocktaileffekten». 
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Mulig utbrudd fra mikroorganismer i morsmelkerstatning i seg selv, eller på grunn av 
forurenset vann, er et problem i utviklingsland, men slike utbrudd har ikke vært registrert i 
Norge. 
 
Metodisk tilnærming i denne nytte og risikovurderingen 
Nyttevurderingen av morsmelk er basert på positive helseeffekter rapportert i systematiske 
kunnskapsoppsummeringer og metaanalyser som er publisert i løpet av de siste ti årene. Dette 
innebærer at VKM ikke har gjennomført et eget litteratursøk for epidemiologiske studier som 
har undersøkt positive helseeffekter av morsmelk, men oppsummerer og diskuterer helseutfall 
som er beskrevet i de inkluderte systematiske kunnskapsoppsummeringene og metaanalysene. 
I tillegg er noen andre relevante, nyere kunnskapsoppsummeringer eller enkeltstudier av høy 
kvalitet inkludert.  
I VKMs konklusjoner har det blitt lagt mest vekt på to nye systematiske 
kunnskapsoppsummeringer, én fra de nye nordiske næringsstoffanbefalingene (2013), og én 
fra WHO (2013). 
Risikovurderingen av kontaminanter i morsmelk er basert på negative helseeffekter rapportert 
i studier fra kohorter som ble funnet gjennom et fullskala systematisk litteratursøk. Det ble 
satt som et absolutt inklusjonskriterium at studiene skulle ha gode ammedata og være i stand 
til å skille effekten av postnatal eksponering fra prenatal eksponering. 
Det systematiske litteratursøket og eksklusjonskriteriene resulterte i 46 studier som ble 
vurdert for kvalitet (A-B-C) i henhold til et sett av forhåndsdefinerte kriterier. Av disse ble 
ingen studier kategorisert som A, mens 24 studier kvalifiserte for kategori B. Kategori C-
studier ble ikke vurdert nærmere. De negative helseeffektene fra kontaminanter i morsmelk 
som er beskrevet i denne rapporten er dermed basert på 24 artikler fra ti kohorter gjennomført 
i syv forskjellige land (USA, Canada, Færøyene, Spania, Tyskland, Nederland og Slovakia). 
Ingen studier om helseeffekter på spedbarn og barn relatert til eksponering for kontaminanter 
via morsmelk var tilgjengelig fra Norge. Kun kontaminantene PCB, dioksiner, DDT/DDE, 
HCB og kvikksølv var undersøkt i de inkluderte studiene. 
 
Gradering av evidens 
Det finnes flere systematiske metoder for å gradere vitenskapelig evidens. Graderingen som 
brukes i denne nytte- og risikovurderingen er lik det systemet som brukes av World Cancer 
Research Fund (WCRF) i rapporten Food, Nutrition, Physical Activity and the prevention of 
Cancer: a global perspective fra 2007. De ulike graderingskategoriene er: 
• Overbevisende (convincing) 
• Sannsynlig (probable) 
• Begrenset – indikerende (limited, suggstive) 
• Begrenset – ingen konklusjon (limited, no conclusion) 
 
I graderingen av evidensen for de positive helseeffektene forbundet med morsmelk har VKM 
gradert summen av arbeidet fra andre. Noen av de inkluderte kunnskapsoppsummeringene og 
metaanalysene som omhandler positive helseeffekter fra morsmelk har ikke gradert sine egne 
resultater. Andre bruker gradering, men ulike systemer. Et element av "beste skjønn" er 
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dermed uunngåelig fra VKM sin side, da det så vidt vi vet, ikke finnes internasjonale 
retningslinjer for gradering av kunnskapsoppsummeringer og metaanalyser. 
 
Ammedata i kunnskapsoppsummeringer og metaanalyser som undersøker positive 
helseeffekter 
Få av metaanalysene, kunnskapsoppsummeringene eller enkeltstudiene som brukes som 
grunnlag for nyttevurderingen muliggjør differensiering av helseeffekter ut fra dose-respons 
og fra måned til måned, og få ser på helseeffekter av langvarig amming. Selv om noen av 
studiene støtter en konklusjon om at fullamming fram til seks måneders alder har mer 
beskyttende effekter enn kortere amming, kan man ikke ut fra disse fastslå hva som er optimal 
lengde for fullamming eller optimal total ammelengde. 
 
Beregnet kontaminanteksponering fra morsmelk i Norge og tolerable inntak 
Eksponeringsestimater for norske spedbarn er gjort for PCB-153, DDE, HCB, dioksiner og 
dioksinliknende PCB (dl-PCB). Det er kun for disse kontaminantene at det finnes 
tilstrekkelige forekomstdata i norsk morsmelk. Disse stoffene er også undersøkt i de 
inkluderte studiene om mulige negative helseeffekter forbundet med kontaminanter i 
morsmelk.  
Barnas akkumulerte mengder av kontaminanter per kg kroppsvekt er estimert ved å 
kombinere konsentrasjonene av kontaminantene i morsmelk fra norske kvinner med 
gjennomsnittlig inntak av morsmelk, gjennomsnittlig fettkonsentrasjon i morsmelk og 
gjennomsnittlig kroppsvekt hos barn. 
Risiko forbundet med eksponering fra kontaminanter generelt er vurdert av internasjonale 
risikovurderingsorganer som Joint FAO/WHO Expert Committee on Food Additives 
(JECFA) eller European Food Safety Authority (EFSA). Tolerable inntak er satt for enkelte 
kontaminanter (for eksempel dioksiner og dl-PCB, DDE, HCB og noen fluorerte 
forbindelser). 
For andre kontaminanter har ikke EFSA kunnet etablere tolerable inntak på grunn av 
manglende data (for eksempel PBDE og ikke-dioksinliknende PCB (ndl-PCB)). Imidlertid har 
VKM tidligere brukt et veiledende nivå for tolerabelt inntak, og brukt dette for summen av 
seks ndl-PCB. 
Så lenge eksponeringen fra morsmelk er lavere enn tolerable inntak, anses eksponering for å 
være trygg. Det er likevel viktig å merke seg at selv om de tolerable inntaksverdiene er 
verdier som anses som trygge, vil ikke overskridelser av tolerable inntak nødvendigvis 
medføre negative helseeffekter. I de tolerable inntakene er det inkludert sikkerhetsmarginer, 
og en overskridelse av tolerabelt inntak resulterer derfor kun i en redusert sikkerhetsmargin. 
Estimatene for norske barn tyder på at DDE- og HCB-eksponering via morsmelk er lavere 
enn tolerabelt daglig inntak (TDI). Veiledende nivå for ndl-PCB er basert på mors 
eksponering fra kohorter der barna er ammet. Eksponeringsberegninger for norske kvinner 
tyder på at minst 95 % av norske spedbarn har et eksponeringsnivå for ndl-PCB som er under 
det nivået som kan anses som trygt. 
Overskridelse av tolerabelt inntak i spedbarn betyr ikke nødvendigvis at konsentrasjonen i 
spedbarnets kropp når et nivå som er til bekymring, og derfor er ikke det tolerable inntaket for 
dioksiner og dl-PCB direkte anvendbart for spedbarn. Det tolerable inntaket av dioksiner og 
dl-PCB er satt for å sikre at konsentrasjonen hos mor (mors kroppskonsentrasjon, uttrykt per 
Norwegian Scientific Committee for Food Safety (VKM) 10-003-final  
2 
 





Helle Margrete Meltzer (chair) 
Per Brandtzæg 
Helle Knutsen 
Beate Fossum Løland 
Jon Øyvind Odland 
Janneche Utne Skåre 
Liv Elin Torheim 
Norwegian Scientific Committee for Food Safety (VKM) 10-003-final  
20 
 
kg kroppsvekt) er lavere enn den høyeste konsentrasjonen som regnes som trygt for fosteret. 
Dette representerer kroppskonsentrasjonen som er forbundet med inntak likt med det 
tolerable. På grunn av spedbarnets raske vekst vil kontaminantkonsentrasjonen i barnet 
fortynnes, og dette gir en langsommere økning i konsentrasjonen i kroppen.  
Inntaket av dioksiner og dl-PCB fra kosten ble nylig estimert i den norske Mor og Barn 
kohorten (MoBa), og var lavere enn det tolerable ukentlige inntaket (TWI11) hos mer en 97 % 
av de gravide kvinnene som deltok. Dette tyder på lav risiko forbundet med prenatal 
eksponering blant spedbarn i Norge. 
 
Eksponering for kontaminanter i norske barn sammenliknet med barn i de inkluderte 
kohortene hvor negative helseeffekter undersøkes 
De norske nivåene av PCB-153 og DDE i morsmelk er vesentlig lavere enn i de fleste av 
kohortene som danner grunnlaget for risikovurderingen. Imidlertid fortsetter norske mødre 
med delamming lenger enn kvinner i de fleste av de inkluderte studier som undersøker 
negative helseeffekter. Selv med en ammelengde på to år, vil den akkumulerte mengden av 
kontaminanter i norske barn ikke nå opp til maksimumsnivået i spedbarna i de inkluderte 
kohortene. Videre vil norske barn nå den høyeste akkumulerte mengden senere i 
spedbarnsalderen enn barna i de inkluderte kohortene. 
 
Andre hensyn 
I denne nytte- og risikovurderingen er det kun inkludert studier som har skilt på helseeffekter 
fra prenatal- og postnatal eksponering for kontaminanter. Effekter fra prenatal eksponering 
kan vurderes ved for eksempel å undersøke sammenhenger mellom spedbarnets og/eller mors 
eksponeringsnivåer ved fødselen og helsemessige konsekvenser senere i livet. Hvis den 
postnatale eksponeringen påvirker helsen, så kan imidlertid dette også påvirke assosiasjoner 
med den prenatale eksponeringen. Dessuten kan assosiasjoner mellom postnatal eksponering 
og helseeffekter bli påvirket av den prenatale eksponeringen. Selv om dette kan justeres for i 
statistiske analyser, kan det ikke utelukkes at det fremdeles finnes konfunderende faktorer 
som ikke er justert for.  
Mange av de inkluderte studiene som undersøkte negative effekter på utviklingen av 
nervesystemet, fant en sammenheng mellom prenatal kontaminanteksponering og økt risiko, 
men ingen konsistent sammenheng med postnatal eksponering. Det å anta at barnet er like 
sensitiv i pre- og postnatal periode er trolig en forsiktig tilnærming som mest sannsynlig 
overvurderer risikoen for barn som når den høyeste kroppskonsentrasjonen først nås ved 12 
måneders alder, som i Norge. 
 
Nytte- og risikovurdering av helseeffekter 
Graderingen av litteraturen danner grunnlaget for denne nytte- og risikovurderingen. Videre 
er evaluering av fordeler og mulig risiko knyttet til morsmelk basert på norske ammedata og 
konsentrasjoner av tungt nedbrytbare organiske miljøgifter i morsmelk. 
 
                                                 
11TWI for dioksiner og dl-PCB er 14 pg TEQ/kg kroppsvekt/uke. 
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Helseutfallene som er beskrevet i de inkluderte studiene for positive og negative helseeffekter 
er knyttet til følgende sykdommer eller tilstander: 
• utvikling av nervesystemet 
• immunrespons-assosierte sykdommer, inkludert infeksjoner, astma/pustevansker og 
allergi, cøliaki, inflammatorisk tarmsykdom (Crohns sykdom og ulcerøs kolitt) og 
type 1 diabetes 
• vekst, overvekt og fedme 
• helseutfall relatert til metabolsk syndrom, for eksempel blodtrykk, serum kolesterol, 





VKMs konklusjoner er organisert etter helseutfall, og starter med de helseutfallene som har 
blitt studert for både fordeler (nytte) og risiko. 
 
Utvikling av nervesystemet – IQ og kognitiv utvikling 
Basert på systematiske kunnskapsoppsummeringer og metaanalyser publisert i løpet av de 
siste ti årene finner VKM at evidensen er overbevisende for at morsmelk fremmer utviklingen 
av nervesystemet. Den optimale lengden på fullamming og delvis amming som stimulerer den 
positive effekten kan ikke fastsettes. 
Graderingen av evidensen for negative helseeffekter fra tungt nedbrytbare organiske 
miljøgifter i morsmelk på utvikling av nervesystemet er basert på syv kohorter, med funn av 
negativ effekt på utvikling av nervesystemet i tre kohorter (nederlandsk, tysk og kanadisk). 
Funnene var forbigående i den nederlandske og den tyske kohorten, mens det fra den 
kanadiske kohorten ikke foreligger noen oppfølgingsstudie. 
VKM konkluderer med at evidensen er begrenset indikerende for en negativ effekt fra tungt 
nedbrytbare organiske miljøgifter i morsmelk på utviklingen av nervesystemet, gitt 
eksponeringsnivåene i disse tre kohortene. Hvilken ammelengde, fullamming eller 
delamming, som er assosiert med de forbigående negative effektene på utvikling av 
nervesystemet kan ikke fastslås. Kvikksølv er bare undersøkt i én av de inkluderte kohortene, 
og VKM konkluderer med at evidensen for en effekt av eksponering av kvikksølv fra 
morsmelk er begrenset, og at det ikke kan trekkes noen konklusjon for kvikksølv. 
Manglende målinger av såkalt “HOME score” var en særlig utfordring i tolkningen av 
resultatene for utvikling av nervesystemet. “HOME score”-målinger ble brukt i syv av de 14 
studiene som undersøkte sammenhenger mellom tungt nedbrytbare organiske miljøgifter i 
morsmelk og utvikling av nervesystemet, inkludert de to studiene som rapporterte forbigående 
funn. 
Den estimerte akkumulerte mengden kontaminanter per kg kroppsvekt i barn i de 
nederlandske, tyske og kanadiske kohortene var høyere enn for norske barn, både prenatalt, 
tidlig postnatalt og ved ett års alder. Selv med en ammelengde på to år vil den akkumulerte 
mengden av kontaminanter i norske barn ikke nå opp til maksimumsnivået i spedbarna i de 
inkluderte kohortene. Videre vil norske barn nå den høyeste akkumulerte mengden senere i 
spedbarnsalderen enn barna i de inkluderte kohortene.  
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Metodiske utfordringer og andre hensyn er tatt i betraktning når VKM kommer fram til 
følgende konklusjon: 
VKM konkluderer med at de helsemessige fordelene ved morsmelk på utvikling av 




Basert på systematiske kunnskapsoppsummeringer og metaanalyser, finner VKM at gradering 
av evidensen er overbevisende for en beskyttende effekt av morsmelk på infeksjoner, i alle 
fall så lenge barnet ammes. 
Evidensen er begrenset og ingen konklusjon kan trekkes for en mulig beskyttende effekt av 
morsmelk på astma/pustevansker, allergi og atopisk dermatitt. 
Graderingen av evidensen for negative helseeffekter fra tungt nedbrytbare organiske 
miljøgifter i morsmelk på immunrespons-assosierte sykdommer er basert på fire kohorter, 
med funn som viser økt risiko i tre kohorter (Færøysk kohorte 3, nederlandsk og slovakisk 
kohorte). Evidensen for negative effekter på tymusvekt, vaksineindusert antistofftiter, 
luftveisinfeksjoner, astma og pustevansker fra tungt nedbrytbare organiske miljøgifter i 
morsmelk er begrenset og ingen konklusjon kan trekkes. VKM understreker at evidensen er 
mangelfull på grunn av få studier og fordi de studiene som finnes har brukt ulike mål for 
helseutfall. Alle studier som har undersøkt immunologiske helseutfall rapporterer imidlertid 
en eller annen effekt. 
I risikovurderingen av andre immunrespons-assosierte sykdommer enn infeksjoner, har det 
vært en stor utfordring å sammenlikne resultatene fordi alle de fem studiene som har studert 
immunresponsutfall i realiteten enten har målt vidt forskjellige endepunkter, eller målt ulike 
parametere for like utfall. 
Kohorte 3 fra Færøyene hadde omtrent ni ganger høyere konsentrasjoner av PCB i morsmelk 
enn dagens norske nivåer. De slovakiske og nederlandske kohortene hadde omtrent tre til fire 
ganger høyere nivåer enn dagens nivå i Norge. I den spanske INMA kohorten fra Menorca ble 
DDE undersøkt, og gjennomsnittsnivået av DDE i morsmelk var 100 ganger høyere enn i 
Norge. 
Den estimerte akkumulerte mengden kontaminanter per kg kroppsvekt i barn i de færøyske, 
slovakiske og nederlandske kohortene var høyere enn for norske barn, både prenatalt, tidlig 
postnatalt og ved ett års alder. Selv med en ammelengde på to år, vil den akkumulerte 
mengden av kontaminanter i norske barn ikke nå samme maksimumsnivå som spedbarna i de 
inkluderte kohortene. Videre vil norske barn nå den høyeste akkumulerte mengden senere i 
spedbarnsalderen enn barna i de inkluderte kohortene.  
Fire av fem studier som har undersøkt sammenhenger mellom tungt nedbrytbare organiske 
miljøgifter i morsmelk og immunologiske parametere har funnet en sammenheng mellom 
prenatal eksponering og immunrespons-assosierte sykdommer. Nervesystemet og 
immunsystemet gjennomgår en betydelig utvikling etter fødselen, og er antatt å være 
følsomme for kjemisk eksponering også etter fødselen. Ettersom vi foreløpig har mangelfull 
av kunnskap om sensitive vinduer, vil det være en konservativ tilnærming å anta at det fødte 
barnet er like følsomt som fosteret. 
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Metodiske utfordringer og andre hensyn er tatt i betraktning når VKM kommer fram til 
følgende konklusjon: 
VKM konkluderer med at de helsemessige fordelene ved morsmelk når det gjelder 
forsvar mot infeksjoner klart oppveier mulig risiko fra tungt nedbrytbare organiske 
miljøgifter i morsmelk for nedsatt motstand mot infeksjoner, i alle fall så lenge barnet 
blir ammet. 
Ingen konklusjon kan trekkes for andre immunassosierte sykdommer på grunn av 
sprikende resultater i studier som har undersøkt positive helseeffekter fra morsmelk, og 
få studier med sprikende resultater i studier som har undersøkt negative helseeffekter 
fra kontaminanter i morsmelk. 
 
Vekst, overvekt og fedme 
Basert på systematiske kunnskapsoppsummeringer og metaanalyser publisert i løpet av de 
siste ti årene, finner VKM at evidensen er overbevisende for at morsmelk beskytter mot 
overvekt og fedme i barndommen. Den optimale lengden på fullamming og delvis amming 
som beskytter kan ikke fastsettes. 
Graderingen av evidensen for negative helseeffekter fra tungt nedbrytbare organiske 
miljøgifter i morsmelk på vekstutvikling hos barn er basert på tre kohorter med negative funn 
i én kohorte; denne antyder redusert (og ikke økt) vekt med økende PCB-eksponering 
(kohorte 2 fra Færøyene). Spedbarna i de færøyske kohortene har historisk sett hatt et 
betydelig høyere nivå av miljøgifter i blodet både ved fødsel, samt tidlig og senere i 
ammeperioden sammenlignet med norske spedbarn. Graderingen av evidensen for negative 
helseeffekter fra tungt nedbrytbare organiske miljøgifter i morsmelk på vekstutvikling hos 
barn er begrenset, og ingen konklusjon kan trekkes.  
Metodiske utfordringer og andre hensyn er tatt i betraktning, når VKM kommer fram til 
følgende konklusjon: 
VKM konkluderer med at redusert risiko for overvekt og fedme ved amming klart 
oppveier en mulig risiko fra kontaminanter i morsmelk. 
 
Skjoldbrukskjertel-parametere 
VKM konkluderer med at evidensen for en sammenheng mellom postnatal eksponering 
for miljøgifter og parametere knyttet til skjoldbruskkjertelhormoner er svært begrenset, 
og ingen konklusjon kan trekkes. 
 
Type 1 og 2 diabetes, høyt blodtrykk, Crohns sykdom, ulcerøs kolitt, cøliaki, kreft hos 
barn og krybbedød 
VKM konkluderer med at evidensen er sannsynlig for at morsmelk har en beskyttende effekt 
på senere risiko for type 1 diabetes, type 2 diabetes og høyt blodtrykk. Den optimale lengden 
på fullamming og delvis amming som gir slik positiv effekt kan ikke fastsettes. 
VKM konkluderer med at evidensen er begrenset indikerende for at morsmelk har en 
beskyttende effekt på senere risiko for Crohns sykdom, ulcerøs kolitt, cøliaki, kreft hos barn 
og krybbedød. 
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Ingen studier som undersøker disse helseutfallene for kontaminanter i morsmelk ble 
identifisert. 
 
Konklusjoner i nytte og risikovurdering av morsmelkinntak – betydningen for helse hos 
norske barn 
Tatt i betraktning dagens nivåer av kontaminanter i morsmelk i Norge, og en lang 
ammeperiode (12 måneder), konkluderer VKM med at: 
• de helsemessige fordelene ved morsmelk på utvikling av nervesystemet klart oppveier 
mulig risiko for redusert utvikling av nervesystemet fra kontaminanter i morsmelk 
• de helsemessige fordelene ved morsmelk når det gjelder forsvar mot infeksjoner klart 
oppveier mulig risiko for nedsatt motstand mot infeksjoner fra kontaminanater i 
morsmelk, i hvert fall så lenge barnet blir ammet 
• redusert risiko for overvekt og fedme ved amming klart oppveier en mulig risiko fra 
kontaminanter i morsmelk 
• evidensen er sannsynlig for at morsmelk har en beskyttende effekt på senere risiko for 
type 1 diabetes, type 2 diabetes og høyt blodtrykk. Ingen studier som undersøker disse 
helseutfallene for kontaminanter i morsmelk ble identifisert 
• ingen konklusjon kan trekkes for andre immunassosierte sykdommer på grunn av 
sprikende resultater i studier som har undersøkt positive helseeffekter fra morsmelk, 
og få studier med sprikende resultater i studier som har undersøkt negative 
helseeffekter fra kontaminanter i morsmelk 
Etter en helhetlig vurdering av den vitenskapelige litteraturen for positive helseeffekter 
av morsmelk og potensielle negative helseeffekter fra kontaminanter i morsmelk, 
kontaminantnivået i norsk morsmelk og ammelengde typisk for norske barn, 
konkluderer VKM med at de helsemessige fordelene forbundet med morsmelk klart 
oppveier mulig risiko som dagens nivåer av kontaminanter i morsmelk kan representere. 
Denne konklusjonen gjelder uansett om barna fullammes eller delammes fram til seks 
måneders alder, og delammes opp til 12 måneder. 
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3-MCPD – 3-Monochloropropane-1,2-diol 
AA – Arachidonic acid 
AAP – American Academy of Pediatrics 
AFSSA – French Agency for Food, Environmental and Occupational Health and Safety (now 
ANSES) 
AI – Adequate intake 
ALA – Alfa linolenic acid 
Bayley Scales of Infant Development – See Appendix 7 
BMD – Bench mark dose 
BMDL – Bench mark dose lower confidence limit 
BMI – Body mass index 
Body burden – The total amount of a particular chemical present in the body 
BPA – Bisphenol A 
BSID – Bayley Scales of Infant Development – See Appendix 7 
bw – Body weight 
CI – Confidence interval 
COT – Committee on Toxicity, UK 
DALY – Disability-adjusted life year 
DDE – Dichlorodiphenyldichloroethane is one of the more common breakdown products of 
DDT 
DEHP – Di-2-ethylhexyl phthalate 
DDT – Dichlorodiphenyltrichloroethane  
DHA – Docosahexaenoic acid 
DiBP – Di-isobutyl phthalate 
dl-PCBs – Dioxin-like PCBs 
DNA – Deoxyribonucleic acid 
DnBP – Di-n-butyl phthalate 
EER – Estimated energy requirement 
EFSA – European Food Safety Authority 
EPA – Environmental Protection Agency, USA 
ESPGHAN – European Society of Paedriatic Gastroenterology, Hepatology and Nutrition 
FAO – Food and Agriculture Organization of the United Nations 
FFQ – Food frequency questionnaire 
GALT – Gut-associated lymphoid tissue 
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GCI – General cognitive index 
HCB – hexachlorobenzene 
HCH – Hexachlorocyclohexane 
Hg – Mercury 
HOME score – See Appendix 7 
HUMIS – Norwegian Human Milk Study 
IARC – International Agency for Research on Cancer 
IgA, IgE, IgG, IgM – Immunoglobulin A, E, G, M 
IOM – Institute of Medicine, USA 
IQ – Intelligence quotient 
JECFA – Joint FAO/WHO Expert Committee on Food Additives 
JMPR – Joint FAO/WHO Meeting on Pesticide Residues 
K-ABC – Kaufman Assessment Battery for Children – See Appendix 7 
Kaufman Assessment Battery for Children – See Appendix 7 
LA – Linoleic acid 
MALT – Mucosae-associated lymphoid tissue 
MDI – Mental Development Index 
McCarthy Scales of Children’s Abilities – See Appendix 7 
MD – Mean difference 
ML – Maximum level 
MOE – Margin of exposure 
MRL – Maximum residue level 
MSCA – McCarthy Scales of Children’s Abilities – See Appendix 7 
NAD – Nicotinamide adenine dinucleotide 
NADP – Nicotinamide adenine dinucleotide phosphate 
NALT – Nasopharynx-associated lymphoid tissue 
ndl-PCBs – Non dioxin-like PCBs 
NEC – Necrotising enterocolitis 
NNR – Nordic Nutrition Recommendations 
NOAEL – No observed adverse effect level 
NOS – Neurological optimality score 
NPN – Non-protein nitrogen 
PAH – Polycyclic aromatic hydrocarbons 
PBB – Polybrominated biphenyl 
PBDEs – Polybrominated diphenyl ethers 
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PBPK – Physiologically based pharmacokinetic modelling 
PCBs – Polychlorinated biphenyls (209 all together, 121, 153 and 180 are the most 
commononly analysed) 
PCDDs and PCDFs – Dibenzo-p-dioxins and dibenzofurans (denoted dioxins) 
PCP – Pentachlorophenol 
PDI – Psychomotor development index 
PFAS – Perfluoroalkylated substance 
PFOS and PFOA – Perfluorooctane sulfonate and perfluorooctanoic acid 
PICO – Population Intervention Comparison Outcome 
POPs – Persistent organic pollutants 
PTDI – Provisional tolerable daily intake 
PUFA – Polyunsaturated fatty acid 
QALY – Quality-adjusted life year 
QAT – Quality assessment tool 
RCT – Randomised controlled trial 
RE – Retinol equivalents 
RNA – Ribonucleic acid 
SACN – Scientific Advisory Committee on Nutrition, UK 
SC – Secretory Component 
SCF – Scientific Committee on Food, EU; now replaced by EFSA 
SD – Standard deviation 
SIDS – Sudden infant death syndrome 
SIgA – Secretory IgA 
TDI – Tolerable daily intake 
TCDD – Tetrachlorodibenzo(p)dioxin 
TE – Toxic equivalent 
TEF – TCDD toxic equivalency factor 
TEQ – sum of TCDD toxic equivalents (concentration of each dioxin, furan and dl-PCB 
multiplied with its corresponding TEF and then summarised) 
TWI – Tolerable weekly intake  
WHO – World Health Organization 
ww – Wet weight 
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Since the 1970s, Norway has been considered to be a model for other countries in its support 
for breastfeeding. The breastfeeding prevalence in Norway is among the highest in Europe in 
spite of a high proportion of women being in employment. This is at least in part the result of 
good parental leave conditions, public guidelines and well organised measures undertaken to 
promote breastfeeding. For most Norwegians, both the message and the practice is that 
”breast is best”. Having said that, only a minority of Norwegian children are breastfed 
exclusively for 6 months, as recommended by the health authorities. 
Norway has adopted the World Health Organization (WHO) recommendations on exclusive 
breastfeeding for the first 6 months of the infant’s life. Thereafter, WHO recommends that 
breastfeeding continue for up to 2 years of age or beyond, while the Norwegian Directorate of 
Health recommends that breastfeeding continues for at least 12 months. 
Nutritionally, breastmilk is adapted to the infant’s nutritional requirements and contains all 
the nutrients and substances the infant needs for optimal growth and development in the first 6 
months, the exception being vitamin D. Equally important, breastmilk contains several 
immunological substances which protect the infant from infections and contribute to the 
development and maturation of the infant’s own immune system. The latter benefit might 
explain some of the positive long-term health effects observed in breastfed children. 
However, over several decades, the discovery of environmental contaminants in breastmilk 
has led to an intermittent debate about how long exclusive or partly breastfeeding should be 
continued. Analyses of breastmilk samples from Norway show that whilst the levels of some 
contaminants are decreasing, exposure to other and new substances continues to rise. For 
example, the levels of several bioaccumulating environmental contaminants such as dioxins 
and dioxin-like polychlorinated biphenyls (dl-PCBs), non dioxin-like PCBs (ndl-PCBs) and 
the pesticides dichlorodiphenyltrichloroethane (DDT), dichlorodiphenyldichloroethane 
(DDE), hexachlorocyclohexane (HCH) and hexachlorobenzene (HCB) have decreased 
considerably since 1986. The concentration level of brominated flame retardants such as 
polybrominated diphenyl ethers (PBDE) in breastmilk increased until about year 2000, but 
now the level of most PBDE substances seems to have been stabilised or decreased. However, 
another group of environmental contaminants, fluorinated compounds, used as surfactants 
(such as perfluorooctane sulfonate (PFOS) and perfluorooctanoic acid (PFOA)), continues to 
show increasing concentration levels in breastmilk. Thus, even if the concentration of most of 
the toxicants covered by the Stockholm convention12 has decreased radically, there are new 
contaminants continuously entering the scene. 
Even if the concentration levels of the most important persistent contaminants (such as PCBs 
and dioxins) have decreased radically, breastfed infants and children may still be exposed to 
higher levels of environmental contaminants per kilo body weight than the average adult. The 
exposure is often compared with internationally accepted tolerable intake levels for the 
different substances, and the exposure of some substances or substance groups in breastfed 
infants and children exceeds tolerable intake levels. The tolerable intake levels for these 
substances are however determined on the assumption of a life-long exposure. In the 
embryonic stage, accumulated contaminant levels in the mother will be of significance for the 
embryo’s exposure. Later, the infant and child’s growth will lead to a dilution of the body 
concentration of the contaminants. So the exceeding of tolerable intake levels in breastfed 
                                                 
12Stockholm Convention on Persistent Organic Pollutants is an international environmental treaty, signed in 2001 and 
effective from May 2004, that aims to eliminate or restrict the production and use of persistent organic pollutants (POPs). 
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14 Pan IJ, Daniels JL, Herring AH, Rogan WJ, Siega-Riz AM, Goldman 
BD, Sjodin A. (2010). Lactational exposure to polychlorinated 
biphenyls, dichlorodiphenyltrichloroethane, and 
dichlorodiphenyldichlor ethylene and infant growth: an ana ysis of 
the Pregnancy, Infection, and Nutrition Babies Study. Paediatr 
Perinat Epidemiol, 24(3), 262-271. 
Does not try to discern pre and postnatal 
effects. Little variation in exposure, all 
breastfed long. 
15 Pan IJ, Daniels JL, Goldman BD, Herring AH, Siega-Riz AM, 
Rogan WJ. (2009). Lactational exposure to polychlorinated 
biphenyls, dichlorodiphenyltrichloroethane, and 
dichlorodiphenyldichloroethylene and infant neurodevelopment: an 
analysis of the pregnancy, infection, and nutrition babies study. 
Environ Health Perspect, 117(3), 488-494. 
Relevant, but study designed for other purpose. 
Does not try to discern pre and postnatal 
effects, and does not include non-breastfed. 
16 Ribas-Fito N, Julvez J, Torrent M, Grimalt JO, Sunyer J. (2007). 
Ben ficial effects of bre stfeeding on cog ition regardles  of DDT 
concentrations at birth. Am J Epidemiol, 166(10), 1198-1202. 
Lacks important cofounders. 
17 Ribas-Fito N, Cardo E, Sala M, Eulalia de MM, Mazon C, Verdu A, 
Kogevinas M, Grimalt JO, Sunyer J. (2003). Breastfeeding, exposure 
to organochlorine c mpounds, and neurodevelopment in infants. 
Pediatrics, 111(5 Pt 1), e580-e585. 
Postnatal results not assessed. 
18 Schell LM, Gallo MV, R venscr ft J, DeCaprio AP. (2009). 
Persistent organic pollutants and anti-thyroid peroxidase levels in 
Akwesasne Mohawk young adults. Environ Res, 109(1), 86-92. 
Cannot be used for assessing effects of 
postnatal exposure. 
19 Schell LM, Gallo MV, Denham M, Ravenscroft J, DeCaprio AP, 
Carpenter DO. (2008). Relationship of thyroid horm ne levels to 
levels of polychlorinated biphenyls, lead, p,p'- DDE, and other 
toxicants in Akwesasne Mohawk youth. Environ Health Perspect, 
116(6), 806-813. 
Cannot be used for assessing effects of 
postnata  exposure. 
20 Torres-Sanchez L, Schnaas L, Cebrian ME, Hernandez MC, 
Valencia EO, Garcia Hernandez RM, Lopez-Carrillo L. (2009). 
Prenatal dichlorodiphenyldichloroe hylene (DDE) exposure and 
neurodevelopment: a follow-up from 12 to 30 months of age. 
Neurotoxicology, 30(6), 1162-1165. 
Too scarce breastfeeding data. No information 
about breastfeeding length or exclusive or 
partial breastfeeding.  
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infants and children is relatively short-termed, but takes place in a sensitive phase of the 
child’s development. 
The following reviews and reports were valuable background documents when starting this 
work: 
• Infant and young child nutrition. Global strategy on infant and young child feeding 
(WHO, 2003b).  
• Evidence of the long-term effects of breastfeeding. Systematic reviews and meta-
analyses (WHO, 2007). 
• Contaminants in human milk; Weighing the risks against the benefits of breastfeeding 
(Mead, 2008). 
• Epidemiologic evidence of relationships between reproductive and child health 
outcomes and environmental chemical contaminants (Wigle et al., 2008). 
• The influence of maternal, fetal and child nutrition on the development of chronic 
disease in later life (SACN, 2011). 
• Breast-feeding: A Commentary by the ESPGHAN Committee on Nutrition (Agostoni 
et al., 2009). 
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Terms of reference 
The Norwegian Scientific Committee for Food Safety has initiated a benefit and risk 
assessment of breastmilk with focus on the infant’s health. The assessment shall be based on 
updated levels of environmental contaminants in Norwegian breastmilk. The assessment shall 
evaluate the nutritional and protective properties of breastmilk compared with possible 
diseases/conditions that can be caused by environmental contaminants (e.g. infections, cancer 
and cognitive development). The purpose is to evaluate the benefits and potential risks related 
to breastmilk based on Norwegian data on prevalence of breastfeeding and concentrations of 
environmental contaminants in breastmilk.  
• The assessment shall review the positive characteristics of breastmilk. Several 
scientific reviews of breastmilk and infant health have been published the last years. 
The beneficial aspects of breastmilk shall therefore be based on these reviews and if 
necessary be updated with newer scientific studies. 
• The assessment shall particularly focus on the duration of exclusive and partly 
breastfeeding and possible diseases/conditions that can be caused by environmental 
contaminants in breastmilk. 
• The assessment shall give a short description of microbiological hazards and 
contaminant conditions that may influence the infant’s health if breastmilk is replaced 
by infant formula.  
• Possible data gaps and need for new surveillance shall be pinpointed. 
• The assessment shall be based on relevant Norwegian and international studies and 
publications. 
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From a nutritional and health point of view, breastmilk is the healthiest form of milk for 
newborns. The nutrient content in breastmilk is tailored for the needs of the newborn. The 
protein and fat concentrations seem to be adapted to the growth velocity of the infant. In 
addition to its content of perfectly balanced nutrients, breastmilk also contains a number of 
non-nutrient protective factors, including immunoglobulins and growth factors. 
While recognizing the superiority of breastfeeding, regulatory authorities have worked to 
minimise the risks that might result from formula feeding. A 2001 WHO report found that 
infant formula prepared in accordance with applicable Codex Alimentarius13 standards is 
nutritionally adequate and safe complementary food and a suitable breastmilk substitute. 
Nonetheless, with few exceptions, the WHO report recommended exclusive breastfeeding for 
the first 6 months of life for all infants (WHO, 2001). These conclusions were updated and 
confirmed in 2009 and 2012 (Kramer et al., 2009; Kramer and Kakuma, 2012). 
In the wake of the WHO recommendation many countries, including Norway, and health 
organisations, have issued guidelines consistent with those of the WHO.  
However, similar to the exchange of substances in utero between mother and foetus, 
breastmilk does not act as a sieve which only lets positive substances pass through to the 
child. The concentration of many substances in breastmilk reflects the levels of substances 
stored in the mother’s body, especially in fat tissue, or exposure levels during the nursing 
period. Accordingly, smoking, alcoholic beverages, caffeinated drinks, drugs and lastly, a 
group of substances which will be examined in this report: environmental contaminants, may 
compromise the beneficial effects of breastmilk.  
Humans are exposed daily to different types of pollutants. Both man-made chemicals and 
natural substances and their degradation products are present in water, soil, air and food. 
Accordingly, studies over the last four decades have shown that polluting chemicals 
have built up in the environment, bioaccumulated in the food chain, are present in our bodies, 
and consequently in breastmilk. 
Contaminant levels in breastmilk largely reflect the mother’s body burden of lipid-soluble 
contaminants. The contaminant concentrations may exceed the internationally set tolerable 
intake levels for some substances. This contributes to the discussion among experts agreeing 
that breastfeeding is beneficial, but disagreeing about the advisable length of breastfeeding. 
Analyses of breastmilk in Norway show that levels of many environmental contaminants, 
such as PCBs, dioxins and insecticide/pesticides such as DDT, HCH and HCB have had a 
substantial decline since the mid-1980s. The concentration of PBDEs increased in human 
milk until about the year 2000, while the levels now seem to have levelled out or are 
declining. However, new contaminants are entering the scene. A group of substances whose 
concentrations in human milk have increased is fluorinated compounds, which are used as e.g. 
surfactants. Many of these more recent contaminants have bio- and physiochemical properties 
that differ from lipid-soluble persistent contaminants. The amount that passes into breastmilk 
varies between substances. 
This report will perform a benefit and risk assessment of breastmilk. The aim is to provide a 
foundation for Norwegian decision-makers to reliably provide future advice on the length of 
breastfeeding taking the environmental contaminant perspective into due consideration. The 
                                                 
13UN agency under the direction of the Food and Agriculture Organisation (FAO) and the WHO.  
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report will attempt to have a broad approach when it comes to the totality of substances in 
breastmilk.  
The varied diet of an adult human being provides some 100 000 different substances in a day, 
and approximately 60 of these are nutrients. The rest (non-nutrients) belongs to various 
groups of bioactive substances, many of which are beneficial, but, some are harmful. Recent 
research indicates that many of the non-nutrients are absorbed and can affect gene, cell or 
organ functions. A number of these substances passes the blood-placenta barrier and are 
excreted in breastmilk after birth. For many of these substances, their impact on health and 
disease risk has been poorly investigated.  
Effective methods for assessing the risks of individual substances have been developed by 
Codex Alimentarius. National bodies (national scientific committees for food safety and 
health, including the Norwegian Scientific Committee for Food Safety (VKM) and 
international organisations such as the FAO/WHO's Joint Expert Committee on Food 
Additives and Contaminants (JECFA), as well as the European Food Safety Authority 
(EFSA) and other bodies), have conducted health risk assessments of many different chemical 
contaminants. However, contaminants are most often evaluated as single substances. Methods 
to assess effects of mixtures of substances are slowly emerging. 
The overall aim of this report is to provide a balanced assessment of the contribution and 
impact of persistent toxic substances in the context of benefits from breastfeeding for 
newborn children in Norway. Levels of all contaminants in breastmilk should be reduced, and 
the ambitious goal for the Norwegian government is to have a “detoxified” community and 
environment by 2020 (NOU 2010:9, 2012). 
 
 Interpretation of the mandate – limitations 1.1
There are a number of aspects connected to breastfeeding that this assessment does not cover. 
They are important aspects that deserve attention in their own right, but are beyond the scope 
of the present work: 
• psychological aspects of breastfeeding, neither from a child nor mother perspective. 
• impact of breastfeeding on maternal physical health, e.g. impact on weight reduction 
or later risk of disease. 
• drug or medicinal contamination of breastmilk, or pathogenic microorganisms such as 
bacteria or virus. 
• classical animal or cell studies dealing with toxicity of the compounds apart from 
using the NOAEL/LOAEL/PTWI etc., i.e. values that are often derived from animal 
studies. 
 
The focus will be on breastmilk and not on the alternative; infant formula. Thus, this 
assessment will not comprise a benefit- and risk assessment of infant formula, although infant 
formula and substances in infant formula will be discussed for comparison reasons.  
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 Infant feeding recommendations and breastfeeding definitions 2.1
The Norwegian Directorate of Health recommends that infants are exclusively breastfed for 6 
months, with a total breastfeeding duration of at least 12 months or more (Norwegian Directorate 
for Health, 2001). The recommendation includes possible reasons why a supplement to 
breastmilk may be needed, such as poor growth, the infant being hungry even after frequent 
breastfeeding, lactation difficulties or maternal perception/experience with breastfeeding. If 
there is a need for additional food after the age of 4 months, semi-solid food instead of infant 
formula is recommended. Complementary foods should be gradually introduced from the age 
of 6 months to cover the infant’s need for energy and nutrients. The national recommendations
for infant nutrition are currently being revised. 
The systematic literature review which forms the basis for the 5th Nordic Nutrition 
Recommendations (NNR 2012), concludes that the recommendation about exclusive 
breastfeeding until 6 months of age from NNR 2004 is unchanged (Hornell et al., 
2013). 
The WHO recommends exclusive breastfeeding for 6 months and a total breastfeeding period 
for up to 2 years or beyond (WHO, 2001). Nutritionally adequate and safe complementary 
feeding should be started from the age of 6 months (for definitions, see Table 2.1). Before 
2001, the WHO recommended that infants should be exclusively breastfed for 4 to 6 months. 
The revised recommendation was based on a systematic review which concluded that 
breastmilk contributed adequate amounts of nutrients for growth and development until 6 
months (Kramer and Kakuma, 2002). As long as breastfeeding supports adequate growth, the 
notion is that nutritionally superior breastmilk should not be replaced by less nutritious 
complementary foods. The most recent systematic review on this issue was published by the 
Cochrane Library in 2012 (Kramer and Kakuma, 2012). It includes two controlled trials and 
21 observational studies and concludes that exclusive breastfeeding for 6 months has 
advantages over exclusive breastfeeding for 3 to 4 months followed by partial breastfeeding. 
These advantages include a lower risk of gastrointestinal and respiratory infections for the 
infant. A reduced risk of allergic diseases through exclusive breastfeeding for 6 months versus 
4 months was not shown in this review. 
In 2007, 20 out of 24 European countries recommended exclusive breastfeeding for 6 months 
and 12 out of 24 recommended breastfeeding for up to 2 years (Cattaneo et al., 2010). 
Exclusive breastfeeding for 6 months is also recommended by the American Academy of 
Pediatrics (AAP), Scientific Advisory Committee on Nutrition, UK (SACN), Health Canada 
and National Food Agency in Sweden (Gartner et al., 2005; Health Canada, 2012; 
Livsmedelsverket, 2011; SACN, 2003)14. In 2012, the AAP affirmed its previous 
recommendation of exclusive breastfeeding for 6 months with a total breastfeeding period for 
one year or longer (Sicherer and Burks, 2008; Thygarajan and Burks, 2008). According to 
AAP, it is documented that exclusive breastfeeding for at least 3 to 4 months reduces the risk 
of allergic diseases both in low-risk and high-risk populations. When considering the most 
appropriate duration of exclusive breastfeeding, various health effects should be evaluated. In 
addition to nutrient adequacy and risk of infections, outcomes such as allergic diseases, 
                                                 
14The conclusions in SACN, 2003 are confirmed in SACN, 2011. 
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cognitive development, development of healthy eating habits and overweight and obesity 
should also be considered. 
At present, there is conflicting evidence regarding timing of adding complementary foods 
after 4 months and the risk of allergic diseases (Sicherer and Burks, 2008; Thygarajan and 
Burks, 2008). A report from the European Food Safety Authority (EFSA) concluded that the 
introduction of complementary food to healthy, term infants between 4 and 6 months is safe 
and does not pose a risk for adverse health effects (short-term and also possible long-term 
effects) (EFSA, 2009b). The European Society for Paediatric Gastroenterology, Hepatology 
and Nutrition (ESPGHAN) Committee on nutrition concludes that exclusive or full 
breastfeeding for about 6 months is a desirable goal. Complementary feeding should not be 
introduced to any infant before 17 weeks (4 months), and all infants should start 
complementary feeding by 26 weeks (Agostoni et al., 2008). 
There is a need for randomised studies comparing the effect of introduction of complementary 
foods at different ages within the 4-6 month interval (Michaelsen et al., 2010). 
 
Table 2.1: WHO criteria that define selected infant feeding practices1. 
Feeding practice Requires that the infant 
receive 
Allows the infant to receive Does not allow the 
infant to receive 
Exclusive 
breastfeeding 
Breastmilk (including milk 
expressed or from a wet nurse) 
ORS2, drops, syrups (vitamins, 





Breastmilk (including milk 
expressed or from a wet nurse) 
as the predominant source of 
nourishment 
Certain liquids (water and water-
based drinks, fruit juice), ritual 
fluids and ORS2, drops, syrups 
(vitamins, minerals, medicines) 






Breastmilk (including milk 
expressed or from a wet nurse) 
and solid or semi-solid foods 
Anything else: any food or liquid 
including non-human milk and 
formula 
NA3 
Breastfeeding Breastmilk (including milk 
expressed or from a wet nurse) 
Anything else: any food or liquid 
including non-human milk and 
formula 
NA3 
Bottle-feeding Any liquid (including 
breastmilk) or semi-solid food 
from bottle with nipple/teat 
Anything else: any food or liquid 
including non-human milk and 
formula 
NA3 
1WHO. Indicators for assessing infant and young child feeding practices: conclusions of a consensus meeting held 6-8 
November 2007 in Washington D.C., USA. 
2ORS=Oral rehydration solutions. 
3NA=Not applicable. 
 
If any solid foods or liquids are introduced, the infant is no longer considered exclusively 
breastfed according to the WHO definition. Cod liver oil is regarded as a vitamin supplement 
and accepted within the definition of exclusive breastfeeding. The term full breastfeeding is 
not used by WHO, but is seen in several publications and comprises exclusive and 
predominant breastfeeding. The term partial breastfeeding is used in several publications for 
breastmilk combined with formula/milk or complementary foods. The term any breastfeeding 
implies that breastmilk is given, regardless of whether additional foods or liquids are given. 
 
 Breastfeeding patterns in Norway 2.2
National surveys on infant and young child feeding practises were conducted in 1998-1999 
and 2006-2007 (Spedkost and Småbarnskost). Spedkost consists of several cohort studies, 
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with surveys at 6 and 12 months of age. Cross-sectional studies were conducted in the same 
periods for 2-year old children (Småbarnskost). 
Short description of the relevant national surveys: 
• 6-month old infants; Spedkost 2006-2007 is based on a semi-quantitative food 
frequency questionnaire. The study was conducted in 2006, and a total of 1986 6-
month old children participated (participation rate: 67%) (Øverby et al., 2008). 
 
• 1-year old children; Spedkost 2006-2007 is based on a semi-quantitative food 
frequency questionnaire. In addition to predefined household units, food amounts were 
also estimated from photographs. The study was conducted in 2007, and a total of 
1635 1-year old children participated (participation rate: 57%) (Øverby et al., 2009).  
 
• 2-year old children; Småbarnskost 2007 is based on a semi-quantitative food 
frequency questionnaire. In addition to predefined household units, food amounts were 
also estimated from photographs. The study was conducted in 2007, and a total of 
1674 2-year olds participated (participation rate: 56%) (Kristiansen et al., 2009). 
 
• 6-month old infants; Spedkost 6 months is based on a semi-quantitative frequency 
questionnaire. The study was conducted in 1998, and a total of 2383 6-month old 
children participated (participation rate: 80%) (Lande, 2003). 
 
• 1-year old children; Spedkost 12 months is based on a semi-quantitative food 
frequency questionnaire. In addition to predefined household units, food amounts were 
also estimated from photographs. The study was conducted in 1999, and a total of 
1932 1-year olds participated (participation rate: 66%) (Lande and Andersen, 2005b). 
 
• 2-year old children; Småbarnskost 1999 is based on a semi-quantitative food 
frequency questionnaire. In addition to predefined household units, food amounts were 
also estimated from photographs. The study was conducted in 1999, and a total of 
1720 2-year old children participated (participation rate: 58%) (Lande and Andersen, 
2005a). 
 
• The Norwegian Mother and Child Cohort Study (MoBa) is a nation-wide 
pregnancy cohort that in the years 1999-2009 included more than 100 000 
pregnancies. The participation rate was 39%. (Meltzer et al., 2008). The mother 
reported breastfeeding length and intensity both at 6 and 18 months after birth 
(Haggkvist et al., 2010).  
 
• The HUMIS study is a birth cohort study that recruited 2500 mother-child pairs in the 
years 2002-2009 by visiting health personnel. Human milk was collected 
approximately one month after delivery and environmental toxicants was measured in 
a subset of 1000 women. The families filled in further questionnaires when the 
children were 6, 12 and 24 months of age (Eggesbo et al., 2009).  
 
Figure 2.1 presents data from Spedkost 2006-07. Almost all mothers initiated breastfeeding, 
80% breastfed at 6 months and 46% at 12 months. After 12 months, breastfeeding rates 
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decreased rapidly, and 8% breastfed at 18 months and 4% at 24 months (Kristiansen et al., 
2009). Breastfeeding rates at 12 months increased from 36% in 1998 to 46% in 2007. 
In 2007, 46% of the mothers breastfed exclusively for 4 months. This is the same percentage 
as in 1998. Furthermore, in 2007, 9% breastfed exclusively for 6 months, while the 
corresponding figure was 7% in 1998. The data from Spedkost are supported by other 
national studies where information on breastfeeding prevalence has been collected, i.e. the 
Norwegian Mother and Child Cohort Study (Haggkvist et al., 2010).  
Spedkost 2006-2007 showed that mean breastfeeding frequency at 6 months was 6.7 times per 
day, and 3.5 times per day at 12 months. 
 
 
Figure 2.1: Exclusive breastfeeding ( ) in Norway during the first 6 months of life and breastfeeding ( ) 
during the first year of life (n=1490). Source: Kristiansen et al., 2010.  
 
 
2.2.1 Historical data and trends 
From an evolutionary perspective, breastmilk has been the prerequisite for survival of the 
offspring. Through history it has provided the primary source of nutrition for newborns before 
they are able to eat and digest other foods. 
A mother is able to produce milk as long as the milk-producing glands are regularly 
stimulated. Thus, it has not been uncommon in some ethnic groups to breastfeed well into 
childhood. Infants are born with a sucking reflex allowing them to extract the milk from the 
nipples of the breasts, as well as an instinctive behaviour known as rooting with which they 
seek out the nipple. If a mother could not, or would not breastfeed, a wet nurse was generally 
necessary for survival of the infant until approximately a century ago. 
Breastfeeding practice is sensitive to socio-demographic factors, cultural perceptions and 
health care practices and hence breastfeeding prevalence may change rapidly. In Norway, we 
have records of breastfeeding prevalence covering the three largest hospitals from 1860 to 
1980, see Figure 2.2 (Liestol et al., 1988). Until 1920, breastfeeding was common in most 
groups of society. About 90% of the mothers breastfed for at least 3 months, and 50% for at 
least a year. There was some variation between socio-economic groups, as breastfeeding was 
more common among low-income and less educated families, which is quite the opposite of 
the trend seen in Norway today. Breastfeeding was more common in rural than in urban areas, 
which is also contrary to the present trend. In 1920 the breastfeeding prevalence started to 
decline and breastfeeding was increasingly replaced by formula feeding. In 1967 
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breastfeeding rates reached an all-time low level, as only 31% of Norwegian women breastfed 
for 3 months. The same trend was seen in many developed countries. 
The increase in infant formula use in the 1930s had a number of reasons. It became more 
common to give birth in hospital. In hospitals, mothers were routinely separated from their 
infants between the feedings (Helsing and Haggkvist, 2012; Liestol et al., 1988). Mothers 
were also subjected to strict feeding regimes where they should breastfeed their infants only 
4-6 times during the day and not at night. This resulted in many mothers having problems 
with producing sufficient breastmilk for their infants, as breastmilk production is self-
regulating and “demand driven”. Only a sufficiently high feeding frequency will stimulate the 
breast to produce sufficient quantities of milk. Information about breastfeeding was not 
included in medical personnel’s curriculum or in their instruction manuals, or the information 
given was not likely to promote lactation. When problems arose and breastfeeding failed, the 
solution was to use bottled milk. The quality of breastmilk was also being questioned by 
pediatricians, who doubted that it could cover the infant’s energy needs. while they warned 
against frequent feeding since the infant’s digestive system needed to rest (Helsing and 
Haggkvist, 2012).  
The infant food industry developed a number of products as substitutes for breastmilk, and 
these were welcomed by many health workers who thought that modern women were not able 
to breastfeed their child (Helsing and Haggkvist, 2012). The producers of infant formulas 
became increasingly aggressive in their marketing. Maternity wards had posters that informed 
mothers about the benefits of using these products and health workers were handing out free 
samples of infant formulas. This kind of marketing probably contributed to the decrease in 
breastfeeding both in developed and developing countries. The consequences were serious, in 
particular in developing countries where diluted infant formulas and the use of contaminated 
water led to under-nutrition, diseases and the deaths of many children. In 1981, the World 
Health Assembly adopted the International Code of Marketing of Breast-Milk Substitutes. 
The aim of the Code is “…to contribute to the provision of safe and adequate nutrition of 
infants, by the protection and promotion of breastfeeding, and by ensuring the proper use of 
breastmilk substitutes, when these are necessary, on the basis of adequate information and 
through appropriate marketing and distribution” (WHO, 1981).  
For several reasons, the rates of breastfeeding began to rise around 1970. As a reaction to the 
medical trend in child rearing, many women had a desire for a more natural behaviour. The 
Norwegian mother-to-mother breastfeeding support group “Ammehjelpen” was started in 
1968 and strongly reinforced this continuing change of attitudes. Gradually, hospital routines 
improved and the aggressive marketing of infant formula halted. After 1980, a plateau was 
reached, and 77% of Norwegian women breastfed for 3 months, 55% for 6 months and 10% 
for 12 months (Liestol et al., 1988).  
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Figure 2.2: Distribution of durations of breastfeeding in Norway, 1860-1998, for all children born in 
subsequent 5-year groups. Source: Liestol et al., 1988 and adapted by Elisabet Helsing. 
 
 
2.2.2 Breastfeeding in Norway compared with other countries 
Socio-demographic and life style factors influence breastfeeding practice. Higher education, 
higher age, no-smoking, living in urban areas and being married are all factors associated with 
longer duration of exclusive breastfeeding and total breastfeeding duration. Low birth weight 
is associated with shorter breastfeeding duration. Infants with asthma or allergy among family 
members are breastfed longer compared with infants from families with no heredity of asthma 
or allergy (Lande et al., 2003).  
Information about breastfeeding practices among non-western immigrants living in Norway is 
limited. Available data indicate that rates of exclusive breastfeeding often are low (Madar et 
al., 2009).  
The EU project Protection, promotion and support of breastfeeding in Europe: a blueprint for 
action collected data about breastfeeding prevalence in Europe (Cattaneo et al., 2010). 
Breastfeeding rates for European countries are presented in Figures 2.3-2.5. The lack of 
standardised definitions, methods, age groups and indicators across countries makes 
comparisons difficult. According to Figure 2.3 the rate of exclusive breastfeeding at 6 months 
in Norway seem to be among the lowest in Europe. This is probably due to a rigorous survey 
method for assessing breastfeeding rates in the Spedkost survey. On the other hand, Norway 
has the highest rate of any breastfeeding at 6 and 12 months.  
A slight increase in breastfeeding rates was reported for most European countries in a survey 
where two points in time were available (Cattaneo et al., 2010). However, the most recent 
breastfeeding statistics from Sweden demonstrates a clear downward trend in breastfeeding of 
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Figure 2.3: Rates of exclusive breastfeeding at 6 months in Europe: 1998-2002   and 2003-2007   . Based on 
Cattaneo et al., 2010 and data from Spedkost 2006-2007. 
AT: Austria, HU: Hungary, LV: Latvia, SE: Sweden, SK: Slovakia, DK: Denmark, CZ: Czech Republic, ES: Spain, RO: Romania, NL: 
Netherland, LT: Lithuania, IC: Iceland, LU: Luxembourg, CH: Switzerland, DE: Germany, PL: Poland, NO: Norway, IT: Italy, UK: United 
Kingdom, FI: Finland, EE: Estonia, BG: Bulgaria, PT: Portugal, BE: Belgium. 
 
Figure 2.4: Rates of any breastfeeding at 6 months in Europe: 1998-2002    and 2003 2007  . Based on 
Cattaneo et al., 2010 and data from Spedkost 2006-2007. 
NO: Norway, SE: Sweden, IC: Iceland, AT: Austria, CZ: Czech Republic, FI: Finland, DE: Germany, IT: Italy, LU: Luxembourg, CH: 
Switzerland, EE: Estonia, ES: Spain, BG: Bulgaria, NL: Netherland, PT: Portugal, LT: Lithuania, BE: Belgium, UK: United Kingdom, LV: 
Latvia. 
 
Figure 2.5: Rates of any breastfeeding at 12 months in Europe: 1998-2002    and 2003-2007   . Based on 
Cattaneo et al., 2010 and data from Spedkost 2006-2007. 
NO: Norway, FI: Finland, LV: Latvia, SE: Sweden, PT: Portugal, DK: Denmark, LU: Luxembourg, IC: Iceland, UK: United Kingdom, DE: 
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 Breastmilk volume and consumption 2.3
Precise and accurate measurements of breastmilk consumption are difficult to obtain because 
the quantity ingested is not directly observable. Several methods for measuring breastmilk 
consumption have been applied. The most common method for measuring milk consumption 
or production has been test-weighing, a procedure in which the infant or the mother is 
weighed before and after each feeding (Butte N. et al., 2002; da Costa et al., 2010). The 
introduction of isotope tracer methods to measure breastmilk consumption represents a 
substantial improvement over test-weighing. However, it is difficult to apply in field 
conditions and unsuitable for large group studies (da Costa et al., 2010).  
In this report, the mean consumption of breastmilk per day is based on results from 28 
different studies at different months in developed countries and was presented in a publication 
from WHO (Butte N. et al., 2002). The studies presented were conducted in presumably well-
nourished populations from developed countries in the 1980s to1990s. In most of these 
studies, breastmilk consumption was assessed using the 24-hour test-weighing method, while 
the 12-hour test-weighing method and the deuterium dilution method were used in a few 
cases. 
Mean breastmilk consumption of exclusively breastfed infants increased from 699 g/day at 
one month to 854 g/day at 6 months. Longitudinal studies reported no marked increase in 
breastmilk volume after 3 months (Reilly et al., 2005). The mean coefficient of variation was 
16% in exclusively breastfed infants compared with 34% in partially breastfed infants. Milk 
intakes among partially breastfed hovered around 675 g/day in the first 6 months and 530 
g/day in the next 6 months. From Tables 2.2-2.4 it appears that the total breastmilk 
consumption in exclusively breastfed children compared with partially breastfed does not 
differ as much as expected. Possible reasons for this may be that complementary foods are 
introduced gradually and in small quantities, and that children with higher energy needs signal 
need for more food and therefore are over-represented among those given complementary 
foods. 
 
Table 2.2: Breastmilk consumption of exclusively breastfed infants 0-6 months of age from developed 
countries (g/day). Source: Butte et al., 2002. 
http://www.who.int/nutrition/publications/infantfeeding/9241562110/en/).  
Age, months 1 2 3 4 5 6 
Mean, weighted for 
sample size 
699 731 751 780 796 854 
Pooled SD1 134 132 130 138 141 118 
N 186 354 376 257 131 93 
Number of study 
groups 
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Table 2.3: Breastmilk consumption of partially breastfed infants 0-6 months of age from developed 
countries (g/day). Source: Butte et al., 2002. 
http://www.who.int/nutrition/publications/infantfeeding/9241562110/en/).  
Age, months 1 2 3 4 5 6 
Mean, weighted for 
sample size 
611 697 730 704 710 612 
Pooled SD1 129 150 149 184 194 180 
N 116 227 241 251 163 380 
Number of study 
groups 
3 7 9 8 8 15 
1SD=standard deviation. 
 
Table 2.4: Breastmilk consumption of partially breastfed infants 7-12 months of age from developed 
countries (g/day). Source: Butte et al., 2002. 
http://www.who.int/nutrition/publications/infantfeeding/9241562110/en/).  
Age, months 7 8 9 10 11 12 
Mean, weighted for 
sample size 
569 417 497 691 516 497 
Pooled SD1 188 226 249 233 215 238 
N 251 123 154 5 6 48 
Number of study 
groups 
11 8 11 1 1 4 
1SD=standard deviation. 
 
Results from a more recent 12 country study on breastmilk consumption, using a standardised 
stable isotope methodology, are presented in Figure 2.6 (da Costa et al., 2010). This dataset 
did not distinguish between exclusive and partial breastfeeding and included mothers from 
both developed and developing countries. The figure depicts similar consumption of 
breastmilk as in the WHO report by Butte et al., although the levels tend to be higher in the 
second half of infancy. A longitudinal study of the adequacy of breastmilk consumption 
during exclusive breastfeeding using double-labelled water method found that the mean 
breastmilk consumption was 923 g/day (SD: 122) at around 15 weeks and 999 g/day (SD: 
146) when the child was around 26 weeks old (Nielsen et al., 2011).  
The volumes presented in Figure 2.6 correspond with the findings from a randomised 
intervention trial (Cohen et al., 1994). To evaluate whether there are any advantages of 
complementary feeding prior to 6 months, low-income primiparous mothers who had 
exclusively breastfed for 4 months were randomly assigned to one of three groups: 1) 
continued exclusive breastfeeding to 6 months (n=50), 2) introduction of complementary 
foods from 4 months onwards without any instruction on breastfeeding frequency from 4 to 6 
months (n=47) and 3) introduction of complementary foods from 4 months onwards with 
instruction to maintain the same high frequency of breastfeeding from 4 to 6 months (n=44) 
(Figure 2.7).  
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Figure 2.6: Results from a 12 country study on breastmilk consumption (human milk=HM). Source: da 




Figure 2.7: Breastmilk intake of Honduran infants from 4 to 6 months (mean +/-SEM). Source: Cohen et 
al., 1994. 
EBF=exclusive breastfeeding. 
SF=introduction of complementary foods from 4 months with ad libitum nursing from 4-6 months. 
SF-M=introduction of complementary foods from 4 months with maintenance of baseline nursing frequency from 4-6 
months. 
 
At 4 months, breastmilk consumption averaged 797 (SD=139) g/day (no difference between 
groups). Between 4 and 6 months consumption was unchanged in EBF infants (+6 g), but 
 
Norwegian Scientific Committee for Food Safety (VKM) 10-003-final  
2 
 





Helle Margrete Meltzer (chair) 
Per Brandtzæg 
Helle Knutsen 
Beate Fossum Løland 
Jon Øyvind Odland 
Janneche Utne Skåre 
Liv Elin Torheim 
Norwegian Scientific Committee for Food Safety (VKM) 10-003-final  
47 
 
decreased in the SF (-103 g), and SF-M (-62 g) groups (p>0.001). Change in total energy and 
infant weight and lengths did not differ significantly between the groups, and were 
comparable to breastfed infants in an affluent US population. According to the authors, the 
results indicate that breastfed infants self-regulate their total energy intake when other foods 
are introduced. The introduction of solid foods in this period will result in replacement of 
breastmilk. 
No similar study on breastmilk consumption in Norwegian infants has been conducted.  
 
 Relative contraindications to breastfeeding 2.4
There are a few conditions where breastfeeding is or may be contraindicated; among these are 
some metabolic disorders, infections and drug use. These contraindications are summarised in 
AAP’s Policy statement 2012: Breastfeeding and the use of human milk (AAP, 2012). 
 
Microbial contaminants in human milk  
Analyses of milk samples from healthy Norwegian milk-donors have revealed bacteria in 
about 10% of the samples; the majority being Staphylococcus epidermidis (Lindemann et al., 
2004). 
A few cases have been reported where breastmilk has been suggested as source for Group B 
Streptococcus (GBS) or Klebsiella pneumonia disease in preterm infants (Godambe et al., 
2005).  
A prospective, population-based study was performed in Italy to investigate GBS late-onset 
disease (LOD; disease from day 7-89) in premature and mature infants in the period 2003-
2010. F2007 milk samples were analysed from the mothers of 45 infants (11 preterm, 34 
term) diagnosed with LOD. Of these, two and nine milk samples were positive in premature 
and mature infants respectively. One and two GBS mastitis cases were diagnosed in the 
mothers of premature and mature infants, respectively. The authors concluded that “most 
mothers of neonates with LOD are identified at diagnosis with anogenital GBS carriage. It 
seems unlikely that GBS infected milk is a source of LOD in the absence of mastitis” (Berardi 
et al., 2013). 
Mothers with human T-cell lymphotropic virus type I or II, untreated brucellose or HIV (in 
developed, but not in developing countries), untreated tuberculosis or active herpes simplex 
lesions on the breast should not breastfeed. Mothers with varicella five days before, through 
two days after delivery, as well as mothers acutely infected with H1N1 influenza virus, should 
be isolated from their infants but can provide expressed breastmilk for feeding. Full-term 
infants may receive breastmilk from a cytomegalovirus seropositive mother, while there are 
specific guidelines for preterm infants (AAP, 2012). 
 
Metabolic disorders 
The metabolic disorder classic galactosemia represents a condition where breastmilk is 
contraindicated, whereas children with phenylketonuria may alternate between modified 
formula and breastmilk (AAP, 2012). 
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There are a limited number of agents that are contraindicated in a nursing mother, and an 
appropriate substitute can usually be found. Every potential drug should however be carefully 
considered with respect to safety and balanced against the benefits to the infant. Specific 
literature exists on this topic (Hale, 2012). 
 
Alcohol, tobacco smoke and drugs 
Regarding use of alcohol, ingestion should be minimized and limited to an occasional intake, 
but not more than 0.5 g alcohol per kg bw, and the mother should not nurse until a minimum 
of two hours after intake. In Norway it is recommended to wait three hours after intake of 
maximum one unit alcohol (Helsedirektoratet, 2011). 
Maternal smoking is not  necessarily a contraindication to breastfeeding but should be 
discouraged because of its association with e.g. increased incidence of sudden infant death 
syndrome. If smoking is continued, it should be restricted to after the breastfeeding 
(Helsedirektoratet, 2011). 
Maternal substance abuse is not a categorical contraindication, but depends on the type of 
drug.  
 
 Summary of recommendations, prevalence, degree and duration of 2.5
breastfeeding 
The WHO and Norwegian health authorities recommend that infants are exclusively breastfed 
for 6 months with a total duration of at least two years and one year, respectively. This is a 
public health recommendation which should be adjusted in individual consultations. Only a 
minority of Norwegian mothers breastfeeds exclusively for 6 months. However, breastfeeding 
prevalence is higher in Norway than in most European countries, with 80% of the mothers 
breastfeeding when the child is 6 months and 46% when the child is 12-months old. At 4 and 
6 months of age 46% and 9% of infants are exclusively breastfed. This is a low rate compared 
with results from other European countries and is probably partly due to differences in the 
methodology used in the surveys. Mean breastmilk consumption in exclusively breastfed 
infants increases from 699 ml/day at age one month to 854 g/day at age 6 months. Breastmilk 
consumption in partially breastfed infants is approximately 675 g/day during the first 6 
months and 530 g/day in the next 6 months, demonstrating only minor differences between 
exclusively and partially breastfed infants. Published reviews on breastmilk consumption are 
largely based on studies using test-weighing methods. Results from some recent studies using 
the isotopic methods find somewhat higher breastmilk consumption both in exclusively and 
partially breastfed infants. There are a few conditions where breastfeeding is or may be 
contraindicated, among these are some infections, metabolic disorders and drug use. 
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 Breastmilk composition 3.1
The composition of breastmilk is not uniform. The concentration of many of its constituents 
changes during the lactation period and differ among individuals, also when samples are 
collected and analysed under controlled, defined conditions (Lawrence and Lawrence, 2010a).  
Breastmilk production can be divided into three phases that differ in the composition and 
volume of milk produced: colostrum (first to approximately seventh day postpartum), 
transitional milk (<14 days postpartum) and mature milk (14 days postpartum) (Lawrence 
and Lawrence, 2010a). Colostrum is the fluid secreted by the mammary gland immediately 
following parturition. During the colostral period, rapid changes occur in milk composition. 
The concentrations of fat and lactose increase while those of protein and minerals decrease. 
Transitional and mature milk also exhibits variability, but to a much smaller extent than in 
early lactation (IOM, 1991).  
Breastmilk composition can also vary during the day and from the beginning to the end of a 
feeding. This is most pronounced for fat; the fat concentration in the hindmilk (the breastmilk 
after several minutes of feeding) has been shown to be approximately 2-3 times that of the 
foremilk (the breastmilk at the onset of the feeding) (Saarela et al., 2005). Other factors which 
may influence breastmilk composition are breastfeeding routines (frequency of feeding), 
parity, age, maternal diet and other maternal characteristics (Prentice, 1996). The extent to 
which the maternal diet influences the nutrient concentrations in breastmilk varies between 
nutrients. The nutrients most affected by low maternal intakes and stores are the B vitamins 
thiamine and riboflavin, vitamin B6 and B12, vitamin A and iodine (Allen, 2005). The quantity 
of fat in breastmilk has not been shown to be influenced by maternal fat intake, but it has been 
shown repeatedly that the nature of the fat consumed by the mother will influence the fatty 
acid composition of the breastmilk (Lawrence and Lawrence, 2010a). 
Assessment of the composition of breastmilk is associated with methodological challenges 
both due to normal variation in the composition and to analytical challenges (IOM, 1991). To 
obtain accurate results, one must apply proper sampling, extraction, handling, and storage 
procedures as well as a sensitive and selective detection system. Large variations reported for 
many milk constituents may reflect improper sampling and/or analytic inaccuracies in 
addition to true biologic variance.  
 
 Estimating adequacy of nutrient intake in infants 3.2
An infant who is exclusively breastfed the first 6 months of life has been shown to have all 
nutritional needs covered, with the exception of vitamin D (Butte N. et al., 2002). The 
recommended daily intake for infants 0-6 months are for most nutrients equal to the actual 
intakes of the various nutrients of breastfed infants, as described in international 
recommendations (IOM, 2006). The mean nutrient intake data of healthy, full-term, 
exclusively breastfed infants is termed Adequate Intake (AI) which is derived by the 
following formula: mean intake of breastmilk multiplied by mean nutrient concentrations 
(Butte N. et al., 2002; IOM, 2006). The Nordic Nutrition Recommendations (NNR) from 
2012 (NNR Project Group, 2013) recommend exclusive breastfeeding the first 6 months, and 
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therefore do not provide specific nutrient recommendations for infants below 6 months. NNR 
2012 states: “recommendations for single nutrients are not given for infants <6 months. If 
breastfeeding is not possible, infant formula formulated to serve as the only food for infants 
should be given (…). If complementary feeding has started at 4-5 months, the recommended 
intakes for 6 to 11-month old infants should be used”. Estimated nutrient needs for infants 7 
to 11 months of age are usually determined by extrapolating from the intake measures of the 
first 6 months. New Norwegian recommendations for infant nutrition are currently under 
preparation. 
 
 Nutrient concentrations in breastmilk 3.3
The concentrations of nutrients in breastmilk presented here are mainly based on NNR (NNR 
Project Group, 2013) and the US Institute of Medicine’s (IOM) “Nutrition during lactation” 
(IOM, 1991). The same figures from IOM were also used in the more recent book 
“Breastfeeding – a guide for the medical profession” (Lawrence and Lawrence, 2010a). 
Although the data for breastmilk nutrient concentrations stem from relatively old research, it 
was out of the scope for the present report to update the figures through a systematic literature 
review.  
Breastfed infants have a special capacity to self-regulate milk intake. Thus, the total intake of 
each nutrient is difficult to assess. In the following section selected nutrients are presented 
with their main physiological function, followed by concentrations and factors influencing the 
concentrations in breastmilk and the recommended intake of the nutrients for infants in 
Norway. The nutritional status of infants in Norway is mentioned for those nutrients where 
such information exists.  
Tables 3.1-3.3 give an overview of the estimated nutrient concentrations per liter breastmilk. 
 
Table 3.1: Estimates of the concentration of macronutrients in mature breastmilk1 and daily 
recommended intake for infants2.  
    Nutrient Amount in breastmilk,  
per L, ± SD3 
Daily recommended intakes  
(6-11 months) 
Energy, kJ3  
             Kcal 
28873 
690 
See Table 3.4 
Protein, g4 7-84 7-15% of total energy intake  
Fat, g 






18:2, n-6 linoleic 
18:3, n-3 linolenic 
C20 and C22 polyunsaturated
 










30-45% of total energy intake 
Lactose, g 72.0 ± 2.50 45-60% of total energy intake 
1Data from Institute of Medicine, unless otherwise indicated. Bold indicate that the nutrient is described in the text (IOM, 
1991). 
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2Data from Nordic Nutrient Recommendations (NNR Project Group, 2013). 
3SD=standard deviation. 
3Data from Butte et al. 2002. Values were given in kJ/g, and are converted by using a density of milk of 1.03 g/ml. Standard 
deviation not reported; range 2678-206 kJ/L and 639-824 kcal/L. 
4Data from Lonnerdal, 2003. 
5Data from Lawrence & Lawrence, 2010, Table A-1. 
 
 
Table 3.2: Estimates of the concentration of vitamins in mature breastmilk1 and daily recommended 
intake for infants 6-11 months of age2.  
    Nutrient Amount in  
breastmilk, 
per L, ± SD3 
Daily recommended 
intakes 6-11 months 
of age 
Vitamin A, RE4, µg 450-6005 300 
Vitamin D, µg 0.55 ± 0.10 10 
Vitamin E, -TE6  2.3 ± 1.0 3  
Vitamin K, µg 2.1 ± 0.1 - 
Thiamin, mg  0.21 ± 0.04 0.4 
Riboflavin, mg  0.35 ± 0.03 0.5 
Niacin, NE7  1.50 ± 0.20 5 
Vitamin B6, mg  93 ± 8 0.4 
Folate, µg 85 ± 37 50 
Vitamin B12, µg 0.42
8 0.5 
Biotin, µg 4 ± 1 n.a. 
Pantothenic acid, mg  1.80 ± 0.20 n.a. 
Vitamin C, mg  40 ± 10 20 
1Data from Institute of Medicine unless otherwise indicated (IOM, 1991).  
2Data from Nordic Nutrient Recommendations (NNR Project Group, 2013).  
3SD=standard deviation. 
4RE, retinol equivalents; 1RE=1 µg retinol=12 µg -carotene. 
5Data from Nordic Nutrient Recommendations (NNR Project Group, 2013). Standard deviation not reported. 
6 -TE, -tocopherol equivalents; 1 -TE=1 mg RRR a-tocopherol. 
7NE, niacin equivalents; 1 NE=1 mg niacin=60 mg tryptophan. 
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Table 3.3: Estimates of the concentration of minerals and trace elements in mature breastmilk1 and daily 
recommended intake for infants 6-11 months of age2.  
    Nutrient Amount in breastmilk, 




months of age 
Calcium, mg  280 ± 26 540 
Phosphorus, mg  140 ± 22 420 
Magnesium, mg  35 ± 2 80 
Sodium, mg  180 ± 40 n.a. 
Potassium, mg  525 ± 35 1100 
Chloride, mg  420 ± 60 n.a. 
Iron, mg  0.3 ± 0.1 8 
Zinc, mg  1.2 ± 0.2 5 
Selenium, µg 20 ± 5 15 
Iodine, µg 110 ± 40 50 
Copper, mg  0.25 ± 0.03 0.3 
Manganese, µg  6 ± 2 0.08 
Fluoride, µg 16 ± 5 n.a. 
1Data from Institute of Medicine (IOM, 1991). 





Energy in the diet is used for basal metabolism, growth and physical activity. The energy 
content in breastmilk has been reported to be in the range of 639 to 824 kcal/L, and Butte et 
al. used a value of 690 in their report from 2002 (Butte N. et al., 2002).  
Proteins, carbohydrates and lipids are the sources of energy in breastmilk. Protein and 
carbohydrate concentration change with duration of lactation but they are relatively stable 
between women at any given stage of lactation (Butte N. et al., 2002). Lipid concentrations 
may vary to a greater extent between both individual women and populations, which accounts 
for the variation observed in the energy content in breastmilk (Butte N. et al., 2002).  
The NNR estimated energy requirement (EER) for infants is based on infants’ energy 
consumption assessed by the double-labelled water method (Table 3.4) (NNR Project Group, 
2013). The Norwegian Directorate for Health points out, however, that the reference values 
for energy intake have no practical meaning for breastfeeding infants who are following a 
normal growth curve (Norwegian Directorate for Health, 2001).  
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Table 3.4: Reference values for estimated average daily energy requirements for infants 6-12 months of 
age assuming partial breastfeeding (NNR Project Group, 2013). 
Age, 
months 
Average daily energy  
requirements kJ/kg body weigh 
 Boys Girls 
6 339 342 
12 337 333 
 
 
3.3.2 Protein  
The protein constituents of breastmilk serve diverse functions. Besides providing essential 
amino acids for growth, they provide protective factors (e.g. immunoglobulins, lysosomes and 
lactoferrin), they are carriers of vitamins and minerals (e.g. folate, vitamin D, vitamin B12 and 
iron-binding proteins) and of hormones (e.g. thyroxin and corticosteroid-binding proteins), 
and they entail enzymatic activity (e.g. amylase and bile-salt stimulated lipase) and growth 
factors (e.g. insulin-like growth factor, epidermal growth factor, and prolactin) (Lonnerdal, 
2003; Picciano, 2001). Breastmilk protein concentration is high early in the lactation period 
(14-16 g/L), and decreases to 8-10 g/L at 3-4 months of lactation and 7-8 g/L at 6 months and 
later (Lonnerdal, 2003). About 25% of the nitrogen in human milk is non-protein nitrogen 
(NPN) compared with only 5% NPN in bovine milk (Lawrence and Lawrence, 2010b). The 
concentration of protein in human milk is lower than in most other animal milks, which 
ranges from about 32 g/L (cow’s milk) to about 114 g/L (polar bear’s milk), perhaps 
reflecting the lower growth rates in humans compared with other mammals (Helsing and 
Heggkvist, 2008). 
Recommended protein intake in infants is based on the factorial method. The calculation is 
based on estimates of the need for maintenance and growth, the efficiency of conversion from 
dietary protein to body protein and intra-individual variation in growth (NNR Project Group, 
2013). The NNR does not provide recommendations for protein intake in infants the first 6 
months. It is stated that the infant’s protein requirement will be covered when adequate 
breastmilk (in terms of energy) is provided (NNR Project Group, 2013). For infants 6-11 
months, the NNR estimates that 1.1 g protein/kg body weight is adequate.  
 
3.3.3 Fats 
Fats are among the most variable constituents in breastmilk. The breastmilk fatty acids are 
crucial not only for energy to support growth but also for the synthesis and development of 
retinal and neural tissues (Picciano, 2001). The polyunsaturated fatty acids (PUFA) linoleic 
acid (LA) (18:2 n-6) and -linolenic acid (ALA) (18:3 n-3) are essential fatty acids that 
cannot be synthesised in the human body and must be consumed as part of the diet. The n-6 
and n-3 fatty acids represent each their PUFA “family” which can be desaturated and 
elongated. Infants have a reduced capacity to transform n-3 fatty acid to docosahexaenoic acid 
(DHA) (22:6 n-3) and n-6 fatty acids to arachidonic acid (AA) (20:4 n-6). These are of special 
importance for infant development and are present in breastmilk (Aggett et al., 1991). 
The total fat concentration in breastmilk varies from 30 to 70 g/L and the corresponding 
energy contribution is approximately 45% to 55% of total energy intake (Michaelsen, Larsen 
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et al., 1994; Picciano, 2001). However, some studies indicate that the variation might be even 
larger, depending on a variety of different parameters as illustrated in Figure 3.1. There are 




Figure 3.1: Some parameters that may influence the fat concentration measured in breastmilk: aHigher 
fat content during day/evening compared with morning/night (Kent et al., 2006), bmother’s body fat 
(Nommsen et al., 1991), cfat concentration positively associated with pregnancy weight gain (Michaelsen, 
Larsen et al., 1994) (see also Figure 3.2) and dgreater energy content in milk of male infant mothers (Powe 
et al., 2010), and egestational age (Molto-Puigmarti et al., 2011). 
 
As an example, in a study by Michaelsen et al. the fat concentration at 5 months varied 
between 20 g/L and 70 g/L, and at 4 months the variability was significantly associated with 
maternal weight gain during pregnancy (Figure 3.2). The median fat concentration, however, 
was 39 g/L and is hence at the same level as reported by others (Michaelsen, Larsen et al., 
1994).  
In the Norwegian Human Milk Study (HUMIS) mean and median fat concentration in 
breastmilk samples was 34g/L15 (n=295) (Polder et al., 2009). This is also in accordance with 
the EFSA opinion on PBDEs in food (EFSA, 2011c). 
 
 
Figure 3.2: Fat concentration in human milk in relation to time after delivery in three groups of mothers 
with different weight gain during pregnancy: low (<11.2 kg), medium or high (>16.8 kg). Error bars 
indicate ± SEM. The association between weight gain and fat concentration in the milk was significant at 4 
months only. Source: Michaelsen et al., 1994. 
 
                                                 
15Calculated from the value of 3.5 g fat/100 g breastmilk which was given in the reference, using a conversion 
factor of 1.03 g milk per ml. 
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It has also been documented that the percent of maternal body fat seems to be a determinant 
for the fat concentration in breastmilk. A study from the USA showed that milk fat 
concentration was positively correlated with maternal skinfold thickness in late lactation (6-
12 months), but not in the early lactation period (Nommsen et al., 1991). 
The hindmilk secreted towards the end of a feed contains more fat than that of the foremilk. 
This seems to be due to the fact that number of fat containing droplets (milk fat globules) 
increase as the feed progresses (Mizuno et al., 2009). 
The fatty acids in breastmilk may originate either from recent dietary fatty acid intake, from 
fatty acids released from maternal adipose tissue or from de novo synthesis or further 
metabolism of dietary fatty acids in the maternal liver (Innis, 2007). While the maternal diet 
has little impact on the total amount of fat in breastmilk, the levels of the various unsaturated 
fatty acids are to a certain extent dependent on the maternal diet (Innis, 2007). The levels of 
populations, and they are readily changed by the maternal dietary intake of the respective fatty 
acids (Innis, 2007). The role of DHA in the infant diet has received particular attention 
because of its critical roles in the development of the visual and neural systems (Innis, 2007). 
A range of 0.1-1.0 g DHA/100 g milk has been documented across various population groups 
with varying intakes of fish and fish oils, which are the main sources of DHA (Innis, 2007).  
NNR does not give recommendations for fat intake for infants under 6 months of age, when 
exclusive breastfeeding is recommended. For infants 6-11 months, it is recommended that the 
proportion of total fat should contribute to between 30 and 45% of the total energy intake 
(NNR Project Group, 2013). NNR further recommend that the total amount of PUFA should 
constitute 5-10% of the total energy intake, including at least 1% of the energy from n-3 fatty 
acids. The optimal ratio of n-6/n-3 fatty acids is not known for the various age groups.  
 
3.3.4 Carbohydrates  
The principal carbohydrate in breastmilk is lactose, which is an important source of energy. 
The concentration is about 72 g/L, which is more than in most other mammal milks (IOM, 
1991). Lactose is one of the most stable constituents of breastmilk, with most of the 
variability caused by maternal individuality (Picciano, 2001). The concentration of unbound 
oligosaccharides in breastmilk is 0.5-1.0 g per 100 g (Bode, 2006). 
NNR states that a minimum of 130 g glycaemic carbohydrates per day will cover the needs 
for glucose for the brain and avoid ketosis, and thus gives this as an average requirement for 
glycaemic carbohydrates (NNR Project Group, 2013).  
 
3.3.5 Vitamins and minerals  
With the exception of vitamin D, breastmilk normally contains sufficient vitamins for an 
infant, unless the mother herself is deficient (Butte N. et al., 2002). The infant needs exposure 
to sunlight to generate endogenous vitamin D, otherwise, a supplement is necessary to ensure 
adequate vitamin D status (NNR Project Group, 2013). Fat-soluble vitamins are generally 
transported into the breastmilk as part of the fat fraction, and the breastmilk concentration of 
these compounds are not easily affected by changes in the maternal diet (Lawrence and 
Lawrence, 2010b). Water-soluble vitamins move with ease from serum to milk, thus their 
dietary fluctuation is more apparent (Lawrence and Lawrence, 2010a). Most levels of 
minerals in breastmilk are not influenced by maternal intake, the exceptions being iodine and 
selenium (IOM, 1991).  
n-6 and n-3, particularly LA, ALA and DHA in breastmilk vary widely within and among 
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3.3.5.1 Fat-soluble vitamins 
Vitamin A 
Vitamin A is a generic term for a group of compounds possessing the biological activity of 
retinol. The term includes retinol, retinal, retinyl esters, retinoic acid and substances 
considered to be pro-vitamin A because they can be transformed into retinol (expressed as 
retinol equivalents (RE))16 (NNR Project Group, 2013). Among the pro-vitamin A 
compounds, -carotene has the highest potential vitamin A activity. Vitamin A is involved in 
a variety of functions such as vision, maintenance of epithelial surfaces, immune competence, 
growth, development and reproduction. Inadequate intake of vitamin A may lead to reduced 
immune function, blindness and increased risk of death (NNR Project Group, 2013). Vitamin 
A intake above the recommended intake has been associated with embryonic malformations, 
reduced bone mineral density and increased risk of hip fracture (NNR Project Group, 2013).  
The vitamin A concentration in breastmilk in developed countries is 450-600 RE/L (NNR 
Project Group, 2013). The concentration is influenced by the maternal nutritional status. NNR 
does not provide recommendations for vitamin A intake for infants but states that the average 
intake (based on an estimated daily consumption of 0.75 L breastmilk per day) will 
correspond to 350-450 RE/day (NNR Project Group, 2013). Recommended intake for infants 
6-11 months is 300 RE/day (NNR Project Group, 2013). High intake of retinol may cause 
negative health effects, but it is unlikely that breastmilk concentrations reach toxic levels due 
to high vitamin A intake by the mother (Allen and Haskell, 2002). The Scientific Committee 
for Food (SCF) has established a tolerable upper intake level (UL) for vitamin A at 800 µg 
RE for 1 to 3-year old children (SCF, 2002). 
 
Vitamin D 
Vitamin D is a steroid-like molecule that exists in two forms: vitamin D3 (cholecalciferol) 
synthesised in the skin and vitamin D2 (ergocalciferol) found in yeast. Factors affecting 
formation of vitamin D from sunlight exposure include the amount of skin pigmentation, age, 
season, degree of pollution and latitude. Dietary sources are fish, fish oils, vitamin D-
containing supplements and fortified foods. Either form of vitamin D is taken up by the liver 
and hydroxylated to 25-hydroxyvitamin D (25-OH-D), which is commonly used for assessing 
vitamin D status. 25-OH-D is further converted into the physiologically active form 1,25-
dihydroxyvitamin D in the kidney. This hormone is necessary for ensuring that the 
concentration of calcium and phosphate in plasma is kept within narrow limits, through 
regulating calcium absorption in the intestine and by stimulating release of calcium from 
bone. Vitamin D is thus essential for a normal bone metabolism (NNR Project Group, 2013). 
The vitamin probably also plays a role in cell differentiation. Inadequate sun exposure or 
vitamin D intake may lead to rickets in children and osteomalacia (soft bones) in adults. It has 
been hypothesised that vitamin D deficiency may play a role in the development of several 
chronic conditions (Nasjonalt råd for ernæring, 2006). 
A systematic literature review conducted by NNR concluded that there is convincing evidence 
that combined supplementation with vitamin D and calcium in adults is associated with 
reduced total mortality (NNR Project Group, 2013). The literature review further found 
suggestive evidence for an inverse association between vitamin D and some types of cancer 
(colorectal and breast cancer), and probable evidence for an inverse association between 
vitamin D status and increased coronary vascular disease risk (NNR 2012). The evidence for 
                                                 
161 retinol equivalent=1 µg retinol. 
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an association between vitamin D and type 1 and type 2-diabetes is limited and inconclusive 
(NNR Project Group, 2013).  
Breastmilk contains very low concentrations of vitamin D (assessed as 25-OH-D) (0.1 to 1.0 
µg/L) (Picciano, 2001). This is not sufficient to prevent rickets even if the mother takes a 
vitamin D supplement (NNR Project Group, 2013). Newborns have a store of vitamin D 
which depends on the mother’s vitamin D status. However, infants born in countries at high 
latitudes, or in places where sun exposure is restricted for cultural or other reasons, are likely 
to be born with low vitamin D stores due to low maternal vitamin D status. During the first 6 
weeks of life there is a rapid fall of serum 25-OH-D concentrations, to a range where there is 
a high risk of developing rickets (NNR Project Group, 2013). 
To ensure adequate levels of vitamin D, NNR recommends that all infants from the first 
weeks of age receive a supplement of 10 µg/day (NNR Project Group, 2013). 
According to Spedkost 2006-2007, 80% of the 6-month old infants were given vitamin D 
supplements, whereas this was the case for 67% of the 12-months old (Øverby et al., 2008; 
Øverby et al., 2009). A study from Oslo found that most of the ethically Norwegian 1-year 
old infants had adequate vitamin D status. Among breastfed infants, 34% had low serum 
levels of vitamin D (serum 25-OH-D levels <50 nmol/L) and among those not receiving 
breastmilk, 20% had low levels (Holvik et al., 2008). Madar et al. found that 47% of 6-weeks 
old infants living in Norway with mothers born in Pakistan, Turkey or Somalia, had sub-
optimal vitamin D status (serum 25-OH-D <25 nmol/L) (Madar et al., 2009). Exclusively 
breastfed infants with no supplements had lowest vitamin D status, with an average 25-OH-D 
level of only 11 nmol/L. Breastfed infants who also received vitamin D supplements had an 
average level of 33.5 nmol/L 25-OH-D. The infants who received infant formula in addition 
to breastmilk, had an average level of 64.5 nmol/L 25-OH-D (Madar et al., 2009). 
 
Vitamin E 
Vitamin E is a generic term for four tocopherols and four tocotrienols, however, alpha-
tocopherol is the only form which is recognised to meet human requirements (NNR Project 
Group, 2013). The main biological function of alpha-tocopherol has been suggested to be its 
antioxidant activity. In addition, several other important biological functions, including 
modulation of cell signalling and gene expression, are ascribed to vitamin E (NNR Project 
Group, 2013). Approximately 83% of the total vitamin E in breastmilk is present as -
tocopherol. One -tocopherol equivalent (-TE) equals 1 mg -tocopherol. The concentration 
of tocopherols, which is high in colostrum (8 mg/L) decreases and stabilises in mature 
breastmilk (2-4 mg/L) (IOM, 1991). The NNR for tocopherol intake for infants is based on 
the relationship to the intake of PUFA and is set at a rate of at least 0.6 -TE/g total PUFA 




Vitamin K is a group of fat-soluble vitamins which are essential for the modification of 
certain proteins, in particular proteins that are required for blood coagulation and bone 
metabolism. Maternal dietary intake has little influence on the breastmilk vitamin K 
concentration. The breastmilk concentration of vitamin K ranges from 0.85 to 9.2 µg/L (IOM, 
1991). Based on this, NNR gives a recommended intake to infants at about 2 µg/kg bw/day 
(NNR Project Group, 2013).  
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3.3.5.2 Water-soluble vitamins 
Thiamine 
Thiamine (vitamin B1) functions as a coenzyme in the metabolism of carbohydrates and 
proteins. There are large variations in the thiamine concentration in breastmilk between 
individuals and over the lactation period (IOM, 1991). Thiamine in breastmilk reflects the 
maternal intake, but seems to reach a plateau (Lawrence and Lawrence, 2010b). The average 
concentration in mature milk has been estimated to 0.2 mg/L (IOM, 1991). Recommended 
thiamine intake is given in relation to the energy intake, and is set to 0.10 mg/MJ for infants 
under 12 months (NNR Project Group, 2013).  
 
Riboflavin 
Riboflavin (vitamin B2) is a central component of the cofactors flavin adenine dinucleotide 
(FAD) and flavin mononucleotide (FMN), which plays a key role in metabolism of energy, 
fat, carbohydrates and proteins. The riboflavin concentration in breastmilk is largely a 
reflection of the maternal diet and is about 0.35 mg/L in mature milk (IOM, 1991). 
Recommended riboflavin intake is also related to total energy intake, and is set to 0.14 mg/MJ 
(NNR Project Group, 2013).  
 
Niacin  
Niacin (also called vitamin B3), in the form of the coenzymes nicotinamide adenine 
dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP), participates 
in many biological redox reactions related to metabolism of energy, fats, carbohydrates and 
proteins. The niacin concentration in breastmilk is largely dependent on maternal intake, with 
an estimated average level at 1.5 mg/L (IOM, 1991). The recommended intake for infants and 
children above 6 months is 1.6 NE17/MJ (NNR Project Group, 2013).  
 
Pyridoxine 
Pyridoxine (vitamin B6) functions as a coenzyme in the metabolism of fat, carbohydrates and 
proteins. The vitamin B6 concentration in breastmilk varies with maternal B6 status and intake, 
and besides vitamin D, it is the vitamin which is most likely to be deficient in the breastmilk 
(Lawrence and Lawrence, 2010b). In infants, vitamin B6 deficiency may adversely influence 
growth (Butte N. et al., 2002). In well-nourished populations, breastmilk appears to maintain 
normal vitamin B6 status in most exclusively breastfed infants during the first 6 months of 
age. The risk of vitamin B6 inadequacy increases beyond 6 months (Butte N. et al., 2002). 
Breastmilk vitamin B6 concentration is on average 93 mg/L in mature milk (IOM, 1991). The 




Folate (also known as vitamin B9) is essential for the production and maintenance of new 
cells and for DNA and RNA synthesis. It is especially important during periods of rapid cell 
                                                 
17NE, niacin equivalents; 1 NE=1 mg niacin=60 mg tryptophan.  
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division and growth, and is essential for production of normal red blood cells and to prevent 
anaemia. The folate concentration in breastmilk is relatively independent of maternal folate 
status (Picciano, 2001). A longitudinal study in Norwegian infants (84% breastfed at 6 
months), showed increasing concentrations of serum folate from birth up to 6 months of age, 
with higher values than reported in older children or adults (Hay et al., 2008). At 6 months of 
age, serum folate was similar in the breastfed and the non-breastfed group, but exclusively 
breastfed infants had the highest concentrations, and serum folate was positively associated 
with exclusive breastfeeding. Between 6-24 months of age, the serum folate levels declined, 
probably due to the introduction of complementary foods. The authors concluded that their 
results support the view that exclusive breastfeeding for 6 months maintains adequate folate 
nutrition. The average breastmilk concentration of folate is about 85 µg/L (IOM, 1991). The 




Vitamin B12 plays a key role in normal functioning of the brain and nervous system and in the 
formation of blood. Vitamin B12 is also involved in DNA synthesis and regulation and fatty 
acid synthesis. The concentration of vitamin B12 in breastmilk from well-nourished mothers is 
about 0.4 µg/L (IOM, 1998). Severe vitamin B12 deficiency has been reported in infants 
nursed by mothers who were strict vegetarians (vegans), and evidence suggests that vitamin 
B12 deficiency early in infancy may cause lasting neurodisability (Picciano, 2001). The 
longitudinal study reported in the folate section also assessed vitamin B12 status (Hay et al., 
2008). They found that vitamin B12 status in breastfed infants declined from birth to 6 months, 
and thereafter increased. Breastfed infants had lower B12-status than non-breastfed infants. 
The authors concluded that low vitamin B12 status is a normal finding in breastfed infants and 
that further studies are required to determine the mechanisms for this finding (Hay et al., 
2008). The Nordic recommendation for infants’ vitamin B12 intake is 0.05 µg/kg bw/day 
(NNR Project Group, 2013). 
 
Vitamin C 
Vitamin C, or ascorbic acid, is an antioxidant and a cofactor in several enzymatic reactions, 
including several collagen synthesis reactions. The average vitamin C concentration in 
breastmilk is about 30 mg/L (IOM, 1991). It has been reported that the vitamin C 
concentration in mature breastmilk levels off at 50-60 mg/L if daily maternal intake is equal 
to or exceeds 100 mg. When maternal vitamin C intake is relatively low, increases in intake 
are associated with increased breastmilk concentrations (IOM, 1991). NNR recommends a 





Adequate calcium intake is important for normal bone mineralisation. The calcium 
concentration in breastmilk is on average 280 mg/L (IOM, 1991). The concentration is fairly 
constant during lactation and is not influenced by maternal diet (Butte N. et al., 2002). NNR 
recommend an intake of calcium of 540 mg/day for infants 6-11 months (NNR Project Group, 
2013). 
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Iron is a component in a number of proteins, including enzymes involved in energy 
metabolism and immune functions, and haemoglobin. The concentration of iron in breastmilk 
decreases rapidly in early lactation and stabilises in mature milk at around 0.3 mg/L (IOM, 
1991; Picciano, 2001). The iron concentration in breastmilk is unaffected by maternal iron 
status or diet (Butte N. et al., 2002). Iron deficiency is a main cause of anaemia. Iron 
deficiency anaemia in 6-24 months infants has been related to poorer cognitive and 
neuropsychological development (Lozoff, 2007). Iron deficiency anaemia is relatively 
common in Norwegian infants, with one study showing a prevalence of 10% among 12-month 
old children (iron deficiency anaemia defined as Hb <110 g/L in combination with ferritin 
<15 µg/L) (Hay et al., 2004).  
The iron concentration in breastmilk is relatively low, and although the bioavailability and 
absorption is high, it is insufficient to meet the infant’s requirements (Picciano, 2001). 
Normal weight, full-term infants are born with a body iron store sufficient to supply their 
needs for approximately 6 months (Butte N. et al., 2002). Thereafter, additional iron from 
complementary foods or supplements is needed to avoid iron deficiency (Butte N. et al., 
2002). The time between delivery and cutting the cord from the placenta has significant 
impact on the newborn’s blood volume and thereby the newborn’s iron stores (McDonald and 
Middleton, 2008). 
NNR does not provide recommendations for iron intake for infants less than 6 months, but 
states that breastmilk and infant formulas have been shown to cover the nutritional need for 
iron. NNR’s recommendation for infants 6-11 months is 8 mg iron per day. As the iron 
concentration in cow’s milk is low, it is recommended to use infant formula instead of cow’s 
milk up to 12 months.  
 
Zinc 
Zinc is a component in a number of enzymes which take part in the maintenance of the 
structural integrity of proteins and in the regulation of gene expression. The concentration of 
zinc in breastmilk declines from 4-5 mg/L in early lactation to 1-2 mg/L 3 months postpartum 
and to about 0.5 mg/L at 6 months (Butte N. et al., 2002). The average concentration is 
estimated to be 1.2 mg/L (IOM, 1991).  
Zinc concentrations in breastmilk are only marginally influenced by maternal zinc intake or 
status (Butte N. et al., 2002). The zinc concentration in breastmilk is insufficient to cover the 
infant’s requirement, and prenatal body stores contribute to adequate zinc status during the 
first 6 months (Butte N. et al., 2002). Zink deficiency is related to impaired growth and 
reduced immune function. No Norwegian studies on zinc status in infants have been 
identified, but a Danish study showed that mean serum zinc concentration did not change 
significantly between two and 6 months, however, serum zinc concentrations then fell 
significantly between 6 and 9 months (Michaelsen, Samuelson et al., 1994). NNR’s 




Selenium is a component of selenoproteins, several of which are enzymes with antioxidant 
functions. The selenium concentration in breastmilk is high in early lactation and decreases as 
lactation progresses, and reflects maternal selenium intake (IOM, 1991). Mean values in 
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mature milk (10 to 30 µg/L) differ geographically both within and between countries (IOM, 
1991). Breastmilk selenium concentration is positively correlated with the infant’s plasma 
concentration and the selenium-containing enzyme glutathione peroxidase (Picciano, 2001).  
NNR’s recommendation for selenium intake is 15 µg/day for infants 6-11 months (NNR 
Project Group, 2013).  
 
Iodine 
Iodine is an essential component of the thyroid hormones which are involved in the regulation 
of various enzymes and metabolic processes that control growth and nervous system 
development. Severe iodine deficiency during fetal development and early childhood is 
associated with physical and cognitive impairment (Melse-Boonstra and Jaiswal, 2010). 
Concentrations of iodine in breastmilk correlate directly with maternal intakes, with an 
estimated average concentration of 110 µg/L (IOM, 1991). Results from the Norwegian 
Mother and Child Cohort Study showed that among pregnant women who were not taking 
iodine containing supplements, 80% had an intake below the daily recommended intake 
(Haugen et al., 2008). A validation study among pregnant women showed that among those 
not taking iodine supplement,median urinary iodine excretion was only 110 µg/24 hours 
(Brantsaeter et al., 2007). Median urinary iodine excretion in pregnant women below 150 
µg/day is regarded as insufficient (WHO et al., 2007). The iodine status of Norwegian infants 
has not yet been studied. NNR’s recommendation for iodine intake is 50 µg/day for infants 6-
11 months (NNR Project Group, 2013).  
 
 Immunological components in breastmilk 3.4
Knowledge about the immunological properties of mammalian milk can be traced back to 
1892, when Paul Ehrlich showed that newborn mice were protected against the toxic effects 
of phytotoxins if they were fed milk from an immunised mouse (Ehrlich, 1892). Almost 80 
years ago, Grulee et al. published a study on the morbidity and mortality of 20 000 infants, 
showing that infants who received breastmilk substitute had significantly higher risk of 
infections (respiratory, gastrointestinal or unclassified) as well as higher mortality rates than 
exclusively or partially breastfed children (Grulee et al., 1935).  
Numerous studies over the last decades have contributed to our present knowledge of the 
immunological potential of breastmilk. The active components not only possess innate and 
adaptive defence properties, but may also aid the nursed infant’s immune development, 
including generation of immunological tolerance with appropriately controlled inflammatory 
reactions. Together, such immunoregulatory properties may explain some of the long-term 
beneficial health effects observed in breastfed children.  
Breastmilk can be regarded as a communication vehicle between the maternal immune system 
and the infant, actively instructing the newborn’s immune and metabolic systems as well as 
the establishing of a beneficial commensal microbiota, while at the same time conferring 
multiple means of protection from pathogens (Field, 2005). Among such bioactive 
constituents are anti-microbial components, factors with anti-inflammatory properties, 
substances important for the active maturation of the infant’s own immune system and factors 
promoting immunological tolerance (see Figure 3.3).  
All these components depend on the mamamalian species, both in terms of concentration and 
characteristics that are determined by the genetic and environmental impact. For instance, the 
concentration of the anti-microbial protein lactoferrin is approximately 10 times higher in 
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human milk than in cow's milk (Fox and McSweeney, 1998; Goedhart and Bindels, 1994; 
Miranda et al., 2004). Similarly, there are striking species differences in milk lipids, both with 
regard to concentrations and the content of fatty acids in triglycerides (Devle et al., 2012). 
Likewise, the oligosaccharides in human milk differ from those in animal milk (Jenness, 
1979; Jensen, 1995; Miller et al., 2000). Also the membranes of milk fat globules show 





Figure 3.3: Main groups of selected bioactive components in breastmilk. 
 
3.4.1 Selected immunological breastmilk components 
Antibodies 
The antibody defence system provided by human milk is well characterised and is of major 
importance to prevent infectious diseases in the newborn and infant and guides the early 
establishment of a balanced mucosal microbiota. This system will be described in more detail 
than other immunological components of breastmilk because we have extensive knowledge 
about its cellular-molecular functions and because it is quite distinct for the human species 
and represents a unique immunological integration between mother and child. 
Antibodies are soluble proteins called immunoglobulins (Ig) because they are responsible for 
humoral immunity – that is, protection performed against antigens in blood and body fluids, 
including external secretions. Microbes and other foreign elements that can stimulate the 
immune system are collectively called antigens, and during the birth process the newborn 
begins to encounter such stimuli. Most of these immunological challenges take place at 
mucosal surfaces such as in the gut and airways. 
The immune system of the newborn is immature, and at birth it is not prepared to meet the 
contaminated external environment, including the mother’s vaginal and fecal microbiota. In 
humans, transplacental transfer of maternal antibodies confers systemic immune protection in 
blood and tissues over the first 2 to 3 months of life. However, these antibodies are of the 
immunoglobulin G (IgG) class which provides a type of defence that is proinflammatory in 
that it may activate complement (an enzyme system) and various phagocytes. Such immune 
reactions require energy and may cause symptoms such as fever, pain and loss of appetite. 
Through breastmilk, the newborn is provided with another type of antibody that normally 
does not cause inflammation, namely immunoglobulin A (IgA) which is the predominant 


















Soluble CD14 and Toll-like 
receptors
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antibody class in human colostrum and mature milk as well as in other external secretions. 
Locally produced IgA antibodies are actively exported to mucosal surfaces and are then 
known as secretory IgA (SIgA). The epithelial “IgA pump” is driven by a receptor-mediated 
mechanism (Figure 3.4 and Box 1.) which also transports small amounts of immunoglobulin 
M (IgM) antibodies to the mucosal surface. SIgA is mainly responsible for a humoral 
protection process called immune exclusion – initiating a first line of defence which uses the 
exported antibodies to bind bacteria and other potentially harmful compounds at the mucosal 
surface. SIgA antibodies coat pathogens to prevent them from invading the mucosal wall, and 
they form foreign cell fragments or macromolecules to regulate their passage into the body. 
Newborn babies produce little or no SIgA during the first vulnerable months of life, so the 
only significant source of such antibodies during this period is breastmilk. Milk SIgA helps 
protect the gut and upper airways until the immune system of the infant has matured, and it is 
the most prominent and best studied bioactive component of human milk. In developed 
countries, the child’s ability to produce SIgA is quite variable, being completed between 1 
and 10 years of age. Infants in developing countries often establish secretory immunity much 
earlier, presumably because of greater exposure to immune-stimulating microbes.  
In addition to their action of binding up troublesome antigens, SIgA antibodies protect the gut 
and upper airway mucosae by enhancing the barrier function of the epithelial constituting the 
surface lining. Although the mucosae of breastfed infants usually matures during the first 
months of life, the epithelial barrier function remains inadequate in some children for several 
years, and incomplete secretory immunity contributes to this delay.  
Immune cells are diffusely woven into the fabric of the gut mucosae (lamina propria) rather 
than being restricted to one place, but there are also discrete structures for immune 
surveillance. Between the tiny villi that cover most of the intestinal tract are swollen domes 
called Peyer’s patches. These regions, part of a larger system of gut-associated lymphoid 
tissue, or GALT, are covered by an epithelial-cell layer containing specialised M cells (the M 
stands for membrane or microfold) that constantly scan the stream of passing antigens in the 
gut lumen and transport them to the principal cell types of the immune system - B cells (from 
the bone marrow), T cells (from the thymus) and antigen-presenting cells (APCs) such as 
macrophages and dendritic cells. It is mainly in the GALT structures that mucosal immunity 
is induced and regulated.  
What follows the identification of an antigen is a complicated ballet of cells, secreted 
molecular signals and migration of immune cells from one compartment of the body to 
another. The keys to the system are the APCs, the “decision makers” in the immune system. 
APCs process chunks of antigen brought in by M cells and then show the pieces, along with a 
selection of co-stimulatory signals, to so-called naïve (unexperienced) T cells, which have 
never met their cognate antigens before. Those specific T cells whose antigen receptors match 
one of the antigen pieces become primed or activated; they then release cytokines (hormone-
like regulatory proteins) and growth factors that instruct B cells to proliferate, differentiate 
and become prepared for producing specialised mucosal IgA. 
Activated T and B cells migrate from GALT structures to nearby lymph nodes (from the gut 
wall, to mesenteric lymph nodes) where they receive additional biological signals; most of 
those cells then enter the bloodstream (Box 1, Fig. 3.4). Many such cells will migrate 
(“home”) to the lamina propria of the gut, but some also to the mammary glands of lactating 
mothers through a kind of chemical navigation system. This is the cellular-molecular basis for 
the immunological integration between mother and child. 
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At the secretory effector sites, depending on what sort of molecular “second signals” the B 
cells receive, they may undergo one last, or terminal, differentiation to become plasma cells, 
which produce antibodies in large quantity (about 10,000 molecules per second). However, 
very few B cells with IgA-producing capacity circulate in the blood of newborns, although 
this number is approximately 75 times higher after the first month of life, a period of 
continuous stimulation of GALT by microbial and other exogenous antigens.  
One lactating mammary gland has on average the same antibody-producing capacity as one 
meter of adult intestine, and the large storage capacity for locally produced IgA in the 
mammary gland stroma, secretory epithelium and ducts explains the remarkable output of 
SIgA during feeding (Brandtzaeg, 1983). As illustrated in Fig 3.4, the breastfed child is 
supplied with maternal SIgA antibodies highly targeted against infectious agents (bacteria, 
viruses and fungi) and other exogenous antigens stimulating the mother’s mucosae-associated 
lymphoid tissue (GALT and nasopharynx-associated lymphoid tissue, NALT), and 
comparable antigens are likely to be encountered by the infant (Brandtzaeg, 2003). 
Interestingly, the reactivity of SIgA antibodies may, in addition, reflect pathogens that the 
mother has been exposed to earlier in life. 
SIgA is a remarkably stable antibody, being far more resistant to degradation by proteolytic 
enzymes than IgG antibodies which predominate in blood. Breastmilk SIgA concentrations 
are highest in colostrum and decrease in mature milk. Concentrations are particularly high in 
the breastmilk of mothers whose infants were born preterm. These phenomena illustrate how 
the composition of breastmilk varies over the course of lactation to meet the demands of the 
growing infant (Gross et al., 1981). The systemic humoral immunity of the newborn is well 
taken care of by the placental transfer of maternal IgG antibodies. However, these are 
catabolised at the same time as the maturation of the newborn’s immune system develops 
gradually. Around 2-3 months of age, therefore, the systemic IgG antibody concentration of 
the baby is particularly low, highlighting the importance of a continuous supply of maternal 
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Figure 3.4: The enteromammaric and nasopharynx-mammaric links of activated antibody-producing 
cells. The figure illustrates the integration of mucosal immunity between mother and the newborn, with 
emphasis on migration of effector B cells (labelled B) from gut-associated lymphoid tissue, or GALT, via 
lymph and peripheral blood to the lactating mammary gland. Such distribution (arrows) beyond the gut 
of precursor B cells for local IgA-producing plasma cells is crucial to obtain export into breastmilk of 
secretory IgA (SIgA) (and smaller amounts of SIgM, not depicted) antibodies specific for enteric (and also 
airway) antigens; i.e. microorganisms and exogenous proteins stimulating GALT (and also nasopharynx-
associated lymphoid tissue, or NALT). By this mechanism, the breastfed infant will receive relevant 
secretory antibodies directed against, for instance, the microorganism colonising its mucosae (reflecting 
the environment of the mother) and, hence, be better protected both in the gut and in the upper airways in 
the same way as the mother’s mucosae are protected by similar antibodies (green areas) (adapted from 
Brandtzaeg, 2010b). 
 


















The mucosal IgA system constitutes the largest adaptive immune defence of our body in terms of the number of immune 
cells and quantities of antibodies produced. At mucosal surfaces these antibodies perform immune exclusion of 
exogenous antigens by inhibiting colonisation of pathogens and restricting the epithelial penetration of potentially 
harmful antigens such as dietary proteins and components of commensal bacteria (Brandtzaeg, 2010b). Lactating 
mammary glands are part of the integrated mucosal immune system, and milk antibodies reflect antigenic stimulation of 
mucosae-associated lymphoid tissue (MALT) both in the gut and airways (Brandtzaeg, 2003).  
After stimulation in gut-associated lymphoid tissue (GALT), such as the Peyer’s patches, naïve (unexperienced) B 
lymphocytes (also called B cells) become activated to memory/effector cells which migrate rapidly via lymphatics to 
mesenteric lymph nodes where some of them become further differentiated to precursors of antibody-producing plasma 
cells, or so-called plasmablasts. After reaching peripheral blood, the activated mucosal B cells, partially now being 
plasmablasts, are targeted for migration (“homing”) particularly to the intestinal lamina propria by so-called gut-homing 
receptors. However, a fraction of the GALT-derived B cells will migrate from peripheral blood into distant secretory 
mucosae and glandular effector sites  notably also to the lactang mammary glands, referred to as the 
enteromammaric link” (Figure 3.4). In this latter selective molecule-mediated extravasation from the blood circulation, 
GALT-derived B cells are joined by B cells that have been activated in nasopharynx-associated lymphoid tissue (NALT) such 
as the adenoids and palatine tonsils.  
At all secretory effector sites, extravasated mucosal memory/effector B cells will undergo terminal differentiation to 
plasma cells (PCs) which mainly produce polymeric IgA (dimeres and some trimers), but also pentameric IgM. Polymeric 
antibody molecules contain a small polypeptide called joining” (J) chain. In addition to stabilising the polymers by 
covalent bridges, the J chain facilitates their receptor-mediated transport by secretory epithelia. This external export of Ig 
polymers is mediated by the epithelial polymeric Ig receptor (pIgR), also known as membrane secretory component (SC). 
After the pIgR-mediated epithelial transport of locally produced IgA dimers/trimers and IgM pentamers to the luminal 
face of secretory epithelia, such as the lactating mammary glands, secretory (S)IgA and (S)IgM are released by apical 
cleavage of the pIgR – only the C-terminal receptor  part  remaining for degradation in the epithelial cell. The extracellular 
pIg-binding receptor domains are incorporated into the secretory antibodies as so-called bound SC, thereby providing 
protection against proteolytic degradation, particularly of SIgA where it becomes covalently integrated. Thus, the 
functional stability of SIgA antibodies in external secretions is remarkable (Brandtzaeg and Prydz, 1984; Brandtzaeg, 
2010b; Brandtzaeg, 2011). 
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Lactoferrin is one of the major milk proteins. It is bactericidal against certain bacteria and has 
antiviral effects and acts against fungi such as Candida albicans. Like SIgA, lactoferrin 
decreases the risk of infections without the use of inflammatory mechanisms as it blocks 
production of proinflammatory cytokines. Lactoferrin is quite resistant to degradation in the 
gut and contributes to the maintenance of an effective intestinal barrier function. It promotes 
growth of beneficial bacteria and is immunostimulatory (Hanson, 2007; Hanson, 2004; 
Lonnerdal, 2003). Lactoferrin is an iron-binding protein that can bind two ferric ions at a 




α-Lactalbumin also exerts anti-microbial activity against bacteria and fungi (Lonnerdal, 
2003). A more studied function of this protein is, however, its effect on malignant cells. After 
a specific reorganisation of the molecule, the so-called HAMLET is formed (Human α-
lactalbumin Made LEthal to Tumor cells). In this form, it induces apoptosis of human 
malignant cells both in vitro and in vivo (Pavet et al., 2011; Svensson et al., 2000). It is not 
known whether this protein may partly explain why breastfeeding reduces the risk of maternal 
breast cancer. The suggested effect of human milk on childhood leukaemia may also be 
related to this protein. 
 
Lysozyme  
Lysozyme is a major part of the whey protein fraction of breastmilk (Lonnerdal, 2003). It may 
act alone or together with lactoferrin, SIgA and other anti-microbial components against 
gram-negative and gram-positive bacteria and probably also against viruses (Hosea Blewett et 
al., 2008). 
 
Carbohydrate components  
Carbohydrate components comprise oligosaccharides and also glycoproteins (e.g. lactoferrin, 
SIgA) and glycolipids (e.g. gangliosides). Oligosaccharides are produced by epithelial cells of 
the mammary gland. Because of their resistance to hydrolysis by gastrointestinal enzymes, 
they are present in the small intestine where they act against microbes by preventing them 
from attaching to the mucosal surface cells. Milk-derived oligosaccharides have been shown 
to protect infants from various pathogenic microbes including E. coli, Campylobacter species, 
S. pneumonia and V. cholerae (Hosea Blewett et al., 2008). This is yet another anti-microbial 
function of breastmilk components acting without inducing inflammation. Oligosaccharides 
may also act as prebiotics in the breastfed infant’s gut by promoting the growth of beneficial 
bacteria, particularly bifidobacteria.  
 
Fats and fatty acids  
Fats and fatty acids in breastmilk (primarily medium-chain saturated, long-chain unsaturated 
fatty acids and monoacylglycerols) have been demonstrated to have antiviral, antiprotozoan 
and anti-microbial properties. The mechanisms are still not clear, but may be due to disruption 
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of the cell membrane of the microorganism or by changing intracellular pH (Hosea Blewett et 
al., 2008).  
 
Cytokines  
Cytokines are multifunctional glycoproteins involved in cell communication and immune 
system activation. They operate in networks and orchestrate the development and functions of 
the immune system. There are numerous cytokines as well as soluble receptors for cytokines 
in breastmilk (Garofalo, 2010). These cytokines have the potential to influence the maturation 
and development of immune cells in the infant (Brandtzaeg, 2010b). Some of the cytokines 
are considered as anti-inflammatory (such as transforming growth factor-β (TGF-β) and 
interleukin-10 (IL-10)), whereas others are proinflammatory (e.g. tumor necrosis factor-
α (TNF-α), IL-1, IL-6, IL-8, IL-12). Also soluble receptors for cytokines, e.g. the receptor for 
TNF-α, may be anti-inflammatory. 
In general, the concentration of cytokines varies widely among breastmilk samples, making it 
difficult to assess the roles of these factors (individually or together) in the development of 
the infant’s immune system (Hosea Blewett et al., 2008). A recent review of published studies 
on the TGF-β levels in breastmilk suggested that this cytokine protects against allergy in 
breastfed infants and young children (Oddy and Rosales, 2010). 
 
Hormones and growth factors  
Hormones and growth factors are found in breastmilk in relatively high amounts. Most likely 
they act as signals from the mother to the infant, thereby having the potential to influence the 
developing immune system. Among the hormones are erythropoietin, prolactin, thyroid 
hormone and leptin, the latter being involved in appetite regulation. Growth factors such as 
epidermal growth factor (EGF), fibroblast growth factor (FGF), insulin-like growth factor-1 
(IGF-1), and vascular endothelial growth factor (VEGF), growth hormone releasing factor 
(GH-releasing factor) and hepatocyte growth factor (HGF) are also present in breastmilk. 
Little is known about the activity of these components on the naïve immune system of an 
infant when ingested, but one suspect that they influence immune development and strengthen 
the barrier function of the gut epithelium (Hanson, 2004; Hosea Blewett et al., 2008). 
 
Immune cells 
Immune cells such as macrophages, neutrophils and lymphocytes are present with an 
activated phenotype in breastmilk after transepithelial migration from the stroma of the 
mammary gland. It is likely that the major role of neutrophils and macrophages in breastmilk 
is local defence of the mammary gland. Some maternal lymphocytes may be taken up through 
the gut wall of the infant, which is surprising because of the differences between the infant 
and the mother as to the tissue type molecules (HLA molecules). Interestingly, breastfed 
infants seem to be relatively tolerant to the mother’s HLA molecules as shown after organ 
transplantation. The maternal lymphocytes may also have a function in compensating for the 
immature function of neonatal T cells and promote their maturation (Hanson and Korotkova, 
2002). Experimental studies indicate that maternal lymphocytes may confer immunological 
information, such as an enhanced responsiveness to a vaccine (Hanson, 1998). Also B 
lymphocytes are present in breastmilk. Little is known about their potential role, but they may 
have an influence on the infant’s immune system (Hosea Blewett et al., 2008). 
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3.4.2 Factors with anti-inflammatory properties 
Inflammation provides amplification of systemic immune reactions, thereby aiding protection 
of the infant against invading pathogens. However, if this process is not controlled, it may 
cause harm to the healthy tissue. Breastmilk protects the infant from infection with no 
obvious unwanted effects, probably because its anti-inflammatory components such as SIgA 
antibodies ensure the development of effective and appropriate immune defence in the infant. 
Among the non-antibody components in breastmilk that may add to this effect are cytokines 
and their soluble receptors (IL-10, TGF-, IL-1 receptor antagonist and soluble TNF-
α receptors), lactoferrin, oligosaccharides and long-chain PUFAs (Hosea Blewett et al., 
2008). 
Also an excess of unoccupied cleaved IgA-transporting receptor (Box 1), so-called free 
secretory component (SC), is present in relatively large amounts in breastmilk (Brandtzaeg, 
2002). Before membrane SC in phylogeny was exploited by the adaptive immune system as 
an epithelial polymeric Ig receptor, SC probably belonged merely to the innate immune 
system. Thus, both in its free and SIgA (or SIgM)-associated form, SC is adding to the 
efficiency of the secretory immune system.  
 
3.4.3 Selected milk components important for the maturation of the infant’s mucosal 
immune system 
At birth, the structural components of the immune system are present both at the mucosal and 
systemic compartments, but adequate antibody responses need some time to develop due to 
the immaturity of the cellular elements involved. After contact with dietary and microbial 
constituents in the gut, the mucosal immune system will become more and more activated, 
depending on the environmental impact. Immune-modulating factors in breastmilk may 
contribute significantly to this development in the newborn (Brandtzaeg, 2010b). The 
presence of TGF-, IL-6, IL-7 and IL-10 in breastmilk is of particular interest for 
immunological maturation and differentiation of IgA-producing cells. Interestingly, a fully 
breastfed infant has a thymus (which is crucial for the development of T cells) twice the size 
of a formula fed infant, possibly because breastmilk provides important signals to the infant’s 
immune system such as cytokine IL-7. In breastfed children, the size of the thymus 
corresponds with the number of T cells, suggesting that breastmilk might have both a current 
and long-term immune-modulating effect on the developing cellular immune system 
(Jeppesen et al., 2004). 
 
3.4.4 Establishment of the commensal intestinal microbiota 
Before birth, the neonate is almost sterile. During a natural delivery, the principally sterile 
gastrointestinal tract is rapidly colonised with microbes from the mother’s faeces and vagina. 
Colonisation of the newborn’s mucosae with beneficial bacteria is what primarily drives the 
differentiation and balanced expansion of the immune system where homeostasis normally 
will prevail (Brandtzaeg, 2013). The indigenous gut microbiota is established during infancy, 
and this process is influenced by genetic, environmental, and dietary factors, as well as by the 
way of birth – whether vaginal or by caesarean section (Rautava and Walker, 2009).  
The number of bacteria in the gut exceeds the total number of cells in our body by some ten 
times, and their total genes (the gut microbiome) are at least hundred times the human 
genome. The commensal bacteria communicate both with each other and with the host 
(Valeur et al., 2011). Among the dominating commensals of the gut in the early colonisation 
Norwegian Scientific Committee for Food Safety (VKM) 10-003-final  
2 
 





Helle Margrete Meltzer (chair) 
Per Brandtzæg 
Helle Knutsen 
Beate Fossum Løland 
Jon Øyvind Odland 
Janneche Utne Skåre 
Liv Elin Torheim 
Norwegian Scientific Committee for Food Safety (VKM) 10-003-final  
69 
 
process of healthy, vaginally delivered and breastfed infants are Bifidobacterium and 
Enterobacteriaceae (Eggesbo et al., 2011). These bacteria modulate the expression of genes 
involved in several important intestinal functions, including nutrient absorption, mucosal 
barrier fortification, xenobiotic metabolism, angiogenesis and postnatal intestinal maturation 
(Brandtzaeg, 2003; Hooper et al., 2001; Neish, 2009).  
Besides its importance for the general maturation of the child’s adaptive defence mechanisms, 
exposure to microbes also aids the developing immune system to learn how to become 
tolerant to environmental constituents that it should not react against, i.e. together with 
relevant antigens the commensal microbiota prevents the infant from allergic and 
inflammatory diseases by its homeostatic anti-inflammatory effects (Brandtzaeg, 2010b). 
During this normal colonisation process, the mother provides protection against the microbes 
originating from herself by the earlier transplacentally transferred IgG antibodies and the 
breastmilk content of optimally targeted SIgA antibodies (the enteromammaric link, described 
in section 3.4.1).  
Breastmilk influences the gut microbiota differently from infant formula (Collins et al., 2012; 
Diamond et al., 2011; Forsythe et al., 2012). 
 
3.4.5 Induction of immunological tolerance 
Mucosal immunity provides a first defence line that reduces the need for elimination of 
penetrating exogenous antigens by proinflammatory systemic immunity. The local immune 
system operates by two adaptive anti-inflammatory mechanisms:  
- immune exclusion performed by SIgA and SIgM antibodies and  
- immune suppressive mechanisms to avoid local and peripheral hypersensitivity to 
innocuous antigens. 
The latter strategy is called mucosally induced tolerance or simply ”oral tolerance” when 
induced via the gut. These strategies may explain why persistent hypersensitivity to food 
proteins is relatively rare (except coeliac disease). Oral tolerance appears rather robust in view 
of the fact that more than a ton of food and drink may pass through the gut of an adult every 
year, including some 100 kg of protein - of which there is a daily absorption of 130-190 mg. 
After a meal, 3-10 ng/ml of the absorbed protein may be found circulating as intact molecules 
or in immune complexes. 
The neonatal period is particularly critical, not only with regard to infections, but also in 
terms of immunological homeostasis and sensitisation to allergic disease. This is so because 
the epithelial barrier function and the immunoregulatory network are poorly developed. 
Notably, the development of immune homeostasis depends on the establishment of balanced 
mucosal microbiota as well as on adequate timing and dose of dietary antigens when first 
introduced (Brandtzaeg, 2010b).  
Innocuous environmental proteins such as dietary antigens and components of the commensal 
microbiota can stimulate both production of SIgA antibodies and the induction of suppressive 
tolerance mechanisms via the gut or airways. Such mucosally induced hypo-responsiveness, 
that operates locally as well as systemically, probably explains why most individuals 
normally show no adverse immune reactions to persistent contact with harmless 
environmental and dietary proteins.  
As an example, breastmilk contains SIgA antibodies to gluten which may partly explain the 
protective or delaying effect of breastfeeding on childhood coeliac disease shown in several 
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studies (Ludvigsson and Fasano, 2012). Similarly, breastmilk SIgA with reactivity against 
commensal bacteria may contribute to the apparent protective effect of breastfeeding on later 
development of inflammatory bowel disease (Gearry et al., 2010). Interestingly, receptors for 
milk SIgA antibodies on the infant’s GALT epithelium can probably guide uptake of selected 
luminal antigens for induction of homeostatic immunity in the infant (Corthesy, 2010). 
Successful induction of oral tolerance depends on the dose and timing of enteric exposure to 
potential allergens, immune-modulating microbial components and dietary factors, such as 
vitamin A and lipids. Strict allergen avoidance during pregnancy, lactation and early 
childhood to prevent food allergy in atopic families seems to be based on mythology rather 
than science (Brandtzaeg, 2010a). Small amounts of allergens continuously present in the gut 
may in fact be required to promote tolerance induction. Environmental antigens, including 
food proteins, present at low levels in breastmilk may contribute to oral tolerance induction in 
infancy (Brandtzaeg, 2010a). Also, some recent studies suggest that postponing solid foods 
beyond 4-6 months does not enhance immunological homeostasis but, on the contrary, may 
increase the risk of hypersensitivity to food (Fewtrell et al., 2011). 
 
3.4.5.1 Prebiotics and probiotics in breastmilk 
The high content of oligosaccharides in breastmilk serves as a prebiotic promoting the growth 
of beneficial lactic acid-producing bacteria (particularly bifidobacteria) and reducing 
anaerobic bacteria in the gut of breastfed infants. Probiotic bacteria of bifidobacterial species 
and lactobacilli can reportedly also occur in breastmilk (Abrahamsson et al., 2009), perhaps 
after being transported to the mammary glands from the gut lumen by dendritic cells (Donnet-
Hughes et al., 2010). However, human milk contains a variety of bacterial genera, and the 
milk microbiome characterised by pyrosequencing of 16S ribosomal RNA genes is quite 
complex and not always stable over time in the same mother (Hunt et al., 2011). Notably, 
changes over lactation and an apparent impact of the mother's weight gain during pregnancy 
have been observed (Cabrera-Rubio et al., 2012). Thus, overweight mothers tended to have 
lower counts of Bifidobacterium group bacteria in their breastmilk which seemed to be related 
to higher levels of the suppressive cytokine TGF-beta2 and the anti-inflammatory endotoxin-
inhibiting factor sCD14 as well as a lower level of the proinflammatory cytokine IL-6 
(Collado et al., 2012). Altogether, the source of the milk microbiome and its potential effects 
on infant gut colonisation and neonatal immune homeostasis remain an intriguing research 
topic. 
 
 Summary of nutrients and immunological components in breastmilk 3.5
An infant who is exclusively breastfed the first 6 months of life has all its nutritional needs 
covered, with the exception of vitamin D, provided that the mother’s diet fulfill all her 
nutritional needs during both pregnancy and the breastfeeding period. Therefore, the daily 
estimated requirement for each nutrient is derived from the nutrient’s concentration in 
breastmilk multiplied with the average intake of breastmilk. Breastmilk is not a uniform fluid 
and the composition of nutrients varies by stage of lactation, the time of day and during a 
given feeding. The concentration of some nutrients also varies according to the mother’s diet. 
The energy content of breastmilk varies, but has been estimated to about 690 kcal/L. The 
concentrations of proteins and carbohydrates are relatively stable, while the fat content has 
large variations. The fatty acid composition reflects the maternal diet. Breastmilk 
concentrations of most vitamins reflect maternal vitamin intake, while the concentrations of 
most minerals are not affected by the maternal diet, except for selenium and iodine.  
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The newborn infant is immunologically immature, but will through breastmilk be provided 
with maternal antibodies and innate defence factors as well as immunity-promoting 
components. This benefits health in childhood, and most likely, also later in life. The milk 
antibodies are targeted against potential pathogens and other antigens to which the mother’s 
airway and gut mucosae have been exposed. These antibodies are mainly of the IgA class, 
being actively transported to the milk as secretory (S)IgA molecules, which are highly 
resistant to proteolytic degradation. The SIgA antibodies act at mucosal surfaces not only by 
inhibiting colonisation of pathogens, but are also dampening epithelial penetration of 
innocuous components such as dietary proteins and commensal bacteria. Contrary to 
circulating IgG antibodies which are potentially proinflammatory, SIgA functions without 
causing inflammation. Numerous other milk proteins, lipids, carbohydrate components, 
cytokines and immune cells may also contribute to the defence of the infant’s mucosae. 
Moreover, maturation of the infant’s immune system depends on contact with the immune 
modulating factors in breastmilk as well as dietary and microbial constituents in the infant’s 
gut. Different components in breastmilk facilitate the establishment of a beneficial intestinal 
microbiota, which is decisive for induction of a balanced mucosal immune system, both with 
regard to the SIgA system and oral tolerance. Through all these mechanisms, breastfeeding 
represents an ingenious immunologic integration of mother and child.  
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Historical data and trends in the use of infant formula are presented in section 2.2.1. The sale 
of infant formula, at least to a certain degree, is inversely proportional to the prevalence and 
duration of breastfeeding in a population.  
The recommended food for infants below 4 months who are not exclusively breastfed, is iron 
fortified, industrially produced infant formula (Norwegian Directorate for Health, 2001). The 
recommended age for introducing complementary food is 4 months for infants who receive 
infant formula. Exclusively breastfed infants who need extra food in the age period between 4 
and 6 months, should in general be given semi-solid food (e.g. porridge) and not infant 
formula. However, if extra milk is needed besides breastmilk, infant formula is recommended 
and not regular cow’s milk, up to the age of one year. (Norwegian Directorate for Health, 
2001). The main reason for this recommendation is the risk of deficient iron intake due to low 
content of iron in cow’s milk.  
The majority of the infant formulas on the Norwegian market are cow’s milk-based. The 
content of nutrients in infant formulas is adjusted to the physiological and nutritional needs of 
the growing infant. However, a number of immunologically protective/bioactive factors 
available in breastmilk will not be provided through infant formula. The Norwegian 
regulation of infant formula is based on the EU Directive for Infant Formula18, and covers the 
composition, labelling, marketing and distribution of infant formula. The regulation has two 
objectives; ensuring that infant formulas are safe and cover the infants’ nutritional needs and 
that breastfeeding is promoted and protected. The regulation gives minimum and maximum 
limits for nearly all nutrients in infant formulas and includes some of the provisions of the 
WHO Code (Norwegian Ministry of Health and Care Services, 2008). 
 
 Use of infant formulas in Norway 4.1
According to the Norwegian study Spedkost 2006-07, 18% of newborn infants received infant 
formula during the first week of life (Øverby et al., 2008). For most of the infants, this was a 
supplement to breastmilk since 98% of the infants were breastfed the first week. Infant 
formula or other milk products were introduced to 22% of infants below 3 months of age 
(Øverby et al., 2008). By 4 months of age, 36% and by 6 months 43% of the infants had been 
introduced to infant formula or other milk, as drink or in porridge (Table 4.1). Among the 
36% of mothers who served infant formula by 6 months, the average frequency of serving the 
infant formula was 3.3 times per day (Øverby et al., 2008).  
Table 4.2 shows the use of infant formula and cow’s milk in the first year of life. Almost 60% 
of infants were introduced to infant formula as drink by the age of one year. Parents seem to 
largely follow the recommendation to delay the introduction of cow’s milk. Spedkost 12 
months also assessed the current diet of the child at 1 year of age, and found that 43% of the 







                                                 
18Commission Directive 2006/141/EC on infant formulae and follow-on formulae. 
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Table 4.1: Age at introduction of infant formula/other milk in the first 6 months of age, n=19861. 




< 3 months 22 22 
3-3.9 months 6 28 
4-4.9 months 8 36 
5-5.9 months 5 41 
6 months 2 43 
1Adapted from Table 14 in Spedkost 6 måneder (Øverby et al., 2008). 
 
Table 4.2: Age at introduction of infant formula/other milk in the first year of life (%), n=16351. 


















< 6 months 34 30 <0.5 <0.5 1 
6-9 months 21 20 4 4 19 
10-12 months 8 2 50 20 47 
1Adapted from Table 12 in Spedkost – 12 måneder (Øverby et al., 2009). 
 
 
 Content of nutrients in infant formulas 4.2
The composition of infant formula should serve to meet the particular nutritional requirements 
and to promote normal growth and development of the infants for whom they are intended 
(Koletzko et al., 2005). The nutrient concentration of formulas should not necessarily mimic 
the composition of breastmilk, since there are considerable differences in the bioavailability 
and metabolic effects of several of the nutrients (Koletzko et al., 2005).  
The regulation of infant formula states that infant formula ready for consumption, shall 
contain no less than 60 kcal (250 kJ) and not more than 70 kcal (295 kJ) per 100 ml. It further 
defines minimum and maximum levels of nutrients (per 100 kJ or 100 kcal prepared formula) 
where applicable, as listed in Tables 4.3-4.5.  
Regarding proteins, the regulation says that for an equal energy value the infant formula must 
contain an available quantity of each indispensable and conditionally indispensable amino 
acid at least equal to that contained in the reference protein, which is protein in breastmilk. 
The regulation states that the protein content needs to be kept between 1.8 and 3 g per 100 
kcal. However, as noted in section 3.1, the protein content in breastmilk is adjusted to the 
changing requirements of the developing infant. Breastmilk protein concentration is high 
early in the lactation period (3.9 g/100 kcal), decreases to about 1.3 g/100 kcal in mature milk 
and further to 1 g/100 kcal at 6 months and later (Lawrence and Lawrence, 2010a; Lonnerdal, 
2003). Protein levels in infant formulas are fixed and designed to meet protein needs when 
they are at their highest (in the first 1-2 months). The relationship between infants’ protein 
intake and growth, satiety and regulation is complex, and more data and greater insight into 
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mechanisms have been called for before changing the current recommendations (Kalhan, 
2009).  
In addition to the nutrients in Table 4.5, the regulation also proposes levels of optional 
ingredients (e.g. taurine, fructooligosaccharides, galactooligosaccharides and various 
nucleotides).  
The Norwegian Food Safety Authority monitors infant foods sold in Norway, including infant 
formulas. The project ”Analysis of nutrients in selected baby food products 2006/2008” 
analysed the concentrations of sugars, vitamins A and D, iron and calcium in five infant 
formulas from different producers (Gjevestad, 2007). The analysis showed that there was 
good correspondence between the values analysed and the amounts declared on the labels of 
the infant formulas.  
Regarding sugars, the level of lactose per 100 g varied between 8.7 g and 11.7 g (based on 
declared information), which is above the minimum recommended level of 4.5 g/100 kcal. 
While the current regulation does not give any upper limit for lactose, the EU Scientific 
Committee on Food suggested in 2003 that the maximum limit of lactose should not exceed 
10 g lactose/100 kcal (SCF, 2003). Four of the five formulas tested had a lactose level above 
this limit.  
Levels of calcium in the formulas varied between 61 mg and 105 mg/100 kcal, and were 
within the limits of the regulation which says minimum 50 mg and maximum 140 mg/100 
kcal. The iron concentrations varied between 0.8 mg to 1.1 mg/100 kcal which is also within 
the limits of 0.3 mg and 1.3 mg/100 kcal.  
The concentration of vitamin A was between 68 µg and 100 g/100 kcal, which was within 
the minimum and maximum limits of 60 µg and 180 g/100 kcal. The analysed formulas’ 
concentrations of vitamin D varied between 1.8 µg and 2.7 g/100 kcal while the limits are  
g/100 kcal. Based on results from this project, the Norwegian Food Safety 
Authority concluded that there was no need to take action against the enterprises in question 
(Gjevestad, 2007).  
In a second phase of the project the content of vitamin A and D were tested in formulas at the 
end of their expiration date. The conclusion from the project was that there was no significant 













1 µg and 2.5 
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Table 4.3: Macronutrient concentrations in infant formula according to EU regulation.  
Component Required levels1 Nutrient labelling  






Energy, kcal/100 ml 60 70 67 650 
Proteins     
  Cow’s milk proteins, g/100 kcal 1.8 3 1.8 15 
  Hydrolysed cow’s milk protein, 
g/100kcal  
1.8 3   
  Soy protein isolates, g/100 kcal 2.25 3   
Total fat, g/100 kcal 4.4 6.0 5.3 33 
  Linoleic acid, g/100 kcal 0.3 1.2   
  -linolenic acid, mg/100 kcal 50 NS2   
  Ratio linoleic/-linolenic acid 5:1 15:1   
  Lauric+mystiric acids, % of fat NS 20   
  Trans fatty acids, % of fat NS 3   
  Euric acid, % of fat NS 1   
Total carbohydrates, g/100 kcal 9.0 14.0 11.1 74 
  Lactose, g/100 kcal 4.5 NS 11.1  
1Compositional requirements in regulation on infant formula and follow-on formula (Norwegian Ministry of Health and Care 
Services, 2008). 
2NS=Not stated. 
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Table 4.4: Vitamin concentrations in infant formula.  
Component Required levels1 Nutrient labelling  






Vitamin A, g RE/100 
kcal2 
60  180  101 590 
Vitamin D, g/100 kcal3 1  2.5  1.4 10 
Thiamin, g/100 kcal 60  300  112 400 
Riboflavin, g/100 kcal  80  400  209 900 
Niacin, g/100 kcal4 300  1500  879 5000 
Pantotenic acid,  
g/100 kcal 
400  2000  939  
Vitamin B6, g/100 kcal 35  175  77 600 
Biotin, g/100 kcal 1.5  7.5  2.2  
Folate, g/100 kcal 10  50  14 60 
Vitamin B12, g/100 kcal 0.1  0.5  0.4 1 
Vitamin C, mg/100 kcal 10  30  16 50 
Vitamin K, g/100 kcal 4  25  8  
Vitamin E,  
mg -TE5/100 kcal 
0.56 5 1.3 8 
1Compositional requirements in regulation on infant formula and follow-on formula (Norwegian Ministry of Health and Care 
Services, 2008). 
2RE=all trans-retinol equivalent. 
3In the form of cholecalciferol, of which 10 g=400 i.u. of vitamin D. 
4Preformed niacin. 
5-TE=d-alfa-tocopherol equivalent. 
60.5 mg -TE/1 g linoleic acid (18:2 n-6); 0.75 mg -TE/1 g -linolenic acid (18:3 n-3); 1.0 mg -TE/1 g arachidonic acid 
(20:4 n-6); 1.25 mg -TE/1 g eicosapentaenoic acid (20:5 n-3); 1.5 mg -TE/1 g docosahexaenoic acid (22:6 n-3). 
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Table 4.5: Concentrations of minerals, trace elements and other substances in infant formula.  
Component Required levels1 Nutrient labelling  






Minerals and trace 
elements 
    
Sodium, mg/100 kcal   20 60  25 150 
Potassium, mg/100 kcal 60  160  101 640 
Chlorine, mg/100 kcal 50  160  70  
Calcium, mg/100 kcal 502  140  64 410 
Phosphorus, mg/100 kcal 252  90  36 200 
Magnesium, mg/100 
kcal 
5  15  8 40 
Iron (formula based on 
cows’ milk protein and 
protein hydrolysate), 
mg/100 kcal 
0.3  1.3  1.0 8 
Iron (formula based on 
soy protein isolate), 
mg/100 kcal 
0.45  2.0    
Zinc, mg/100 kcal 0.5  1.5  1.0 5 
Copper, g/100 kcal 35  100  77 0.4 
Iodine, g/100 kcal   10  50  19  
Selenium, g/100 kcal 1  9  2  
Manganese, g/100 kcal 1  100  22  
Fluoride, g/100 kcal NS  100  
Other substances     
L-carnitine, mg/100 kcal 1.2 NS3 1.5  
Choline, mg/100 kcal 7 50 18  
Inositol, mg/100 kcal 4 40 15  
1Compositional requirements in regulation on infant formula and follow-on formula (Norwegian Ministry of Health and Care 
Services, 2008). 
2The calcium:phosphorus ratio shall not be less than 1 nor greater than 2.  
3NS=not stated. 
4Source: Norwegian Food Composition Table, 2001. 
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 Summary of infant formula 4.3
Although breastmilk is the main recommended food for infants in Norway, infant formula is 
recommended under some conditions. If breastfeeding is not possible or if there is a need for 
more milk in addition to breastmilk, infant formula, and not cow’s milk, is recommended 
until 12 months of age. Data from the national dietary survey among infants (Spedkost) 
showed that at 6 months of age, 43% of the infants had been introduced to infant formula, and 
36% used it regularly. At 1 year of age, 43% of the infants were given infant formula 
regularly.  
Infant formulas in Norway are subject to regulations which cover the composition, labelling, 
marketing and distribution of infant formula. Theregulations are in line with relevant EU 
directives. The regulations give minimum and maximum limits for nutrients in infant 
formulas and include some of the provisions of the WHO Code. Monitoring of the nutrient 
levels of some selected nutrients by the Norwegian Food Safety has not revealed any serious 
deviations neither from the allowed nor from the declared nutrient content.  
The content of nutrients in infant formulas is adjusted to the physiological and nutritional 
needs of the growing infant. However, a number of immunologically protective and bioactive 
factors available in breastmilk are not provided through infant formula. 
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5 Contaminants and other undesirable compounds in 
breastmilk and infant formula 
Compounds that can be hazardous to health may be present both in breastmilk and in infant 
formula. The purpose of this chapter is to describe the presence of specific groups of 
substances in breastmilk and infant formula, the ability of these substances to cause adverse 
health effects, and the exposure level which can be regarded as safe. Furthermore, 
concentrations in breastmilk and infant formula in Norway have been included when 
available; otherwise concentrations reported in Nordic or other European countries are given. 
This has been done to facilitate a comparison of concentrations in breastmilk and infant 
formula. 
Environmental contaminants are mostly present in breastmilk as a result of man-made 
emissions from industry and other activity, but some also occur naturally. All contaminants 
which are present in breastmilk can in principle be present in formula, and vice versa. 
However, depending on the substance or class of substance, the concentrations found in 
breastmilk and infant formula can be quite different. Humans are exposed to low levels of an 
increasing number of chemicals, and taking improved analysing methodologies into account, 
a range of these substances may potentially be found at low levels in breastmilk and infant 
formula. This chapter has been restricted to descriptions of a) substances that were included 
as criteria in the literature search for negative health effects of breastfeeding (Table 7.4, 
substances described in sections 5.1 and 5.2), and b) substances for which there were 
available studies on occurrence in infant formula, based on findings in a literature search 
performed on contaminants in infant formula (literature search described in Appendix 6, 
substances described in sections 5.3 and 5.4). Possible microbiological hazards in infant 
formula are described in section 5.5. 
The risks from exposure to contaminants have been assessed by international risk assessment 
bodies such as the Joint FAO/WHO Expert Committee on Food Additives (JECFA) or the 
EFSA. The short description of contaminants considered relevant for breastmilk and infant 
formula is based on the most recent international risk assessments. For some substances a 
tolerable daily intake (TDI) has been set. A TDI is the amount of a substance, or substance 
group, which can be consumed safely throughout a person's lifetime without appreciable risk 
of adverse health effects19.  
Many of the contaminants discussed below accumulate in the body, causing detectable effects 
only when a certain concentration has been reached. Therefore, variations in daily intake have 
little significance and, as a result, tolerable intake levels are sometimes expressed on a weekly 
(TWI) or even monthly basis.  
Tolerable intakes have been derived from studies in humans when sufficient quantitative data 
have been available. If that is not the case, data from studies in laboratory animals have been 
used. If the tolerable value has been derived from animal studies, data from the most sensitive 
animal species and the most critical effect have been used. Uncertainty factors (also called 
assessment factors) have been used to account for uncertainty in the extrapolation of the data 
derived from animals to humans and to account for variations among humans. Usually, a 
default factor of 10 is used for extrapolation from animals to humans and a factor of 10 is 
                                                 
19WHO (1994) has defined adverse effect as follows: ”A change in morphology, physiology, growth, development and life 
span of an organism which results in impairment of functional capacity or impairment of capacity to compensate for 
additional stress or increase susceptibility to the adverse effects of other environmental influences. Decisions on whether or 
not any effect is adverse require expert judgement.” 
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used for variation among humans (100 altogether). Tolerable intakes derived from large-scale 
epidemiological studies encompassing the most sensitive segment of the population justify the 
use of small uncertainty factors. This approach for deriving tolerable intake levels assumes 
that the adverse health effects are of such a nature that there is a dose threshold for effect, i.e. 
that a certain amount of exposure must be reached before adverse health effects occur. 
Two different methods have been used to express dose threshold: 1) the no adverse effect 
level (NOAEL), which is the highest dose without any adverse effect, or 2) benchmark dose 
lower bound (BMDL), which is the 95-percentile lower confidence limit of the benchmark 
dose (BMD). The BMD is a dose associated with adverse effect in 5% or 10% of the animals, 
derived from a modelled dose-response curve. The tolerable intake levels are derived by 
dividing the NOAEL or BMDL by the uncertainty factor (usually 100).  
It follows from the above that the tolerable intake level is not a threshold for toxicity above 
which adverse or toxic effects will instantly occur. The level is conservative and has, as a 
general rule, built-in safety margins. Consequently, when the level is moderately exceeded, 
the safety margin is eroded. 
Some chemical compounds are considered to be carcinogenic. In a large-scale programme 
spanning many years, the International Agency for Research on Cancer (IARC), an agency of 
the WHO, has assessed the carcinogenic potential of chemicals, work processes and 
exposures. IARC classifies chemicals and exposures according to the quality of scientific 
evidence of carcinogenicity. The most solid evidence comes from studies in humans that 
unambiguously show carcinogenic effects. Chemicals with evidence of carcinogenicity in 
laboratory animals are generally regarded as possibly or probably carcinogenic to humans, 
unless the mechanism is not relevant to humans. The ability of a substance to damage genetic 
material (to be genotoxic) is assessed as part of the basis for the classification. The 
classification system operates with the following groups:  
Group 1:  The agent is carcinogenic to humans. 
Group 2A:  The agent is probably carcinogenic to humans. 
Group 2B:  The agent is possibly carcinogenic to humans. 
Group 3:  The agent is not classifiable as to its carcinogenicity to humans. 
Group 4:  The agent is probably not carcinogenic to humans. 
IARC does not assess carcinogenic potency. For carcinogenic substances that are toxic to 
genetic material and cause cancer via genotoxic mechanisms, it is not possible to identify a 
dose-threshold under which there is no risk. In other words, any exposure down to zero may 
result in a theoretical risk. In such cases, various methods have been used for quantitative 
extrapolation. In Norway and some other countries, such as the USA, linear extrapolation 
from a dose that causes cancer in a certain percentage of the laboratory animals down to a 
negligible lifetime risk, e.g. 10-5, has been used. Methods like these most probably result in 
conservative risk estimates. In recent years, a margin of exposure (MOE) approach has been 
used. The MOE specifies the margin between current human exposure and the lower 
confidence level of the exposure causing e.g. cancer in 10% of the laboratory animals 
(BMDL10). The assessment of margins considered to be tolerable is comparable to the 
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5.1.1 Lead (Pb) 
The human body is exposed to lead through diet, drinking water and air. The metal 
accumulates in several tissues and organs of the body, but first and foremost it is stored in 
bone. The bone lead stores can be mobilised together with calcium during pregnancy and 
lactation. Lead in blood is considered to be the best indicator of the concentration of lead in 
soft tissues, reflecting recent and, to some extent, past exposure. During pregnancy lead easily 
crosses the placenta. Long-term, low level exposure to lead is associated with impaired 
neurodevelopment in children. Both EFSA (2010) and JECFA (2011) identified 
developmental neurotoxicity and reduction of the Intelligence Quotient (IQ) in children up to 
the age of 7 as the most critical effect of lead exposure, and foetuses, infants and children are 
considered to be the most sensitive subgroups for lead exposure (EFSA, 2010b; JECFA, 
2011). EFSA assessed the risk of reduction of IQ and chose a BMDL01 of 12µg lead/L blood 
as reference point for the risk characterisation of lead to children. This concentration 
corresponds to an average daily dietary intake of lead of 0.5 µg/kg bw. According to EFSA 
and JECFA, a small IQ-decrease may be viewed as having a small impact for an individual 
child, but is considered important as a reduction in a population’s IQ. Since no threshold for 
this critical lead-induced effect was found, a tolerable intake has not been established. It was 
concluded by EFSA that the MOEs were such that a possibility for effects from lead in some 
consumers, particularly in children from one to 7 years of age, cannot be excluded.  
Generally, the concentration of lead in blood in European populations has decreased 
dramatically over the last three decades due to prohibition of use of lead in petrol, paint and 
seams of tinned food. The geometric mean or median concentrations of lead in blood in recent 
Norwegian studies are from 11 to 27 µg/L, which is in the same range as studies in most 
European countries the last 10 years. Median concentration of lead in blood in pregnant 
Norwegian women sampled in 2003-2004 was 11µg/L (VKM, 2013). 
Data on lead in breastmilk samples from Norway have not been found. Swedish breastmilk 
samples have shown lead concentrations of 0.5 ± 0.3 µg/L (Hallen et al., 1995). Several 
studies indicate that breastmilk concentrations are less than 5% of the concentrations in 
mother’s blood (Gulson et al., 1998). In their opinion on lead, EFSA used a mean lead 
concentration in breastmilk of 1.6 g/L based on a study from Austria and concluded that the 
risk from lead in breastfed infants is likely to be low since their exposure is predicted to be 
below 0.5 µg/kg bw (EFSA, 2010b).  
Both infant formula powder and water can contribute to the lead content in ready-to-drink 
infant formula. According to the EFSA-opinion, the concentration in ready-to-drink infant 
formula was calculated to be 2-4.7 µg/kg. Thus, infant formula might contain up to three 
times the lead concentration of breastmilk. In the EFSA opinion, lead exposure based on 
lower bound20 assumptions in both average and high 3-month old infant consumers of infant 
formula was below 0.5 µg/kg bw, but may exceed this level, based on upper bound21 
estimates. Therefore, EFSA concluded that the possibility of a risk to infants consuming 
infant formula cannot be excluded. 
 
                                                 
20Lower bound: Values below LOD or LOQ are set to zero. 
21Upper bound: Values below LOD or LOQ are set equal to the LOD or LOQ. 
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5.1.2 Mercury (Hg) 
Mercury is released into the environment from both natural and anthropogenic sources. Once 
released, mercury undergoes a series of complex transformations and cycles between 
atmosphere, ocean and land. The three chemical forms of mercury are (i) elemental or 
metallic mercury (Hg0), (ii) inorganic mercury (mercurous (Hg2
2+) and mercuric (Hg2+) 
cations) and (iii) organic mercury. Methylmercury is by far the most common form of organic 
mercury in the food chain, and after oral intake, methylmercury is much more extensively and 
rapidly absorbed than mercuric and mercurous mercury. Seafood is a main dietary source of 
both inorganic mercury and methylmercury exposure. 
 
Methylmercury 
Methylmercury accumulates in the body and crosses the placenta- and blood-brain barriers. 
Total mercury in hair and blood are routinely used as biomarkers of methylmercury exposure.  
Unborn children constitute the most vulnerable group for developmental effects of 
methylmercury exposure. EFSA recently reduced the TWI for methylmercury from 1.6 to 1.3 
g/kg bw/week, expressed as mercury, based on recent findings of neurodevelopmental 
effects in children at slightly lower methylmercury exposure than previously reported (EFSA, 
2012a). EFSA calculated that mean exposure in Europe is below the TWI, whereas 95-
percentile exposure is in the range of or exceeding the TWI. This was confirmed by 
biomonitoring data. 
The mean concentrations of methylmercury in breastmilk in a limited number of European 
studies were used for exposure assessment in EFSA. EFSA found that based on mean 
concentrations of methylmercury in breastmilk, the dietary exposure to methylmercury for 3-
month old infants (6.1 kg) with an average daily breastmilk consumption (800 ml), ranged 
from 0.09 to 0.62 g/kg bw per week and for infants with high milk consumption (1200 ml) 
the dietary exposure ranged from 0.14 to 0.94 g/kg bw per week. Since these exposures are 
below the TWI, the exposure to methylmercury from breastmilk was considered not of 
concern (EFSA, 2012a). Since the exposure was estimated based on limited data, higher 
exposure to breastfed children in Europe cannot be excluded. Data on methylmercury in 
breastmilk from Norway is not available. 
Data on methylmercury in infant formula have not been found. In general, all mercury in 
other food groups than fish and other seafood is believed to be inorganic.  
 
Inorganic mercury 
The kidney is sensitive to inorganic mercury toxicity. Inorganic mercury is also toxic to the 
liver, the nervous system and the immune system, and is also a reproductive and 
developmental toxicant. 
EFSA recently established a tolerable intake of inorganic mercury of 4.0 g/kg bw/week, 
expressed as mercury (EFSA, 2012a). This was in line with the evaluation from the JECFA in 
2010. EFSA found that based on mean concentrations of inorganic mercury in breastmilk in 
Europe, the dietary exposure to inorganic mercury for 3-month old infants (6.1 kg) with an 
average daily breastmilk consumption (800 ml), ranged from 0.17 to 1.29 g/kg bw per week 
and from 0.25 to 1.94 g/kg bw per week for infants with a high milk consumption (1200 ml). 
Since these exposures are below the TWI, this was not considered to be of concern (EFSA, 
2012a). Since the exposure was estimated based on limited data, higher exposure to breastfed 
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children in Europe cannot be excluded. Data on inorganic mercury in breastmilk from 
Norway are not available. 
Only two surveys reported consumption data for infants to EFSA, and mean middle bound22 
exposure from the diet, including milk formula, was 0.74 and 0.80 g/kg bw/week, which is 
lower than the TWI. 
 
5.1.3 Cadmium (Cd) 
Cadmium is a heavy metal found as an environmental contaminant both through natural 
occurrence and from industrial and agricultural sources. Cadmium is primarily toxic to the 
kidney, especially to the proximal tubular cells where it accumulates over time and may cause 
renal dysfunction. IARC has classified cadmium as a human carcinogen (Group 1). EFSA 
established a tolerable weekly intake (TWI) for cadmium of 2.5 g/kg bw in 2009, and 
confirmed this in 2011 (EFSA, 2009a; EFSA, 2011e). The mean exposure for adults across 
Europe is close to, or slightly exceeding, the TWI.  
According to EFSA, cadmium concentrations in human milk are 5-10% of levels in blood. A 
higher maternal cadmium exposure during pregnancy and lactation results in a higher fetal 
and infant exposure, although at lower concentrations than maternal levels. The intestinal 
absorption of cadmium during infancy is most likely considerably higher than in adults. No 
data on cadmium in breastmilk in Norway have been found. Swedish breastmilk samples have 
shown cadmium concentrations of 0.06 ± 0.04 µg/L (Hallen et al., 1995). Infant formula on 
the Swedish marked based on cow’s milk contained 0.08 to 0.39 µg/L, whereas 1.17 µg/L was 
found in formula based on soy protein (Ljung et al., 2011). 
A higher gastrointestinal absorption in combination with consumption of infant formula 
composed by ingredients with higher cadmium content than breastmilk (e.g. wheat or soy) 
may lead to increased internal cadmium exposure in these infants (Eklund and Oskarsson, 
1999). Cadmium from drinking water would come in addition. 
 
5.1.4 Other metals 
In a recent paper from Sweden, the content of essential and toxic elements in infant formulas 
was analysed (Ljung et al., 2011). The daily intakes of manganese and molybdenum were 
much higher from infant formulas than the intake from breastmilk at the ages of 1 and 4 
months. The daily intake of manganese from infant formula varied from ten up to several 
hundred times the intake of a breastfed infant. The authors criticise the acceptable upper limit 
of manganese in infant formula, arguing that it does not consider the increasing evidence of 
neurotoxicity in children. The arsenic concentration was higher in some hypoallergenic 
formulas for special medical purposes than in breastmilk and in infant formula based on 
cow’s milk. Also aluminum has been shown to be present at higher concentrations in infant 
formula than in breastmilk, and particularly in soy-based formula. The aluminum intake from 
infant formula (in particular soy-based formula) may exceed tolerable weekly intake of 2 





                                                 
22For samples below LOQ, the concentration has been set to half of the LOQ. 
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 Halogenated organic compounds 5.2
A large number of substances in the group of chlorine-, fluorine-, or bromine-substituted 
organic compounds can represent a hazard to human health. This applies to polychlorinated 
dibenzodioxins and furans (PCDD/Fs denoted dioxins), PCBs, campheclor (toxaphene), DDT 
and its metabolites (DDD and DDE), chlordane, dieldrine, aldrin, endrin, heptachlor, HCB, 
chlorinated cyclohexane, brominated flame retardants such as PBDEs and fluorinated 
compound such as PFOS and PFOA. Some of these compounds occur as by-products of 
industrial production (PCDD/Fs), in products (PCBs and PBDEs) or from past use as 
pesticides. They are fat-soluble and persistent to degradation, they bioaccumulate and are 
biomagnified in the environment. They are found in the highest concentrations in organisms 
located high up in the food chain. Fat of animal origin, and in particular fat of marine origin, 
is the major exposure source. Most of these compounds are no longer in use. Cleaning of 
industrial emissions has been implemented, and as a result, the levels in the environment are 
generally declining.  
The situation is different for the fluorinated compounds. These substances have been widely 
used for decades because of their water and oil repellent abilities, but this did not gain much 
attention until approximately 10 years ago. Although substances in this class are not fat-
soluble, they are persistent and the highest concentrations are found in organisms high up in 
the food chain. A summary of the features of the health hazards represented by the most 
relevant compounds is given below. 
 
5.2.1 Dioxins and polychlorinated biphenyls (PCBs) 
Dioxins and PCBs are closely related groups of chlorinated organic compounds. They are fat-
soluble and persistent to degradation, they bioaccumulate and are biomagnified in the 
environment. They are found in the highest concentrations in organisms located high up in the 
food chain. Fat of animal origin, and in particular marine fat, is the major exposure source.  
The term ”dioxins” usually encompasses both the 75 chlorinated dibenzo-p-dioxins (PCDDs) 
and 135 chlorinated dibenzofurans (PCDFs). There are 209 different PCB congeners. The 
chemical properties and toxicological effects of dioxins and PCBs vary according to the 
number and positions of the chlorine atoms on the aromatic rings. 
Of the 209 possible PCB congeners, 12 are included in the group of dioxin-like PCBs (dl-
PCBs) and are evaluated together with the dioxins, since they share mechanism of action with 
the most toxic dioxins. The rest of the PCBs are referred to as non dioxin-like PCBs (ndl-
PCBs).  
 
5.2.1.1 Dioxins and dioxin-like PCBs 
The toxicity of 17 dioxins and 12 dl-PCBs is related to binding and activation of the 
transcription factor Ah (aryl hydrocarbon) receptor, also known as the TCDD or dioxin 
receptor. These substances have been assigned toxic equivalency factors (TEF) in relation to 
2,3,7,8-TCDD, which is the most potent dioxin congener and has a TEF of 1. The total 
amount of toxic equivalents (total TEQ) in a sample is calculated by multiplying the 
concentration of each congener with the associated TEF and then adding up the contributions 
from the different congeners. The total TEQ in a sample is an estimate of the total dioxin 
effect, which is a simplified method for making risk assessments of dioxin/PCB-mixtures. 
The WHO-TEFs were set in 1998 (WHO1998-TEF) and revised in 2005 (WHO2005-TEF). 
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Abnormal activation of the Ah-receptor may disrupt cell function by altering the transcription 
of a vast array of genes whose activities are involved in a number of processes, including 
growth regulation and development. The most significant hazardous effects on health 
resulting from chronic exposure to dioxins and dl-PCBs are impairment of the reproductive 
system, a weakened immune system, impairment of the endocrine system and neurotoxic and 
carcinogenic effects. Dioxins have been classified as carcinogenic to humans (Group 1) by 
IARC (IARC, 1997), but they are not genotoxic (JECFA, 2001; SCF, 2001). The critical 
effect used in risk assessments was the reproductive effects in rats. Risk assessments 
performed by SCF and JECFA took into account the large difference in biological half-life of 
TCDD between rats and humans (i.e. about one month versus 7.5 years), the insufficiency of 
the toxicological database, and limited knowledge about the variation in the biological half-
lives in different population groups. The TWI established by SCF is 14 pg TE/kg bw/week 
(SCF, 2001). JECFA's assessment is comparable with that of SCF, except that JECFA 
expresses the tolerable intake level on a monthly basis (70 pg TE/kg bw/month) (JECFA, 
2001).  
 
Levels and trends for dioxins and dl-PCBs in breastmilk and infant formula  
From 1986 to 2005 the concentration of dioxins and dl-PCBs in breastmilk from Norway 
decreased by almost 70% (Figure 5.1). 
 
Figure 5.1: Dioxins and dl-PCBs in breastmilk samples from Norwegian primiparous women collected in 
1986, 1993, 2001 and 2005 as part of the WHO surveillance programme on breastmilk (pooled data from 
10-50 mothers per year) Source: “Morsmelk og miljøgifter faktaark”, Norwegian Institute of Public 
Health based on Becher et al., 1995; Becher et al., 2002; NILU, 2013; Stigum et al., 2005. 
 
Individual breastmilk samples from HUMIS (n=27) collected in 2003-2005 are in the same 
range as the results from 2005 in Figure 5.1, and show in addition inter-individual variations 
in contamination levels from 4.6 to 18 pg WHO2005 TEQ/g lipid for dioxins and dl-PCBs. 
Mean level was 11 pg WHO2005 TEQ/g lipid (Stigum et al., 2005). 
The maximum level (ML) of dioxins and dl-PCBs in infant formula is 0.1 pg WHO2005-
TEQ/g wet weight for dioxins and 0.2 pg WHO2005-TEQ/g wet weight for the sum of dioxins 
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and dl-PCBs, as laid down in the EU regulation for MLs for dioxins, dl-PCBs and ndl-PCBs 
in foods23. 
The occurrence of dioxins and dl-PCBs in six samples of infant formula sold in Norway in 
2008 showed a mean UB concentration of 0.37 pg WHO2005-TEQ/g fat (range 0.17-0.55 pg 
WHO2005-TEQ/g fat) (personal communication
24). European samples of liquid and powder 
infant and follow-on formula showed upper bound levels maximally up to 0.06 pg WHO2005-
TEQ/g wet weight for the sum of dioxins and dl-PCBs (EFSA, 2013a). Provided a fat 
concentration of 3.5% in infant formula, the ML corresponds to 5.7 pg/g fat, whereas the 
highest upper bound level reported to the EU was 1.71 pg/g fat. 
 
5.2.1.2 Non dioxin-like PCBs 
The presence of non dioxin-like PCBs (ndl-PCBs) is often expressed as the sum of three PCB 
congeners (PCB-138, -153 and -180) or PCB-6 (PCB-28, -52, -101, -138, -153, -180), or as 
PCB-7, which in addition to PCB-6 includes PCB-118 (a dl-PCB). Sometimes the PCB 
concentration is expressed as total PCBs. PCB-153 is often used as an indicator of total PCB 
or PCB-6 because the correlation between PCB-153 and PCB-6 is usually high. 
IARC has classified PCBs in Group 2A, i.e. probably carcinogenic to humans. There are 
reasons to believe that it is the dl-PCBs (and not the ndl-PCBs) that are responsible for the 
carcinogenic effect (EFSA, 2005a). In epidemiological studies, the most important adverse 
health effects associated with exposure from food and the environment were related to 
perinatal PCB exposure and the impairment of reproduction, including delayed development 
of the central nervous system and an impaired function of the immune system. It has not been 
possible to distinguish between the effects resulting from dioxins and dl-PCBs and the effects 
resulting from ndl-PCBs. This is because exposure to ndl-PCBs is normally highly correlated 
with exposure to dioxins and dl-PCBs. Furthermore, in many experimental studies the PCB 
test substance has been contaminated with dioxins. As a result, EFSA concluded that it is not 
possible to establish a tolerable intake level for ndl-PCBs (EFSA, 2005a).  
Neurotoxic effects of dioxins and dl-PCBs are well known. The ndl-PCBs act via several 
different mechanisms and not via the AhR. Mechanistic studies indicate that they may affect 
components of the nervous system in several different ways. They alter intracellular signal 
transduction pathways by interfering with intracellular sequestration of calcium and increase 
the activation of protein kinase C (PKC). Induction of apoptosis and increased production of 
reactive oxygen species and changes in levels of neurotransmitters such as dopamine and 
acetylcholine have been reported. The latter is suggested to be linked to interference with 
PCB on thyroid hormone levels because cholinergic fibres are particularly sensitive to thyroid 
hormone deficiency. Furthermore, increased release of arachidonic acid has been observed. 
Changes in the PKC signalling pathway and calcium homeostasis as well as reduced 
dopamine levels have been confirmed in animal studies (EFSA, 2005a). 
A provisional tolerable intake of 20 ng/kg bw/day for all 209 PCB congeners was proposed at 
the “2nd PCB workshop” in Brno (Czech Republic, May 2002) and has been used in France, 
the Netherlands, and Norway (AFSSA, 2007; Baars et al., 2001; VKM, 2008). This 
corresponds to a provisional tolerable daily intake of 10 ng PCB-6/kg bw/day, since half the 
total intake of PCBs consists of PCB-6.  
                                                 
23Commission Regulation (EU) No 1259/2011 of 2 December 2011 amending Regulation (EC) No 1881/2006 as 
regards maximum levels for dioxins, dioxin-like PCBs and non dioxin-like PCBs in foodstuffs. 
24Analysed by the Norwegian Institute of Public Health. 
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The reference dose was derived from the BMDL from human studies described in the EFSA 
opinion from 2005. In 2008, VKM used 10 ng PCB-6/kg bw/day as a reference value in an 
evaluation of whether the TWI for dioxins and dl-PCBs was also protective to ndl-PCB 
exposure from the diet, given the relative composition of dioxins, dl-PCBs and ndl-PCBs in 
the food consumed in Norway. VKM concluded that with the combination of dioxins and 
PCBs in Norwegian food, exposure to dioxins below the TWI would also protect against 
toxicological effects from exposure to ndl-PCBs (VKM, 2008). 
 
Levels and trends for ndl-PCBs in breastmilk and infant formula  
From 1986 to 2005 the concentration of ndl-PCBs in breastmilk from Norway has decreased 
by approximately 70% (Figure 5.2). 
 
Figure 5.2: PCB-6 (ndl-PCBs) in breastmilk samples from Norwegian primiparous women collected in 
1986, 1993, 2001 and 2005 as part of the WHO surveillance programme on breastmilk (pooled data from 
10-50 mothers per year). Source: “Morsmelk og miljøgifter faktaark”, Norwegian Institute of Public 
Health based on Becher et al., 1995; Becher et al., 2002; NILU, 2013; Polder et al., 2009. 
 
Individual breastmilk samples from HUMIS (n=377) collected in 2003-2005 show inter-
individual variations in contamination levels between 10 to 454 ng/g lipid for sum PCB-6. 
Mean and median levels were 83 and 73 ng/g lipid, respectively (Polder et al., 2009). The 
mean, median and 95-percentile PCB-153 concentrations were 36, 32 and 64 ng/g lipids 
respectively (Polder, personal communication). 
The maximum levels (MLs) of sum PCB-6 in infant formula is 1.0 ng/g wet weight, as laid 
down in the EU regulation for MLs for dioxins, dl-PCBs and ndl-PCBs in foods25. Provided 
3.5% fat in infant formula, this corresponds to 29 ng/g fat. 
Norwegian occurrence data of PCB-6 in in infant formula have not been found. The mean 
concentration of sum of PCB-138, -153 and -180 was 3.4 ng/g fat (range 8.1-11 ng/g fat) in 
six samples of infant formula analysed at the Norwegian Institute of Public Health for the 
Norwegian Food Safety Authority in 2008 (personal communication26). The mean PCB-153 
concentration in these samples was 1.9 ng/g fat (range <LOQ to 4.8 ng/g fat). 
                                                 
25Commission Regulation (EU) No 1259/2011 of 2 December 2011 amending Regulation (EC) No 1881/2006 as 
regards maximum levels for dioxins, dioxin-like PCBs and non dioxin-like PCBs in foodstuffs. 
26May Frøshaug, Norwegian Institute of Public Health. 
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5.2.2 Brominated flame retardants 
5.2.2.1 Polybrominated biphenyls (PBBs) 
PBBs are structurally similar to PCBs, but are brominated instead of chlorinated. PBBs have 
similar toxicological characteristics as PCBs. They have been used as flame retardants and 
were produced until the mid-1980s. The current levels in Europe including Norway are low 
and of no toxicological concern (EFSA, 2010c). 
 
5.2.2.2 Polybrominated diphenyl ethers (PBDEs)  
PBDEs are a class of brominated hydrocarbons with a basic structure consisting of two phenyl 
rings linked by an oxygen atom. Similarly as for PCBs, there are 209 possible congeners, with 
different numbers depending on the position of bromine atoms on the phenyl rings. Mixtures 
of PBDEs have been widely used as flame retardants in e.g. plastics, textiles, electronic 
casings and circuitry since the early 1970s. International agreements on regulation and use of 
some PBDEs have been introduced since 2004. 
In general, PBDEs are persistent and bioaccumulative, with the exception of PBDE-209, 
which can undergo debromination reactions leading to formation of PBDE congeners 
containing seven to nine bromine atoms. The eight PBDE congeners; PBDE-28, -47, -99, -
100, -153, -154, -183 and -209 are the ones most often found in food and consequently, in 
humans. 
The risk from PBDE exposure was assessed by EFSA in 2011. Relevant toxicity data were 
only available for PBDE-47, -99, -153 and -209. Therefore a risk assessment could only be 
carried out for these four individual PBDE congeners (EFSA, 2011c). The main targets for 
PBDE toxicity are the liver, thyroid hormone homeostasis, and the reproductive and nervous 
system, but effects on neurodevelopment, which affect behaviour in mice, has also been 
identified as a critical endpoint. Due to limitations and uncertainties in the current database on 
PBDEs, no tolerable intakes have been established. Instead a margin of exposure (MOE) 
approach was used for the risk characterisation of PBDE congeners, by comparing the range 
of dietary intake for each of the different PBDE congeners with the estimated human intake 
associated with the body burden at the BMDL10 in the experimental animal studies. 
Based on interpretation of the basis for the body burden data, EFSA reasoned that a MOE 
larger than 2.5 might indicate that there is no health concern. 
For breastfed European infants (3 months, with body weight of 6.1 kg) the MOE for PBDE-
47, -99 and -153 the MOE was 12, 0.8 and 2.5 with average human milk consumption (800 
ml/day). For infants with high human milk consumption (1200 ml/day), the MOEs were 8, 0.6 
and 1.45, respectively. For PBDE-209, the MOE was about two orders of magnitude. EFSA 
concluded that the intake of PBDE-47 and -209 by breastfed infants does not constitute a 
health risk. For PBDE-99 and -153, the MOE is equal or smaller than a factor of 2.5 and thus 
exposure of breastfed infants might pose a potential health concern. It was noted that the 
highest mean exposure estimates across European countries were used for the MOE 
calculation and that the lowest estimated mean values for average and high consumption of 
human milk for PBDE-99and -153 are respectively about 40 and 25 times lower. In addition, 
EFSA noted that it takes three to four half-lives to reach steady state, i.e. 10 or more years for 
PBDE-99 and -153 in humans. Hence, the calculated MOEs for these PBDEs for breastfed 
infants based on the body burden would be an overestimation of the risk. Therefore, EFSA 
concluded that MOEs for PBDE-99 and -153 in human milk are unlikely to raise health 
concern to breastfed infants in Europe. 
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Levels and trends for PBDEs in breastmilk and infant formula 
In contrast to dioxins and PCBs, the concentration of PBDEs in breastmilk in Norway 
increased until approximately 2000, after which a decline has been observed, as illustrated in 
Figure 5.3. Similar trends have been observed in Sweden as well as elsewhere in Europe, 
while the levels in the USA are in the range of 10-fold higher. (Fangstrom et al., 2008; Toms 
et al., 2012).  
 
Figure 5.3: Sum of 7 PBDEs (PBDE-28, -47, -99, -100, -153, -154, -183) in breastmilk samples from 
Norwegian primiparous women collected in 1986, 1993, 2001 and 2005 as part of the WHO surveillance 
programme on breastmilk (pooled data from 10-50 mothers per year). Source: “Morsmelk og miljøgifter 
faktaark”, Norwegian Institute of Public Health based on Thomsen et al., 200; Thomsen, Stigum et al., 
2010.  
 
Individual breastmilk samples from HUMIS (n=393) collected in 2003-2005 provide 
information on inter-individual variation in contamination level for sum 7 PBDEs in women 
in Norway (Thomsen, Stigum et al., 2010). The results are presented in Table 5.1 and indicate 
a wide variation among breastmilk samples. 
 
Table 5.1: Concentration of sum 7 PBDEs (ng/g lipid) in individual breastmilk samples collected in 2003-
2005 in the HUMIS project (n=393) (Thomsen, Stigum et al., 2010). 
Substance Min Median Mean 75-percentile 95-percentile Max 
Sum 7 PBDEs 0.48 2.1 3.4 3.2 3.7 82 
 
According to EFSA 2011, the average concentrations of the predominant PBDE congeners in 
human milk show a comparable mean contamination across various European countries. 
PBDE-47 had mean concentrations across countries of 0.14 to 3.0 ng/g lipid and the range of 
means for PBDE-99 and PBDE-153 were found to be <0.03-1.1 ng/g lipid and 0.10-2.4 ng/g 
lipid, respectively. There were wide concentration ranges for several PBDEs from various 
countries. For PBDE-209, mean concentrations between 0.21 and 2.9 ng/g lipid were reported 
for seven European countries (EFSA, 2011). The Norwegian data (Thomsen, Stigum et al., 
2010) were part of the assessment. 
The mean concentration in six samples of infant formula analysed at the Norwegian Institute 
of Public Health for the Norwegian Food Safety Authority in 2008 was for PBDE-47: 0.06 
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(range 0.03-0.13) ng/g lipid (personal communication27). The range of PBDE-99 was 0.04-
0.16 ng/g lipid and of PBDE-153 <LOQ-0.013 ng/g lipid. The mean BDE-209 concentration 
was 0.73 (range 0.25-2.2) ng/g lipid. 
 
5.2.2.3 Other brominated flame retardants 
Hexabromocyclododecane (HBCDD) and tetrabrombisphenol A (TBBPA) are two other 
classes of brominated flame retardants which were assessed by EFSA in 2011 (EFSA, 2011b; 
EFSA, 2011d). Knowledge about the toxicity of these two compounds is limited and no 
tolerable intakes have been established. Based on present knowledge, the margins of exposure 
(the margin between levels causing toxic effects in animals and levels of exposure in humans, 
including from breastmilk) are large. 
 
5.2.3 Chlorinated pesticides 
DDT and many other chlorinated and persistent pesticides (HCH, aldrin/dieldrin, endrin, 
HCB, endosulphane and heptachlor) have been used extensively in the past. These have now 
been phased out and are generally no longer in use. DDT is an exception and is still used to 
fight mosquitoes carrying malaria in some non-European countries.  
DDT and HCB are the most studied pesticides, and as no epidemiological data were available 
for other pesticides (see section 7.1) the description in the sections below is restricted to these 
two pesticides.  
 
5.2.3.1 Dichlordiphenyltrichlorethane (DDT) 
DDT was commercially introduced as an insecticide in the 1940s. Technical DDT contains 
65-80% p,p’-DDT, which harbour the main insecticide activity. Major breakdown products of 
DDT are p,p’-DDE and p,p’-DDD. Sum of DDT refer to p,p’- DDT, o,p’-DDT, p,p’-DDE, 
o,p’-DDE, p,p’-DDD and o,p’-DDD.  
DDT was banned in many European countries for most uses in the early 1970s and was 
banned in the EU in 1986. DDT is still used for vector control, especially in areas with 
endemic malaria. Extended use was recently recommended by WHO for indoor residual 
spraying to control malaria. 
Because of the lipophilic properties and persistence in the environment, DDT and related 
compounds bioaccumulat and biomagnify along the food chain. 
The DDT metabolite DDE has antiandrogenic activity, while p,p'-DDT (a main component) 
has little or no androgenic or estrogenic activity. The minor component o,p'-DDT has weak 
estrogenic activity. DDT and its metabolites have neurotoxic capacity and can directly affect 
nerve cells by interference with the membrane transport of potassium, sodium, calcium, or 
chloride ions. Inhibition of selective enzymatic activities, or contribution to the release and/or 
the persistence of chemical transmitters at nerve endings which results in repetitive discharges 
in neurons have also been reported.  
The main target organs are the nervous system and the liver. It also affects hormonal tissues, 
reproduction, fetal development and the immune system. DDT is classified by IARC as 
                                                 
27May Frøshaug, Norwegian Institute of Public Health. 
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possibly carcinogenic to humans (group 2B). The Joint FAO/WHO Meeting on Pesticide 
Residues (JMPR) derived a provisional tolerable daily intake (PTDI) for DDT of 0.01 mg/kg 
bw (WHO, 2000). 
According to EFSA (2006), a mean dietary intake for adults and children is approximately 5-
30 ng/kg bw/day (EFSA, 2006a). This exposure level is more than two orders of magnitude 
below the PTDI of 0.01 mg/kg bw. 
 
Levels and trends for DDT in breastmilk and infant formula 
Since chlorinated pesticides are phased out and no longer in use in Norway, the level of these 
substances in the environment and in breastmilk has declined dramatically, as illustrated in 
Figure 5.4. Breastmilk from 10 to 50 mothers were combined and analysed as one sample and 
represent a mean concentration for each year.  
 
Figure 5.4: Sum DDT (p,p’- DDT, o,p’-DDT, p,p’-DDE, o,p’-DDE, p,p’-DDD and o,p’-DDD) in breastmilk 
samples from Norwegian primiparous women collected in 1986, 1993, 2001 and 2005 as part of the WHO 
surveillance programme on breastmilk. Source: “Morsmelk og miljøgifter faktaark”, Norwegian Institute 
of Public Health based on Polder et al., 2008; Polder et al., 2009. 
A general default EU maximum residue level (MRL) for baby food/infant formula of 0.01 
mg/kg is applicable to all pesticides unless specific MRLs lower than 0.01 mg/kg were 
established in EU legislation28 for this food type. No specific data on levels of DDT or 
derivatives in infant formula in Norway or Europe were found. According to a recent report 
from EFSA, no baby food from Norway had pesticide concentrations above 0.01 mg/kg 
(EFSA, 2013b). 
 
5.2.3.2 Hexachlorbenzene (HCB) 
HCB as pesticide (fungicide) has been phased out but it is still used as an industrial chemical 
to some extent. It is released as a by-product from the manufacture of industrial chemicals and 
several pesticide formulations, and can be released to the environment during incineration.  
HCB is readily absorbed in humans and animals. It has low acute toxicity. The liver is the 
                                                 
28Commission Directive 2006/141/EC for infant formulae and follow-on formulae and in Commission Directive 
2006/125/EC for processed cereal-based foods and baby foods for infants and young children. 
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predominant organ to be affected resulting in enzyme induction and porphyria. HCB is 
classified by IARC as a possible human carcinogen and since HCB exhibits weak mutagenic 
activity in some tests, a genotoxic mode of action cannot been excluded. 
Although neurobehavioural effects in rat pups exposed to HCB has been reported, no data 
were located regarding possible mechanisms of HCB-induced neurotoxic effects (EFSA, 
2006b). 
Foods containing animal fat are the major source of HCB exposure in humans. There is no 
tolerable intake of HCB because it might be a genotoxic carcinogen. EFSA stated in 2006 
(EFSA, 2006b), that there is a 1.6-80 x 105 margin between a dose causing 5% liver tumours 
in rats and the human exposure, and concluded that current HCB exposure was of low 
concern. EFSA estimated the exposure in breastfed infants to be approximately two orders of 
magnitude higher (per kg body weight) than the median daily intake in adults.  
 
Levels and trends for HCB in breastmilk and infant formula 
After the ban as pesticide in Europe in 1981, the level of HCB has declined approximately 
95% in Norwegian breastmilk as illustrated in Figure 5.5. Breastmilk from 10 to 50 mothers 
were combined and analysed as one sample and represent a mean concentration for each year. 
The same trend has been seen in other European countries (Furst, 2006). 
 
Figure 5.5: HCB in breastmilk samples from Norwegian primiparous women collected in 1986, 1993, 2001 
and 2005 as part of the WHO surveillance programme on breastmilk. Source: “Morsmelk og miljøgifter 
faktaark”, Norwegian Institute of Public Health based on Eggesbo et al., 2009; Polder et al., 2009. 
 
Individual breastmilk samples from HUMIS (n=423) collected in 2003-2005 provide 
information on inter-individual variation in contamination levels between 3.6 to 42 ng/g lipid 
for HCB (12-fold variation from lowest to highest concentration) in women in Norway. Mean 
and median levels were 12 and 11 ng/g lipid, respectively (Polder et al., 2009). 
No specific data on levels of HCB in infant formula in Norway or Europe was found. 
According to a recent report from EFSA, no baby food recently reported from Norway had 
pesticide concentrations above the default EU MRL of 0.01 mg/kg (EFSA, 2013b). 
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5.2.4 Fluorinated compounds 
Perfluoroalkylated substances (PFAS) consist of neutral and anionic surface active 
compounds with high thermal, chemical and biological inertness. Perfluorinated compounds 
are generally hydrophobic, but also lipophobic, and will therefore not accumulate in fatty 
tissues as is usually the case with other persistent halogenated compounds. An important 
subset is the organic surfactants, to which PFOS and PFOA belong. It is generally recognised 
that food is a major source to PFOS and PFOA exposure. A recent study on Norwegian 
women showed that the indoor environment may be an important contributor to human 
exposure (Haug et al., 2011). 
Since PFOS and PFOA show highest occurrence and have been most studied, these are 
shortly described below.  
 
5.2.4.1 PFOS 
In sub-acute and chronic studies of PFOS, the liver is the major target organ, but 
developmental toxicity has also been seen. Other sensitive effects were changes in thyroid 
hormone- and high density lipoprotein levels in rats and Cynomolgus monkeys. PFOS 
induced liver tumours in rats, which appears to be due to a non-genotoxic mode of action. 
EFSA (2008) established a TDI for PFOS of 150 ng/kg bw per day by applying an overall 
uncertainty factor (UF) of 200 to the NOAEL of 0.03 mg/kg bw per day in a study with 
subchronic exposure in monkeys (EFSA, 2008a). Updated exposure calculations from EFSA 
indicate that for PFOS, the dietary exposure estimate in the adult population is <3.5% of the 
TDI for average consumers and <6.7% of the TDI in high consumers, and that exposure in 
toddlers is 2 to 3 times higher than in adults (EFSA, 2012b). 
 
5.2.4.2 PFOA 
In studies with sub-acute and chronic exposures, PFOA primarily affected the liver. PFOA 
can also cause developmental and reproductive toxic effects at relatively low dose levels in 
experimental animals. 
EFSA has established a TDI for PFOA of 1.5 g/kg bw per day by applying an overall UF of 
200 to the lowest BMDL10 for increased liver weight in rodents (EFSA, 2008a). Updated 
exposure calculations from EFSA indicate that for PFOA, the dietary exposure estimates in 
the adult population was 0.3% of the TDI for average consumers and 0.5% of the TDI in high 
consumers, and that exposure in toddlers was two to 3 times higher compared to adults 
(EFSA, 2012b). 
 
Levels and trends for PFOS and PFOA in breastmilk and infant formula 
The concentration of PFOS and PFOA in breastmilk is low compared to blood. Still, Thomsen 
et al. (Thomsen, Haug et al., 2010) showed that the intake of PFCs through breastmilk  (per 
kg body weight) is similar to the dietary intake for Norwegian adults.  
In breastmilk in Sweden, PFOS and PFOA showed increasing trends from 1972 to 2000, with 
concentrations reaching a plateau in the 1990s. Then there was a significant decreasing trend 
from 2001 to 2008. At the end of the study, in 2008, the measured concentrations of PFOS, 
and PFOA in pooled human milk were 75 pg/mL and 74 pg/mL, respectively. The temporal 
trends for PFOS and PFOA observed in human milk are parallel to those reported in serum in 
the the general population in Sweden and Norway (Haug et al., 2009; Karrman et al., 2007). 
Norwegian Scientific Committee for Food Safety (VKM) 10-003-final  
2 
 





Helle Margrete Meltzer (chair) 
Per Brandtzæg 
Helle Knutsen 
Beate Fossum Løland 
Jon Øyvind Odland 
Janneche Utne Skåre 
Liv Elin Torheim 
Norwegian Scientific Committee for Food Safety (VKM) 10-003-final  
94 
 
The concentrations in breastmilk in Norway are in the same range as in Sweden (Haug et al., 
2011). 
 
5.2.5 The relationship between children’s exposure to persistent organic pollutants 
and body burden 
Persistent organic pollutants (POPs) accumulate in the body over time and it is generally 
recognised that toxicity is more related to the body burden than to recent dietary exposure. 
The body burden is the total amount of a substance in the body, and is commonly expressed 
per kilo body weight. For lipophilic POPs, such as PCBs, virtually all will be found in the 
lipid compartments of the body. Furthermore, the contaminant concentration in body lipids, 
(e.g. different fat deposits, blood lipids, membranes) are in equilibrium with each other, and 
all body fats can be regarded as one compartment. Thus, the PCB body burden can be 
calculated based on the concentration of PCBs in blood lipids, body weight, and percent fat in 
the body. Several POPs follow 1st order toxicokinetics, meaning that the half-life (the time 
needed to reduce the concentration in the body to the half in the absence of exposure) is 
constant and therefore independent of the concentration in the body. In an individual with 
constant exposure, equilibrium between the intake and excretion will be reached after 3-5 
half-lives, and the body burden (or the concentration in blood) is then constant (illustrated in 
Figure 5.6). It therefore takes approximately 25 years to reach steady state for a substance 
with a half-life of 7.5 years (e.g. dioxins). 
 
 
Figure 5.6: Illustration of dioxin body burden over time when exposure and body weight is constant. A 
half-life (T1/2) of 7.5 years has been used. Sorurce: HK Knutsen. 
 
The illustration in Figure 5.6 is a simplification of the development of the body burden in 
adults. Depending on physical and chemical properties, environmental contaminants are to 
different extents excreted in breastmilk, and the concentration in the maternal body will be 
reduced during the breastfeeding period. In a study of breastmilk in 10 Norwegian women, 
the change in contaminant concentration in the milk during a 12 months nursing period was 
monitored. After a year of breastfeeding, the concentrations of different PCBs, PBDEs and 
PFCs were reduced by 15-94% (Thomsen, Haug et al., 2010). For several reasons, children do 
not have a steady state concentration in the body. First, they are born with approximately the 















BB = (intake x fraction absorbed x T1/2 /ln2) x (1 – e -ln2/T1/2 x time)
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same blood concentration as the mother. After birth the blood concentration increases with 
their dietary exposure, but the increase is not as steep as adults would have had with similar 
contaminant intake, because the child’s body weight is increasing and the amount of body fat 
is changing. Furthermore, the exposure duration in childhood is too short to reach a steady 
state.  
The most important determinant of postnatal exposure to POPs in breastfed infants is the 
concentration in the breastmilk, breastmilk consumption and duration of breastfeeding. 
Although it is difficult to obtain blood samples from children at the end of the nursing period, 
several studies have documented a relationship between breastfeeding and children’s POP 
concentration in blood, and thereby the body burden (see below). It is well recognised that 
breastfed infants have substantially higher exposure to persistent organic pollutants than 
formula fed infants. However, the difference in the concentration in the breastfed infant and 
the unborn child (postnatal versus prenatal exposure) is not well described. This difference 
might be of high toxicological relevance, since the infant may be equally susceptible to 
environmental contaminants as the unborn child as a concervative approach.  
In a study from Germany, Lackman et al. compared concentrations of contaminants at birth, 6 
weeks and 6 months in 10 breastfed and 10 formula fed infants. At 6 weeks, the infants’ 
serum concentrations of the POPs measured were approximately 10-fold higher in the 
breastfed than in the formula fed. An almost doubling in PCBs and DDE was observed in the 
breastfed from 6 weeks to 6 months of age, as illustrated in Figure 5.7 (Lackmann et al., 
2004; Lackmann et al., 2005). The study group was small, but analytical results from children 




Figure 5.7: Median serum organochlorine concentration in 10 breastfed (BF) and 10 formula fed (FF) 
German children sampled at 6 weeks and 6 months. Based on data in Lackmann et al. 2005. 
 
Data from 6-month old infants are available from an Inuit cohort, where the concentration of 
PCB-153 in serum from 6-month old children that were breastfed for less than 3 months 
(n=26) was 1.6-fold that of those never breastfed (n=14). The serum concentration in those 
breastfed for more than 3 months (n=50) was slightly more than 4-fold higher than in those 
breastfed for less than 3 months. In comparison with the maternal concentration in the overall 
cohort (n=128), the level was 1.5-fold that of the mean maternal concentration in those 
breastfed for more than 3 months (Ayotte et al., 2003).  
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In the Faroe Islands cohort 3, the serum PCB concentration at age 18 months was slightly 
higher than the average maternal level during pregnancy. The average exclusive and total 
breastfeeding period was 4.6 months and 9.8 months (Heilmann et al., 2010).  
In children from Menorca born in 1997-98, the concentration of several different chlorinated 
contaminants was significantly higher (approximately 3-fold for PCB-153 and DDE) in 
breastfed 4-year olds (n=244, 83% breastfed, duration 0.93 to 96 weeks) than in non-
breastfed. Compared with the concentration in cord blood, the concentration of PCB-153 was 
almost 2-fold higher at 4 years than at birth, while the concentration of DDE was only 
marginally higher. In formula fed children the concentration of most compounds were lower 
at 4 years of age than at birth (Carrizo et al., 2006). The difference between ever breastfed and 
formula fed children differed depending on the length of breastfeeding. The PCB 
concentration (PCB-153, -138, -180) at 4 years of age was approximately twice as high in 
children breastfed for 3 months or longer compared with a median duration of breastfeeding 
shorter than 3 months (Grimalt et al., 2010). For other chemicals the differences were even 
more marked (for instance DDE), while for a few substances, there was little difference (for 
instance PCB-118). In the same cohort from Menorca, levels of PBDEs were measured in 
cord blood and sera at 4 years of age. A lower concentration of e.g. the abundant PBDE-47 
was found in formula fed than in ever breastfed infants. Since birth, the concentration had 
decreased markedly in the formula fed children, but was in average 20% higher in serum at 4 
years than in cord blood in the breastfed group (Carrizo et al., 2007).  
In a German cohort recruited in 1993-95, a 4.5-fold higher PCB concentration was reported in 
4-year old children who had been breastfed more than 4 months compared with children who 
had been breastfed two weeks or less (Walkowiak et al., 2001). The data did not allow for 
comparison with levels at birth. 
Several POPs were analysed in serum of 323 Swedish pregnant women born in the 1980s 
with a mean age of 28 years (Glynn et al., 2007). When these women were infants in the 
1980s, they were breastfed with a mean duration of 4 months. Concentrations of PCB-156, 
PCB-180 and p, p'-DDE were significantly associated with the duration these women had 
been breastfed. The largest effect was observed for current adult levels of DDE, where a 34% 
increase was estimated for 10 months of breastfeeding. Significant associations were also 
shown for PCB-180 and PCB-156, although weaker.  
These studies all show that body burdens are strongly influenced by duration of breastfeeding 
and that this influence might be of long-lasting character and can still be evident in adulthood.  
The effect of breastfeeding on levels measured in blood are not directly comparable because 
of differences in maternal exposure, age of the children when contaminants were measured, 
duration of breastfeeding, and the ratio of exclusive to partial breastfeeding. With increasing 
child age, the influence of other factors than breastmilk, such as individual differences in 
growth/body size increase and individual differences in the diet, will have an increased impact 
on body burdens. More importantly, none of the studies described above had results that allow 
for an assessment of amount of POPs increase per month of breastfeeding. None of the studies 
allow for a separate evaluation of the effects of exclusive and partial breastfeeding.  
A way of estimating body burdens due to breastfeeding is by modelling the change in body 
burden over time, taking excretion and dilution due to the expansion in the child’s body mass 
into account (PBPK) as proposed by Verner et al. (Verner et al., 2009). Recently, Verner’s 
model was further refined and validated on two datasets which contained repeatedly measured 
concentrations of PCB-153 and p, p'-DDE in infants/children, and a good prediction was 
obtained (Verner et al., 2012). According to this model, POP levels drop drastically after birth 
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in babies who are not breastfed due to the fast growth during the first months after delivery, 
and the thereby resulting dilution of the body burden at birth. In contrast, as long as the baby 
is still breastfed, a steady increase occurs. Four months of breastfeeding results in a doubling 
of the concentration from birth. Then, after cessation of breastfeeding at 4 months, the levels 
decline back to the levels observed at birth over the next 6 to 8 months. Twelve months of 
breastfeeding results in a doubling of the level at 4 months, and after cessation of 
breastfeeding at one year, the levels are not estimated to decrease markedly over the next two 
years. This is due to the fast growth spurt during the infant’s first year of life which levels off 
at 1 year of age. Taken together this results in 4-fold higher PCB and DDE levels at both one 




Figure 5.8: Examples of simulated toxicokinetic profiles in children breastfed for 0, 4 and 12 months. 
Simulations were carried out using a daily dose of 5 ng PCB-153/kg bw/day in mothers (Verner et al., 
2012). 
 
Similar illustrations have not been found for breastfeeding beyond 12 months, but it is 
reasonable to predict that the body burden will increase as long as the child is breastfed. The 
example in Figure 5.8 used 5 ng PCB-153/kg bw/day as a daily intake in the mothers. The 
median and 95-percentile PCB-153 intake was 0.73 ng/kg bw/day and 5.8 ng/kg bw/day, 
respectively, in Norwegian mothers participating in the MoBa study between 2002 and 2009 
(Caspersen et al., 2013). 
There is no toxicokinetic model for dioxins and dl-PCBs in breastfed children. There is, 
however, a high correlation between exposure to ndl-PCBs and dioxins and dl-PCBs, and a 
rough estimate can be done based on this correlation. An exposure to dl-compounds at the 
TWI of 14 pg TEQ/kg bw/week is associated with a daily intake of approximately 10 ng/kg 
bw/day of PCB-6 with the present composition of dl-compounds and ndl-PCBs in Norwegian 
food (VKM, 2008). Consequently, a PCB-6 intake below this level would protect against 
eventual toxic effects of both ndl-PCBs and dl-compounds. Approximately 33% of PCB-6 in 
the diet is PCB-153, thus approximately 3.3 ng PCB-153/kg bw/day would correspond to an 
intake of 10 ng/kg bw/day of PCB-6 (VKM, 2008). In other words, with the present 
composition of dioxins and PCBs in food in Norway, a daily intake of approximately 3.3 ng 
PCB-153/kg bw/day will give a concomitant intake of dioxins and dl-PCBs approximately at 
a level which is similar to the TWI for this group of substances. The median intake of PCB-
153 in Norwegian pregnant women is estimated to be much lower, while the 95-percentile is 
less than 2-fold higher than 3.3 ng/kg bw/day, as indicated above.  
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 Process-generated contaminants 5.3
During processing of food, contaminants can be formed, often because of heat treatment. 
Acrylamide, PAH, furan and 3-monochloropropane 1,2-diol (3-MCPD) are examples of 
substances that may be of relevance for infant formula, and for which some data were 
retrieved by literature search (Appendix 6).  
 
5.3.1 Acrylamide 
Acrylamide is produced at higher temperatures when preparing foods containing both proteins 
and carbohydrates. Food is the major acrylamide source in non-smokers. Acrylamide is 
classified by IARC as “probably carcinogenic to humans” (group 2A) (IARC, 1994). It is 
water soluble and does not accumulate in the food chain. JECFA concluded in their risk 
assessment that the MOEs are low and may indicate a human health concern. Therefore, 
appropriate efforts to reduce acrylamide concentrations in foods should continue (JECFA, 
2005).  
The low MOEs were confirmed in an updated exposure assessment in Europe performed by 
EFSA. For toddlers (1-3 years) mean intake was estimated to range between 1.2 and 2.4 g/kg 
bw per day and 95th percentile between 2.4 and 6.5 g/kg bw per day. Major contributors to 
acrylamide exposure were fried potatoes, bread and biscuits (EFSA, 2011a).  
Acrylamide levels in infant formula or breastmilk have not gained much attention, being a 
much smaller source than the foods mentioned above. However, occurrence in both infant 
formula and breastmilk was reported in a Swedish study on baby food (Fohgelberg et al., 
2005). For all breastmilk samples except one, the acrylamide level was below the limit of 
quantification (0.5 µg/kg). Assuming an acrylamide level of 0.25 µg/kg in breastmilk, the 
mean acrylamide intake during the first 6 months for children who were exclusively breastfed 
was estimated to be 0.04 µg/kg bw/day. In three out of eight analysed samples of infant 
formula, the acrylamide content was verified and possible to quantify (0.6, 0.6, and 0.7 µg/kg, 
respectively).  
In a Bavarian study conducted in 2005, acrylamide concentrations ranging between 0.1 and 
1.3 g/kg (median: 0.11 g/kg; 95th percentile: 0.33 g/kg) were discovered in 172 
breastmilk samples. The infant formula investigated in the same study showed comparable 
results, which were on average slightly above the mean level of breastmilk (German Federal 
Environment Agency, 2008). 
 
5.3.2 Polycyclic aromatic hydrocarbons (PAHs) 
PAHs are formed during incomplete combustion of organic materials and are therefore 
produced in industrial processes, during heating of wood or fossil fuel, and during food 
preparation (e.g. barbequing and smoking). PAHs generally occur in complex mixtures which 
may consist of hundreds of compounds. Several PAHs evaluated by EFSA in 2008 have been 
classified as genotoxic and carcinogenic. Of these, benzo(a)pyrene (BaP) is most extensively 
characterised (EFSA, 2008b). For non-smokers the major route of exposure is consumption of 
food, and grain-based food and seafood are the largest contributors. 
According to EFSA, the MOEs in Europe indicate a low concern for consumer health at the 
average estimated dietary exposures. However, for high level consumers the MOEs are close 
to or less than 10,000, indicating a potential concern for consumer health (EFSA, 2008b). 
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In a study from urban and rural areas in Tuscany in Italy, PAH was determined in milk 
collected in 2004-2005 from 32 women. PAH concentration was higher in milk from women 
living in urban than in rural regions. Furthermore, the PAH level in breastmilk was highly 
influenced by cigarette smoking (Zanieri et al., 2007). In this study, the BaP concentration 
was below the detection limit in all non-smoking donors, and ranged from below the detection 
limit to 1.17 µg/kg milk fat in breastmilk from smoking donors. The detection rates of 
benz(a)anthracene, benzo(b)fluoranthene and chrysene were low, but higher in milk from 
smoking than from non-smoking mothers. 
The maximum level for PAH in infant formula is 1.0 µg/kg for both BaP alone and for the 
sum of four PAHs (BaP, benz(a)anthracene, benzo(b)fluoranthene and chrysene) (EU, 2011). 
In a report from Food Standards Agency (FSA) in UK (2006), 97 samples of infant formula 
obtained from across the UK were tested for 15 PAHs. Most PAHs were not detected in the 
majority of samples. The BaP concentrations were in the range of <0.01-0.2 µg/kg in infant 
formulas. BaP was below the limit of detection in 57 of the samples (59%). The estimated 
intakes from infant formula in this survey indicated a low concern for human health (FSA, 
2006). 
 
5.3.3 3-Monochloropropane-1,2-diol (3-MCPD) 
3-MCPD is formed in heat-treated foods and was first detected in various foods such as 
hydrolysed vegetable proteins and soy sauce. It is classified as possibly carcinogenic to 
humans by IARC (group 2B agent), but is not acting via a genotoxic mechanism. Studies have 
linked 3-MCPD with infertility in rats, suppression of the immune function and possible 
carcinogenicity.  
In 2001, JECFA considered 3-MCPD and assigned a provisional maximum tolerable daily 
intake (PMTDI) of 2 g/kg bw/day, which was retained in 2006 (JECFA, 2006).  
In 2007, the presence of fatty esters of 3-MCPD (3-MCPD esters) was reported for the first 
time in a number of foods including refined edible fats, such as margarine and oils, as well as 
in infant formula and breastmilk. Since 3-MCPD can be released from the esters, the presence 
of 3-MCPD esters should be addressed. While there are a number of toxicological animal 
studies on 3-MCPD, little is known about the occurrence, toxicokinetics or toxicity of 3-
MCPD esters. Such data are needed to assess the possible risks to human health. 
There are reports on 3-MDCP esters in both infant formula and in breastmilk, indicating 
higher levels in infant formula than in breastmilk (BfR, 2007; Zelinkova et al., 2006; 
Zelinkova et al., 2008).  
 
5.3.4 Furan 
Furan is a volatile and lipophilic compound formed in a variety of heat-treated commercial 
foods, including infant formula. The presence of furan is of potential health concern because 
it has been classified as “possibly carcinogenic to humans” (group 2B agent) by IARC. A 
genotoxic mechanism is likely in furan-induced carcinogenesis and in a risk assessment from 
2012, VKM concluded that the current exposure to furan in all age groups, particularly among 
infants and children, is of health concern (VKM, 2012).  
No occurrence data for furan in infant formula sold on the Norwegian market is available. 
VKM recently published a risk assessment of furan (VKM, 2012). The calculated furan 
exposures were based on the mean furan concentration (upper bound) in dry infant formula of 
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3.2 g/kg (n=11) from data in an EFSA monitoring report (EFSA, 2011f) and the mean and 
95-percentile consumption of infant formula reported for all participants and for the non-
breastfed 6-month old infants in a Norwegian dietary survey (Spedkost, 2006-2007) 
(consumers only for both groups). A mean furan exposure from infant formula was 0.02 
µg/kg bw/day for consumers only among all 6-month olds, while the 95-percentile exposure 
was 0.05 µg/kg bw/day. For the 6- and 12-month old infants, especially jarred baby food 
contributed more to the exposure than infant formula.  
No data on concentration of furan in breastmilk has been identified. 
 
 Substances migrating from food contact materials – bisphenol A and 5.4
phthalates  
The infant feeding bottles and the attached teats used to supply formula or expressed 
breastmilk are potential sources of exposure to contaminants for infants. Likewise, substances 
leaking from food packaging material into food consumed by the mother can also be present 
in breastmilk. Food contact materials can also leak into infant formula. Two classes of 
hormone active substances (bisphenol A and phthalates) which are considered to be of special 
relevance are described shortly below. These substances are short-lived and will therefore not 
accumulate in the food chain or in the body. 
 
5.4.1 Bisphenol A (BPA) 
Bisphenol A (BPA) is a hormone active substance and acts by activation of the estrogen 
receptor. A main concern regarding exposure in early life has been migration of BPA from 
baby bottles. BPA is permitted for use in food contact materials in the EU under a regulation 
relating to plastic materials and articles intending to come into contact with foodstuffs29. In 
2011, the European Commission adopted a directive prohibiting the use of BPA for the 
manufacture of polycarbonate infant feeding bottles30. Norway also banned the use of BPA in 
baby bottles from 2011. 
EFSA completed its full risk assessment of BPA in 2006 and set a TDI of 0.05 mg/kg bw/day 
for this substance (EFSA, 2006c). EFSA also evaluated intakes of BPA through food and 
drink for adults, infants and children and found that they were all well below the TDI. 
Following further consideration of new scientific studies, EFSA in 2012 decided to undertake 
a full re-evaluation of the human risks associated with exposure to BPA through the diet, also 
taking into consideration the contribution of non-dietary sources to the overall exposure to 
BPA. The new opinion (expected to be published in 2014) will review all the available data 
and scientific studies on dietary exposure published since EFSA’s 2006 Opinion.  
Since the ban of the use of BPA in polycarbonate (PC) baby bottles in 201131, baby bottles 
made of other plastics materials have appeared on the market. As part of this benefit and risk 
                                                 
29Commission regulation No 10/2011 of 14 January 2011 on plastic materials and articles intended to come into contact with 
food. 
30Commission Directive 2011/8/EU of 28 January 2011 amending Directive 2002/72/EC as regards the restriction of use of 
Bisphenol A in plastic infant feeding bottles and Commission implementing regulation (EU) No 321/2011 of 1 April 2011 
amending Regulation (EU) No 10/2011 as regards the restriction of use of Bisphenol A in plastic infant feeding bottles. 
31Commission Regulation (EU) No. 10/2011 of 14 January 2011 on plastic materials and articles intended to come into 
contact with food. Off J Eur Union, L12: 1–89 and Commission implementing Regulation (EU) No. 321/2011 of 1 April 
2011 amending Regulation (EU) No. 10/2011 as regards the restriction of use of bisphenol A in plastic infant feeding bottles. 
Off J Eur Union, L87: 1–2. 
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assessment of breastmilk, VKM asked various EU member states for information about the 
materials used in baby bottles and possible migration of chemicals from infant feeding (baby) 
bottles and teats after the BPA ban. Information about chemical contaminants in infant 
formula was also requested. The information received on the basis of this call is summarised 
in Appendix 8. 
 
5.4.2 Phthalates 
Based on their chemical and physical properties, phthalates have been commonly used for 
decades as plasticizers to soften consumer products and make them more flexible and 
resilient. Phthalates may be present in foods as a result of migration from food contact 
materials. Phthalates commonly found are di-2-ethylhexyl phthalate (DEHP), di-n-butyl 
phthalate (DnBP) and di-isobutyl phthalate (DiBP). Although it is reported that phthalates are 
no longer used in the production of food contact plastics, they may be used as carriers for 
pigments in printing inks and in adhesives applied to a plastic food contact material. Further, 
phthalates are commonly found in food contact materials made of paper and board, in 
particular when the material has been recycled. As a result of their widespread use and their 
moderate resistance to degradation, phthalates are also ubiquitous in the environment. 
Therefore, they may also be present in foods as a consequence of environmental 
contamination.  
Phthalates have adverse effects on the liver, kidneys and reproductive system in particular and 
they can act on endocrine systems. For DEHP, a TDI of 50 g/kg bw was established by 
EFSA in 2005 based on developmental and testicular toxicity (e.g. germ cell depletion and 
reduced testis weight) in the F1 generation of rats32. For DnBP, a TDI of 10 g/kg bw was set 
based on reproductive effects in rats (EFSA, 2005b). A TDI has not been established for 
DiBP. 
In a recent German study on 78 breastmilk samples, median concentrations were 3.9 ng/g for 
DEHP, 0.8 ng/g for DnBP, and 1.2 ng/g for DiBP. In infant formula (n=4), mean values were 
19.7 ng/g for DEHP, 3.8 ng/g for DnBP, and 3.6 ng/g for DiBP. The authors concluded that 
the calculated intake for breastfed infants corresponded to about 2% to 7% of the tolerable 
daily intake. For infants nourished with formula, phthalate intake was of the same magnitude 
or slightly higher (DEHP) than for exclusively breastfed infants (Fromme et al., 2011). 
In a study from 2012 by the Food Standards Agency in UK determining phthalates in food, 
among 16 samples of infant formula, one sample of infant milk formula contained 13 g/kg 
DiBP and two samples, goat milk infant formula and organic infant milk formula, contained 
96 and 125 g/kg DEHP, respectively (Food Standard Agency, 2012). 





                                                 
32Statement of the EFSA Scientific Panel on Food Additives, Flavourings, Processing Aids and Materials in Contact with 
Food on a request from the Commission on the possibility of allocating a group-TDI for Butylbenzylphthalate (BBP), di-
Butylphthalate (DBP), Bis(2-ethylhexyl) phthalate (DEHP), di-Isononylphthalate (DINP) and di-Isodecylphthalate (DIDP) 
(Minutes statement expressed on 28 June 2005 at its 12th Plenary meeting, corresponding to the item 10 of the agenda). 
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 Microorganisms that may influence infant health if breastmilk is 5.5
replaced by infant formula  
The description below is focused on powdered infant formula since it is not sterile (in contrast 
to available liquid, rehydrated, ready-to eat infant formula).  
Based on the strength of the evidence of a causal association between the presence of 
microorganisms in powdered infant formula and illness in infant, FAO/WHO placed 
microorganisms of concern into three categories (FAO and WHO, 2004): 
Category A organisms – clear evidence and causality: Bacterial species belonging to the 
family Enterobacteriaceae, like Salmonella spp. and Cronobacter spp. 
Category B organisms – causality plausible, but not yet demonstrated: Other bacterial species 
within the family Enterobacteriacae, such as Pantoea agglomerans, Escherichia vulneris, 
Hafnia alvei, Klebsielle pneumoniae, Citrobacter koseri, Citrobacter freundii, Klebsiella 
oxytoca, and Enterobacter cloacae, 
Category C – causality less plausible, or not yet demonstrated: Bacillus cereus, Clostridium 
perfringens, Clostridium difficile, Clostridium botulinum, Staphylococcus aureus, and Listeria 
monocytogenes. 
Among these bacterial species, microorganisms belonging to Category A are of special 
concern. Several outbreaks of Salmonella infection among infants have been attributed to 
contaminated, powdered infant formula, resulting in diarrhoea and, in some infants, 
bacteraemia and meningitis (Cahill et al., 2008). According to Cahill and co-workers, 
outbreaks of salmonellosis among infants due to powdered infant formula are probably 
underreported. Nevertheless, they highlight the need to recognise powdered infant formula as 
a potential source of Salmonella infection in infants.  
In particular Cronobacter spp. (formerly Enterobacter sakazakii), which comprise six 
different genomospecies (Healy et al., 2010) is a rare cause of invasive infection with high 
death rates in neonates (Lai, 2001). Clinical symptoms related to this emerging opportunistic 
pathogen include necrotizing enterocolitis (NEC), meningitis and sepsis both in premature 
and full-term infants. Neonates aged <28 days and infants <2 months are at greatest risk (FAO 
and WHO, 2004). The high tolerance of Cronobacter spp. to osmotic stress and elevated 
temperature may contribute to survival of the bacteria in powdered infant formula (Healy et 
al., 2010). Cronobacter spp. is ubiquitous in nature and food. Its natural habitat may be plant 
material like herbs and spices (Iversen and Forsythe, 2013). 
Powdered infant formula may be contaminated by Cronobacter spp. either due to introduction 
during the manufacturing process or from the use of contaminated utensils, such as blenders 
or spoons used in reconstitution of powdered infant formula (Noriega et al., 1990). Enteral 
feeding tubes and feeding bottle teats may harbour the bacterium, since Cronobacter has 
ability to grow on plastics and silicon rubber surfaces by producing and growing in biofilm 
(Zogaj et al., 2003). The formation of biofilm may decrease their susceptibility to anti-
microbial agents and probably to soap and dish detergents.  
According to recommendations from the Norwegian Food Safety Authority, only one serving 
infant formula should be prepared at each meal, to prevent outbreaks of Cronobacter spp. and 
Salmonella. The most important source of information on outbreaks in Norway is The 
Norwegian Surveillance System for Communicable Diseases (MSIS) and the web-based 
outbreak reporting system (Vesuv). As an official monitoring system for infectious diseases, 
MSIS collates notifications from microbiological laboratories, hospitals and physicians of 
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new cases of a number of infectious diseases. There have been no registered outbreaks due to 
infant formula in Vesuv or MSIS, however information about sporadic cases is not available. 
 
 Summary of contaminants and other undesirable compounds in 5.6
breastmilk and infant formula 
Lead and mercury concentration in breastmilk and infant formula are generally low, and 
exposure among infants is generally not above tolerable intake levels set by EFSA or JECFA 
(Table 5.2), although higher exposure in some infant groups (both breastfed and formula fed) 
cannot be excluded. There are indications that exposure to other elements (e.g. aluminum, 
manganese and molybdenum) might be substantially higher in infants given infant formula 
compared to breastfed infants.  
For halogenated organic compounds, there are generally large differences in levels between 
breastmilk and infant formula. They are found in the highest concentrations in organisms 
located high up in the food chain, which include humans. The tolerable intakes are 
summarised in Table 5.3. 
 
Table 5.2: Tolerable intakes for lead, mercury and cadmium. 
Metals Tolerable intake References 
Lead No tolerable intake, but BMDL01  




1.3 µg/kg bw/week 
4.0 µg/kg bw/week 
(EFSA, 2012a) 
Cadmium 2.5 µg/kg bw/week (EFSA, 2009a; EFSA, 
2011e) 
 
Table 5.3: Tolerable daily intake (TDI) and other safety limits for human intake of organic contaminants 
used in the risk assessment. 
 Contaminants Tolerable intake or  
other safety parameters 
Reference 
Dioxins and dl-PCB 14 pg TEQ/kg bw/week (SCF, 2001) 
Sum PCB-6* 10 ng PCB-6/kg bw/day (AFSSA, 2007; VKM, 2008) 
PBDE PBDE-47, -99,  
-153 and -209 
MOE approach for each 
individual congener 
(EFSA, 2011c) 
DDT 0.01 mg/kg bw/day (WHO, 2000) 
HCB MOE approach (EFSA, 2006b) 
PFOS 150 ng/kg bw/day (EFSA, 2008a) 
PFOA 1.5 g/kg bw/day (EFSA, 2008a) 
*PCB-28, -52, -101, -138, -153, -180. 
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The levels of several of these compounds have been declining, especially for dioxins, PCBs 
and chlorinated pesticides. This is illustrated in Figure 5.9, where also the concentrations of 
these substances relative to each other are shown. In contrast, levels of the brominated flame 
retardants belonging to the class PBDEs were increasing until 2000, when they levelled off 
and have later decreased. The fluorinated surfactants PFOS and PFOA have shown a 
resembling time trend as the PBDEs.  
Because of a long half-life, and that breastmilk is a dominating source for exposure for the 
baby, the infant’s body concentration (and thus serum concentration) of POPs is strongly 
influenced by the duration of breastfeeding. The serum concentrations in children increase 
during the breastfeeding period, and thereafter decline. Simulation data indicate that the 
maximum serum PCB-153 concentration in the child can reach approximately 4-fold the 
concentration at birth after 12 months of breastfeeding. At 4 month of exclusive 
breastfeeding, simulation data indicate a doubling of the concentration at birth. 
Whereas the hormone active substance BPA has recently been banned in infant feeding 
bottles in EU and Norway, little is known about their replacement substances. Substances 
from food packaging material such as phthalates may be present in both breastmilk and infant 
formula, as well as process-generated substances such as acrylamide, PAHs, furan and 3-
MDCP. Occurrence data in breastmilk and formula are scarce, and it is not clear whether 
exposure is different in breastfed and formula fed infants. Tolerable intakes for such 
substances are listed in Table 5.4. 
 
Table 5.4: Tolerable intakes of process-generated contaminants and substances migrating from food 
contact materials 
 Contaminants Tolerable intake or other  
safety parameters 
Reference 
Acrylamide No tolerable intake, MOE approach (EFSA, 2006c) 
PAH No tolerable intake, MOE approach (EFSA, 2006c) 
3-MDCP No tolerable intake (JECFA, 2006) 
Furan No tolerable intake, MOE approach (VKM, 2012) 
BPA 0.05 mg/kg bw/day (EFSA, 2006c) 
DEHP 50 g/kg bw/day (EFSA, 2005b) 
DnBP 10 g/kg bw/day (EFSA, 2005b) 
DiBP No tolerable intake (EFSA, 2005b) 
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Figure 5.9: Time trends of persistent organic pollutants in Norwegian breastmilk. Source: See Polder et 
al., 2008 and references herein. 
 
To sum up, the main difference between the contaminants in breastmilk and in infant formula 
is that breastmilk generally contains higher levels of POPs, while most of the unwanted 
substances imposed by infant formula or feeding bottles have a shorter half-life and do not 
accumulate to the same degree. 
Several worldwide outbreaks of Salmonella infections among infants have been attributed to 
contaminated, powdered infant formula, resulting in diarrhoea and, in some infants, 
bacteraemia and meningitis. In addition Cronobacter spp. (formerly Enterobacter sakazakii) 
is a rare cause of invasive infection with high death rates in neonates. There have been no 
registered outbreaks due to infant formula in Norway. 
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This chapter describes epidemiological studies of positive health effects associated with 
breastmilk consumption. To comply with the terms of reference, the assessment of benefits is 
based on systematic reviews and meta-analyses published within the last 10 years.  
In general, studies on health outcomes associated with any exposure need to take into account 
the concentration of components in breastmilk and duration of breastfeeding, since the 
exposure usually is highly dependent on these two variables. However, the issue of 
breastfeeding, i.e. whether exclusively breastfed or not, and for how long, is often not clearly 
defined in all papers. Many studies compare ever breastfed children to those who were never 
breastfed. Other studies compare infants who are breastfed for less than a given number of 
weeks or months, often 2-3 months, to those breastfed for longer periods. Few studies treat 
breastfeeding duration as a continuous variable, which would allow for dose-response 
analyses. Furthermore, more detailed data would have allowed for assessment of effect of 
partial breastfeeding with duration up to a year or more, which is the case for many children 
in Norway. At present, few studies exist with good data on long-term breastfeeding and health 
effects. 
The methodological challenges are discussed in the reviews and meta-analyses used as a basis 
for sections under 6.2, and in addition in papers by Kramer and Brion (Brion, 2010; Kramer, 
2009) in particular, and will also be discussed in chapter 9. 
First and foremost, breastmilk provides the baby with a perfectly balanced supply of nutrients 
with high bioavailability. The nutrient concentrations in breastmilk form the national and 
international standard for infant formula. Some nutrients in breastmilk also have additional 
immunological properties. Thus, the health effects of breastmilk relates to nutritious as well 
as immunological properties not exhibited by infant formula.  
Breastmilk influences the immune system of the child in different ways. While numerous 
immunity-related components such as SIgA, leukocytes, lactoferrin, oligosaccharides and 
interferons provide protection by preventing pathogens from mucosal adherence, other 
breastmilk constituents like fatty acids, enzymes, hormones and growth factors may be of 
importance for health in the long term. Another important function relates to the different 
immunomodulating components of breastmilk, which contribute to the development of the 
infant’s immune-system (described in section 3.4). Benefits of breastmilk feeding, which may 
be directly explained by the various nutrients and immune components, are presented below.  
 
 Methodology, the literature assessment of positive health effects 6.1
associated with breastmilk  
The description of positive health effects associated with consumption of breastmilk in this 
report is based on conclusions from systematic reviews and meta-analyses published within 
the last 10 years. The main reason for this approach is that the Norwegian Directorate of 
Health has had a group working in parallel to VKM, covering the benefits of breastfeeding, in 
the revision of the present-day Norwegian recommendations on infant nutrition (healthy 
infants 0-12 months). The working group has focused on breastfeeding in relation to health 
outcomes based on an extensive literature review. Revision of the Norwegian national 
guidelines on infant nutrition is scheduled to be published in 2014. In addition, the basis for 
the revised Nordic Nutrition Recommendations (NNR) became available at the end of our 
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work with the present report (Hornell et al., 2013). The revised NNR is based on a full-scale 
systematic literature review in compliance with international guidelines. Finally, an updated 
systematic review from WHO regarding long-term effects of breastfeeding became available 
in May 2013 (WHO, 2013). The conclusions from the Nordic systematic literature review 
Hörnell (2013) and WHO (2013) have been added to relevant sections below. 
Thus the sections reporting positive health effects associated with consumption of breastmilk 
are mainly based on (1) Breast-feeding: A Commentary by the ESPGHAN Committee on 
Nutrition (Agostoni et al., 2009), (2) The influence of maternal, fetal and child nutrition on 
the development of chronic disease in later life from the Scientific Advisory Committee on 
Nutrition in UK (SACN, 2011), (3) Breastfeeding, introduction of other foods and effects on 
health: A systematic literature review for the 5th Nordic Nutrition Recommendations (Hornell 
et al., 2013) and (4) Long-term effects of breastfeeding: A systematic review (WHO, 2013). 
An overview is presented in Figure 6.1, and the methods used in these systematic reviews and 
meta-analyses are described below. 
 
 
Figure 6.1: Overview of the most important reviews and meta-analyses included in the sections for 
benefits of breastfeeding under section 6.2. These are also the reviews and meta-analyses included in 
Table 6.1. 
 
1) Breast-feeding: A Commentary by the ESPGHAN Committee on Nutrition (Agostoni et 
al., 2009) is a medical position paper grading evidence on breastmilk and health 
outcomes, and includes the following meta-analyses and systematic reviews: 
 
a) Breastfeeding and maternal and infant health outcomes in developed countries (Ip et 
al., 2007)33.  
Literature search: Until May 2006. 
Aim: To examine the evidence concerning the benefits and harms of breastfeeding on 
13 different short- and long-term infant outcomes (and six maternal health outcomes). 
Type of studies: Systematic reviews, meta-analyses, randomised controlled trials 
(RCTs), non-RCT comparative trials, prospective cohort, and case-control studies. 
Category of breastfeeding: Breastfeeding, exclusive or partially feeding34.  
Length of breastfeeding: From zero up to more than one year. Most of the studies did 
not differentiate between exclusive and partial breastfeeding. 
                                                 
33Main paper is from 2007 (Ip, 2007), and a shorter version was presented in 2009 (Ip, 2009). 
34The majority of the studies did not distinguish between exclusively and partially breastfed infants or explain the difference 
between “breastfeeding” and “feeding of expressed breastmilk”. The term “breastfeeding” was selected for studies in full-
term infants. All definitions of “exclusive breastfeeding” were accepted as provided by the study authors of the studies 
included, but Ip et al. qualified their findings by the details regarding those definitions.  
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Comparator: Formula feeding (preterm or term formula, fortified or unfortified) and 
different durations of breastfeeding. 
Evaluated for methodological quality: Yes. 
Grading of evidence: No. 
 
Ip et al. include systematic literature reviews and meta-analyses published before May 
2006, from developed countries. Associations between differential exposure to 
breastfeeding and health outcomes were examined; 13 infant and six maternal. For 
three infant outcomes (asthma, cognitive development and childhood diabetes) 
previously published systematic reviews were updated. For the rest of the outcomes, 
previous systematic reviews were summarised, or new systematic reviews were 
conducted; randomised and non-randomised comparative trials, prospective cohorts, 
and case-control studies were included. Adjusted estimates were extracted from non-
experimental designs. The studies were graded for methodological quality. Only 
reviews with rigorous criteria for study selection, unbiased data collection, and 
appropriate methods of analyses were included. Included studies had to have either a 
comparator arm that evaluated formula feeding or different durations of breastfeeding.  
This systematic review is later summarised in 2009 (Ip et al., 2009), and the 
summarised version (2009) will be referred to in the following sections. 
b) Evidence on the long-term effects of breastfeeding (WHO, 2007).  
Literature search: 1966 until March 2006. 
Aim: To assess the long-term consequences of breastfeeding on blood pressure, 
diabetes and related indicators, serum cholesterol, overweight and obesity, and 
intellectual performance. 
Type of studies: The majority were observational studies.  
Category of breastfeeding: Most of the reviewed studies compared ever breastfed 
subjects to never breastfed. Other studies compared breastfeeding less than a given 
number of months (often 2 to 3 months; including those who were never breastfed) to 
those breastfed for longer periods. Few studies treated breastfeeding duration as a 
continuous or ordinal variable with several categories, thus allowing dose-response 
analyses. Breastfeeding patterns (exclusive, predominant or partial) have rarely been 
assessed. 
Length of breastfeeding: Different durations of breastfeeding, see above. 
Comparator: Mostly different types of formula. In some of the oldest cohorts, diluted 
animal milk may have been used. Different durations of breastfeeding. 
Evaluated for methodological quality: Yes. 
Grading of evidence: No. 
 
The report from WHO (2007) includes systematic reviews and meta-analyses from 
1966 to March 2006. Long-term consequences of breastfeeding on blood pressure, 
obesity/overweight, total cholesterol, type 2 diabetes and intellectual performance 
were assessed. Observational and randomised studies were selected, and the following 
possible sources of heterogeneity were considered: Year of birth (the content of 
different formulas potentially affecting long-term health), length of recall of 
breastfeeding, source of information on breastfeeding duration, categories of 
breastfeeding duration (time and exclusivity), study-setting (nearly all studies from 
high-income countries/Caucasians). Only studies with internal comparison groups 
were included. Two reviewers independently evaluated study quality, using a 
standardised protocol, and disagreement was resolved by consensus rating. Fixed and 
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random-effects models were used to pool the effect estimates, and a random-effects 
regression was used to assess several potential sources of heterogeneity.  
c) Quantifications of health effects of breastfeeding. Review of the literature and model 
simulation (van Rossum et al., 2005).  
Literature search: 1980 until February 2005. 
Aim: To give an overview of the literature on breastfeeding and health (including both 
beneficial and harmful effects) in infants (and mothers). 
Type of studies: Mainly observational. 
Category of breastfeeding: Every paper was evaluated regarding its quality according 
to a clear definition of (exclusive) breastfeeding and clear statements about the 
duration of (exclusive) breastfeeding. Also all publications reported the time of 
assessing breastfeeding (ideally not longer than 12 months after birth). 
Length of breastfeeding: From zero to 12 months. 
Comparator: Formula feeding, different durations of breastfeeding. 
Evaluated for methodological quality: Every paper evaluated on its quality; if a paper 
did not fulfil every quality requirement the study was excluded. 
Grading of evidence: Yes (according to the criteria given by WHO in 2003; (WHO, 
2003a)). 
 
Van Rossum et al. is a systematic literature review of published epidemiological 
studies conducted in the general (‘western’) population, including papers from 1980 to 
February 2005 published in English or Dutch. In addition, only study populations from 
Western Europe, North America, Australia and New Zealand were included in the 
overview. Every paper was evaluated on its quality according to the following points: 
Time of assessing breastfeeding data (<12 months after birth), clear definition of 
(exclusive) breastfeeding and clear statement about duration, blind assessment of 
breastfeeding data and health outcome(s), well-defined health-outcome(s), correction 
for relevant confounders. Inclusion presupposed that all quality requirements were 
fulfilled. The strength of evidence for an association as convincing, probable, possible 
or insufficient was based on WHO criteria (2003) for evidence. In addition the terms 
“conflicting evidence” and “no evidence” were added. 
 
2) The influence of maternal, fetal and child nutrition on the development of chronic disease 
in later life (SACN, 2011).  
Literature search: Systematic literature review originally from 2004, now including 
additional relevant evidence published before January 1st 2010. 
Aim: To review the influence of child nutrition, including growth and development in 
utero and up to the age of 5 years, on the development of chronic disease in later life. 
SACN 2011 has focussed attention on cardiovascular disease, diabetes and cancer as the 
leading causes of mortality, but recognises that early life nutritional exposures may affect 
many other outcomes. 
Type of studies: Systematic reviews and meta-analyses, with additional studies published 
after 2004 considered separately. In the absence of reviews, relevant retrospective or 
prospective studies and trials were identified. 
Category of breastfeeding: Breastfeeding versus formula feeding, exclusive breastfeeding 
versus formula feeding. 
Length of breastfeeding: Different lengths of breastfeeding.  
Comparator: Formula feeding. Different durations of breastfeeding. 
Evaluated for methodological quality: SACN 2011 did not evaluate the quality of meta-
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analyses or systematic reviews and the heterogeneous nature of this evidence obviated the 
use of standard grading methods (often employed to judge the quality of evidence) 
applicable to systematic reviews of the human studies. 
Grading of evidence: No. 
 
3) Breastfeeding, introduction of other foods and effects on health: A systematic literature 
review for the 5th Nordic Nutrition Recommendations (Hornell et al., 2013). 
Literature search: Until June 2011. 
Aim: To review recent scientific data valid in a Nordic setting on the short- and long-term 
health effects of breastfeeding (duration of both any and exclusive breastfeeding) and 
introduction of foods other than breastmilk in order to assess the validity of the current 
Nordic recommendations.  
Type of studies: Systemic literature reviews, meta-analyses, prospective cohort-studies 
(including the PROBIT Study), reports from organisations, committees and similar. 
Category of breastfeeding: Different durations and exclusivity of breastfeeding. Studies 
defining breastfeeding as ever or never were excluded. Retrospective studies with recall 
feeding data older than 3 years were excluded. 
Length of breastfeeding: Varying from zero to 1 year. 
Comparator: Formula, different durations of breastfeeding¸ introduction of solid foods. 
Evaluated for methodological quality: Yes. 
Grading of evidence: Yes. 
The paper by Hörnell et al., which has formed the basis for the new NNR, is a systematic 
literature review including papers until June 2011. Sixty studies were included and graded 
for methodological quality using the Quality Assessment Tools (QAT) developed in 
NNR5 (AMSTAR) (Shea et al., 2007).  
The aim of the study was to review recent scientific data on the short-term (infections) 
and long-term health outcomes (growth and overweight/obesity, blood-pressure, serum 
cholesterol, diabetes mellitus type 1 and 2, cancer, atopic disease, asthma, IQ and 
neurological development, coeliac disease and inflammatory bowel disease) related to 
various degrees and durations of breastfeeding. 
The grade of evidence was classified as convincing (grade 1), probable (grade 2), limited-
suggestive (grade 3) and limited-no conclusion (grade 4) depending on the number and 
quality of supporting, non-supporting and contradicting studies. 
 
4) Long-term effects of breastfeeding. A systematic review (WHO, 2013). 
Literature search: Updated search from 2006 to September 2011. The former search with 
results published in 2007 (WHO, 2007) included articles from 1966 until March 2006.  
Aim: To assess the long-term consequences of breastfeeding on blood pressure, type 2 
diabetes, serum cholesterol, overweight and obesity and intellectual performance. 
Type of studies: Observational and randomised studies. Studies restricted to outcome 
measures in infants were excluded from the meta-analyses. 
Category of breastfeeding: Some of the reviewed studies compared ever breastfed subjects 
to never breastfed. Other studies compared breastfeeding less than a given number of 
months to those breastfed for longer periods. Few studies treated breastfeeding duration as 
a continuous or ordinal variable with several categories, thus allowing dose-response 
analyses. Breastfeeding degree (exclusive, predominant or partial) has rarely been 
assessed. 
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Length of breastfeeding: Different durations of breastfeeding, see above. 
Comparator: Mostly different types of formula. In some of the oldest cohorts (first 
decades of the 20th century), diluted whole cow’s milk or top milk with high sodium 
concentrations and levels of cholesterol and fatty acids that were similar to those in 
mature breastmilk, may have been used. Later, commercially prepared formulas changed 
in composition, until today, where formulas have levels of nutrients (more) similar to 
those in breastmilk.  
Evaluated for methodological quality: Yes. 
Grading of evidence: No. However, in addition to the studies forming the basis for the 
WHO 2007 version, 60 additional studies have been included in the 2013 review, 
allowing meta-analysis for all studies as well as meta-analysis for the studies judged as 
“high quality studies”. High quality studies include those with larger sample sizes and 
adjustment for confounding variables relevant to each outcome.  
 
The report from WHO (2013) is an updated systematic review with meta-analyses, based 
on the former version published in 2007, now including studies from 1966 until 
September 2011. Long-term consequences of breastfeeding on blood pressure, 
obesity/overweight, total cholesterol, type 2 diabetes and intellectual performance were 
assessed. Observational and randomised studies were selected, and the following possible 
sources of heterogeneity were considered: Year of birth (the content of different formulas 
potentially affecting long-term health), length of recall of breastfeeding, source of 
information on breastfeeding duration, categories of breastfeeding duration (time and 
exclusivity), study-setting (nearly all studies from high-income countries/Caucasians). 
Only studies with internal comparison groups were included. Two reviewers 
independently evaluated study quality, using a standardised protocol, and disagreement 
was resolved by consensus rating. Statistically, fixed and random-effects models were 
used to pool the effect estimates, and a random-effects regression was used to assess 
several potential sources of heterogeneity.  
 
6.1.1 Additional reviews, meta-analysis or single studies 
In addition to the reviews and meta-analyses presented above, some other reviews or single 
studies of high quality have been included in sections 6.2.1-6.2.6 if recent publications of 
relevance to the benefit assessment have appeared, or the above described reviews and meta-
analyses have not commented on diseases/conditions of interest. 
Included several places 
(Kramer and Kakuma, 2012): There are few studies investigating advantages of exclusive 
breastfeeding beyond 3, 4 or 5 months of age. In the updated literature review by Kramer & 
Kakuma (2012) Optimal duration of exclusive breastfeeding, an update of the reviews from 
2002 and 2004, this issue was specifically in focus.  
Included in section 6.2.1 Cognitive development 
(Brion et al., 2011): See above. 
(Kramer et al., 2008): Follow-up of the children 6.5 years from the cluster-randomised trial 
described below (included in Agostini (ESPGHAN, 2009) and Hörnell (NNR, 2012)). 
Included in section 6.2.2 Infections  
The Generation R Study is a Dutch prospective birth cohort study taking place in Rotterdam. 
The children form a prenatally recruited birth cohort and will be followed until young 
adulthood. In total, 9778 mothers with a delivery date from April 2002 until January 2006 
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were enrolled in the study. Of all eligible children at birth, 61% participate in the study. A 
large part of the study cohort consists of ethnic minorities (see 
http://www.generationr.nl/researchers.html). 
Included in section 6.2.3 Immune response-associated diseases  
(Brandtzaeg, 2010a): Review on food allergy with focus on immunological mechanisms as 
well as the scientific basis for future food allergy prevention. 
(Nwaru et al., 2010; Nwaru et al., 2013): A prospective birth cohort study including 994 and 
3781 children respectively, with susceptibility to type 1 diabetes mellitus. The aim was to 
examine the relationship between age of introduction of solid foods during the first year and 
allergic sensitisation at 5 year. 
(Greer et al., 2008): Statement regarding effects of early nutritional interventions on the 
development of atopic disease in infants and children. 
(SACN and COT, 2011) (Scientific Advisory Committee on Nutrition/Committee on Toxicity 
Joint Statement, March 2011): Timing of introduction of gluten into the infant diet. 
Included in section 6.2.4 The metabolic syndrome 
(Brion et al., 2011): A novel approach for improving causal inference in observational studies 
by comparing cohorts from high-income with low- or middle-income countries; where 
confounding structures differ. This approach was applied for assessing the confounding 
structure of breastfeeding by socio-economic position in the British Avon Longitudinal Study 
of Parents and Children (ALSPAC; N~5000) and Brazilian Pelotas 1993 cohorts (N~1000). 
Analyses were extended to include results from a meta-analysis of five low- or middle-
income countries (N~10 000). 
(Gillman et al., 2006): Within family analysis surveying 5614 siblings aged 9-14 years and 
their mothers; these children were a subset of participants in the Growing Up Today Study in 
USA. Prevalence of overweight in siblings who were breastfed longer than the mean duration 
of their sibship was compared with those who were breastfed for a shorter period. 
Included in section 6.2.6 Sudden infant death syndrome 
(Hauck et al., 2011): Meta-analysis including studies from 1966-2009, revealing 18 studies, 
measuring the association between breastfeeding and sudden infant death syndrome. 
 
6.1.2 The PROBIT Study from Belarus 
Although included in the reviews of ESPGHAN, SACN, Hörnell and WHO, one 
breastfeeding study deserves special attention, i.e. the Promotion of Breastfeeding 
Intervention Trial (PROBIT) conducted in the Republic of Belarus. It is the only RCT of its 
kind, it is very large, and it allows for investigating the impact of exclusive versus partial 
breastfeeding.  
The PROBIT Study is a cluster-randomised trial including 17 046 mother-infant pairs at 31 
maternity hospitals and polyclinics, with 96.7% and 81.5% follow-up at 1 and 6.5 years, 
respectively (Kramer et al., 2001; Kramer, Matush, Vanilovich, Platt, Bogdanovich, 
Sevkovskaya, Dzikovich, Shishko, Mazer, 2007). The aim of the study was to assess the 
effect of structured lactation counselling. The intervention sites in this trial received qualified 
lactation and postnatal breastfeeding support based on the Baby-Friendly Hospital Initiative 
of the WHO and United Nations Children’s fund, while the control intervention received 
conventional counselling on infant feeding practices. The intervention led to increased 
exclusive (44.4% vs 6.4%; p<0.001 at 3 months) and partial breastfeeding rates. It is 
important to be aware that non-breastfed infants were excluded from the study. Thus the study 
does not allow for comparison of non-breastfed versus breastfed children – the study 
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compares longer and more exclusive breastfeeding against shorter and less exclusive 
breastfeeding. Furthermore, the mothers, in general, were highly educated, and maternity 
leave in Belarus is three years. Thus, the children would have a different exposure pattern to 
microbes than children entering kinder garden at an earlier age (Martens, 2012). 
All included mothers initiated breastfeeding, and although the differences between the groups 
as to exclusive breastfeeding were impressive, the difference in any breastfeeding was less 
dramatic, as illustrated in the Figure 6.2. Both groups represent a mixture of breastfeeding 
practises. A consequence of this is that the effect of breastfeeding itself on outcomes is 
underestimated and power is reduced. 
 
 
Figure 6.2: Comparison of proportion of infants still breastfeeding (to any degree) during year of follow-
up. Source: Kramer et al., 2001. 
 
The study was designed to assess the effects of breastfeeding promotion on breastfeeding 
duration and exclusivity, and the primary health outcome was gastrointestinal infections. 
Secondary outcomes were respiratory tract infections, atopic eczema and wheezing during the 
first year of life. Also results from follow-ups at 6.5 and 11 years have been published. As to 
statistical methodology, all results were handled as “intention to treat”.  
Results from the PROBIT Study have been handled in two ways, statistically speaking: 
a) As originally designed, i.e. a cluster randomised controlled study 
b) As an observational study, pooling all data and investigating outcomes according to 
exclusive vs partial breastfeeding 
Results from these two ways of handling the data more or less overlap, but we choose to 
report them separately here. 
 
RCT results 
At 1 year of age, results from the RCT showed that children in the intervention groups had a 
significant reduction in the risk of one or more gastrointestinal tract infections (9.1% vs 
13.2%; adjusted OR, 0.60; 95% CI, 0.40-0.91) and of atopic eczema (3.3% vs 6.3%; adjusted 
OR, 0.54; 95% CI, 0.31-0.95), but no significant reduction in respiratory tract infections 
(intervention group, 39.2%; control group, 39.4%; adjusted OR, 0.87; 95% CI, 0.59-1.28). 
At 6.5 years of age, the intervention group had higher means on all of the Wechsler 
Abbreviated Scales of Intelligence measures, with cluster-adjusted mean differences (95% 
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confidence intervals) of +7.5 (+0.8 to +14.3) for verbal IQ, +2.9 (-3.3 to +9.1) for 
performance IQ, and +5.9 (-1.0 to +12.8) for full-scale IQ. Teachers' academic ratings were 
significantly higher in the intervention group for both reading and writing (Kramer et al., 
2008). 
Other health outcomes studied in the 6.5 years follow-up were child height, weight, adiposity 
and blood pressure (Kramer, Matush, Vanilovich, Platt, Bogdanovich, Sevkovskaya, 
Dzikovich, Shishko, Collet et al., 2007), cited in Agostini (ESPGHAN, 2009), SACN and 
Hörnell (2013) and risk of allergy and asthma (Kramer, Matush, Vanilovich, Platt, 
Bogdanovich, Sevkovskaya, Dzikovich, Shishko, Mazer, 2007), cited in Hörnell (2013). In 
these studies, no differences between the intervention and control groups were observed.  
In a recent publication investigating adiposity and Insulin-like Growth Factor at age 11.5 
years in the PROBIT Study, no differences were observed between the two groups (Martin et 
al., 2013). The authors conclude that population strategies to increase the duration and 
exclusivity of breastfeeding are unlikely to curb the obesity epidemic. 
 
Results from pooling the data, treating the study as an observational trial 
When pooling the data, one can compare the impact of exclusive versus non-exclusive 
breastfeeding and breastfeeding length across all groups participating in the study. Five 
publications from the PROBIT Study have treated the data this way. A number of 
confounding effects were controlled for, like geographic region, living urban or rural, hospital 
at birth, maternal education, number of siblings, birth weight and length and weight/length 
gain from birth to 3 months age.  
At 1 year of age, the observational pooling of data confirmed the findings from the RCT that 
exclusive breastfeeding for 6 months are associated with a lower risk of gastrointestinal 
infections (Kramer et al., 2003). This publication was instrumental when WHO in 2004 
revised their infant feeding recommendations and encouraged exclusive breastfeeding for the 
first 6 months of life. The benefit, when analysing the data this way, was limited to the actual 
period the child was exclusively breastfed (Kramer et al., 2003). No significant difference was 
observed for atopic eczema or recurrent wheezing, in contrast to what was found in the RCT 
data. 
Investigating the impact of 3 vs 6 months of exclusive breastfeeding on health at 6.5 years, 
very few differences were found. In fact, the children exclusively breastfed for at least 6 
months had slightly higher BMI, triceps skinfold thickness and hip circumference (Kramer et 
al., 2009), although this probably is due to residual confounding. The results at 6.5 years for 
cognitive development, including verbal, performance and full-scale IQ, showed no statistical 
difference between 3 and 6 months of exclusive breastfeeding.  
 
Conclusion, the PROBIT Study 
For the purpose of the present benefit risk assessment, the most important finding in the 
PROBIT Study was that exclusive breastfeeding for 6 months substantially reduceed the risk 
of gastrointestinal infections. There are uncertainties as to whether the effect lasted beyond 
the period of exclusive breastfeeding. At 6.5 years of age, the intervention group in the RCT 
study scored substantially higher in various IQ tests than the control group, but this result was 
not found when using the observational design. As to other health outcomes, irrespective of 
being measured at 1 or 6.5 years, the study found little or no difference between the groups 
who were breastfed exclusively for 3 compared to 6 months.  
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 Beneficial health outcomes reported in the literature 6.2
Table 6.1 shows a list of health outcomes based on conclusions in the evidence based reviews 
Ip (2009), WHO (2007) and van Rossum (2005), and is modified from ESPGHAN (Agostoni 
et al., 2009). Our modification from ESPGHAN is an inclusion of results of health outcomes 
from SACN (2011), Hörnell (2013) and WHO (2013). The list of health outcomes is retrieved 
from the available documentation on associations between breastmilk consumption and health 
outcomes. The arrows represent reduced risk of disease, and may be regarded as a reflection 
of present scientific knowledge about breastmilk and health outcomes. It should be 
emphasised that the content in Table 6.1 is a summary of results from previous evidence 
based reviews and is not evaluations done for this report. It should also be noted that the 
systematic reviews and meta-analyses do not differentiate on length of breastfeeding. 
 
Table 6.1: Comparison of recent systematic reviews and meta-analyses on children’s health effects of 
breastfeeding in developed countries (adapted from Table 1 in ESPGHAN (Agostoni, 2009). As for WHO 
(2013) two numbers are given; the first represents the pooled effect for all studies included, and the second 
represents the high quality studies only. 
Main results in 
infants 
WHO, 2007 Ip, 2007 van Rossum, 
2005 





 MD 4.9 
(2.97; 6.92)a 
- - - Probable   MD 3.45 
(1.92; 4.98) a 
 MD 2.19 




- - Probable 
evidence  
- - - 
Otitis media -  Convincing 
evidence  
- Convincing  - 
Gastrointestinal 
infections 
-  Convincing 
evidence  
- Convincing  - 
Respiratory 
infections 
- - Possible 
evidence  




-  - -  - 
Atopic disease - - Probable 
evidence  
- Limited, no 
conclusion 
- 
Atopic dermatitis -  Eczema, 
Probable 
evidence  





-  Probable 
evidence  
- Limited, no 
conclusion 
- 
Wheezing - - Probable 
evidence  
- Limited, no 
conclusion 
- 




 Convincing   OR 0.76 
(0.71; 0.81)c 
 OR 0.88 
(0.83; 0.93)d 
Coeliac disease - - - - Probable  - 
Type 1 diabetes   Possible 
evidence  
No evidence Probable  - 
Norwegian Scientific Committee for Food Safety (VKM) 10-003-final  
2 
 





Helle Margrete Meltzer (chair) 
Per Brandtzæg 
Helle Knutsen 
Beate Fossum Løland 
Jon Øyvind Odland 
Janneche Utne Skåre 
Liv Elin Torheim 
Norwegian Scientific Committee for Food Safety (VKM) 10-003-final  
116 
 
Main results in 
infants 
WHO, 2007 Ip, 2007 van Rossum, 
2005 
SACN, 2011* Hörnell,2013  
(NNR)* 
WHO, 2013* 
Type 2 diabetes  OR 0.63 
(0.45; 0.89)c  
 -  Probable   OR 0.66 
(0.49; 0.89)c 





SIDS -  Insufficient 
evidence 
- - - 
NEC -  - - - - 
Cardiovascular 
diseases 
- Not clear No evidence No evidence2 - - 
Crohn’s disease - - Possible 
evidence  
- Probable   - 
Ulcerative colitis - - Insufficient 
evidence 








































- -  Probable  No evidence 
 
*Not included in Table 1 in ESPGHAN (Agostoni et al., 2009). 
aMean difference (MD) and 95% confidence intervals by meta-analysis comparing breastfed vs. not-breastfed subjects in 
different studies. 
bMean difference (MD) and 95% confidence intervals by meta-analysis comparing breastfed vs. not-breastfed subjects in 
different studies, restricted to studies considered high quality 
cOdds ratio (OR) and 95% confidence intervals by meta-analysis comparing breastfed vs. not-breastfed subjects in different 
studies. 
dOdds ratio (OR) and 95% confidence intervals by meta-analysis comparing breastfed vs. not-breastfed subjects in different 
studies, restricted to studies considered high quality. 
1Reduced risk for acute lymphoblastic leukemia, Hodgkin’s disease and neuroblastoma. 
2SACN 2011 has looked into cardiovascular mortality whereas the others have reported morbidity. 
- (=Not investigated). 
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As pointed out in the introduction to this chapter, many studies compare ever breastfed 
children to those who were never breastfed. Other studies compare infants who are breastfed 
for less than a given number of weeks or months, often 2-3 months, to those breastfed for 
longer periods. Few studies treat breastfeeding duration as a continuous variable, which 
would allow for dose-response analyses. Furthermore, more detailed data would have allowed 
for assessment of effect of partial breastfeeding with duration up to a year or more, which is 
the case for many children in Norway. The results in the Table 6.1 are described more 
detailed in the sections below.  
 
6.2.1 Cognitive development 
Several observational studies have found a positive correlation between breastmilk 
consumption and favourable neurodevelopment (reviewed in van Rossum 2005, Espghan 
2009 and WHO 2007). However, socio-economic factors, parental intelligence and HOME 
score are vital confounding factors. Of interest is therefore a study from The Philippines, 
where breastfeeding was inversely correlated to socio-economic status and other healthy 
maternal behaviours. Cognitive scores at 8.5 years were higher for infants breastfed longer 
(1.6 points and 9.8 points higher among normal birth weight and low birth weight infants 
respectively, breastfed for 12-18 months versus <6 months) (reviewed in Agostini 
(ESPGHAN, 2009)). According to the authors, using the same novel approach as described 
below for Overweight/obesity for improving causal inference in observational studies, earlier 
findings that breastfeeding may have causal effects on IQ are supported (Brion et al., 2011). 
Long-chain polyunsaturated fatty acids, docosahexanoic acid (DHA) and arachidonic acids 
(AA) are important for brain development and accumulate in the brain most rapidly in the last 
trimester of pregnancy and the first months after birth. This is therefore a potential 
mechanism for an effect of breastfeeding on intellectual development. An intervention study 
in the United Kingdom in the early 1980s involved preterm infants randomised to receive 
either breastmilk or formula. At 7.5-8 years of life, children who had consumed breastmilk 
had an 8.3 point advantage in IQ after adjustment for differences in mother`s education and 
social class. Both breastmilk and formula were given by tube in order to eliminate a possible 
benefit of the breastfeeding process (reviewed in van Rossum (2005) and WHO (2007)).  
The PROBIT Study (for further details, see section 6.1.2) cannot be used to compare effects 
of breastmilk versus formula, only varying durations of breastfeeding, as breastfeeding rates 
were high in both control and intervention groups. Despite this fact, higher means of verbal 
IQ as measured by the Wechsler Abbreviated Scales of Intelligence was significantly higher 
in the intervention group (verbal IQ +7.5, (+0.8-14.3)), (Kramer et al., 2008) reviewed in 
Agostini (ESPGHAN, 2009) and in Hörnell (Hornell et al., 2013). 
In the systematic literature review by Hörnell et al. it is concluded that there is probable 
evidence (grade 2) that breastfeeding is beneficial for IQ and developmental scores of 
children, with increasing benefit with increasing duration (Hornell et al., 2013). 
WHO (2013) found an increase in test scores both in the pooled analysis of all studies, as well 
as in the high-quality studies included. They conclude that there is a strong evidence of causal 
effect of breastfeeding on IQ, although the magnitude of this effect seems to be modest 
(WHO, 2013). 
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6.2.2 Reduction of infectious diseases in developed countries  
A reduced risk of lower respiratory infections, especially the severe ones, as well as 
gastroenteritis and otitis media in breastfed versus non-breastfed children is well documented 
(Agostoni et al., 2009; Ip et al., 2009; van Rossum et al., 2005). Such a reduced risk is 
demonstrated when comparing exclusive with partial breastfeeding or formula feeding and 
when comparing different lengths of exclusive or partial breastfeeding with formula feeding.  
In the recent systematic literature review by Hörnell et al. (2013) it is concluded that the 
evidence is convincing (grade 1) that breastfeeding protects infants in industrialised countries 
against overall infections, acute otitis media and gastrointestinal and respiratory tract 
infections. The magnitude of the effect varies depending on the specific outcome and the 
exclusiveness of breastfeeding (Hornell et al., 2013). 
Some examples of dose-response associations with infectious outcomes and breastfeeding - 
both regarding exclusivity and duration from the included literature, are described below. 
 
Gastroenteritis 
Raisler et al., included in van Rossum et al. (2005), compared risk of diarrhoea related to 
degree of breastfeeding 0-6 months in a cohort with 7092 children from USA. Using formula 
fed infants as reference, the odds ratio (OR) for gastroenteritis was 0.54 (0.43-0.66) for 
exclusively breastfed infants at 6 months. Results for partially breastfed infants 
(breastfeeding<formula feeding), OR=0.95 (0.78-1.16) or (breastfeeding>formula feeding) 
OR=0.83 (0.69-0.99) indicated a dose-response relationship (Raisler et al., 1999). 
A similar dose-response relationship between breastfeeding and risk of gastroenteritis was 
found in a cohort from USA study including 1743 children 0-7 months. Scariati et al., 
included in van Rossum et al. (2005), compared the risk of diarrhoea with regard to 
exclusivity and duration of breastfeeding. Compared to exclusive breastfeeding for two to 7 
months, the OR for gastroenteritis was 1.8 (p<0.05) for formula fed infants. Partial 
breastfeeding between two and 7 months of age gave an intermediate OR (Scariati et al., 
1997).  
In the Generation R study, Duijts et al. found that compared with never breastfed, those 
exclusively breastfed for 4 months and thereafter partially breastfed, had a lower risk of 
gastrointestinal infections until 6 months (adjusted OR (95% CI): 0.41 (0.26, 0.64). No 
significant differences were found for partial breastfeeding up to 6 months compared to 
formula fed children (Duijts et al., 2010), see also Table 6.2. 
Results from the PROBIT Study showed that infants in the intervention group (with a higher 
degree of both partly and exclusive breastfeeding) had a significantly reduced risk of one or 
more gastrointestinal infections during the first 12 months compared to the control group 
(adjusted OR 0.60; 95% CI 0.40-0.90) (Kramer et al., 2001), cited in Agostini (ESPGHAN, 
2009) and SACN (2011). 
When comparing infants exclusively breastfed for 6 months with infant exclusively breastfed 
for 3 months in Kramer and Kakuma (2012), a reduced risk of one or more gastrointestinal 
tract infections was observed (adjusted OR 0.60, 95% CI 0.40-0.91) (Kramer and Kakuma, 
2012), cited in Hörnell (2013). 
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Severe lower respiratory tract infection 
In a meta-analysis by Bachrach et al., reviewed in Ip et al. (2009), it was reported an overall 
reduced risk (summary relative risk 0.28, 95% CI 0.14-0.54) of hospitalisation secondary to 
lower respiratory tract diseases in infants less than 1 year of age who were exclusively 
breastfed for 4 months or more compared with those who were formula fed. The results 
remained consistent after adjustment for possible confounders like smoking and socio-
economic status (Bachrach et al., 2003). 
In the Generation R study, Duijts et al. also found that compared with never breastfed, those 
exclusively breastfed for 4 months and thereafter partially breastfed had a lower risk of lower 
respiratory tract infections until 6 months (OR 0.50 (0.32, 0.79). Furthermore, they found a 
lower risk of lower respiratory tract infections between 7 to 12 months, adjusted OR 0.46 
(95% CI: 0.31, 0.69) (Duijts et al., 2010), see also Table 6.2. 
 
Table 6.2: Duration of exclusive breastfeeding and risk of infectious diseases in the first year of life in the 
Generation R study (Duijts et al., 2010).  
Duration of 
Breastfeeding 
6 months, 0R (95% CI) 7-12 months, 0R (95% CI) 
 URTI LRTI GI URTI LRTI GI 
Never breastfed 1.00 1.00 1.00 1.00 1.00 1.00 
Partially for <4 months, 

























Exclusively for 4 











































P <.01 <.01 <.01 NS <.01 NS 
Reference group is never breastfed infants. Values were adjusted for maternal education, ethnicity, smoking, gestational age, 
birth weight, siblings, and day care attendance. Complete information about duration of exclusive breastfeeding, infectious 
diseases, and all confounders until the age of 6 months was available for 3504 infants (upper respiratory tract infections), 
3489 infants (lower respiratory tract infections), and 3438 infants (gastrointestinal infections). For ages 7 to 12 months, 
complete information on breastfeeding and infectious diseases was available for 2958 infants (upper respiratory tract 
infections), 3027 infants (lower respiratory tract infections), and 2938 infants (gastrointestinal infections). URTI indicates 
upper respiratory tract infections; LRTI, lower respiratory tract infections; GI, gastrointestinal infections; NS, not significant. 
*P<.01.  
 
Acute otitis media 
In the meta-analysis by Ip et al. (2009), infants exclusively breastfed for more than 3 or 6 
months were compared with exclusively bottle-fed, and the pooled OR of acute otitis media 
was 0.50 (95% CI 0.36-0.70). When comparing ever with never breastfed children, the pooled 
adjusted OR of acute otitis media was 0.77 (95% CI 0.64-0.91) (Ip et al., 2009).  
In the Generation R study, Dujits et al. investigated the effect of breastfeeding on upper 
respiratory tract infections, including ear and throat infection: Compared to formula fed 
children, children exclusively breastfed for 4 months and thereafter partially breastfed showed 
an OR for getting upper respiratory tract infections of 0.65 (95% CI 0.51-0.83). Exclusive 
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breastfeeding for 6 months increased this effect; OR 0.37 (95% CI 0.18-0.74) (Duijts et al., 
2010). 
In the study of Scariati et al., included in van Rossum et al. (2005), infants were classified as 
exclusively breastfed; high, middle, or low mixed breast-and formula fed or exclusively 
formula fed from 2 to 7 months. The risk of ear infection was significantly higher among 
formula fed children (RR 1.7), and a dose-response protective effect of breastmilk was 
demonstrated (Scariati et al., 1997). 
 
6.2.3 Reduction of immune response-associated diseases 
Asthma and allergy 
The incidence of allergic diseases such as subtypes of asthma, rhinitis, atopic dermatitis and 
food allergies has increased over the last decades. Although allergic diseases have a clear 
genetic basis, environmental factors, including early infant nutrition, may exert an important 
influence on their development. The mainstream theory for the postulated rise in the 
prevalence of such disorders is the extended hygiene hypothesis. This hypothesis underscores 
the role of environmental changes in immune-mediated disorders and explains why these 
conditions represent an increasing burden in developed countries. In essence, the notion is 
that modern hygienic measures introduced in affluent societies have deprived infants of 
adequate immunological stimuli (Brandtzaeg, 2010a). 
The role of exclusive breastfeeding in the prevention of allergic diseases is not clear. 
Conflicting findings have been reported from several studies investigating whether prolonged 
and exclusive breastfeeding increases, decreases or has no influence on the risk of asthma and 
allergy (Agostoni et al., 2009; Ip et al., 2009; Kramer et al., 2001; Kramer, Matush, 
Vanilovich, Platt, Bogdanovich, Sevkovskaya, Dzikovich, Shishko, Mazer, 2007; Kramer and 
Kakuma, 2012; Nwaru et al., 2010; van Rossum et al., 2005)35. Minor dys-regulations of both 
innate and adaptive immunity (especially low levels of IgA, see section 3.4) have been 
observed in children with multiple food allergies. In line with these observations, exclusive 
breastfeeding up to the age of at least 4 months is associated with a reduced risk of allergy 
both in families with and without a predisposition to allergy (Agostoni et al., 2009; 
Brandtzaeg, 2010a; Greer et al., 2008; van Rossum et al., 2005).  
However, it is hypothesised that introduction of foreign proteins in taste samples or 
complementary foods together with breastmilk before 6 months of age may promote tolerance 
induction. Results from a recent study support this, as introduction of i.e. cereals at 5 to 5.5 
months (but not earlier than 4.5 months) was shown to reduce the risk of asthma and allergic 
rhinitis at the age of 5 years. A total breastfeeding period less than 9.5 months was however 
associated with an increased risk of non-atopic asthma (Nwaru et al., 2013). On the other 
hand, environmental antigens, including food proteins, present at low levels in breastmilk 
apparently can provide the necessary allergens for oral tolerance induction. 
Several clinical studies are under way to identify the optimal timing of solid food introduction 
to prevent allergic disease. 
As mentioned in section 6.1.2 about the PROBIT Study, they found no differences between 
the intervention and control groups at 6.5 years as to asthma and allergy ((Kramer, Matush, 
Vanilovich, Platt, Bogdanovich, Sevkovskaya, Dzikovich, Shishko, Mazer, 2007) cited in 
                                                 
35Kramer (2001) is cited in Agostini (ESPGHAN, 2009) and SACN, 2011. Kramer (2007 and 2012) is cited in 
Hörnell (NNR, 2012).  
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Hörnell (NNR, 2012). However, both the intervention- and control group in this study had a 
high prevalence of breastfeeding and the main difference between them was the degree of 
exclusive breastfeeding. 
In the systematic literature review by Hörnell et al. it is concluded that the evidence linking 
breastfeeding or introduction of solid foods to asthma and wheeze is inconsistent, and the 
evidence is limited and no conclusions can be drawn (grade 4) (Hornell et al., 2013). 
 
Type 1 Diabetes 
Two recent meta-analyses suggest that breastfeeding for at least 3 months reduces the risk of 
childhood type 1 diabetes, and the effect may persist later in life (Ip et al., 2009; van Rossum 
et al., 2005). Two meta-analyses included in the study by Ip report an OR of 1.23 (95% CI 
1.12, 1.25) and 1.43 (95% CI 1.15, 1.77) respectively for the risk of type 1 diabetes if 
breastfeeding duration was less than 3 months compared to more than 3 months. It is not clear 
whether other environmental factors, such as early introduction of gluten and cow’s milk 
protein, influence the risk of type 1 diabetes. Cow’s milk has been regarded as the main risk 
factor (Agostoni et al., 2009). The suggested association between breastfeeding and type 1 
diabetes may be due to breastmilk per se or to the associated delayed introduction of gluten 
and/or cow’s milk protein.  
In the systematic literature review by Hörnell et al. it is concluded that the evidence for any 
breastfeeding having a protective effect against type 1 and type 2 diabetes is probable (grade 
2). The evidence for a stronger protective effect for longer duration of breastfeeding is still 
limited but suggestive (grade 3) (Hornell et al., 2013). 
 
Coeliac disease 
In a review of six observational studies, it was suggested that breastfeeding could confer 
protection against development of coeliac disease (Agostoni et al., 2009). Except for one 
small study, the risk reduction was dose-dependent. However, it is still unclear whether the 
protective effect is permanent or delays the onset of the disease. A joint statement from 
SACN and the Committee on Toxicity (COT) in 2011 concluded that introduction of gluten-
containing foods before 3 months might be linked to an increased risk of coeliac disease 
(SACN and COT, 2011). They also stated that the evidence is not strong enough to support a 
recommendation to introduce gluten before 6 months of age. Thus the evidence currently 
available is not strong enough to make specific recommendations about the appropriate timing 
of introduction of gluten. There might be an increased chance of infants developing coeliac 
disease if they are not breastfed when gluten is introduced into the diet (SACN and COT, 
2011).  
In the systematic literature review by Hörnell et al. it is judged to be probable evidence (grade 
2) for breastfeeding as a protective factor for coeliac disease if gluten is introduced in small 
amounts while still breastfeeding. Also this report states that it is, unclear whether the 
protection only delays the onset of coeliac disease or if it provides permanent protection 
(Hornell et al., 2013). 
 
Inflammatory bowel disease 
The potential benefit of breastmilk regarding the risk of developing inflammatory bowel 
disease (IBD), including Crohn’s disease and ulcerative colitis, is not clear. The Dutch meta-
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analysis pointed to evidence of a protective effect of breastfeeding with regard to Crohn’s 
disease and to insufficient evidence for ulcerative colitis (van Rossum et al., 2005).  
In the systematic literature review by Hörnell et al. it is judged that there is probable evidence 
(grade 2) that breastfeeding provides protection against IBD (both Crohn’s and ulcerative 
colitis) (Hornell et al., 2013). 
 
6.2.4 The metabolic syndrome 
The concept that early nutrition may influence or reduces the risk of later cardiovascular 
disease in humans is supported by the findings that breastfeeding may influence overweight 




Findings from recent meta-analyses based on studies from the developed world suggest that 
breastfeeding may reduce the risk of overweight and obesity (Agostoni et al., 2009; Ip et al., 
2007; SACN, 2011; van Rossum et al., 2005; WHO, 2007). However, although known 
confounding variables are controlled for, residual confounding is still a concern. Accordingly 
there is a need for methodological approaches where control of possible confounders is 
embedded. A novel approach has been explored for improving causal inference in 
observational studies by comparing cohorts from high-income with low- or middle-income 
countries, where confounding structures differ. By this approach, breastfeeding was not 
strongly associated with BMI (Brion et al., 2011). Another approach is sibling studies. As 
siblings have similarities in their genetic make-up and grow up in the same socio-economic 
environment, a number of important confounders are reduced. The association between 
different durations of breastfeeding on the risk of obesity was investigated in more than 5600 
siblings. Increased breastfeeding duration was associated with reduced risk of obesity 
(Gillman et al., 2006). 
As mentioned in section 6.1.2 about the PROBIT Study, they found no differences between 
the intervention and control groups at 6.5 years (Kramer, Matush, Vanilovich, Platt, 
Bogdanovich, Sevkovskaya, Dzikovich, Shishko, Mazer, 2007), cited in Hörnell (2013) or 
11.5 years (Martin et al., 2013) in prevalence of obesity. 
In the systematic literature review by Hörnell et al. (not including the recent 2013 PROBIT 
Study on overweight) it is concluded that growth in infancy (length and height) varied only a 
little between those exclusively breastfed for 4 months or 6 months. Nonetheless, it is 
concluded that there is probable evidence (grade 2) that exclusive breastfeeding for more than 
4 months is associated with slower weight gain during later infancy compared with those 
exclusively breastfed for less than 4 months. The evidence is convincing (grade 1) that longer 
duration of exclusive breastfeeding or any breastfeeding is associated with a protective effect 
against overweight and obesity in childhood and adolescence. With regard to the association 
with overweight/obesity in adulthood, due to a scarcity of strong studies, it is judged that the 
evidence is limited-suggestive (grade 3) for a protective effect of breastfeeding (Hornell et al., 
2013). 
In the updatet WHO review; a significant reduction was found both in the pooled analyses of 
all studies (24% reduction) as well as in the high quality studies (12% reduction). The report 
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concludes that breastfeeding may provide some protection against overweight and obesity, but 
residual confounding cannot be ruled out (WHO, 2013). 
 
Lipid metabolism 
During early childhood, breastfed children have higher levels of total cholesterol than formula 
fed, reflecting the high fat content in breastmilk, which is of importance for development of 
the infant’s central nervous system. This difference seems, however, to be temporary. Total 
cholesterol seems to be significantly lower among adults who had been breastfed in infancy 
(SACN, 2011; WHO, 2007). These studies suggest that long-term changes in cholesterol 
metabolism are likely to occur in breastfed individuals.  
In the systematic literature review by Hörnell et al. it is judged to be (at least) probable 
evidence (grade 2) for a small reduction on blood cholesterol in adulthood from breastfeeding. 
There is, however, less evidence for an association between breastfeeding and blood 
cholesterol in childhood (Hornell et al., 2013). 
In the updated review by WHO (2013), the earlier observed significant lower cholesterol level 
in adults was no longer demonstrable (WHO, 2013). 
 
Blood pressure 
In some reviews and meta-analysis, a small but significant association between breastfeeding 
and reduced blood pressure, especially systolic, has been found (Agostoni et al., 2009; Ip et 
al., 2009; SACN, 2011; WHO, 2007). The magnitude of such an eventual association has 
been estimated to be similar to the effect of salt restriction (Agostoni et al., 2009).  
In the systematic literature review by Hörnell et al. it is judged that there is (at least) probable 
evidence (grade 2) for this association (Hornell et al., 2013). 
The updated WHO systematic review (2013) found a small effect on systolic blood pressure, 
but conclude that the protective effect of breastfeeding, if any, is too small to be of 
public health significance (WHO, 2013). 
 
Cardiovascular disease 
Contrary to the published data on isolated risk factors (lipids, type 2 diabetes and blood 
pressure), findings suggesting a direct association of breastmilk on cardiovascular disease are 
less consistent. However, the existing studies are all based on old birth cohorts, with limited, 
but good quality data on breastfeeding status. In addition, the infant formula types used at that 
time (around 1920) differs from the present formulas. There is at present no convincing 
evidence that breastfeeding influences cardiovascular morbidity and mortality (Agostoni et 
al., 2009; Ip et al., 2009; SACN, 2011; van Rossum et al., 2005). 
 
Type 2 Diabetes 
Results from studies with different study designs suggest that breastfeeding is associated with 
a reduced risk of type 2 diabetes in later life compared with formula feeding (Ip et al., 2009; 
SACN, 2011; WHO, 2007). Possible mechanisms for the protective effect may be the content 
of long-chain polyunsaturated fatty acids in breastmilk as well as the lower basal and 
postprandial concentrations of insulin and neurotensin in breastfed children (WHO, 2007).  
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In the systematic literature review by Hörnell et al. it is concluded that the evidence for any 
breastfeeding to have a protective effect against type 1 and 2 diabetes, is probable (grade 2). 
The evidence for a stronger protective effect for longer duration of breastfeeding is still 
limited but suggestive (grade 3) (Hornell et al., 2013). 
In the updatet WHO (2013) report, a substantial protection in the pooled analyses was found. 
However, only two high quality studies were identified, with conflicting results (one showing 
an increase and the other a reduction among breastfed subjects. The authors conclude that 
further studies are needed on this outcome (WHO, 2013). 
 
6.2.5 Malignant disease 
In some, but not all studies, long-term breastfeeding has been associated with a reduced risk 
of acute lymphatic leukaemia (Ip 2009; comparing breastfeeding > or <6 months) and 
childhood leukaemia in general (van Rossum 2005, showing dose-response effect from 0-15 
months of breastfeeding). By comparing ever versus never breastfed children, reduced risk of 
acute lymphoblastic leukaemia, Hodgkin’s disease and neuroblastoma was found (SACN, 
2011). The possible protective mechanisms of breastmilk on the development of childhood 
cancers include better early defence against infectious diseases, modulation and stimulation of 
the immune system and the positive influence of the humoral factors in the breastmilk (e.g. 
HAMLET) (see section 3.4).  
In the systematic literature review by Hörnell et al. it is judged that there are limited but 
suggestive evidence (grade 3) for a risk reduction of breastfeeding against childhood leukemia 
and possibly other childhood cancers. The effect on childhood leukemia seems larger with 
longer breastfeeding duration (>6 months). However, as childhood cancers are relatively rare, 
the public health importance of these associations may be small (Hornell et al., 2013). 
 
6.2.6 Sudden Infant Death Syndrome 
Whether breastfeeding lowers the risk of sudden infant death syndrome (SIDS) has been 
unclear. In the meta-analysis by Ip, 2009, three good and three fair quality studies were 
included. ”Ever being breastfed” was associated with a statistically significant reduced risk of 
SIDS. A new meta-analysis by Hauck et al. includes 18 case-control studies from the period 
1966-2009 (Hauck et al., 2011). The authors conclude that “breastfeeding is protective against 
SIDS, and this effect is stronger when breastfeeding is exclusive”. SIDS is an exclusion 
diagnosis and is probably multifactorial. SIDS cases may be associated with acute upper 
respiratory infections or diarrhoea, and breastfeeding plays a preventive role in the etiology of 
these diseases. Breastfed children also seem to have a different sleeping pattern with lower 
arousal thresholds than formula fed infants, which may provide a mechanism for protection 
against SIDS. 
 
 Summary of positive health effects associated with consumption of 6.3
breastmilk 
The description of positive health effects presented in section 6.2 is mainly based on 
systematic reviews and meta-analyses, including the very recent one that forms the basis for 
the new Nordic Nutrition Recommendations and an updated systematic review from WHO 
(2013). Because few of the meta-analyses or reviews used as a basis for this benefit 
assessment enabled differentiation of health benefits of breastmilk in a long-term dose-
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dependent manner, some additional reviews and recent single studies of high quality were 
included to show that this field of research is gradually accumulating more knowledge. The 
meta-analyses, reviews and single studies pinpoint methodological challenges connected to 
confounding issues, with unsatisfying measurements or descriptions of length and degree of 
breastfeeding being the most prominent. Most of the evidence in human studies demonstrates 
associations that are susceptible to confounding by environmental and behavioural factors at 
different stages of the life course. 
 
Cognitive development 
Neurodevelopment may be influenced by infant feeding (as performance in intelligence tests 
seems to be better in children breastfed in infancy). WHO (2007) reports an increased mean 
difference for intelligence and schooling in breastfed children, while Hörnell et al. (2013) 
conclude that there is a “probable” increase. Van Rossum et al. (2005) conclude that the 
evidence is “probable” for intellectual and motor development. The PROBIT Study found 
significantly higher IQ among children in the intervention group compared to the control 
group when the children started school. 
WHO (2013) concludes that there is a strong evidence of causal effect of breastfeeding on IQ, 
although the magnitude of this effect seems to be modest. 
 
Immune response-associated diseases 
Infections 
In spite of the methodological challenges, the meta-analyses and reviews show that up to 6 
months of age, there is convincing evidence for a reduced risk of infectious diseases such as 
gastroenteritis, otitis media and lower respiratory tract infections with increased duration and 
degree (exclusivity) of breastfeeding, as illustrated in Table 6.1 which shows the ratings by Ip 
et al. (2007), van Rossum et al. (2005) and Hörnell et al (NNR, 2012). The same results have 
been found in the PROBIT and Generation R studies.  
 
Asthma and wheezing 
As for asthma, it is often difficult to distinguish between an allergic and a non-allergic (e.g., 
caused by infection) condition, and wheezing in childhood may be a sign of both. In many 
studies this distinction has not been made. The review by Ip et al. (2007) indicates that 
breastfeeding reduced risk for asthma, while van Rossum et al. (2005) state that there is 
“probable evidence” for reduced risk and Hörnell et al. (2013) conclude that there is “limited 
evidence” and that no conclusion can be given. The statements about wheeze are similar, and 
one is left with uncertainty about how the results are influenced by a protective effect against 
infection. In the PROBIT Study, no differences in asthma prevalence were observed between 
the intervention and control groups when the children were 6.5 years old. 
 
Allergies and atopic dermatitis (eczema) 
Exclusive breastfeeding for at least 4 months seems to reduce the incidence of immune-
mediated diseases such as asthma and other allergic disorders. It is however questioned 
whether it might be the total breastfeeding period rather than its exclusivity that might confer 
protection. In the study by Nwaru et al. (2013), children introduced to cereals at the age of  
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5-5.5 months experienced reduced risk of asthma and allergic rhinitis, whereas children 
breastfed shorter than 9.5 months increased the risk of non-allergic asthma. In the PROBIT 
Study, no differences in allergy incidence were observed between the intervention and control 
groups when the children were 6.5 years old. 
Atopic dermatitis is another unclear disorder, but it is often associated with food allergy. Van 
Rossum et al. (2005) conclude that there is “probable evidence” for a protective effect of 
breastfeeding while Hörnell et al. (2013) sum up the evidence saying that there is “limited 
evidence” and no conclusion can be given.  
 
Type 1 diabetes 
Available evidence suggests that breastfeeding may reduce the risk of type 1 diabetes 
mellitus. WHO (2007) concludes that the OR is substantially reduced, van Rossum et al. 
(2005) indicated “possible evidence” for a protective effect from breastfeeding while Hörnell 
et al. (2013) indicate “probable evidence”.  
 
Coeliac disease 
In the systematic literature review by Hörnell et al. (2013) it is judged to be “probable evidence” 
for breastfeeding as a protective factor for coeliac disease, at least for delaying its clinical 
presentation, while SACN/COT (2011) states that the evidence currently available is not strong 
enough to make specific recommendations about the appropriate timing of introduction of 
gluten. 
 
Inflammatory bowel disease 
Crohn’s disease is included in the reviews by van Rossum et al. (2005) and Hörnell et al. 
(2013). The first concludes that there is “possible evidence” for a protective effect of 
breastmilk while the latter concludes that the evidence is “probable”. As to ulcerative colitis, 
van Rossum et al. conclude that the evidence is insufficient and Hörnell et al. conclude that 
the evidence for a protective effect from breastfeeding is “probable”.  
 
Metabolic syndrome 
For disease entities belonging to the metabolic syndrome, such as type 2 diabetes mellitus, 
high cholesterol, high blood pressure and possibly overweight, breastfeeding in infancy may 
reduce the risk later in life. For the many health conditions included in this concept the 
following were found: 
 
Overweight/obesity 
WHO (2007), Ip et al. (2007) and SACN (2011) indicate a reduced risk for obesity from 
breastmilk, and van Rossum et al. (2005) and Hörnell et al. (2013) conclude that the evidence 
is “convincing”. On the other hand, the PROBIT randomised, controlled intervention study in 
Belarus did not observe differences in obesity risk at 6.5 or 11.5 years of age.  
The updated WHO systematic review (2013) concludes that breastfeeding may provide some 
protection against overweight and obesity, but residual confounding cannot be ruled out. 
Norwegian Scientific Committee for Food Safety (VKM) 10-003-final  
2 
 





Helle Margrete Meltzer (chair) 
Per Brandtzæg 
Helle Knutsen 
Beate Fossum Løland 
Jon Øyvind Odland 
Janneche Utne Skåre 
Liv Elin Torheim 




Long-term reduction in serum cholesterol is included in the review from WHO (2007) which 
reports a reduced mean difference in adulthood. Also in SACN (2011) indicate reduced serum 
cholesterol from breastmilk and Hörnell et al. (2013) conclude that there is a “probable” 
reduction. A significant reduction in serum cholesterol among adults was not found in the 
updated systematic review from WHO (2013). 
 
Blood pressure 
WHO (2007) and SACN (2011) conclude that the blood pressure is reduced (systolic and 
diastolic). Van Rossum et al. (2005) indicated “convincing evidence” while Hörnell et al. 
(2013) indicates “probable evidence”. The WHO (2013) systematic review found a small 
protective effect of breastfeeding against systolic, but not diastolic blood pressure. 
 
Cardiovascular diseases 
There is no convincing evidence that breastfeeding influences cardiovascular morbidity and 
mortality. 
 
Type 2 diabetes 
As to diabetes type 2, Ip et al. (2007) and SACN (2011) indicate a protective effect from 
breastmilk, while Hörnell et al. (2013) conclude that there is a “probable” reduced risk. WHO 
(2013) concludes that further studies are needed. 
 
Malignant disease 
Regarding childhood malignancies, some studies suggest a reduced incidence of some cancers 
among breastfed individuals. Ip et al. (2007) and SACN (2011) indicate that there is a 
reduced risk, while van Rossum et al. (2005) and Hörnell et al. (2013) conclude that the 
evidence for a reduced risk of childhood cancer from breastfeeding is limited suggestive. 
 
Sudden infant death syndrome 
SIDS may have several causes, and airway infection may be one predisposing factor. 
Breastfed children also seem to have a different sleeping pattern with lower arousal thresholds 
than formula fed infants, which may provide a mechanism for protection against SIDS. Ip et 
al. (2007) indicate that there is a reduced risk, while van Rossum et al. (2005) concludes that 
the evidence is “insufficient”. A later meta-analysis published in 2011 Hauck et al., concludes 
that breastfeeding is protective and that the effect is stronger when breastfeeding is exclusive. 
 
Duration of breastfeeding 
As the mandate of this report explicitly says that “the assessment shall particularly focus on 
the duration of exclusive and partly breastfeeding…” we include a separate point on this in 
the summary although such results have already been partly included in the text above. 
The updated 2012 Cochrane review of Kramer and Kakuma, focusing solely on the issue of 
optimal length of exclusive breastfeeding, concluded that children exclusively breastfed for 6 
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months experience less morbidity from gastrointestinal infections than those exclusively 
breastfed for 3 months, and no deficits have been demonstrated in growth among infants from 
either developing or developed countries who are exclusively breastfed for 6 months or 
longer.  
Additional single studies support the conclusions from Kramer and Kakuma, e.g. the Dutch 
study (Generation R), where children exclusively breastfed for 4 months had significant 
reduced risk of infection of the respiratory or gastrointestinal tract during the first 12 months 
of life. The effect of exclusive breastfeeding was even better in children exclusively breastfed 
for 6 months with regard to upper respiratory tract infections. 
The PROBIT studies support the conclusions that prolonged and exclusive breastfeeding 
reduces the risk of infections in early life and provide evidence for improvement of children's 
cognitive development at school age. However, this RCT study did not find differences 
between the intervention and control groups for the outcomes asthma, allergy, overweight and 
blood pressure at 6.5 years nor risk of obesity at 11.5 years.  
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This chapter describes epidemiological studies of negative health effects associated with 
contaminants in breastmilk. To comply with the terms of reference, the assessment of risks is 
based on findings from a full-scale systematic literature search. 
It is well known that environmental contaminants may affect the risk of a number of diseases 
or health problems, where detrimental effects on the cognitive development of children have 
received special attention the last decades. However, the issue of how contaminants in 
breastmilk, isolated, have an impact on health and disease risk has remained unresolved – and 
triggered the initiation of this benefit-risk assessment.  
It is important to be aware that most studies within human toxicology have been conducted 
with one substance and one health outcome in focus at a time. In reality, we are exposed to 
multiple substances simultaneously. The impact of this aspect is an emerging science – very 
few studies address this issue at present. 
Most of the evidence in human studies demonstrates associations that are susceptible to 
confounding by environmental and behavioural factors at different stages of the life course, 
e.g. socio-economic status. Partly independent of parents’ income, educational level and 
occupational status, is the home environment and the degree of intellectual stimulation and 
emotional support a child gets. The so-called “HOME score” has been developed the last 
decades to capture these aspects of a child’s environment (Caldwell and Bradley, 1985; Tong 
et al., 2007). The endpoints (health outcomes) in many studies involving environmental 
contaminants are related to child IQ and motor and cognitive development. If the “HOME 
score” is not taken into account, results may be biased.  
 
 Methodology – literature search, negative health effects associated 7.1
with contaminants in breastmilk 
In sections under 7.1 the methods and results of a systematic literature search based on Nordic 
guidelines for systematic reviews36 are described, with some minor modifications for the 
purpose of this work. Together with the librarian, a PICO-table and search strategy for 
literature search was set up which was discussed and accepted in the working group.  
 
7.1.1 Search strategy 
Test searches were conducted to find relevant terms and search words, and controlled 
vocabulary (MeSH and EMTREE) in some relevant papers were examined. Search strategies 
were developed and literature searches conducted in Medline and Embase. Both databases 
were used to ensure comprehensive study retrieval. The searches were conducted in January 
2011 using a combination of both controlled vocabulary (MeSH and EMTREE) and text word 
searching. A final search was conducted in (June) 2012 to capture papers published in 2011 
until June 2012. Table 7.1 shows the PICO-table that became the basis for the search strategy. 
The search criteria were developed based on the experience in the project group regarding 
presence of contaminants in breastmilk and previous and on-going epidemiological studies 
                                                 
36A guide for conducting Systematic Literature Reviews for the 5th edition of the Nordic Nutrition Recommendations, 
available at http://www.slv.se/en-gb/Startpage-NNR/A-guide-for-conducting-systematic-literature-reviews-for-the-5th-
edition-of-the-Nordic-Nutrition-recommendations-/  .
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and health effects. Malignancies were not included in the search because an initial pilot search 
gave no harvest. Theoretically, one would need child cohorts with several hundred thousand 
participants to get statistical power to study eventual associations between exposure to 
contaminants and these rather rare outcomes. So far, such large cohorts, including relevant 
data, do not exist and may explain why no scientific publications cover the issue. 
 
Table 7.1: PICO-table for search strategy in Medline and Embase1. 



























































Childhood mental disorder 
Adolescent mental disorder 
1Exact controlled vocabulary used in Medline and Embase (MeSH and EMTREE) is not listed as these differ. 
 
The environmental contaminants were divided into three main groups:  
• Pesticides (DDT37 and HCB25) 
• Other halogenated organic pollutants (PCBs25, dioxins25, brominated flame 
retardants25, perflourinated compounds25) 
• Heavy metals (lead, mercury and cadmium) 
The substances mentioned in parentheses were the ones focused on in this report. The two 
main reasons for choosing these compounds were  
a) most of the compounds are included in the Stockholm Convention  
b) these are the bioaccumulating environmental toxicants most extensively studied till now  
The search period covered publications from 1990 onwards unless substantial contributions to 
the field had been published before this date. An extensive review by Wigle was used to 
check if relevant articles published before 1990 were missed in the literature search (Wigle et 
al., 2008). Articles in English, German and a Scandinavian language were included in the 
search. The method allows for inclusion of studies found in references. 
                                                 
37Compounds included in the Stockholm Convention (see 
http://chm.pops.int/Home/tabid/2121/mctl/ViewDetails/EventModID/871/EventID/230/xmid/6921/Default.aspx) 
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Animal studies were not included in the search even if they give extensive information on 
dosages and mechanisms of toxic action and are thus a basis in many of the works cited in 
chapter 5. They may also hint at where to look for negative health effects in humans, or they 
may confirm observations done in humans. It is recognised that animal and epidemiological 
studies complement each other in risk assessments (Boyes et al., 2007; Brunekreef, 2008). 
However, with the time frame given to conduct the assessment, we concluded that well 
performed epidemiology studies are sufficient and provide adequate methodology for 
determining the human risks and the effects of persistent environmental toxicants. 
 
7.1.2 Publication selection 
Two reviewers working separately assessed the titles and abstracts of all papers identified in 
the search process for relevance, see Figure 7.1. Grey literature such as dissertations, 
conference proceedings and reports were excluded. Papers were excluded if they did not 
include information on breastfeeding in addition to a health outcome. Reviews were also 
excluded. 
In the next step, two reviewers working alone or together, assessed full text papers. A second 
selection was performed (see Figure 7.1), and papers were excluded if they: 
 
• did not allow for a clear separation between prenatal and postnatal exposure 
• included preterm infants who were not separated in the statistical analyses 
• did not seem relevant for Nordic background levels. This would include exceptionally 
high exposures as a result of heavy industrial contamination 
• in other ways were irrelevant 
 
Examined full text papers that were excluded according to the criteria listed above are shown 
in Appendix 1. 
  
7.1.3 Data extraction, relevance and quality assessment 
To assess the relevance and quality of included studies a three-category (A-B-C) rating 
system based on the NNR5 AMSTAR Quality Assessment Tool (QAT) was applied (Shea et 
al., 2007), modified for our purposes, see Appendix 2. The rating system included questions 
for evaluating all aspects of a study, e.g. study design, population characteristics, assessment 
of breastfeeding, assessment of outcome, relevance for the present purpose, confounding 
factors, methods, results etc. Only studies categorised as A or B are included in the results. 
The studies included in the results are listed in Appendix 3. Studies categorised as C are listed 
in Appendix 4 where also the reason for category C is described. Two independent reviewers 
performed data extraction for all included papers for halogenated compounds and pesticides. 
For capacity reasons, only one person extracted data from the heavy metal papers. Extracted 
data were compared and any inconsistencies noted and corrected as necessary. Extracted data 
were entered into Summary Tables and Quality Assessment Tool Tables. The Summary 
Tables (Appendix 5, Table 1-24) and Quality Assessment Tool Tables show how each article 
has been evaluated.  
Figure 7.1 shows a flow chart for the literature search and selection process 
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Figure 7.1: Flow chart for literature search and data extraction in chapter 7. The figure does not include 
papers which were added from the last literature search in June 2012. 
 
After the last literature search in June 2012, six additional papers were identified and 
examined in full text. Five of these met the inclusion criteria, and are included in the results. 
Some of the included papers investigate combinations of contaminant groups, and all together 
24 papers are included in the results. None of the papers investigate Norwegian infants. 
The quality of exposure information varied substantially between publications. Four main 
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Table 7.2: Ways of reporting exposure to contaminants, pre- and postnatally.  
Time point Measurement Quality assessment 
During pregnancy Contaminants in mother’s 
blood, urine. 
Studies with additional postnatal exposure measurements or postnatal 
exposure estimates (e.g. PBPK) were included. 
Qualified for A or B if outcomes were adequately described and 
duration of breastfeeding was appropriately taken into consideration 
in statistical analyses. 
At birth Contaminants in cord 
blood, mother’s hair or 
blood. 
Studies with additional postnatal exposure measurements or postnatal 
exposure estimates were included. 
Qualified for A or B if outcomes were adequately described and 
duration of breastfeeding was appropriately taken into consideration 
in statistical analyses. 
During lactation Contaminants in 
breastmilk.  
Studies included if duration of breastfeeding was given.  
Qualified for A or B if outcomes were adequately described and 
duration of breastfeeding was appropriately taken into consideration 
in statistical analyses. 
Postnatal or in 
childhood 
Contaminants in child’s 
blood or hair in a relevant 
period of exposure for the 
outcome. 
Studies included if duration of breastfeeding was given together with 
a measure of prenatal exposure.  
Qualified for A or B if outcomes were adequately described, duration 
of breastfeeding was appropriately taken into consideration and 
associations between prenatal exposure and outcomes were adjusted 
for in statistical analyses. 
 
 
 Negative health effects – overview of results 7.2
 
Overview of results – contaminants 
Some of the contaminants included in the literature search did not appear in the papers 
fulfilling our inclusion criteria. We found no papers with lead, cadmium, PFOS, PFOA and 
brominated flame retardants studying breastmilk levels and the health outcomes in question. 
 
Overview of number and types of cohorts 
The literature search revealed that a limited number of birth cohorts laid the foundation for 
most of the studies published as of (June 2013). These are cohorts with both lactation 
information and contaminant measurements. Table 7.3 gives an overview of the included 
cohorts. They are all prospective observational studies. In order to facilitate comparison of 
contaminant exposure between the cohorts, median PCB-153 concentrations in maternal 
serum and/or cord serum as well as cord serum median DDE is indicated for cohorts from 
which such information was found. Some of the concentrations were obtained by conversion 
from breastmilk or maternal serum samples to cord serum by use of conversion factors 
(explained in Govarts et al., 2012). In order to facilitate comparison with levels in Norway, 
results from the HUMIS study is shown in the last row. 
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Table 7.3: Overview of the cohorts included in the assessment, including (where available) selected 




of children  
in the cohort 


















The USA cohorts       
The North Carolina 
cohort,  
born 1978-1982 















Maternal and cord blood PCBs, 
breastmilk PCBs. PCBs, PBBs, 
DDT and HCB in 4-year old 




The Faroe Islands 
birth cohorts  
     
Faroe 1,  
born 1986-87 
1022 Mercury and PCBs at birth and at 
age 7, 14 and 23 years. Hair Hg in 
mother at birth and in child at 12 
months (Grandjean et al., 1995) 
  a 
(n~1022) 
 
Faroe 2,  
born 1994-95 
182 Mercury in cord, PCBs in 
breastmilk and serum at age 54 







Faroe 3,  
born 1999-2001 
656 Pregnancy and milk PCB, child 
PCB at 18 months and 5 & 7 
years. Hg in maternal hair, cord, 
and in child blood at 5 and 7 
years (Heilmann et al., 2010) 




The Dutch cohort 
born 1990-92 
418  Maternal and cord blood PCBs. 
Breastmilk dioxins and PCBs 2 
weeks postpartum (Huisman et 







The German cohort 
(Düsseldorf) 
born 1993-1995 
171 Cord blood and breastmilk PCBs. 
Serum PCBs at 42 months 








204 PCBs, PCP and HCB in maternal 
plasma at delivery, cord plasma 
and in infant plasma at 7 months 




born 1995-2002 333 PCB-153, DDE, Pb, Hg in cord 
blood and infant blood at 6th 




    
The Spanish cohorts 
(INMA) 
      
The Menorca region 
       born 1997-1999 
482 DDE and DDT in cord blood and 
child serum at 4 years (Sunyer et 
al., 2006) 




The Sabadell, Valencia      
and Gipuzkoa regions 
       born 2003-2008 
 
2150 Pregnancy PCBs, DDE and HCB 
in maternal serum and postnatal 
exposure estimated month by 
month through PBPK modelling 
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of children  
in the cohort 






















The Slovakian cohort  
       born 2002-2004 
 
1134 Maternal, and 6- and 16 month 
infant blood (serum) (Jusko et al., 
2012) 
  1433 
(n=1104) 
 
Norway, HUMIS for 
comparison levels 
       born 2002-2006 
409 The concentration in the next two 
columns are estimated levels 
based on breastmilk analyses  




1)Contaminant concentration from Longnecker et al. unless other reference is given (Longnecker et al., 2003). All values are 
maternal plasma or serum levels apart from the Düsseldorf study which are converted breastmilk levels. 
2)Contaminant concentration from Govarts et al. unless other reference is given (Govarts et al., 2012). Some of the 
concentrations are obtained by conversion from breastmilk or maternal serum samples. 
3)Contaminant concentration from the cohort reference paper. 
*Cord serum. The n indicates that several INMA cohorts are included. 
**Maternal blood. The n indicates that several INMA cohorts are included. 
a)In Grandjean et al. 2012 they analysed the geometric mean of cord blood total PCB sum(-118, -138, -153, and -180)x2 
(n=“almost all cohort members”). Not lipid adjusted, the value was 1860 ng/L (Grandjean, Weihe et al., 2012).  
 
In the Dutch cohort, 418 children have been studied as a whole or in a sub-group of 
Rotterdam children. In Spain, four regions are included in the INMA cohort. 
 
Overview of results, quality assessment 
In spite of excellent design, adequate descriptions of breastfeeding quality (e.g. exclusive or 
partial) and length and correction for relevant confounders in many of the included studies, 
none achieved the category A. The main reasons were inadequacies in their description of 
statistics, e.g. not describing statistical power in sufficient detail, or no correction for home 
environment e.g. HOME score. Description of statistical power is set as a criterion for 
category A in the NNR5 AMSTAR system and seems strict for the included studies, but is 
maintained in this report in order to be in compliance with the NNR-method. The reasons 
appear in more detail in the Quality Assessment Tool (QAT) Tables38. However, within the 
B-category, there were also relatively large differences in quality, so we decided to indicate 
this by giving the best studies a plus, i.e. B+. It should be kept in mind that the QAT used in 
this report was developed solely on the basis of a study’s relevance for this risk assessment 
and is not an evaluation of the papers per se. Category C studies were excluded from further 
analyses first and foremost because they could not separate the impact of pre- and postnatal 
exposure. 
Some papers were categorised as B for one contaminant group (e.g. PCBs) but as category C 
for another (e.g. mercury). 
 
 
                                                 
38Available at VKM website: 
http://www.vkm.no/eway/default.aspx?pid=277&trg=Content_6498&Main_6177=6498:0:31,2369&Content_64
98=6187:1781229::0:6271:3:::0:0.   
Norwegian Scientific Committee for Food Safety (VKM) 10-003-final  
2 
 





Helle Margrete Meltzer (chair) 
Per Brandtzæg 
Helle Knutsen 
Beate Fossum Løland 
Jon Øyvind Odland 
Janneche Utne Skåre 
Liv Elin Torheim 
Norwegian Scientific Committee for Food Safety (VKM) 10-003-final  
136 
 
Overview of results, health outcomes 
The most common outcomes studied in relation to contaminant exposure in these cohorts 
were neurodevelopment, respiratory diseases, immunology and allergies, growth and thyroid 
status. Details are described in the sub-sections below. Table 7.4 gives an overview of the 
included studies, sorted by outcome.  
 
Table 7.4: Overview of studies included in the results of risks related to persistent contaminants in 
breastmilk (sorted by health outcome). 















 PCBs, DDE, HCB in 
maternal pregnancy 
serum 
Child’s exposure to PCBs, 
DDE and HCB estimated 
month by month by PBPK-
modelling 
B+ 





at 4 years 
follow-up 
 PCBs, DDE, HCB in 
cord blood 
PCBs, DDE, HCB in child 
blood at 4 years 
B 
Neurodevelopment Verner et al., 
2010 




 PCBs in maternal blood, 
PCB-153, DDE, Pb and 
Hg in sub-group cord 
blood  
Child’s exposure to PCBs, 
DDE, Pb and Hg estimated by 
PBPK-modelling 
B 






910 at 7 
years 
follow-up 
 Hg in maternal hair, cord 
Hg  
Hg in child hair at 12 months B 
Neurodevelopment Winneke et al., 
2005 
Germany 171, 70 
at 6 years 
follow-up 
 PCBs in cord blood PCBs in breastmilk 2 weeks 
postpartum and serum PCBs 
at 42 months 
B 
Neurodevelopment Vreugdenhil et 




at 7 years 
follow-up 
 PCBs in plasma and cord 
blood 
PCBs and dioxins in 
breastmilk within 2 weeks 
postpartum 
B+ 
Neurodevelopment Vreugdenhil et 




at 6 years 
follow-up 
 PCBs in plasma and cord 
blood 
PCBs and dioxins in 
breastmilk within 2 weeks 
postpartum 
B+ 
Neurodevelopment Walkowiak et 
al., 2001 




 PCBs in cord blood PCBs in breastmilk 2 weeks 
postpartum and serum PCBs 
at 42 months 
B 








 PCBs in plasma and cord 
blood 
PCBs and dioxins in 
breastmilk 6 weeks 
postpartum. Child blood at 42 
months 
B+ 








 PCBs in serum and cord 
blood 
PCBs and dioxins in 
breastmilk 6 weeks 













 PCBs in plasma and cord 
blood 
PCBs and dioxins in 
breastmilk within 2 weeks 
postpartum 
B+ 








 PCBs in serum and cord 
blood 
PCBs and dioxins in 
breastmilk within 2 weeks 
postpartum  
B 







at 3, 4 
and 5 
years 
follow-up   
 PCBs and DDE in 
serum, cord blood and/or 
placenta  
PCBs and DDE in breastmilk 
postpartum and at 3 months 
B 
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 PCBs and DDE in 
plasma and placenta and 
cord blood  
PCBs and DDE in breastmilk 
postpartum and at 3 months 
B 






583 at 1 
year 
follow-up  
 Hg in maternal hair at 
delivery 
Hg in child hair at 12 months B 
Neurodevelopment 
and growth 









at 4 year 
follow-up 
 PCBs in cord blood PCBs in breastmilk and child 
serum at 4 years. 
Additionally, lead and a 
number of pesticides were 




Jusko et al., 
2012 
Slovakia 1134, 




 PCBs, dioxins in 
pregnancy 
PCBs, dioxins in child serum 










at 7 year 
follow-up  
 PCBs in serum, maternal 
hair and cord blood Hg 
PCBs in breastmilk 
postpartum. PCBs and Hg in 










at 5 and 7 
year 
follow-up 
 PCBs in child blood PCBs in postpartum milk B 
Immunology and 
allergy 
Sunyer et al., 
2006 
Spain 482, 462 
at 6 year 
follow-up  
 DDE and DDT in cord 
blood 
DDE and DDT in child serum 













 PCBs in plasma and cord 
blood 
PCBs and dioxins in 
breastmilk within 2 weeks 
postpartum 
B+ 











121 at 54 
months 
follow-up 
 Hg in cord blood PCBs in postpartum 
breastmilk 
B 
Weight, height and 
puberty signs 










 PCBs in plasma, cord 
blood, placenta 
PCBs, DDE in breastmilk 
postpartum and at 3 months 
B 










 PCBs, PCP and HCB in 
mothers at delivery, cord 
blood 
PCBs, PCP and HCB in child 
blood at 7 months 
B 
*N=number of children at inclusion in cohort and at follow-up. 
 
Some of the studies include more than one contaminant group, e.g. halogenated organic 
pollutants in combination with pesticides or heavy metals. These papers are included and 
discussed in the sections relevant for the contaminant groups included in the cohort. This 
implies that some studies are mentioned twice, e.g. if a study has analysed both PCBs and 
pesticides (DDT), it may appear both in the halogenated organic pollutant sections and in the 
pesticide sections. There is, however, only one Summary Table for each paper. 
Norwegian Scientific Committee for Food Safety (VKM) 10-003-final  
2 
 





Helle Margrete Meltzer (chair) 
Per Brandtzæg 
Helle Knutsen 
Beate Fossum Løland 
Jon Øyvind Odland 
Janneche Utne Skåre 
Liv Elin Torheim 
Norwegian Scientific Committee for Food Safety (VKM) 10-003-final  
138 
 
7.2.1 Halogenated organic pollutants (PCBs, dioxins, brominated flame retardants, 
perfluorinated compounds) 
As indicated in the flow chart (Figure 7.1), the search strategy identified 44 papers as relevant 
for halogenated organic pollutants and their full texts were retrieved. Examination of full texts 
resulted in the exclusion of 21 papers which did not meet the inclusion criteria; i.e. did not 
allow for assessment of postnatal exposure or did not include breastfeeding information or did 
not describe a specific health outcome or did not seem relevant for Nordic background levels. 
A final total of 23 publications were identified for PCBs, dioxins, PBDEs, PFOS and PFOA 
and assessed in Summary Tables and Quality Assessment Tool Tables. Seven papers were 
categorised as C, and therefore not further interpreted. Five additional papers were identified 
as relevant and included after the last literature search. Finally, 21 papers with halogenated 
organic pollutants were categorised as B. No papers fulfilled the criteria for being categorised 
as A. An overview of the publications on halogenated compounds included in the results in 
this opinion is provided in Table 7.4. For a detailed presentation of the papers, see the 
Summary Tables (Appendix 5). 
 
7.2.1.1 Halogenated organic pollutants – neurodevelopmental outcomes 
Fourteen papers reported results of breastfeeding exposure to halogenated organic compounds 
in relation to neurodevelopmental milestones. Two of these were based on the North Carolina 
cohort (Gladen and Rogan, 1991; Rogan and Gladen, 1991), one from the Lake Michigan 
cohort (Jacobson et al., 1990), six from the Dutch cohort (Huisman et al., 1995; Lanting et al., 
1998; Patandin, Lanting et al., 1999; Vreugdenhil, Slijper et al., 2002; Vreugdenhil, Lanting 
et al., 2002), two from the German cohort (Walkowiak et al., 2001; Winneke et al., 2005), one 
from the Canadian cohort (Verner et al., 2010) and two from the INMA cohort in Spain 
(Forns et al., 2012; Gascon et al., 2013). A brief overview of measurements and results are 
given in Table 7.5 below. If reported, results from investigation of prenatal exposure and 
health outcome have been included in the table. 
 
Table 7.5: Evidence table for outcomes - halogenated organic pollutants included for assessment on 
neurodevelopment associations. 























Short: 0-9 weeks  
(0-4 mostly 
breastfed), medium: 
10-19 weeks (0-4 
mostly breastfed), 
long: mostly 
breastfed for 20 
weeks, very long: 




Scales) at 18 and 
24 months 
No consistent association 
between exposure to PCBs or 
DDE through breastmilk and 
outcomes 
Psychomotor delay up to 2 
years of age associated with 
the highest 5% of 











As above McCarthy Scales 





No consistent association with 
lactational exposure to PCBs 
and DDE was observed at 3, 4 
and 5 years on 
neuropsychological 
development 
No association with prenatal 
exposure either 
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Not given Length of 
breastfeeding mean 






at 4 years 
 
Activity level decreased with 
increasing postnatal PCB 
exposure. The association was 
negligible unless the infant 















Zero, short (6-16 




18 months, focus 
on motor 
functions. 
No association between 
lactational exposure to PCBs 
and dioxins and neurological 
conditions 
Prenatal PCB exposure had a 
weak negative association to 
the neurological condition at 








Zero, short (at least 6 




Scales) at 3, 7 
and 18 months of 
age 
At 7 months the psychomotor 
scores for the highest exposed 
breastfed children were 
comparable to bottle-fed 
children. At 18 months mental 
and psychomotor development 
affected neither by 
PCB/dioxin exposure nor by 
feeding type.  
Prenatal PCB exposure was 
associated with small 
reduction in psychomotor 







Zero, short (6-16 




42 months, focus 
on motor 
functions 
Neither prenatal PCB nor 
postnatal exposure to 
PCBs/dioxins related to 








Zero, short (6-16 






Battery) at 42 
months 
No associations between 
lactational exposure to 
PCBs/dioxins nor to current 
PCB level in child and 
cognitive abilities at 42 
months of age 
In utero exposure to PCBs 
associated with poorer 
cognitive functioning in 
preschool children. Children 
of mothers at the upper end of 
exposure especially at risk 
Vreugdenhil 






Zero, short (6-16 
weeks) or long >16 
weeks 
Play behaviour 
at school age 
No association between 
postnatal exposure and play or 
problem behaviour at school 
age 
Some associations from 
prenatal exposure 
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 Reference Exposure Bf degree*  Bf length  Health outcome Results 
 
Vreugdenhil 






Zero, short (6-16 







at school age  
Postnatal exposure to 
PCBs/dioxins through 
lactation not significantly 
related to GCI, memory, and 
motor scores, and effects of 
postnatal exposure were not 
significantly modified by 
parental and home 
environmental characteristics 
Subtle neurotoxic effects of 
prenatal exposure to PCBs and 











PCBs Not given Breastfeeding length 
(<2 weeks; >2 weeks-





and mental) at 7, 
18 and 30 
months, and at 
42 months of 
age, intelligence 
was measured 





Negative associations between 
early milk PCBs and 
mental/motor development at 
all ages, significant from 30 
months onwards. Intelligence 
at 42 months negatively assoc. 
with calculated breastmilk 
PCB exposure and PCB-level 
in serum from 42-month olds 
Prenatal PCB exposure was 
associated with impaired child 
development. A favourable 
home environment had the 
opposite effect and supported 
mental and motor 




PCBs Not given  Intelligence at 72 
months follow-
up was measured 





The negative associations with 
PCBs in milk (prenatal 
exposure) and in 42-month-
serum (postnatal exposure) 
was no longer significant at 72 
months, although associations 
















Length of exclusive 
breastfeeding 
recorded. Mean 155.9 
days (range 0-466) 
Infant behaviour 
at 11 months of 
age. Behaviour 
Rating Scales, 
BRS, of Bayley 
Scales, BSID-II.  
Postnatal exposure associated 
with activity level, measured 
by non-elicited activity. The 
strongest association was 
found for simulated PCB 
levels during the 4th month of 
life 














Recorded Recorded. Mean 
duration exclusive 
breastfeeding 3.8 








giving MDI and 
PDI test scores at 
around 14 
months of age 
Postnatal PCB-153 exposure 
was not associated with any of 
the outcomes 
Prenatal PCB-153 exposure 
was associated with PDI, but 
not MDI (as reported 
separately, from this cohort), 
also when postnatal PCB-153 
exposure was included in the 
model 
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 Reference Exposure Bf degree*  Bf length  Health outcome Results 
 



















The levels of postnatal PCBs 




No statistically significant 
effects of sum of prenatal 
PCBs on MSCA scores, but 
significant detrimental effects 
of prenatal PCB-153 on the 
majority of MSCA scores, 
while no effects reported for 
the other PCB congeners 
*Degree of breastfeeding is defined in a number of different ways in the papers. 
**Contaminants in parentheses are analysed, but not included in the reported health outcomes in the paper. 
***SD=standard deviation. 
 
In the North Carolina cohort (1978-82) (n=858), the follow-up period was 5 years and the 
outcomes studied were child development (psychomotor scores, Bayley Scales of Infant 
Development (BSID)) at 18 and 24 months of age (n=670 at 24 month follow-up) (Rogan & 
Gladen, 1991), and neuropsychological development (McCarthy Scales of Children`s 
Abilities (MSCA) at 3, 4 and 5 years of age). Information about school grades was also 
included (n=712 at 5 year follow-up) (Gladen and Rogan, 1991). Both PCB and DDT/DDE 
exposures were studied. Degree of breastfeeding is described as mostly or partly breastfed and 
breastfeeding length as short, medium, long or very long, see Table 7.5. Rogan & Gladen 
(1991) concluded that there was no evidence of an association between motoric maturation 
and postnatal exposure to PCBs through breastmilk, while they found small, but stronger with 
age, association to psychomotor development and prenatal exposure after a threshold of 3.4 
ppm PCBs (Rogan and Gladen, 1991). Gladen & Rogan (1991) found some significant and 
consistent patterns, however, due to inconsistent dose-response patterns, they concluded that 
no association between neither pre- nor postnatal PCB and DDE exposure could be observed 
at 3, 4 and 5 years of age on neuropsychological development as assessed by McCarthy 
Scales and school grades. 
In the Michigan cohort (1990-92) (n=313), the follow-up period was 4 years and the outcome 
studied was activity in children assessed by McCarthy Scales of Children`s Abilities (n=231 
(growth) and n=265 (activity) at follow-up) (Jacobson et al., 1990). The exposure was PCBs, 
PBB and some chlorinated pesticides. Degree of breastfeeding was not described. Mean 
breastfeeding length was reported as 29.6 weeks. The 15 children whose mothers had higher 
than average breastmilk PCB levels and who nursed for more than a year, scored lower in 
activity measurements when they were 4 years old than children of mothers who breastfed 
shorter than a year. In the rest of the group, n=297, no associations between breastmilk PCB 
levels and activity scores were observed. 
There are three relevant cohorts from Europe for the neurodevelopment endpoint; the Dutch 
cohort (Vreugdenhil, Lanting et al., 2002; Vreugdenhil, Slijper et al., 2002; Patandin, Lanting 
et al., 1999; Lanting et al., 1998; Koopman-Esseboom et al., 1996; Huisman et al., 1995), the 
German cohort (Walkowiak et al., 2001; Winneke et al., 2005) and the INMA cohort from 
Spain (Gascon et al., 2013 (three regions at mainland) and Forns et al., 2012 (Menorca)). 
In the Dutch cohort (1990-1992) (n=418, (211 in Groningen and 207 in Rotterdam)), the 
follow-up periods were 3, 7, 18, 42 and 78 months and the outcome studied were 
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neurodevelopment with focus on cognitive and motor abilities (3,7, 18 and 42 months), and 
play behaviour (78 months) (Koopman-Esseboom et al., 1996; Lanting et al., 1998; Patandin, 
Dagnelie et al., 1999; Vreugdenhil, Slijper et al., 2002; Vreugdenhil, Lanting et al., 2002). 
Different approaches and methods to study the health outcomes were used in these papers, all 
studying exposures from PCBs and dioxins. Degree of breastfeeding is described as fully 
breastfed and breastfeeding length as zero, short or long, see Table 7.5.  
Koopman-Essebom et al., (1996) demonstrated a slight negative association between prenatal 
exposure to PCBs and dioxins and psychomotor functions at 3 months of age (n=182 at 7 
month follow-up) in the Rotterdam arm of the Dutch cohort (Koopman-Esseboom et al., 
1996). PCB and dioxin exposure through breastfeeding had adverse effect on psychomotor 
outcome at 7 months of age. There was however a beneficial effect of breastfeeding overall, 
so that breastfed infants with the highest exposure had test results similar to the formula fed. 
At 18 months of age, neither PCBs nor dioxin or feeding type affected the psychomotor 
outcome. Furthermore, no such influence was seen at 42 months of age (n=394 at follow-up) 
(Lanting et al., 1998). Huisman et al. (1995) found that prenatal PCB exposure had a weak 
negative association with psychomotor function (neurological optimality score (NOS), quality 
of movements in terms of fluency; normal, mildly abnormal, abnormal NOS, fluency cluster 
score, different measurement of outcome compared with Koopman-Essebom et al. (1996) at 
18 months of age (n=373 at follow-up), but found no effect of exposure via breastfeeding 
(Huisman et al., 1995). Patandin et al. (1999) found that in utero exposure to “background 
PCBs levels” was associated with poorer cognitive functions in preschool children at 42 
month of age (n=395 at follow-up), and that children of mothers at the upper end of PCB and 
dioxin exposure were particularly at risk (Patandin, Dagnelie et al., 1999). No associations 
between lactational exposure to PCBs and dioxins nor level in the blood at 42 months and 
cognitive abilities were found at this age (Koopman-Esseboom et al., 1996). Vreugdenhil et 
al., 2002 (1 and 2) who studied cognitive and motor abilities (n=372 at follow-up), and play 
behaviour (n=158 at follow-up) of Dutch children at school age, found that neurotoxic effects 
of prenatal exposure to PCBs and dioxins persisted into school age, resulting in a subtle 
cognitive and motor development delay. More optimal intellectual stimulation provided to the 
child may counteract the effects of prenatal exposure to PCBs and dioxins. They found no 
associations between the studied outcomes and postnatal exposure through breastfeeding 
(Vreugdenhil, Slijper et al., 2002; Vreugdenhil, Lanting et al., 2002).  
In the German Düsseldorf cohort (1993-1995) (n=171), the initial follow-up period was up till 
42 months (n=91 at follow-up). The outcome studied was psychomotor and cognitive 
development assessed at 7, 18, 30 and 42 months of age, and the exposure measured was 
PCBs (Walkowiak et al., 2001). Degree of breastfeeding is not given, but breastfeeding 
duration is reported in weeks or months, see Table 7.5. Of the Bayley Scales of Infant 
Development, the mental and motor scales were used at 7, 18 and 30 months of age, while 
intelligence was measured at 42 months of age with the German version of the Kaufman 
Assessment Battery for Children (KABC). Scores from the Sequential Processing and 
Simultaneous Processing subscales were combined to yield the Mental-Processing-
Composite-Index that was standardised to a mean of 100 and SD 15. No significant or 
borderline association with calculated postnatal PCB exposure was found for any of the 
Bayley Scales. However, a significant negative association was found between postnatal 
exposure and Kaufman Assessment Battery at 42 months of age. Increasing PCB levels in 
early milk combined with duration of breastfeeding, as well as measured PCB level in serum 
from 42-month old children, predicted decreased Kaufman Assessment Battery scores at 42 
months. The authors concluded that prenatal PCB exposure at current European background 
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levels inhibits, and a favourable home environment supports, mental and motor development 
until 42 months of age. PCBs also had an effect postnatally.  
In a later follow-up at 72 months (6 years) the children (n=70) were again assessed by the 
Kaufman Assessment Battery for Children and the HOME score was again assessed. At 72 
months the negative associations with PCBs in milk (prenatal exposure) and in 42-months-
serum (postnatal exposure) and intelligence, were no longer significant, although associations 
still remained negative. The positive effect of the home environment became even more 
pronounced. The authors concluded that early PCB exposure at levels in their cohort possibly 
induces transient delay in cognitive development rather than irreversible deficit (Winneke et 
al., 2005). 
In the Canadian cohort, conducted among Inuits by the Hudson Bay coast in Artic Quebec 
(1995-2002) (n=333), the follow-up period was 11 months (n=168 at follow-up). Infant 
behaviour was assessed at 11 months of age, and the exposure measured was PCB-153 in cord 
or maternal blood obtained at delivery or within a few weeks postpartum (n=168). Hg, Pb, 
PCBs, and other chlorinated compounds were analysed in a subset of cord blood and infant 
blood at 6 months of age (n=83-85). Infant blood PCB-153 profiles were estimated month by 
month using a previously validated (at 6 months) PBPK modelling framework developed by 
Verner et al. (2009), (Verner et al., 2010). Mean length of exclusive breastfeeding was 155.9 
days (range 0-466). Exclusive breastfeeding only was included in the PBPK model. The 
outcomes were assessed using Behaviour Rating Scales (BRS) of Bayley Scales of Infant 
Development, BSID-II at 11 months of age. Video coding of inattention and activity was 
measured during administration of the mental developmental subscale of BSID-II. The 
estimated pre- and postnatal PCB exposure measures predicted significant increases in 
inattention and activity at 11 months of age. Inattention was mostly related to prenatal 
exposure, while activity level, measured by non-elicited activity, was best predicted by 
postnatal exposure, with the strongest association obtained for simulated PCB levels during 
the fourth month of life. Thus, windows of susceptibility were revealed by simulated infant 
toxicokinetic profiles for the first year of life during which PCBs may impair infant attention 
and activity.  
In the Spanish INMA cohort (Menorca) (1997-1999) (n=482), the follow-up period was 4 
years (n=472 at follow-up). The outcome studied was general neuropsychological 
development at 4 years of age, and the exposure measured was PCBs -28, -101, -118, -138, -
153,- 180, DDE and HCB (355 mother-child pairs with complete information of outcome 
assessment and contaminant levels in cord blood, and child blood at 4 years of age from 285 
children) (Forns et al., 2012). Length and degree of breastfeeding were recorded but not 
given. McCarthy Scales of Children’s Abilities was adapted to the Spanish population. The 
general cognitive scale and the five subtests were reorganised into sub-area scores (executive 
functions, working memory, quantitative and motor) and were examined. In addition, new 
measures were included by reorganising the McCarthy Scales sub-tests into new sub-area 
scores (executive functions, working memory, visual and verbal span, verbal memory, gross 
and fine motor skills, and cognitive functions of posterior cortex) according to those tasks that 
are highly associated with specific neuropsychological functions. Postnatal exposure to PCBs 
was not associated with neuropsychological development in the preschool period. Prenatal 
PCB exposure, particularly PCB-153, was adversely associated with general 
neuropsychological development at 4 years of age, including negative effect on executive 
function, verbal functions and visiospatial abilities, but not on motor development.  
In the Spanish INMA cohort (Gipuzkoa, Catalonia and Valencia) (2003-2008) (n=2150), the 
follow-up period was 14 months, (range 11-21 months) (n=1175 at follow-up). Child 
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neuropsychological development was assessed at 14 months (mean), and the exposure 
measured was PCB-153, DDE and HCB in maternal serum (at pregnancy week 7-26, median 
12.9 weeks), while the child`s exposure was estimated month by month by a physiologically 
based pharmacokinetic modelling (PBPK) developed by Verner et al.39 (Gascon et al., 2013). 
Length and degree of breastfeeding were recorded, and the mean duration of exclusive 
breastfeeding was 3.8 months and partly breastfeeding 6.1 months. Breastmilk consumption 
during partial breastfeeding was calculated as a constant decrease in intake. The outcomes 
were measured by Bayley Scales of Infant Development, BSID-I test (giving mental 
development index (MDI) and psychomotor development index (PDI) test scores) in children 
aged around 14 months of age (range 11-21 months). Mean estimated PCB-153, DDE and 
HCB levels increased in child’s blood after birth due to breastfeeding. Prenatal PCB-153 
exposure was associated with PDI, but not with MDI (has been reported earlier from this 
cohort), also when postnatal exposure was included in the model. Postnatal PCB exposure 
was not associated with any of the outcomes. Thus, even though breastfeeding increased the 
levels of POPs in children`s blood during postnatal life, no associations were found between 
different periods of postnatal exposure to these POPs and mental or psychomotor scores. 
Thus, the authors suggested that deleterious effects of PCB-153 on early brain development, 
particularly on psychomotor development, are mainly attributable to prenatal exposure to low 
levels of POPs. 
 
7.2.1.2 Halogenated organic pollutants – immunological or allergic outcomes   
Four papers reported results of breastmilk exposure to halogenated organic compounds in 
relation to immunological or allergic outcomes. Two of these were based on the Faroe Islands 
cohort 3 (Grandjean et al., 2010; Heilmann et al., 2010), one was from the Dutch cohort 
(Weisglas-Kuperus et al., 2000), and one from the Slovakian cohort (Jusko et al., 2012). A 
brief overview of measurements and results are given in Table 7.6 below. If reported, results 
from prenatal exposure and health outcome have been included in the table. 
In the Faroe Islands cohort 3 (1999-2001) (n=656), Grandjean et al. (2010) studied allergy, 
asthma and sensitisation during childhood with prenatal and lactational exposure to marine 
pollutants (PCBs and Hg). The degree of breastfeeding is described as exclusive breastfeeding 
or any breastfeeding and breastfeeding duration is reported in months, see Table 7.6.  
The immunological outcomes were total IgE, grass-specific IgE and occurrence of allergic 
disease in 7-year old children (n=464 at follow-up). The results indicate that PCBs in 
breastmilk may cause an IgE increase in children and thus interact with the beneficial effects 
of breastfeeding, but a history of asthma or atopic dermatitis was not associated with the 








                                                 
39Verner et al., 2009. 
Norwegian Scientific Committee for Food Safety (VKM) 10-003-final  
2 
 





Helle Margrete Meltzer (chair) 
Per Brandtzæg 
Helle Knutsen 
Beate Fossum Løland 
Jon Øyvind Odland 
Janneche Utne Skåre 
Liv Elin Torheim 
Norwegian Scientific Committee for Food Safety (VKM) 10-003-final  
145 
 
Table 7.6: Evidence table for outcomes - halogenated organic pollutants included for assessment of 
immunological or allergic parameters. 





















not exclusive  
Exclusive 
breastfeeding 4.6  
+/- 2 months. Any 
breastfeeding 9.8  





Dependant on outcome 
measures, postnatal PCB 
exposure both increased and 
decreased the risk of allergic 
disease 
Prenatal exposures to PCBs 
were inversely associated with 
a history of atopic dermatitis, 
but showed a week positive 








breastfeeding 4.6  
+/- 2 months. Any 
breastfeeding 9.8  





Breastmilk PCB exposure 
associated with immunotoxic 
outcomes on serum 
concentration of antibodies 
against diphtheria and tetanus 
vaccinations 
No significant association 















Fully breastfed  Zero, short (0-6 





at school age 
PCB plasma levels in 42-
month old children were 
associated with higher 
prevalence of chicken pox and 
recurrent middle-ear 
infections and a lower 
prevalence of allergic 
reactions. A higher dioxin 
TEQ was associated with a 
higher prevalence of 
coughing, chest congestion, 
and phlegm 
Prenatal exposures associated 













PCBs  Fully breastfed 0-<3 months, 3-6 
months, >6 months 
Thymus volume 6 month PCB concentration in 
infant plasma was inversely 
associated with thymus 
volume. The association 
became positive at 16 months 
of age 
Prenatal PCB concentration 
associated with smaller 
thymus volume at birth. No 
association beyond the 
neonatal period 
*Degree of breastfeeding is defined in a number of different ways in the papers. 
**Contaminants in parentheses are analysed, but not included in the reported results in the paper. 
Heilman et al. (2010) studied serum concentrations of antibodies against vaccine toxoids in 
the Faroe Islands cohort 3 at age 5 and 7 years (n=587 at follow-up). The serum PCB 
concentration was measured at 18 months in addition to at ages 5 and 7. Postnatal PCB 
exposure was associated with reduced serum concentration of specific antibodies after 
diphtheria vaccination and to a lesser extent after tetanus vaccination (Heilmann et al., 2010). 
The strongest associations suggested a decrease in the antibody levels by about 20% for each 
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doubling in PCB exposure. At the age of 5 years, the odds of an antidiphtheria antibody 
concentration below a clinically protective level of 0.1 IU/L increased by about 30% for a 
doubling in PCBs in milk and 18-month serum. Maternal pregnancy serum PCB 
concentration showed only a small and not statistically significant association with antibody 
concentrations and with serum PCB concentrations determined at ages 5 and 7 years (cross-
sectional analyses).  
In the Dutch cohort (1990-1992) (n=418, (211 in Groningen and 207 in Rotterdam)), 
Weisglas-Kuperus et al. (2000) found that the PCB concentration in serum from 42-month old 
children (n=175 at follow-up) was associated with a higher occurrence of chicken pox and 
recurrent middle ear infection, and a lower prevalence of allergic reactions to food, pollen, 
dust and household pets (Weisglas-Kuperus et al., 2000). The authors hypothesised that 
common infections acquired early in life may prevent development of allergy, so PCB 
exposure therefore might be associated with a lower prevalence of allergic diseases. Degree of 
breastfeeding is described as fully breastfed and breastfeeding length as zero, short or long, 
see Table 7.6. Breastfeeding duration was found to counteract the increased odds ratio for 
middle ear infection. The authors concluded that the study did not provide data to discourage 
breastfeeding at the background PCB levels in the Netherlands at that time.  
In the Slovakian cohort (2002-2004) (n=1134), Jusko et al. (2012) found that higher maternal 
PCB concentration was associated with reduced thymus volume at birth, but the maternal 
concentration was not predictive of 6- and 16 month thymus volume. The plasma PCB 
concentration in infants was measured at 6 months, and was associated with a decrease in 6-
month thymus volume. This association was weaker when exclusive breastfeeding was not 
adjusted for. An indication of a positive association between 16 month infant PCB 
concentration and thymus volume was also seen. Since thymus volume peaks at 6 to 8 months 
of age and then shrinks, the authors speculate that this could be related to delayed thymus 
maturation. The potential adverse effect of in utero PCB exposure on thymic development 
may extend beyond the neonatal period, and postnatal PCB exposure was influential. The 
physiological implications of the findings are however not known (Jusko et al., 2012). 
 
7.2.1.3 Halogenated organic pollutants – child growth and weight 
Three papers reported results of breastfeeding exposure to halogenated organic compounds in 
relation to child growth. Two were from the USA (the North Carolina cohort and the 
Michigan cohort) (Gladen et al., 2000; Jacobson et al., 1990) and one was from the Faroe 
Islands cohort 2 (Grandjean et al., 2003). A brief overview of measurements and results are 
given in Table 7.7 below. If reported, results from prenatal exposure and health outcome have 
been included in the Table. 
In the North Carolina cohort (1978-82) (n=858) Gladen et al. (2000) did not observe 
associations between postnatal exposure to PCBs and DDE and pubertal growth and 
development (n=594 at follow-up) (Gladen et al., 2000). Degree of breastfeeding in the North 
Carolina cohort is described as mostly or partly breastfed and breastfeeding length as short, 
medium, long or very long, see Table 7.7. 
In the Michigan cohort (1980-81) (n=316), Jacobsen et al. observed no association between 
postnatal PCB exposure and growth in children at 4 years (n=231 at follow-up) (Jacobson et 
al., 1990). Degree of breastfeeding is not described in the Michigan cohort. Mean 
breastfeeding length is reported as 29.6 weeks, see Table 7.7. 
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Table 7.7: Evidence table for outcomes - halogenated organic pollutants included for assessment of 
growth. 
 



















Mostly or partly 
breastfed 
Short: 0-9 weeks  
(0-4 w mostly 
breastfed), medium: 
10-19 weeks (0-4 w 
mostly breastfed), 
long: mostly 
breastfed for 20 
weeks, very long: 
weaning after 49 
weeks 
Weight and 
height at 14 
years, age at 
menses, breast 
stage 3-5, pubes 
3-5 
No association between 
postnatal PCB exposure and 
growth or puberty signs (but 
tendency to later maturation in 
bottle-fed girls) 
Prenatal exposure to PCBs 
positively associated with 















Not given Mean breastfeeding 






No association between 
postnatal PCB exposure and 
growth  
Prenatal exposure associated 























7.8 +/- 5.7 months. 
Exclusive 
breastfeeding 3.5  
+/- 2.0 months. 
18.2% exclusively 
breastfed for 6 
months  
Height and 
weight at 18 and 
42 months 
At 18 months, children who 
had been exclusively breastfed 
for at least 6 months weighed 
0.59 kg less and were 1.50 cm 
shorter than those not 
breastfed 
A weaker, but similar negative 
association was observed 
between cord blood PCB 
concentration and weight and 
height at 6 months 
*Degree of breastfeeding is defined in a number of different ways in the papers. 
**Contaminants in parentheses are analysed, but not included in the reported results in the paper. 
***SD=standard deviation. 
 
In the Faroe cohort 2 (1994-95) (n=182), Grandjean et al. (2003) investigated the relationship 
between pre- and postnatal exposure to PCBs and mercury and growth. Degree of 
breastfeeding is described as exclusive breastfeeding, and breastfeeding duration is reported 
in months, see Table 7.7. They found that children who were exclusively breastfed for the 
first 6 months weighed less and were shorter than those not breastfed (Grandjean et al., 2003). 
This was most clearly observed after 18 months (n=171), but was also observed at 42 months 
(n=154), albeit not statistically significant. The impact of PCB versus mercury exposure could 
not be separated.  
 
7.2.1.4 Halogenated organic pollutants – thyroid parameters 
One paper from Canada, studying Inuits (Dallaire et al., 2009), reported results of 
breastfeeding exposure to halogenated organic compounds in relation to effects on thyroid 
parameters. Measurements and results are given in Table 7.8 below. Results from prenatal 
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Table 7.8: Evidence table for outcomes - halogenated organic pollutants included for assessment on 
thyroid parameters. 
 
















Not given 0-7 months Thyroid 
hormone status 
in mothers and 
infants 
No association was observed 
between postnatal exposure to 
PCBs, HCB or PCP and 
thyroid hormones at 7 months 
of age 
Prenatal exposure was 
negatively associated with 
TBG levels and T4 
concentration in the newborn 
 
In the Canadian cohort (1995-98) (n=204 at inclusion), Dallaire et al. (2009) studied the 
relationship between thyroid hormone status and postnatal exposure to PCBs, PCP and HCB 
in 7-month old children of Canadian Inuit women (n=130 at follow-up); no association was 
found (Dallaire et al., 2009). Degree of breastfeeding is not given in the Canadian cohort and 
breastfeeding duration is reported as 0-7 months, see Table 7.8. 
 
7.2.2 Heavy metals – Mercury 
As indicated in the flow chart (Figure 7.1), the search strategy identified 17 papers as relevant 
for heavy metals and their full texts were retrieved. Examination of full texts resulted in the 
exclusion of eleven papers which did not meet the inclusion criteria; i.e. did not allow for 
assessment of postnatal exposure or did not include breastfeeding information or did not 
describe a specific health outcome or did not seem relevant for Nordic background levels. A 
final total of six publications were identified for mercury and lead, and assessed in Summary 
Tables and Quality Assessment Tool Tables. Four papers were categorised as C and therefore 
not further interpreted. Finally, two papers were categorised as B. No papers fulfilled the 
criteria for being categorised as A. An overview of the publications on mercury included in 
the results in this opinion is provided in Table 7.4. For a detailed presentation of the studies, 
see the Summary Tables (Appendix 5). 
 
7.2.2.1 Mercury – neurodevelopmental outcomes 
Two papers from Faroe Islands cohort 1(1986-87) (n=1022) investigated mercury from 
breastmilk in relation to developmental milestones, first at the age of 1 (n=583) and later 
when the child was 7 years old (n=910) (Grandjean et al., 1995; Jensen et al., 2005). A brief 
overview of measurements and results are given in Table 7.9 below. Results from 
examination of prenatal exposure and health outcome have been included in the table. 
Mercury exposure from breastmilk was assessed by relating mercury in the child’s hair at age 
1 to length of breastfeeding. Degree of breastfeeding is described as exclusive breastfeeding, 
and breastfeeding duration is reported in months, see Table 7.9. Neither at 1 (Grandjean et al., 
1995) nor at 7 years (Jensen et al., 2005) of age was the mercury exposure from breastmilk 
associated with a reduction in the developmental outcomes measured. On the contrary, at age 
1, higher hair mercury was associated with earlier development (earlier sitting, creeping and 
rising), which the authors attributed to the positive impact of breastfeeding per se. 
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However, in a recent publication from the investigators, a re-evaluation of the first data 
brought forth that prenatal mercury exposure is the primary explanatory variable for 
neurobehavioural deficits at the age of 7 years (Grandjean, Weihe et al., 2012).  
 
Table 7.9: Evidence table for outcomes – heavy metals included for assessment on neurodevelopment 
associations. 
 

















Hg Mostly or partly 
breastfed 
Short: 0-9 weeks  
(0-4 w mostly 
breastfed), medium: 
10-19 weeks (0-4 w 
mostly breastfed), 
long: mostly 
breastfed for 20 
weeks, very long: 
weaning after 49 
weeks 
Month of child 
sitting, creeping, 
rising 
Higher Hg in hair at 12 
months associated with earlier 
development 
 
Milestone development was 
not associated with prenatal 
Hg exposure as measured by 
hair-Hg at parturition 
Jensen et 
al., 2005 
Hg Mostly or partly 
breastfed 
As above A number of 
neuropsycho-
logycal tests at 
age 7  
Postnatal exposure to Hg was 
not associated with reduction 
in neuropsychological 
performance at 7 years 
Prenatal association not 
reported. Adjustment for 
prenatal exposure to Hg, as 
measured by cord blood Hg, 





As indicated in the flow chart (Figure 7.1), the search strategy identified 31 papers as relevant 
for pesticides and their full texts were retrieved. Examination of full texts resulted in the 
exclusion of 14 papers which did not meet the inclusion criteria; i.e. did not allow for 
assessment of postnatal exposure or did not include breastfeeding information or did not 
describe a specific health outcome or did not seem relevant for Nordic background levels. A 
final total of 18 publications were identified for DDT and DDE, and assessed in Summary 
Tables and Quality Assessment Tool Tables. Thirteen papers were categorised as C and 
therefore not further interpreted. One additional paper was identified after the last literature 
search. Finally, six papers were categorised as B. No papers fulfilled the criteria for being 
categorised as A. An overview of the publications on pesticides included in the results in this 
opinion is provided in Table 7.4. For a detailed presentation of the studies, see the Summary 
Tables (Appendix 5).  
 
7.2.3.1 Pesticides – neurodevelopmental outcomes 
Three papers investigated the association between breastfeeding exposure to pesticides and 
neurodevelopmental outcomes. Two of these papers were from the North Carolina cohort 
(1978-82) (n=858), (Rogan and Gladen, 1991; Gladen and Rogan, 1991) and one was from 
the INMA mainland sub-cohort (2003-2008) (n=2150) (Gascon et al., 2013). A brief 
overview of measurements and results are given in Table 7.10 below. If reported, results from 
investigation of prenatal exposure and health outcome have been included in the table. 
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Table 7.10: Evidence table for outcomes – pesticide studies included for assessment of neurodevelopment 
outcomes. 


















Mostly or partly 
breastfed  
Short: 0-9 weeks (0-4 
mostly breastfed), 
medium: 10-19 
weeks (0-4 mostly 
breastfed), long: 
mostly breastfed for 
20 weeks, very long: 
weaning after 49 
weeks 
McCarthy Scales 





No consistent association 
between prenatal or lactational 
exposure to DDE or PCBs and 
neuropsychological 
development was observed at 





Mostly or partly 
breastfed 
As above Psychomotor 
scores (Bayley 
Scales) at 18 and 
24 months 
No consistent association 
between exposure to DDE or 
PCBs through breastmilk and 
outcomes 
At 18 and 24 months there 
was lower psychomotoric 
scores among children in the 














Recorded Recorded. Mean 
duration exclusive 
breastfeeding 3.8 








giving MDI and 
PDI test scores at 
around 14 
months of age 
Neither pre- nor postnatal 
DDE and HCB exposure was 
associated with any of the 
outcomes 
 
*Degree of breastfeeding is defined in a number of different ways in the papers. 
In the North Carolina cohort, Rogan & Gladen (1991) assessed DDE and PCB exposure and 
child development at 18 and 24 months. 670 participants completed the 24 months follow-up 
(Rogan and Gladen, 1991). The proportion of solely formula fed was 10.8%. The degree of 
breastfeeding was divided into mostly and partly, and breastfeeding duration reported in four 
categories (short: mostly breastfed 0-4 weeks and weaned by 9 weeks 10.5%, medium: either 
mostly breastfed from 0-4 weeks and weaned after 9 weeks or mostly breastfed for 5 to19 
weeks and weaned by 19 weeks, 19.7%, long: mostly breastfed for 5 to19 weeks and weaned 
after 19 weeks or mostly breastfed for 20 weeks or longer and weaned by 49 weeks 35.8% 
and very long: mostly breastfed for 20 weeks or longer weaned after 49 weeks 23.2%). 
Postnatal exposure was assessed as breastfeeding duration times concentration levels of the 
contaminants (sum PCBs and pp-DDE). The outcome variables were Bayley Scales PDI and 
MDI (see Appendix 7 for explanation) at 18 months and 24 months. At 18 and 24 months, 
adjusted scores on the psychomotoric scales were 4-9 points lower among children in the top 
fifth percentile of prenatal exposure. The association between prenatal exposure and 
psychomotoric development became stronger with age and was statistically significant at 24 
months. Postnatal associations were not demonstrated.  
Gladen and Rogan (1991) also assessed the association between DDE and PCBs and later 
development, measured as McCarthy Scales score at 3, 4, and 5 years. Prenatal exposure was 
measured in maternal blood, cord blood and placenta. The postnatal exposure was measured 
in breastmilk and the duration of the breastfeeding was assessed in detail. The categories 
given are bottle-feeding, short, medium, long, and very long period of breastfeeding (see 





















DDE, PCBs Mostly or 
partly 
breastfed  
Short: 0-9 weeks (0-4 
mostly breastfed), 
medium: 10-19 weeks 
(0-4 mostly 
breastfed), long: 
mostly breastfed for 
20 weeks, very long: 
weaning after 49 
weeks 
McCarthy Scales 




No consistent association 
between prenatal or 
lactational exposure to DDE 
or PCBs and 
neuropsychological 
development was observed at 




DDE, PCBs Mostly or 
partly 
breastfed 
As above Psychomotor 
scores (Bayley 
Scales) at 18 and 
24 months 
No consistent association 
between exposure to DDE or 
PCBs through breastmilk and 
outcomes 
At 18 and 24 months there 
was lower psychomotoric 
scores among children in the 













Recorded Recorded. Mean 
duration exclusive 
breastfeeding 3.8 







BSID-I test giving 
MDI and PDI test 
scores at around 
14 months of age 
Neither pre- nor postnatal 
DDE and HCB exposure was 
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DDE, although not in a dose-response manner. Higher postnatal DDE exposure was 
associated with poorer English grades, of borderline significance, but not to mathematics. No 
association between postnatal PCB and school performance was observed. The inconsistent 
patterns resulted in the authors stating that no conclusive associations could be found between 
exposures and the McCarthy Scales or school performance (Gladen and Rogan, 1991). 
In the Spanish INMA cohort (Gipuzkoa, Catalonia and Valencia) (2003-2008) (n=2150), the 
follow-up period was 14 months, (range 11-21 months) (n=1175 at follow-up). Child 
neuropsychological development was assessed at 14 months (mean), and the exposure 
measured was PCB-153, DDE and HCB in maternal serum (at pregnancy week 7-26, median 
12.9 weeks), while the child`s exposure was estimated month by month by a physiologically 
based pharmacokinetic modelling (PBPK) developed by Verner et al. (2009) (Gascon et al., 
2013). Length and degree of breastfeeding were recorded, and the mean duration of exclusive 
breastfeeding was 3.8 months and partly breastfeeding 6.1 months. Breastmilk consumption 
during partial breastfeeding was calculated as a constant decrease in intake (n=382). The 
outcomes were measured by Bayley Scales of Infant Development, BSID-I test (giving MDI 
and PDI test scores) in children aged around 14 months of age (range 11-21 months). Pre- and 
postnatal DDE and HCB exposure was not associated with any of the outcomes.  
 
7.2.3.2 Pesticides – immunological or allergic outcomes 
One paper from the INMA cohort (Menorca) (1997-1999) (n=482) investigated the 
association between breastfeeding exposure to pesticides and immunological or allergic 
parameters (Sunyer et al., 2006). Measurements and results are given in Table 7.11 below. 
Results from investigation of prenatal exposure and health outcome have been included in the 
table. 
 
Table 7.11: Evidence table for outcomes – pesticide studies included for assessment of immunological or 
allergic parameters. 




















Zero, 0-20 weeks, 
>20 weeks 
Asthma and 
wheezing at  
6 years 
Postnatal exposure to 
DDE/DDT as assessed by 
child levels at 4 years: No 
negative association with 
asthma/wheezing. No 
modification by breastfeeding. 
No modification by atopy. 
Breastfeeding had a protective 
effect on asthma (relation to 
duration of breastfeeding not 
given) 
Diagnosed asthma and 
wheezing at 6 years were 
associated with DDE at birth, 
indicating an impact of 
prenatal effects 
 
Sunyer et al. (2006) from the Menorca cohort investigated the exposure indicators DDE and 
DDT and association to asthma and wheezing, parentally reported by interviews. Degree of 
breastfeeding was reported as exclusive, and breastfeeding duration in weeks. The results 
showed that prenatal exposure to DDE was associated with increased risk of asthma, while 
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DDT showed no relationship (Sunyer et al., 2006). Postnatal exposure as assessed by child 
levels at age 4 showed no association with asthma/wheezing. There was no effect 
modification by breastfeeding. Breastfeeding protected against diagnosed asthma (OR=0.33, 
95% CI=0.08-0.87) and wheezing (OR=0.53, 95% CI=0.34-0.82) in children with low and 
high DDE levels at birth. The protective effect of breastfeeding was strongest and significant 
for short term breastfeeding (breastfeeding>0 to 20 weeks). The authors concluded that 
prenatal exposure may have a negative impact on immunological parameters which is not 
seen postnatally. 
 
7.2.3.3 Pesticides – child growth and weight 
One paper from the North Carolina cohort (1978-1982) (n=858) investigated the association 
between breastfeeding exposure to pesticides and growth and puberty signs (Gladen et al., 
2000). Degree of breastfeeding is described as mostly or partly breastfed and breastfeeding 
length as short, medium, long or very long. A brief overview of measurements and results are 
given in Table 7.12 below. Results from investigation of prenatal exposure and health 
outcome have been included in the table. 
 
Table 7.12: Evidence table for outcomes – pesticide study included for assessment of relation to growth. 



















Mostly or partly 
breastfed 
Short: 0-9 weeks  
(0-4 w mostly 
breastfed), medium: 
10-19 weeks (0-4 w 
mostly breastfed), 
long: mostly 
breastfed for 20 
weeks, very long: 
weaning after 49 
weeks 
Weight and 
height at 14 
years, age at 
menses, breast 
stage 3-5, pubes 
3-5 
No association between 
postnatal exposure to DDE 
and growth or puberty signs 
(but tendency to later 
maturation in bottle-fed girls) 
Prenatal exposure to DDE was 
associated with tendency to 
higher weight in boys at 14 
years, but not girls 
 
Gladen et al. (2000) explored prenatal and lactational exposure to PCBs and DDE and 
pubertal growth and development. Postnatal measurements in breastmilk were performed in 
fully breastfed and partially breastfed infants. Outcome variables were weight and height at 
14 years (n=594 at final follow-up), age at onset of puberty, and breast and pubes 
development. The conclusions were that prenatal exposure to DDE was associated with boys’ 
length and height while in the girls a borderline positive association between prenatal 
exposure to PCB and weight was observed. However, no postnatal associations were 
observed, except a tendency for later maturation in bottle-fed girls (Gladen et al., 2000). 
 
7.2.3.4 Pesticides – thyroid parameters 
One paper from Canada, studying Inuits (Dallaire et al., 2009), reported results of 
breastfeeding exposure to halogenated organic compounds in relation to effects on thyroid 
parameters. Measurements and results are given in Table 7.13 below and include findings of 
associated with prenatal exposure.  
 
 
Norwegian Scientific Committee for Food Safety (VKM) 10-003-final  
2 
 





Helle Margrete Meltzer (chair) 
Per Brandtzæg 
Helle Knutsen 
Beate Fossum Løland 
Jon Øyvind Odland 
Janneche Utne Skåre 
Liv Elin Torheim 
Norwegian Scientific Committee for Food Safety (VKM) 10-003-final  
153 
 
Table 7.13: Evidence table for outcomes - halogenated organic pollutants included for assessment on 
thyroid parameters. 
 
















Not given 0-7 months Thyroid hormone 
status in mothers 
and infants 
No association was observed 
between postnatal exposure to 
PCBs, HCB or PCP and 
thyroid hormones at 7 months 
of age 
Prenatal exposure negatively 
associated with TBG levels 
and T4 concentration in the 
newborn 
 
In the Canadian cohort (1995-98) (n=204 at inclusion), Dallaire et al. (2009) studied the 
relationship between thyroid hormone status and postnatal exposure to PCBs, PCP and HCB 
in 7-month old children of Canadian Inuit women (n=130 at follow-up). No association was 
found (Dallaire et al., 2009). Degree of breastfeeding is not given in the Canadian cohort 
while breastfeeding duration was reported as 0-7 months, see Table 7.13. 
 
7.2.4 Positive effects of breastfeeding in the papers reporting negative health effects 
It has to be mentioned that several of the studies and cohorts described above found positive 
effects of breastmilk per se in spite of this not being the main focus in the study.  
In the Faroe Island cohort 1, an overall beneficial effect of breastfeeding on 
neurodevelopment was observed, and in Grandjean et al. (1995) the following is stated: “even 
if exposure to mercury from milk is increasing during the breastfeeding period and resulting 
in considerable increase in mercury concentrations in infant hair (18 months of age), duration 
of breastfeeding did not act as a predictor for neurodevelopmental delays (Grandjean et al., 
1995). On the contrary, an extended period of breastfeeding was associated with earlier 
attainment of developmental milestones, indicating that beneficial effects of breastfeeding 
compensated for possible neurotoxic effects of mercury on milestone development”. The 
authors concluded that when evaluating the possible health implications of neurotoxicants in 
human milk, the developmental benefits associated with breastfeeding must be taken into 
consideration. In the Faroese cohort 3, Grandjean et al. (2010) showed that an apparent 
association between breastfeeding duration and increased serum IgE in children was 
weakened and no longer significant after adjustment for the concomitant PCB exposure 
(Grandjean et al., 2010).  
In the Dutch cohort, a beneficial effect of breastfeeding was observed for several of the 
outcomes studied. Huisman et al. (1995) reported that the fluency cluster score was not 
related to PCBs and dioxins in cord blood, maternal blood or breastmilk (Huisman et al., 
1995). However, breastfed children had a higher fluency cluster score compared to formula 
fed. The study by Koopman-Essebom et al. (1996) in the same cohort showed a negative 
association between exposure to dioxins and dl-PCBs via breastmilk and the mental 
developmental index of the Bayley Scales of Infant Development at 7 months of age 
(Koopman-Esseboom et al., 1996). However, there was a positive effect of breastmilk per se, 
meaning that the beneficial effect of breastfeeding was negatively confounded by dioxins and 
dl-PCBs in breastmilk. This effect was not observed at 3 months of age, where prenatal 
exposure was most influencal. No association with breastfeeding duration or dioxin and dl-
PCB exposure was seen at 18 months.  
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In another study on the Dutch cohort, Weisglas-Kuperus et al. (2000) reported that PCB 
concentration in serum from 42-month old children was associated with a higher occurrence 
of recurrent middle ear infection, and that breastfeeding duration counteracted the increased 
odds ratio for middle ear infection (Weisglas-Kuperus et al., 2000).  
The impact of breastmilk per se was not reported in all studies (e.g. the German cohort), 
although most studies included breastfeeding duration as a parameter in their models. 
Together, the data above indicate that possible negative effects of contaminants in breastmilk 
may be camuflaged by beneficial effects of breastmilk itself. This needs to be taken into 
consideration both when interpreting possible negative effects of contaminants and positive 
effects of (or lack of effects of) breastfeeding on different endpoints.  
 
7.2.5 Studies without data on breastfeeding 
The present benefit-risk assessment has had as an inclusion criterion that a paper had to have 
information on breastfeeding length and preferably degree of breastfeeding (e.g. exclusive 
versus partial breastfeeding) to be included. It is appropriate to ask if we might have missed 
out on important publications and knowledge by applying such strict inclusion criteria. 
Knowing that breastmilk is a major source to contaminants, another approach to evaluate risk 
from exposure to contaminants present in breastmilk would be to use the child’s blood 
concentration of a contaminant, even if there is no information on the history of breastfeeding. 
This approach may be useful when evaluating the risk of adverse health outcomes from 
exposure to contaminants in general, but has not been considered appropriate in this benefit- 
and risk assessment of breastmilk. Examples of this approach are the many publications from 
e.g. Slovakian cohorts, with levels of measured POPs in blood/serum of a highly exposed 
mother-child pairs (Jusko et al., 2010; Trnovec et al., 2008; Trnovec et al., 2010).  
As another example, perfluorinated compounds assessed in pregnant women have been 
associated with increased risk of overweight and obesity in the offspring 20 years later 
(Halldorsson et al., 2012), and also to reduced sperm quality in males (Vested et al., 2013). 
Another study used the levels of flame retardants in breastmilk as a proxy for fetal exposure 
and found increased risk of cryptocordism in the boys with higher levels in the mother’s milk 
(Main et al., 2007).  
However, no breastfeeding data were included in these studies and they were therefore 
excluded when we applied our exclusion criteria. In a study on prenatal (measured in maternal 
serum) and postnatal (measured in child serum at 5 years) exposure to perfluorinated 
compounds and serum tetanus and diphtheria vaccine antibody concentrations in 5 and 7-year 
old children in the Faroe Islands (Faroe 3), it was found that at doubled postnatal PFC 
exposure (PFOS, PFOA, PFHxS) the antibody concentration at age 7 was approximately 
halved (Grandjean, Andersen et al., 2012). The difference remained after adjusting for 
prenatal exposure. According to the authors, the association with PFCs is much stronger than 
that observed for PCBs (described in 7.2.1.2). Breastmilk is an important source of PFC 
exposure in children and given the long half-life, it can still be an important determinant in 
the child’s serum at 5 years. However, data on breastfeeding was not included as a parameter 
in the statistical analyses in this study, and it was thus not captured by the literature search.  
 
Norwegian Scientific Committee for Food Safety (VKM) 10-003-final  
2 
 





Helle Margrete Meltzer (chair) 
Per Brandtzæg 
Helle Knutsen 
Beate Fossum Løland 
Jon Øyvind Odland 
Janneche Utne Skåre 
Liv Elin Torheim 
Norwegian Scientific Committee for Food Safety (VKM) 10-003-final  
155 
 
7.2.6 Other pollutants 
As mentioned in section 7.1, the focus of this assessment has been on a limited amount of 
persistent environmental contaminants, i.e. the pesticides DDT and HCB, the pollutant groups 
PCBs, dioxins, brominated flame retardants and perfluorinated compounds and last but not 
least, heavy metals. These bio-accumulating compounds have so far been known to have the 
largest potential to cause harm in early life. More pragmatically, these are the compounds 
most extensively studied till now in relation to detrimental health effects in children. 
However, no studies including brominated flame retardants, perfluorinated compound or lead 
and cadmium were found which fulfilled our inclusion criteria.  
A number of emerging chemicals have attracted public attention the last decade, like 
phthalates and phenols (BPA). Many of these are not persistent, i.e. they do not accumulate in 
the body and are, accordingly, even more difficult to study than the persistent contaminants. It 
is scientifically challenging to study the separate impact of a contaminant on risk of a disease, 
especially if the effect is connected to a disease with low prevalence. Assessments of 
contaminant burdens thus often become assessments of levels in body fluids (like blood or 
urine), more than assessments of direct harm. Furthermore, the levels found are often so low 
that known harmful effects are not known.  
 
 
 Summary of potential negative health effects related to persistent 7.3
contaminants in breastmilk 
The following persistent contaminants substances were included in the literature search: 
halogenated organic pollutants (PCBs, dioxins, BFRs), pesticides (DDT/DDE and HCB) and 
heavy metals (mercury). 
A full-scale literature search was conducted and studies were selected according to standard 
procedures for systematic reviews. An important inclusion criterion was that a study had to 
have well documented breastfeeding data, thus the absence of breastfeeding information was 
an exclusion criterion. All included studies were described in Summary Tables and evaluated 
in Quality Assessment Tool Tables into category A, B or C. The quality assessment resulted 
in no studies in category A, the main reasons being inadequacies in their description of 
statistics, e.g. not describing statistical power in sufficient detail, or no correction for “HOME 
score” or other measures of home environment. Twenty four studies qualified for category B. 
The category C-studies are not included for further consideration, and an explanation for 
category C is given in Appendix 4. 
All studies are based on eleven cohorts in Europe and the North Americas, totally including 
approximately 7900 children at enrolment.  
The health outcomes were connected to neurodevelopment (including motoric and cognitive 
development), infections, immunology and allergy, child growth and thyroid hormone status. 
A brief summary of main findings are given in the tables below. 
The focus of the risk assessment was on eventual findings of negative health effects. 
However, many of the 24 studies included in chapter 7 observed better scoring or reduced risk 
in children who were breastfed, in spite of high contaminant exposure. Such results were 
found in e.g. the North Carolina cohort, the Faroese cohort 1, the Dutch cohort and the 
German cohort and are duly discussed in the respective papers (see section 7.2.4).  
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Summary and evaluation of the results for neurodevelopment  
The methodology used to study outcomes varied between studies, as did the age of the 
children when subject to the various tests. Overall, the Bayley Scales of Infant Development 
was used before the age of 2.5 years and the McCarthy Scales of Children’s Abilities was 
used for the older children. Several cohorts used country-adapted versions of these tests. The 
tests are described in more detail in Appendix 7. The HOME score is considered essential as a 
correction factor when assessing the impact of breastfeeding on neurodevelopment, and its 
use in the various studies has been included in a separate column in Table 7.14. 
Table 7.14 gives an overview of time points, tests used and results in the studies of child 
neurodevelopment. 
 
Table 7.14: Overview of time points, tests used and results in the studies of child neurodevelopment. 






  0-5 mo 1 y 2 y 3 y 4 y 5 y 6 y 7 y   
North 
Carolina 












Dutch PCBs, dioxins       Yes Assoc at 7 
mo, but not 
at 18 mo 
Koopman 
Essebom 1996 




PCBs, dioxins         No No 
association 
Patandin 1999 
PCBs, dioxins         No No 
association 
Lanting 1998 








German PCBs        Yes Association 
at 4 y, but 




Canada PCBs         Yes Association 
with 
activity 


























 The Bayley Scales of Infant Development        
 The McCarthy Scales of Children’s Abilities        
 DM=Development milestones (focus on motor functions), a test described in Hempel MS, 1993   
 The Kaufman Assessment Battery for Children      
 MISC=Miscellaneous test used in the Faroese cohort       
 
Halogenated organic pollutants 
The results for halogenated organic pollutants and the endpoint neurodevelopment are based 
on seven cohorts (North Carolina, Michigan, Dutch, German, Canadian and Spanish) with 
  










































PCBS, DDE       No No association Rogan& 
Gladen 1991 
PCBS, DDE       No No association Gladen& 
Rogan 1991 
Michigan PCBs         Yes No association 
 
Jacobsen 1990 
Dutch PCBs, dioxins       Yes Assoc at 7 mo, 
but not at 18 mo 
Koopman Essebom 
1996 
PCBs, dioxins         No No association 
 
Huismann 1995 
PCBs, dioxins         No No association 
 
Patandin 1999 
PCBs, dioxins         No No association 
 
Lanting 1998 
PCBs, dioxins         Yes No association 
 
Vreugdenhil 2002 (1) 
PCBs, dioxins         Yes No association 
 
Vreugdenhil 2002 (2) 
German PCBs       Yes Association at 




Canada PCBs         Yes Association 
with activity 









        No No association Gascon 2013 
Faroe 1 Hg    
 
    No No association Grandjean 1995 
Hg        
 
 No No association Jensen 2005 
 The Bayley Scales of Infant Development     
 The McCarthy Scales of Children’s Abilities        
 DM=Developm nt ilestones (focus on motor functions), a test described in Hempel MS, 1993 
 The Kaufman Assessment Battery for Children      
 MISC=Miscellaneous test used in the Faroese cohort       
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4725 mother-child pairs at inclusion, the smallest having 70 children at follow-up (the 
German cohort) and the largest having 1175 children at follow-up (three regions in Spain (the 
INMA cohort). 
The studies had varying information about degree and duration of breastfeeding. Three 
cohorts did not give information on degree of breastfeeding. All papers, however, included 
information about breastfeeding length in intervals, e.g. short, medium or long duration, each 
interval defined by number of breastfeeding weeks. PBPK modelling was used in two studies. 
No consistent persistent association between neuropsychological development (cognitive or 
motor abilities) and postnatal exposure to PCBs and dioxins was found in 13 out of 14 studies 
(see Table 7.14). In three studies, various results were reported. 
One Dutch paper found that postnatal exposure to PCBs via breastmilk was associated with 
poorer developmental outcomes at 7 months of age, but the effects did not persist to 18 or 42 
months of age. In general, the breastfed infants scored significantly higher than the formula 
fed infants at 7 months, but when corrected for PCB and dioxin exposure, the score was 
reduced and became comparable to the formula fed infants. 
Results from the German cohort showed a negative overall association with prenatal PCB 
exposure and mental/motor development, becoming significant from 30 months onwards. 
Both pre- and postnatal exposure to PCBs was negatively associated with child intelligence at 
4 years of age, but this was no longer significant at 6 years of age. They also found a very 
strong positive effect of the home environment as assessed by the HOME score.  
In both the Dutch and German studies, postnatal exposure assessments mostly relied on 
metrics of overall exposure, such as multiplying the level of PCBs in breastmilk by the 
duration of breastfeeding and/or PCB concentration measured in children postnatally, which 
may not reveal associations with neuropsychological development where specific postnatal 
windows of susceptibility exist.  
When using the advanced PBPK model to estimate infant blood concentration profile during 
the first year of life in the Canadian cohort of Inuits, the authors found an association between 
blood PCB-153 around 4 months of age and the infant’s ability to control activity (Bayley 
Scales of Infant Development) at 11 months of age. So far, no follow-up of these children has 
been published, testing if the model can predict associations at later ages. 
Table 7.3 gives an overview of PCB-153 and DDE levels in the various cohorts, presented in 
a comparable way. To the degree that serum PCB-153 represents most PCBs and dioxins, the 
PCB and dioxin exposures in the Dutch and North Carolina cohorts were more than twice the 
levels of today’s exposure in Norway, whereas the German, Michigan, Canadian (Inuit) and 
the INMA (Menorca) cohorts had about 3 times higher PCB-153 levels than the present 
corresponding exposure in Norway. The INMA mainland sub-cohorts had PCB levels 
comparable to Norwegian levels.  
 
Mercury  
The results for the associations between neurodevelopment and mercury are based on one 
cohort, the Faroe Islands cohort 1, with 1022 mother and child pairs at inclusion, 583 children 
at follow-up 1 year and 910 at follow-up 7 years. In this study, the degree of breastfeeding is 
described as exclusive breastfeeding, and breastfeeding duration is reported in months. 
The Faroe population has historically had an exceptionally high mercury intake from their 
traditional diet. In the decades after the first publications came out (approx. 1990), many 
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Faroese women have reduced their consumption of pilot whale, the main source of mercury. 
In the wake of this, exposure to mercury (and PCBs/dioxins) has declined substantially, as 
illustrated by PCB-153 in Table 7.3. 
None of the two included papers showed negative associations between postnatal exposure to 
mercury and neurodevelopment (cognitive or motor abilities). 
 
Pesticides 
The results for pesticide exposure and neurodevelopment endpoints are based on two cohorts 
with 3008 mother and child pairs at inclusion. The North Carolina cohort had 712 participants 
at the 12 month follow-up and 670 at the 24 month investigation. The Spanish INMA study 
had 1175 participants at the follow-up at 24 months. 
The degree of breastfeeding was divided into mostly and partly, and breastfeeding duration 
reported in months in the North Carolina cohort. PBPK modelling was used in the INMA 
cohorts. 
None of the four publications showed associations between postnatal exposure to pesticides 
and neurodevelopment (cognitive or motor abilities). 
In the North Carolina study no association was found between postnatal exposure to DDE 
from breastmilk and child development as measured by the McCarthy Scales or school 
performance. The same lack of association was reported in the two very recent Spanish 
publications, one from Menorca and one from mainland Spain, the latter using PBPK 
modelling. 
The exposure levels of DDE in the North Carolina cohort were approximately twice of 
present-day Norwegian levels (see Table 7.3). In the Spanish sub-cohorts, the Menorca 
participants had approximately 10 times higher DDE levels than present-day Norwegian 
while the mainland participants had 3 times higher levels.  
 
Summary and evaluation of the results for immunological or allergic outcomes 
The outcomes varied between the five included studies, as did the age of the children when 
subject to the various tests, see Table 7.15.  
Four out of five publications found associations between postnatal exposure to PCBs and 
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Table 7.15: Overview of time points, tests used and results in studies of immunological or allergic 
outcomes.  
Cohort Contaminant Childs age in months or years when tested Results, postnatal 
exposures 
Reference 
  6-16 mo 3-4 y 5 y 6 y 7 y   
Faroe 3 PCBs    Inverse association 
with vaccine antibody 
titers 
Heilmann 2010 
PCBs, Hg      Positive association 
PCBs and IgE 
Grandjean 2010 
Dutch PCBs and 
dioxins 
     Increased prevalence 
of infectious and 







DDE, DDT    No association Sunyer 2006 
Slovakia PCBs      Small decrease in 
thymus voulum at 6 
mo, but not at 16 mo 
Jusko 2012 
 Vaccine antibody concentrations      
 IgE-changes, allergic disease occurrence     
 Middle ear infections, allergic reactions, chickenpox, antibody levels for mumps, measles and rubella 
 Asthma, wheezing       
 Thymus volume       
 
Halogenated organic pollutants 
The results for the halogenated organic pollutants and the immunological endpoints are based 
on three cohorts (Dutch, Faroe Islands cohort 3 and Slovakian cohorts) with 2208 mother-
child pairs at inclusion, the smallest having 100 children at follow-up (the Slovakian cohort) 
and the largest (Faroe Island cohort 3) having 587 children at follow-up. 
The studies had varying information about degree and duration of breastfeeding. Degree of 
breastfeeding is described as exclusive, fully, partial or any breastfeeding. All papers, 
however, included information about breastfeeding in months or in intervals, e.g. short, 
medium or long duration, each interval defined by number of breastfeeding weeks.  
As illustrated in Table 7.15, interpretations of these papers are complex, both because 
different time points and endpoints have been investigated in the different cohorts, but also 
because results within the studies are conflicting.  
In the Dutch cohort, postnatal PCB and dioxin exposure was associated with increased risk of 
middle ear infection, but this was counteracted by longer duration of breastfeeding. To 
complicate the interpretation, they also observed a lower prevalence of allergic disease with 
higher PCB and dioxin exposure. There was no association between postnatal PCB exposure 
and antibody titer to mumps, measles and rubella vaccination, however, a reduction 
associated with prenatal exposure was seen.  
The Faroe Islands cohort 3 found that higher breastmilk PCB exposure was associated with 
reduced serum concentration of antibodies against diphtheria and tetanus vaccinations at 7 
years of age. Furthermore, higher PCB exposure was associated with higher serum IgE at 7 
years, which might be indicative of allergic disease, but no association with allergic disease 
was observed.  
In the Slovakian cohort there was a small, but statistically significant decrease in thymus 
volume at 6 months, but not later, associated with breastmilk PCB exposure. The results 
indicate an association between pre- and postnatal PCB exposure and altered thymus 
  


























Faroe 3 PCBs    Inverse association with 
vaccine antibody titers 
Heilmann 2010 
PCBss, Hg      Positive association 
PCBs and IgE 
Grandjean 2010 
Dutch PCBs and 
dioxins 
     Increased prevalence of 






DDE, DDT    No association Sunyer 2006 
Slovakia PCBs      Small decrease in 
thymus voulum at 6 mo, 
but not at 16 mo 
Jusko 2012 
 Vaccine antibody concentrations      
 IgE-changes, allergic disease occurrence     
 Middle ear infections, allergic reactions, chickenpox, antibody levels for mumps, measles and rubella 
 Asthma, wheezing       
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development, but even though the thymus is important for T-cell differentiation and 
maturation, eventual physiological implications of this observation are unknown. 
To the degree that serum PCB-153 represents most PCBs and dioxins, the PCB and dioxin 
exposures in the Faroe Islands cohort 3 was almost 10 times higher than present-day 
Norwegian levels and the Dutch cohort had more than twice the levels of today’s exposure in 
Norway (see Table 7.3 with comparison of PCB-153 concentrations). The Slovakian PCB-
153 levels were approximately 3.5 times higher than present-day Norwegian levels.  
 
Pesticides 
The results for the immunological and allergic outcomes and pesticides are based on one 
cohort (the Menorca region in the Spanish INMA cohort) with 482 mother and child pairs at 
inclusion and 462 at 6 year follow-up.  
Degree of breastfeeding was reported as exclusive breastfeeding and breastfeeding duration 
was reported in weeks. 
Breastfed infants in the Menorca study had a reduced risk of asthma at the age of 6 years. The 
authors concluded that prenatal exposure may have a negative impact on immunological 
parameters which is not seen postnatally. 
The exposure level to DDE in the Menorca cohort was more than 10 times the present-day 
Norwegian exposure levels (see Table 7.3). 
 
Summary and evaluation of the results for child growth and weight 
The classical anthropometric measurements height and weight were used to study associations 
between growth and contaminant exposure in two of the included studies, while a third study 
measured development of puberty. Table 7.16 shows that the children were measured at very 
different time points. 
Table 7.16 gives an overview of time points, tests used and results in studies of growth and 
puberty signs. 
 
Table 7.16: Overview of time points, tests used and results in studies of growth and puberty signs. 
Cohort Contaminant Childs age in months or years when tested Results, postnatal 
exposures 
Reference 
  18-42 mo 4 years Puberty   
North  
Carolina 
PCBs, DDE    No  
association 
Gladen 2000 
Michigan PCBs    No 
association 
Jacobsen 1990 
Faroe 2 PCBs    Lower weight and 
height at 18 mo, 
same tendency at 42 
mo 
Grandjean 2003 
 Weight, height and stage of pubertal development    
 Weight and height (+ McCarthy Scales and activity rating)   
 Weight and height at 18 and 42 months    
 
Two out of the three publications included for growth showed no associations between 
postnatal exposure to PCBs and dioxins and DDE and growth, while one found an association 
at 18 months. 
  Childs age in months or 















Results, postnatal exposures Reference 
North  
Carolina 
PCBs, DDE    No  
association 
Gladen 2000 
Michigan PCBs    No 
association 
Jacobsen 1990 
Faroe 2 PCBs    Lower weight and height at 18 
mo, same tendency at 42 mo 
Grandjean 2003 
 Weight, height and stage of pubertal development  
 Weight and height (+ McCarthy Scales and activity rating)  
 Weight and height at 18 and 42 months    
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Hallogenated organic pollutants 
The results for the halogenated organic pollutants and the growth endpoints are based on three 
cohorts (Michigan, North Carolina and Faroe Islands cohort 2) with 1353 mother and child 
pairs at inclusion, the smallest having 171 children at follow-up and the largest having 595 
children at follow-up. 
The studies had varying information about degree and duration of breastfeeding. Degree of 
breastfeeding is described as exclusive, mostly, partial or not given. All papers, however, 
included information about breastfeeding in weeks or in intervals, e.g. short, medium or long 
duration, each interval defined by number of breastfeeding weeks.  
The Michigan study found no association between weight and height at 4 years and 
breastmilk PCB exposure. The North Carolina study investigated height, weight and puberty 
development and found that trans-placental PCB exposure was associated with increased 
weight in a sub-set of girls. The association was attributed to prenatal exposure. 
The data from the Faroe Island cohort 2 might indicate a growth-reducing effect of 
contaminant exposure and growth in 18 months children. However, reduced growth in 
breastfed versus formula fed children is well known, and cannot only be ascribed to 
contaminant exposure (Nommsen-Rivers and Dewey, 2009). Thus, in order to explore 
eventual effects of contaminant exposure on growth, comparison of children with 
approximately similar duration of breastfeeding but with different contaminant exposure 
would have been a better approach. 
The PCB and dioxin exposures in the Faroe Islands cohort 2 was almost 10 times higher than 
present-day Norwegian levels, and the PCB-153 levels in the North Carolina and Michigan 
cohorts were 2 to 3 times higher than the present corresponding exposure in Norway (see 
Table 7.3 with comparison of PCB-153 and DDE concentrations). 
 
Pesticides 
The results for pesticides and the growth endpoints are based on one cohort (the North 
Carolina cohort) with 858 mother and child pairs at inclusion, reduced to 594 children at the 
final follow-up. 
Degree of breastfeeding is described as mostly or partly breastfed and breastfeeding length as 
short, medium, long or very long. 
The authors found no association between postnatal DDE exposure and weight and height at 
puberty. The exposure levels for DDE in the North Carolina cohort were about twice as high 
as in present-day Norway. 
 
Summary and evaluation of the results for the thyroid parameters 
There was only one study investigating associations between PCBs, HCB and thyroid 
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Table 7.17: Overview of time points, tests used and results in studies of thyroid parameters. 





  7 mo   
Canada PCBs, HCB  No 
association 
Dallaire 2009 
 Thyroid hormone status (TSH, T4, T3 and TBG)  
 
Halogenated organic pollutants and pesticides 
The results for halogenated organic pollutants and the endpoint thyroid parameters are based 
on one cohort with 204 mother and child pairs at inclusion and 130 children at 7 months 
follow-up. 
In this Canadian cohort the degree of breastfeeding is not given, and the breastfeeding 
duration is reported to be 0-7 months. No association was observed between postnatal 
exposure to PCBs or HCB and thyroid hormones at 7 months of age. Prenatal exposure was 
negatively associated with TBG levels and T4 concentration in the new born. 
The Canadian Inuits had 2.5 times higher levels of PCB-153 in breastmilk compared to 
present-day Norwegian levels. 
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Table 7.17: Overview of time points, tests used and results in studies of thyroid parameters. 
Cohort Contaminant Childs age in months 
when tested 
Results, postn tal 
exposures 
R ference 
  7 mo   
Canada PCBs, HCB  No 
association 
Dallaire 2009 
 Thyroid hormone s atus (TSH, T4, T3 and TBG)  
 
Halogenated organic pollutants and pesticides 
The results for halogenated organic pollutants and the endpoin  thyroid parameters are based 
on one cohort with 204 mother and child pairs at inclusion and 130 children at 7 months 
follow-up. 
In this Canadian cohor  the degr e of breastf eding is not given, and the breastf eding 
duration is reported to be 0-7 months. No a sociation was observed betw en postnatal 
exposure to PCBs or HCB and thyroid hormones at 7 months of age. Prenatal exposure was 
negatively a sociated with TBG levels and T4 concentration in the new born. 
The Canadian Inuits had 2.5 times higher levels of PCB-153 in breastmilk compared to 
present-day Norwegian levels. 
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Dietary exposure assessment of contaminants in breastmilk combines information of 
breastmilk consumption data with data on the concentration of contaminants in breastmilk. A 
variety of factors may affect both consumption data and concentration data and thus the 
estimation of contaminant exposure. The infant`s consumption of breastmilk will vary with 
age and weight of the infant. The concentration of contaminants in the breastmilk will depend 
on maternal exposure and body burden (including parameters such as age, body mass index, 
parity and the nutritional and health condition of the mother) as well as fat content of the 
milk, time of sampling the breastmilk during the meal, the day and the breastfeeding period.  
Available data on levels of breastmilk contaminants used in this exposure assessment are 
presented in chapter 5. Exposure estimates have been performed for PCB-153, total TEQ, 
DDE and HCB. The reason for the choice of these compounds is that these were the only 
persistent contaminants where we have good Norwegian data on their levels in breastmilk and 
which were also included in chapter 7 investigating negative health effects of contaminants in 
breastmilk. Since breastmilk is not recognised as a substantial heavy metal exposure source, 
and since there are no available data from Norway, exposure estimates have not been 
performed for mercury.  
Exposure calculations are presented in sections 8.4-8.7. Importantly, the exposures to 
persistent organic pollutants should be seen in light of the change in body concentration in 
children during the nursing period (see section 5.2.5). PCB-153 is the PCB congener most 
abundant in food and is often used as an indicator of total PCB exposure. The levels correlate 
strongly with total PCB exposure from food. PCB-153 can be seen as a marker for total 
dioxin and PCB exposure, since it shows high correlation with total TEQ in breastmilk and 
because it constitutes a large part of PCB-6. The PCB-153 exposure data are based on milk 
from 377 mothers and provides a better measure of variability among Norwegian women than 
the exposures to dioxins and dl-PCBs, which are based on only 27 samples. DDE and HCB 
were calculated as representatives of different classes of substances for which there were 
epidemiological data on associations between exposure and health outcomes. 
It is well known that exposures to several persistent organic pollutants are lower from infant 
formula than from breastmilk, as also shown in section 5.2.5. Thus, no specific exposure 
calculation for infant formula has been performed.  
In order to estimate contaminant exposure among Norwegian children, a mean consumption 
of breastmilk, the mean fat concentration in breastmilk and the weight development in 
children has been used, as described in sections 8.1-8.3. 
 
 Breastmilk consumption 8.1
Breastmilk consumption data (breastmilk volumes) used in the contaminant exposure 
assessments in sections 8.4-8.7 are based on the WHO report Nutrient adequacy of exclusive 
breastfeeding for the term infant during the first six months of life (Butte N. et al., 2002). 
Breastmilk volumes during the first 6 months in exclusively breastfed infants are shown in 
Table 2.2. The volume for the rest of the breastfeeding period is set to 500 ml/day 
independent of age of the child since studies showed that the breastmilk volume hovered 
around 530 ml/day from 6-12 months of age, see Table 2.4. The same volume has been used 
for children 13-24 months (500 ml/day). This volume is probably an overestimate for children 
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this age since breastmilk consumption most likely decreases as the intake of solid foods and 
other drinks than breastmilk increases. 
Breastmilk volumes are further described in section 2.3. 
According to the Norwegian studies Spedkost and Småkost (2007), 46% of the mothers 
breastfeed exclusively for 4 months, while only 9% breastfeed exclusively for 6 months. 
Mean duration of breastfeeding is 10.3 months. 
 
 Fat concentration in breastmilk 8.2
The total fat concentration in breastmilk depends on a variety of parameters described in 
section 3.3.3. In the Norwegian Human Milk Study (HUMIS), mean and median fat 
concentration in breastmilk samples was 3.5 g/100g (n=295) (Polder et al., 2009). This is also 
in accordance with the EFSA opinion on PBDEs in food (EFSA, 2011c) and in the lower 
range of concentrations reported in studies described in section 3.3.3 (range 20-70 g/L). The 
fat concentration from HUMIS is used in the exposure assessments of PCB-153, total TEQ, 
DDT and HCB. 
 
 Infant body weight development 8.3
In the exposure assessment of PCB-153, total TEQ, DDT and HCB, body weights for children 
1-24 months are based on tables (Table 39 boys and Table 50 girls) in the WHO report Child 
Growth Standards (WHO Multicentre Growth Reference Study Group, 2013). There were 
only small body weight differences between the genders (300-700 g in children 1-24 months), 
and in the exposure estimates, the median value for each month (mean for boys and girls) are 
used, see Table 8.1. 
 
Table 8.1: Body weight for children 0-24 months. Source: WHO Multicentre Growth Reference Study 
Group, 2013. 
Age, months 1 2 3 4 5 6 7 8 9 10 11 12 
Mean body weight, kg 4.4 5.4 6.1 6.7 7.2 7.6 8.0 8.3 8.6 8.9 9.1 9.3 
Age, months 13 14 15 16 17 18 19 20 21 22 23 24 




PCB-153 is often used as an indicator of total PCB or PCB-6 because the correlation between 
PCB-153 and PCB-6 is usually high. In Norway, the correlation between PCB-153 and total 
TEQ is also high. PCB-153 has been presented in several epidemiological studies (section 
7.2.1) and is therefore selected as a representative PCB for exposure calculation in Norwegian 
infants. 
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In HUMIS, PCB-153 was analysed in 377 breastmilk samples from women with Norwegian 
background40 (Polder et al., 2009), and Polder, personal communication. The mean, median 
and 95-percentile PCB-153 concentrations were 35.6, 32.3 and 63.6 ng/g lipids respectively. 
Reduction in breastmilk concentration of PCB-153 during the breastfeeding period has not 
been taken into consideration in the exposure estimation, which was based on a mean 
consumption of breastmilk, the mean body weight in children, and the mean fat concentration 
in breastmilk (sections 8.1-8.3) combined with the above-mentioned concentrations. The 
highest daily PCB-153 exposure per kg body weight was seen the first months of life and 
decreased with age and increasing body weight (Tables 8.2 and 8.3, Figure 8.1 and 8.2). The 
95-percentile exposure was approximately 1.8-fold higher than the mean.  
 
Table 8.2: PCB-153 exposure estimates from breastmilk in exclusively breastfed infants 0-6 months, based 
on mean consumption1 of breastmilk and mean, median and 95-percentile concentrations of PCB-153, 
ng/kg bw/day (n=377). 
Age, 
months 
1 2 3 4 5 6 
Mean  197.9 168.7 153.4 145.1 137.8 140.0 
Median 179.6 153.0 139.2 131.6 125.0 127.0 
95-percentile 353.6 301.3 274.1 259.2 246.1 250.1 
1See Table 2.2. 
 
Table 8.3: PCB-153 exposure estimates from breastmilk in partially breastfed children 5-24 months, 
based on mean consumption1 of breastmilk and mean, median and 95-percentile concentrations of PCB-
153, ng/kg bw/day (n=377). 
Age, months 5 6 7 8 9 10 11 12 13 14 
Mean  122.9 100.3 77.9 75.1 72.4 70.0 68.5 67.0 64.9 63.6 
Median 111.5 91.0 70.7 68.1 65.7 63.5 62.1 60.8 58.9 57.7 
95-percentile 219.5 179.3 139.1 134.1 129.4 125.1 122.3 119.7 115.9 113.6 
Age, months 15 16 17 18 19 20 21 22 23 24 
Mean 62.3 61.1 59.9 58.8 57.7 56.6 55.6 54.2 53.3 52.4 
Median 56.5 55.4 54.4 53.3 52.3 51.4 50.5 49.2 48.3 47.5 
95-percentile 111.3 109.1 107.0 105.0 103.1 101.2 99.4 96.8 95.1 93.5 
1See Table 2.2 and Table 2.4. Volume 500 ml/day is used for children 12-24 months. 
                                                 
40The women were ethnic Norwegian. 
 
Norwegian Scientific Committee for Food Safety (VKM) 10-003-final  
2 
 





Helle Margrete Meltzer (chair) 
Per Brandtzæg 
Helle Knutsen 
Beate Fossum Løland 
Jon Øyvind Odland 
Janneche Utne Skåre 
Liv Elin Torheim 




Figure 8.1: PCB-153 exposure (ng/kg bw/day) from breastmilk in infants 1-6 months, based on mean, 
median and 95-percentile PCB-153 concentrations in breastmilk (n=337) (bf=breasfeeding). 
 
 
Figure 8.2: PCB-153 exposure (ng/kg bw/day) from breastmilk in partially breastfed children 7-24 
months, based on mean, median and 95-percentile PBB 153 concentrations in breastmilk (n=377). 
 
 
 Total TEQ 8.5
In HUMIS, total TEQ (included dioxins, furans and dl-PCB) was determined in 27 individual 
samples from women with a Norwegian background41 (Stigum et al., 2005). The mean, 
minimum and 95-percentile total TEQ concentrations were 11, 4.6 and 18 pg TEQ/g lipids 
respectively. Reduction in breastmilk concentration of total TEQ during the breastfeeding 
                                                 
















































PCB-153 exposure, 1-6 months 
95-percentile, exclusive bf, 1-6 mo Median, exclusive bf, 1-6 mo
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period has not been taken into consideration in the exposure assessment, which was based on 
a mean consumption of breastmilk, the mean body weight in children, and the mean fat 
concentration in breastmilk (section 8.1-8.3) combined with the above-mentioned mean and 
maximum concentrations. The exposure was highest in the younger age group and decreased 
with increasing age and body weight (Tables 8.4 and 8.5, Figure 8.3 and 8.4). The maximum 
exposure was approximately 1.6-fold higher than the mean.  
 
Table 8.4: Total TEQ exposure (pg/kg bw/day) from breastmilk in exclusively breastfed infants 0-6 
months, based on mean1 and maximum concentrations in breastmilk (n=27).  
Age, months 1 2 3 4 5 6 
Mean  61.2 52.1 47.4 44.8 42.6 43.3 
Maximum 100.1 85.3 77.6 73.3 69.7 70.8 
1See Table 2.2. 
 
Table 8.5: Total TEQ exposure (pg/kg bw/day) from breastmilk in partially breastfed infants 5-24 months, 
based on mean1 and maximum concentrations in breastmilk (n=27).  
Age, months 5 6 7 8 9 10 11 12 13 14 
Mean  38.0 31.0 24.1 23.2 22.4 21.6 21.2 20.7 20.1 19.6 
Maximum 62.1 50.7 39.4 38.0 36.6 35.4 34.6 33.9 32.8 32.1 
Age. Months 15 16 17 18 19 20 21 22 23 24 
Mean 19.3 18.9 18.5 18.2 17.8 17.5 17.2 16.7 16.5 16.2 
Maximum 31.5 30.9 30.3 29.7 29.2 28.6 28.1 27.4 26.9 26.5 
1See Table 2.2 and Table 2.4. Volume 500 ml/day is used for children 12-24 months. 
 
 
Figure 8.3: Total TEQ exposure (pg/kg bw/day) from breastmilk in infants 1-6 months, based on mean 
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Figure 8.4: Total TEQ exposure (pg/kg bw/day) from breastmilk in partially breastfed children 7-24 
months, based on mean and maximum concentrations in breastmilk (n=27). 
 
 
 DDE  8.6
1,1-dichloro-2,2-bis(4-chlorophenyl)ethylene (p.p’-DDE) is a major breakdown product of 
DDT, and was determined in 377 breastmilk samples from women with a Norwegian 
background42 in the HUMIS study (Polder et al., 2009). The mean, median and 95-percentile 
DDE concentrations were 52.5, 40.5 and 115.9 ng/g lipids respectively. Reduction in 
breastmilk concentration of DDE during the breastfeeding period has not been taken into 
consideration in the exposure assessment, which is based on a mean consumption of 
breastmilk, the mean body weight in children, and the mean fat concentration in breastmilk 
(sections 8.1-8.3) combined with the above-mentioned concentrations. The highest daily DDE 
exposure per kg body weight was seen the first months of life and decreased with age and 
increasing body weight. (Tables 8.6 and 8.7, Figure 8.5 and 8.6). The 95-percentile exposure 
was approximately 2.2-fold higher than the mean.  
 
Table 8.6: DDE exposure from breastmilk in exclusively breastfed infants 0-6 months, based on mean 
consumption1 of breastmilk and mean, median and 95-percentile concentrations of DDE, ng/kg bw/day 
(n=377). 
Age, months 1 2 3 4 5 6 
Mean  291.9 248.7 226.2 213.9 203.2 206.5 
Median 225.2 191.9 174.5 165.0 156.7 159.3 
95-percentile 644.4 549.1 499.4 472.3 448.5 455.8 
1See Table 2.2. 
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Table 8.7: DDE exposure from breastmilk in partially breastfed children 5-24 months, based on mean 
consumption1 of breastmilk and mean, median and 95-percentile concentrations of DDE, ng/kg bw/day 
(n=377). 
Age, months 5 6 7 8 9 10 11 12 13 14 
Mean  181.2 148.0 114.8 110.7 106.8 103.2 101.0 98.8 95.7 93.8 
Median 139.8 114.2 88.6 85.4 82.4 79.6 77.9 76.2 73.8 72.3 
95-percentile 400.0 326.7 253.5 244.4 235.8 227.9 222.9 218.1 211.3 207.0 
Age, Months 15 16 17 18 19 20 21 22 23 24 
Mean 91.9 90.1 88.3 86.7 85.1 83.5 82.0 79.9 78.5 77.2 
Median 70.9 69.5 68.2 66.9 65.6 64.4 63.3 61.6 60.6 59.6 
95-percentile 202.8 198.9 195.0 191.3 187.8 184.4 181.1 176.4 173.4 170.4 




Figure 8.5: DDE exposure (ng/kg bw/day) from breastmilk in infants 1-6 months, based on mean, median 
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Figure 8.6: DDE exposure (ng/kg bw/day) from breastmilk in partially breastfed children 7-24 months, 
based on mean, median and 95-percentile concentrations in breastmilk (n=377). 
 
 
 HCB  8.7
In HUMIS, HCB was determined in 377 breastmilk samples from women with a Norwegian 
background43 (Polder et al., 2009). The mean, median and 95-percentile HCB concentrations 
were 11.5, 11.1 and 18.3 ng/g lipids respectively. Reduction in breastmilk concentration of 
HCB during the breastfeeding period has not been taken into consideration in the exposure 
assessment, which was based on a mean consumption of breastmilk, the mean body weight in 
children, and the mean fat concentration in breastmilk (sections 8.1-8.3) combined with the 
above-mentioned concentrations. As for PCB-153 and DDE, the HCB exposure was highest 
in the first month of life and decreased with increasing age and body weight (Tables 8.8 and 
8.9, Figure 8.7 and 8.8). The 95-percentile exposure was approximately 1.6-fold higher than 
the mean. 
 
Table 8.8: HCB exposure from breastmilk in exclusively breastfed infants 0-6 months, based on mean 
consumption1 of breastmilk and mean, median and 95-percentile concentrations of HCB, ng/kg bw/day 
(n=377). 
Age, months 1 2 3 4 5 6 
Mean  63.9 54.5 49.6 46.9 44.5 45.2 
Median 61.7 52.6 47.8 45.2 43.0 43.7 
95-percentile 101.8 86.7 78.9 74.6 70.8 72.0 
1See Table 2.2. 
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Table 8.9: HCB exposure from breastmilk in children 5-24 months, based on mean consumption1 of 
breastmilk and mean, median and 95-percentile concentrations of HCB, ng/kg bw/day (n=377). 
Age, months 5 6 7 8 9 10 11 12 13 14 
Mean  39.7 32.4 25.2 24.3 23.4 22.6 22.1 21.6 21.0 20.5 
Median 38.3 31.3 24.3 23.4 22.6 21.8 21.4 20.9 20.2 19.8 
95-percentile 63.2 51.6 40.0 38.6 37.2 36.0 35.2 34.4 33.4 32.7 
Age, months 15 16 17 18 19 20 21 22 23 24 
Mean 20.1 19.7 19.4 19.0 18.6 18.3 18.0 17.5 17.2 16.9 
Median 19.4 19.0 18.7 18.3 18.0 17.7 17.3 16.9 16.6 16.3 
95-percentile 32.0 31.4 30.8 30.2 29.7 29.1 28.6 27.9 27.4 26.9 
1See Table 2.2 and Table 2.4. Volume 500 ml/day is used for children 12-24 months. 
 
 
Figure 8.7: HCB exposure (ng/kg bw/day) from breastmilk in infants 1-6 months, based on mean, median 
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Figure 8.8: HCB exposure (ng/kg bw/day) from breastmilk in partially breastfed children 7-24 months, 
based on mean, median and 95-percentile concentrations in breastmilk (n=377). 
 
 
 Summary of exposure 8.8
Exposure estimates to PCB-153, dioxins and dl-PCBs, DDE and HCB are based on mean and 
high (95-percentile, maximal for dioxins and dl-PCBs) concentrations in breastmilk from 
women with Norwegian background combined with mean consumption of breastmilk, mean 
body weight in children, and the mean fat concentration in breastmilk. Highest exposure per 
kg bw was seen the first month of life, and it thereafter declined. High exposures were in the 
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In this chapter there will be a brief discussion of the methodological challenges we 
encountered when evaluating the literature in chapters 6 and 7. The challenges were 
somewhat different for the literature used in the chapter describing the positive health effects 
associated with breastmilk (chapter 6) compared to the chapter describing the negative health 
effects associated with persistent contaminants in breastmilk (chapter 7). In the benefit 
assessment, we used reviews and meta-analyses as a starting point. In the risk assessment, we 
used a systematic literature review approach and retrieved original research papers.  
 
 Study design  9.1
It is generally recognised that randomised controlled trials (RCT), if adequately designed and 
conducted, provide the best evidence for a causal association between exposure, such as 
breastfeeding, and a health and developmental outcome. However, for ethical reasons, no 
country would currently permit an RCT design to investigate pros and cons of breastfeeding 
versus formula feeding.  
Therefore, all but one (the PROBIT Study) of the studies used as a basis for chapters 6 and 7 
are observational studies. Observational studies have their own challenges irrespective of 
topic and how well or poorly they are designed. An observational study draws inferences 
about the possible relationship between exposure and health outcome, but is not able to say 
that the relationship is a cause-effect one. To be able to handle this limitation, Austin 
Bradford Hill in the 1960s developed what is now known as the Hill’s Criteria of Causation. 
The criteria outline the minimal conditions needed to establish a causal relationship between 
two items and include consistency, strength of association, dose-response, time order, 
specificity, consistency on replication, predictive performance, biological plausibility and 
coherence (HILL, 1965). Hill's Criteria form the basis of modern epidemiological research, 
which attempts to establish scientifically valid causal connections between potential disease 
agents and the many diseases that afflict humankind. 
 
 Dose and body burden 9.2
In general, studies on health outcomes associated with any exposure need to take into account 
dose and duration, since the effects of exposure usually are highly dependent on these two 
variables. The total exposure of environmental contaminants to the infant is directly 
proportional to the total dose of breastmilk. However, in studies of breastfeeding, the issue of 
dose, e.g. whether exclusively breastfed or not and for how long, is often not clearly defined.  
Many studies compare ever breastfed children to those who were never breastfed, without 
reporting if the children were exclusively or partly breastfed. Other studies compare infants 
who are breastfed for less than a given number of weeks or months, often 2-3 months, to 
those breastfed for longer periods. Few studies treat breastfeeding duration as a continuous 
variable, which would allow a dose-response analysis.  
In chapter 6 (describing the positive health effects), based on reviews of the literature, four of 
the six reports did not focus specifically on breastfeeding duration. Thus, the impact of dose 
(breastfeeding length and degree) cannot be disentangled in these systematic reviews without 
having to read and interpret the separate papers included. This was not part of the mandate. 
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The two very recently published systematic literature reviews (Hörnell et al., 2013 and WHO, 
2013) have a much larger focus on dose and thus we have chosen to give these most weight in 
our final analyses. In addition, we give some weight to the PROBIT Study, the only RCT so 
far conducted in term-born infants. Although it is a breastfeeding counselling study, 
investigating the impact of increased breastfeeding promotion, and does not have a classical 
control group, it does allow for a certain degree of dose-response information. Furthermore, 
when reorganising their data to an observational design, results do allow for separating the 
exclusively and the partly breastfed children. 
In chapter 7, the 24 original research papers used are characterised by having adequate dose 
data as this was an inclusion criterion. 
However, the methodological approaches for assessing postnatal exposure to contaminants in 
most of these studies only give an overall estimate of postnatal exposure because they rely on 
samples of breastmilk and/or infant blood collected at a single time point together with 
information on breastfeeding duration. Infant toxicokinetics, which is the result of complex 
interactions between several concurrent events including breastfeeding and growth, may 
influence the daily blood concentration of contaminants, but are most often not taken into 
consideration. Thus associations with contaminants that impact health during narrow time 
windows of exposure may not be elucidated and a failure to detect developmental impairment 
may occur (Verner et al., 2010; Verner et al., 2012).  
Critical windows of exposure is an emerging issue in research related to infant development 
and environmental contaminants. The subject is discussed in section 10.3.1. 
 
 Prenatal versus postnatal exposure 9.3
Another methodological challenge encountered has been to separate if the health outcomes 
are related to pre- or postnatal exposures. In many papers it is virtually impossible to separate 
health effects caused by in utero exposure from postnatal exposure. This issue is discussed in 
section 10.3.1. 
 
 Uncertainty in the contaminant exposure estimations 9.4
9.4.1 Volume  
Different methods of measurement have been used to quantify human milk consumption. 
Weighing of mother or child before and after feeding is the most common method. The 
uncertainties are expected to be relatively small and tend to even out when the number of 
observations increase.  
In the present assessment, the estimates of breastmilk volume is based on WHO values (Butte 
N. et al., 2002) (section 2.3). The estimated monthly volume in infants 0-6 months is based on 
results from 28 different studies from developed countries (Butte et al. 2002). However, the 
number of studies and participants varies between different months, and the infants followed 
over a long time period were not the same all the time.  
The monthly breastmilk volume in children 7-24 months has been chosen to have a default 
value of 500 g/day in the present report. This is probably an overestimation of intake, but was 
the best value attainable. Values for partially breastfed infants were chosen due to 
introduction of complementary food. This corresponds with the WHO report from 2002  
(Butte N. et al., 2002), but the variation between the different months varies between 417 to 
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569 g/day in months 7-12. Variations in consumption of breastmilk are likely to be larger 
between children also having complementary food than between exclusively breastfed 
children.  
 
9.4.2 Fat percentage 
Persistent organic pollutants are fat-soluble, and their concentrations in breastmilk are 
therefore correlated to the fat percentage of the milk. The mean and median fat percentage of 
3.5 in HUMIS is chosen as the default fat percentage value in this opinion. There are several 
factors that influence the breastmilk fat content as previously described in section 3.3.3. The 
variations are reported to be between 3 and 7% fat (per 100 g breastmilk), and some studies 
indicate that the variations might even be larger (Michaelsen, Larsen et al., 1994; Picciano, 
2001). The variations are both inter-and intra-individual. The fat percentage, and thereby the 
exposure estimates can therefore both be an over- or an underestimate of the true value.  
 
9.4.3 Body weight 
Exposure estimates of contaminants are expressed per kg body weight. In the exposure 
assessments in this opinion, mean body weights reported in “Child Growth Standards” (WHO 
Multicentre Growth Reference Study Group, 2013), which includes Norwegian children, are 
used. By choosing the mean body weight, the body weight estimate and thereby the exposure 
estimates can both be an over- or an underestimate of the true value.  
 
 Exposure profile  9.5
Among the papers included in chapter 7 (describing negative health effects from contaminants 
in breastmilk), there are variations in how many substances are reported within a paper, and 
within a group of substances, e.g. PCBs, where variable numbers of PCB congeners are 
assessed. The issue can be illustrated by four main approaches when looking at it from this 
perspective:  
 
a) one substance, one outcome – classical toxicology 
b) several substances, one outcome  
c) co-variation between substances  
d) real life exposure: multiple exposures 
 
Most studies within human toxicology have been conducted with one substance or group of 
substances and one health outcome in focus at a time. In reality, man is exposed to multiple 
substances simultaneously. The impact of real life exposure is an emerging science – very few 
studies address the issue at present. The co-variation between some contaminants can be 
considerable, e.g. mercury and dioxins/PCB have overlapping food sources, and 
concentrations in breastmilk may thus be strongly correlated. It may be difficult to isolate the 
biological impact of a specific contaminant, or to examine the independent effect in statistical 
analysis. Only few studies have been published where this issue has been discussed in detail. 
The co-variation between some contaminants and nutrients in breastmilk may also be 
considerable for the same reason as mentioned above; i.e. they have the same food sources. 
There are very few, if any, publications in this field, but when aiming to understand (positive 
or) lack of negative health effects of contaminants, this is a dimension to consider. However, 
both the prenatal and postnatal exposure include all contaminants present in either mother’s 
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blood or breastmilk and thus possible impairment of specific health outcomes in reality 
integrate all exposures (see also section 10.3.4). 
 
 Confounders 9.6
Socio-economic and lifestyle factors often show co-variation with breastfeeding initiation and 
duration; the influences from these factors may be difficult to isolate. Factors that are 
independently associated with the decision to continue breastfeeding are e.g. maternal 
smoking, maternal age, single parent status, atopy risk and number of siblings (Haggkvist et 
al., 2010; Dulon et al., 2001). Nowadays it is difficult to get a paper published without 
adequate statistical correction for obvious confounding factors, and this was not a challenge in 
the risk articles apart from one parameter: lack of the HOME score assessment. 
The HOME score measures how stimulating the child’s home environment is and may be 
independent of socio-economic status. A specific confounder challenge for interpretation of 
studies on neurodevelopment is the lack of HOME score measurements. Where it had been 
included, several of the papers came to the conclusion that a stimulating home environment 
outbalanced an eventual negative effect of contaminants in breastmilk.  
 
 Bias 9.7
Selection bias is of particular concern since babies who receive exclusive and prolonged 
breastfeeding might be those growing well and remaining healthy. Furthermore, if the infant 
or the mother gets ill it may be weaned. Weaned infants cannot be switched back to 
breastmilk. Thus, there might be a selection of healthy children among those breastfed 
(Kramer, 2009). On the other hand, health information about the potential protective effect of 
breastfeeding on asthma and allergy might in particular motivate mothers with a family 
history of asthma or allergy to breastfeed exclusive and prolonged. Likewise, mothers whose 
infants experience recurrent respiratory infections might decide to prolong breastfeeding in 
order to provide the infant some sort of “protection”. This kind of selection bias may attenuate 
any effect of impact of breastfeeding on these conditions.  
The strong assumption of beneficial effects from breastfeeding poses a risk of report bias, e.g. 
that only studies confirming these positive effects are reported and cited.  
 
 Outcomes 9.8
A challenge when interpreting the benefit results was the lack of explicit sorting of results by 
length of breastfeeding, whether exclusive or partial. Furthermore, it has been challenging to 
separate the beneficial health outcomes apparent while breastfeeding, e.g. infections, from the 
long-term benefits measured after weaning, e.g. obesity. 
As to the risk assessment, the major challenge is the heterogeneity within each main group of 
outcomes, e.g. immunologically or allergic related diseases, where all five papers included in 
reality measured widely different parameters. The outcomes investigated within the category 
neurodevelopment cover a number of different tests: The McCarthy Scales of Children's 
Abilities in four studies, the Bayley Scales of Infant Development in five studies, the 
Kaufman Assessment Battery for Children in two studies, but also more unspecified tests: 
play behaviour, or neurological examination or motoric development. Furthermore, the 
timepoint of investigation varied from some weeks to teenage years. 
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 Summary of methodological issues 9.9
A number of methodological challenges are encountered when working with observational 
epidemiological studies. The ideal study design, an RCT, can for ethical reasons not be used 
to study breastfeeding and health outcomes. The particular methodological challenges 
appearing in this assessment were related to lack of adequate description of breastfeeding 
length and extent (exclusive or partial), thus making accurate doses and body burdens 
somewhat uncertain. Other challenges were related to whether the studies truly could separate 
pre- and postnatal exposure to contaminants. Many risk studies had investigated only one 
contaminant while in reality the infant is exposed to a mixture of many contaminants at the 
same time. All studies had corrected for traditional confounders like socioeconomic status, 
but several lacked information on HOME score, a parameter which is particularly important 
to include when studying the health effects of breastfeeding. We also noted that outcome 
measurements varied substantially between studies even within the same field of research, 
e.g. immune response-associated diseases, thus making comparisons of outcomes challenging. 
In chapter 10 we have tried to assess the impact of the methodological challenges in the final 
benefit risk assessment. 
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10 A comprehensive assessment of benefits and risks 
The Norwegian health authorities’ responsibility does not comprise the safety of human milk. 
In the wake of intermittent public debates about contaminants in breastmilk, there has been no 
official body to handle the unease. VKM thus took the initiative to perform a benefit and risk 
assessment of breastmilk with focus on the infant’s health. 
There is an extensive body of documentation showing that breastmilk is beneficial for the 
child. Apart from covering the nutritional needs of the infant, it is especially well documented 
that the immunological properties of human milk protect against infections and boost the 
child’s own immunological development. Following this, a breastfed child seems to have 
lowered risk of a number of health conditions, both during the breastfeeding period itself and 
after weaning. However, there has been a continuous debate as to what the optimal duration 
of breastfeeding is. In 2011, the Norwegian Directorate of Health set up a working group 
whose mandate is to develop national guidelines on infant feeding, i.e. nutrition for healthy 
infants aged 0-12 months. The working group aims to finish its work in 2014. An assessment 
of contaminants in breastmilk is not part of the mandate of the Directorate of Health working 
group. 
Breastmilk contains contaminants that have entered the mother’s body through the lungs, skin 
and gastrointestinal tract. Breastmilk concentrations of contaminants reflect the contaminant 
history of the mother. In 1951, DDT became the first environmental pollutant to be found in 
human milk. The last four decades, additional chemicals have been detected in breastmilk, 
including persistent organic pollutants such as dioxins, PCBs, brominated flame retardants 
and a number of pesticides other than DDT. The majority of the most toxic early 
environmental contaminants have been banned, and their levels in breastmilk are decreasing 
(see Background chapter and the Stockholm convention), but low levels of a number of more 
recent contaminants have been introduced. It follows from this that previously, mothers were 
exposed to higher concentrations of a smaller number of contaminants, while the present-day 
situation may be exposure to a wider range of contaminants but at lower concentrations. 
The discussion about optimal duration of breastfeeding therefore has a contaminant 
dimension. While there is no discussion about the benefits of breastfeeding initiation, there is 
a need to clarify whether environmental contaminants should have their say in the discussion 
about length and degree of breastfeeding. 
Norwegian women have a high prevalence of breastfeeding and a particular high rate of 
partial breastfeeding at 12 months. Mean breastfeeding duration is 10.3 months, and at 12 
month of age, 46% of the children are still breastfed. However, the prevalence of exclusive 
breastfeeding in Norway declines rapidly from 3 months onward (Figure 2.1). The mean 
volume of breastmilk given to the child is surprisingly similar in exclusively and partially 
breastfed infants up till 5 month of age (see Tables 2.2 and 2.3). Thus, the child may receive 
almost the same exposure to substances per kg body weight from the mother whether being 
exclusively or partly breastfed, at least up to a certain point in time. 
This chapter attempts to tie all previous chapters and sections together into a whole and 
address benefits from breastmilk and risks from contaminants in breastmilk in a systematic 
way, taking factors relevant for Norwegian conditions into consideration. As there are many 
threads to be woven together, the following illustration might serve as a reading map: 
The chapter starts with a go-through of guidelines for conducting benefit and risk assessments 
(section 10.1) and performing a grading (section 10.2). Then follows the actual grading, first 
of the documentation on positive health effects described in chapter 6, than a grading of the 
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documentation on negative health effects described in chapter 7. However, the grading alone 
is not sufficient for a benefit and risk assessment. Additional aspects also have to be taken 
into consideration (section 10.3). Additional considerations include e.g. exposure levels in 
Norway and infant formula as an alternative to breastmilk. Finally, all these aspects will be 





Figure 10.1: A reading guide to chapter 10 and 11. 
 
 
 A health-based risk-benefit assessment – guidelines and grading 10.1
10.1.1 Benefit and risk assessment guidelines 
In 2010, the EFSA Scientific Committee developed “Guidance on human health risk-benefit 
assessment of foods” (EFSA, 2010a). They recommended a stepwise approach for the risk-
benefit assessment, i.e.  
i) an initial assessment, addressing the question whether the health risks clearly 
outweigh the health benefits or vice versa,  
ii) a refined assessment, aiming at providing semi-quantitative or quantitative 
estimates of risks and benefits at relevant exposure by using common metrics, and  
iii) a comparison of risks and benefits using a composite metric such as disability-
adjusted life years (DALYs) or quality-adjusted life years (QALYs) to express the 
outcome of the risk-benefit assessment as a single net health impact value.  
Furthermore, the EFSA guidance document stated the following:”The outcome of each step of 
the assessment should also include a narrative of the strengths and weaknesses of the evidence 
base and its associated uncertainties. The overall magnitude of uncertainty associated with a 
risk-benefit assessment may often be large. This should not be regarded as implying a failure 
of the assessment; on the contrary, it provides essential information for decision-making and 
helps in identification of data needs.” 
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This report focuses on step i) and ii). The common metrics will be the health outcomes. 
Employing step iii) has been beyond the capacity of the working group. To our knowledge 
no-one has worked with DALYs or QALYs and breastmilk in a risk-benefit perspective in 
healthy, born at term infants. 
 
10.1.2 Grading the evidence – guidelines 
There are several methods in use for grading evidence in systematic literature reviews. The 
different methods became apparent in the reviews used as a basis for our benefit assessment.  
When grading the results of the risk assessment part of this work, we will use the grading 
system developed by the 2007 World Cancer Research Fund (WCRF) report (World Cancer 
Research Fund, 2007) and adopted by the Nordic Nutrition Recommendation project group 
(NNR) as a starting point. This grading system is especially developed for a situation where 
observational studies form the basis, as in this assessment. Evidence is classified as 
convincing (grade 1), probable (grade 2), limited-suggestive (grade 3) and limited – no 
conclusion (grade 4) depending on the number and quality of supporting, non-supporting and 
contradicting studies.  
As described in chapter 7, the majority of the papers reviewed showed no statistically 
significant association between contaminant exposure from breastmilk and the health outcome 
in focus. Thus, if many studies show no association, a discussion arises, whether lack of 
association is equivalent to convincing evidence of no effect. We have tried to keep in mind 
that “Absence of evidence is not evidence of absence”. As the method for systematic literature 
reviews in NNR is inspired by the approach used in the extensive work performed in the 
WCRF report from 2007 it is relevant to see how WCRF handles the issue.  
The WCRF introduces the expression “substantial effect on risk unlikely” when there is 
evidence to support a judgement that a particular exposure is unlikely to have a substantial 
causal relation to the outcome. The evidence should be robust enough to be unlikely to be 
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This box lists the criteria modified from the WCRF cancer report that have been connected to the three category quality 
grading system developed by the AHQR. The grades shown here are ‘convincing’, ‘probable’, ‘limited — suggestive’, 
‘limited — no conclusion’.  
Convincing (High) 
These criteria are for evidence strong enough to support a judgement that there is a convincing causal relationship or 
absence of relationship. A convincing relationship, or absence of relationship, should be robust enough to be highly 
unlikely to be modified in the foreseeable future as new evidence accumulates. All of the following criteria are generally 
required: 
• Evidence from more than one study type (RCT, prospective cohort or nested case-control studies). For some 
outcomes (e.g. some riskfactors) evidence from several RCT may be sufficient. 
• Evidence from at least two independent cohort studies (cf above). 
• No substantial unexplained heterogeneity within or between study types or in different populations in relation 
to the presence or absence of an association or the direction of effect. 
• Several good quality studies (quality grading category A) with consistent findings to exclude with confidence 
the possibility that the observed association, or absence of association, results from random or systematic 
error, including confounding, measurement error, and selection bias.  
• Presence of a biological gradient (‘dose response’) in the association. Such a gradient need not be linear or 
even in the same direction across the different levels of exposure, so long as this can be explained plausibly. 
• Strong and plausible experimental evidence, either from human studies or relevant animal models, that 
typical exposures in humans can lead to relevant outcomes. 
 
Probable (Moderate) 
These criteria are for evidence strong enough to support a judgement of a probable causal relationship. All the following 
criteria are generally required: 
• Evidence from at least two independent cohort studies, or at least five case-control studies. For some 
outcomes (e.g. some riskfactors) evidence from a few RCT may be sufficient 
• No substantial unexplained heterogeneity between or within study types in the presence or absence of an 
association, or the direction of effect. 
• Several good quality studies (quality grading category A and B) with consistent findings to exclude with 
confidence the possibility that the observed association, or absence of association. results from random or 
systematic error, including confounding, measurement error, and selection bias.  
• Evidence for biological plausibility, in case of an observed association. 
 
Limited — suggestive (Low) 
These criteria are for evidence that is too limited to permit a probable or convincing causal, or absence of causal, 
relationship, but where there is evidence suggestive of a direction of effect. The evidence may have methodological 
flaws, or be limited in quantity, but shows a generally consistent direction of effect. All the following criteria are 
generally required: 
• Evidence from at least two independent cohort studies or at least five case-control studies. 
• The direction of effect is generally consistent though some unexplained heterogeneity may be present. 
• Several studies of at least moderate quality (quality grading category B). 
• Evidence for biological plausibility 
 
Limited — no conclusion (Insufficient) 
Evidence is so limited that no firm conclusion can be made. A body of evidence for a particular exposure might be 
graded ‘limited — no conclusion’ for a number of reasons. The evidence might be limited by the amount of evidence in 
terms of the number of studies available, by inconsistency of direction of effect, by poor quality of studies (for example, 
lack of adjustment for known confounders), or by any combination of these factors. Most of the studies are in the 
quality grading category C or there are 2 or more high (A) or moderate (B) quality studies with contradicting or null 
results. 
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This report will discuss grading that falls in the “substantial effect on risk unlikely”-category 
defined as above if relevant. 
 
 Grading of evidence  10.2
The grading of evidence on the positve and negative side will have one important difference: 
when grading the positive health effects of breastmilk, it is the documentation for the 
breastmilk as such which is evaluated, while the grading on the negative side is an evaluation 
of the documentation for negative health effects, or hazard, of substances in breastmilk.  
 
10.2.1 Grading of evidence – postive health effects 
As described in chapter 6, positive health effects associated with consumption of breastmilk 
in this report is based on conclusions from systematic reviews and meta-analyses published 
within the last 10 years. When grading the evidence on the benefit side, we will thus have to 
perform the “excercise” of grading the sum of others work, some of whom have not graded 
their results and some using grading, but various grading systems. An element of “best 
judgement” is thus unavoidable from VKM’s side, as there to our knowledge are no 
international guidelines for grading on the basis of reviews and meta-analyses. 
While the reports by Ip et al. (2007), WHO (2007) and SACN (2011) have no grading of 
evidence within their reports, grading was used in both the van Rossum et al. (2005) and 
Hörnell et al. (2013). The recent WHO-review (2013) uses statistical models and odds ratios 
to come to conclusions. 
Table 6.1 summarises most of the reported positive health effects of breastfeeding from the 
six systematic reviews and meta-analyses. The health outcomes are multiple and represent 
various disease categories, such as infectious diseases, immune response-associated diseases, 
metabolic syndrome (e.g. overweight/obesity and diabetes), cognitive development, malignant 
disease and sudden infant death syndrome. 
In the following grading of evidence most attention will be given to those health outcomes 
which also have been studied from a risk point of view, i.e. neurodevelopment, immune 
response-associated diseases and growth and overweight/obesity. A short paragraph on 
biological plausibility will be given if the grade of evidence is convincing or probable or 
otherwise relevant.  
- Evidence from more than one study type 
- There is evidence from at least two independent prospective cohort studies 
- Summary estimate of effect close to 1.0 for comparison of high versus low exposure categories 
- No substantial unexplained heterogenicity within or between study types or in different populations 
- Good quality studies to exclude, with confidence, the possibility that the absence of an observed association 
results from random or systematic error, including inadequate power, imprecision or error in exposure 
measurement, inadequate range of exposure, confounding, and selection bias 
- Absence of a demonstrable biological gradient (“dose-response”) 
- Absence of strong and plausible experimental evidence, either from human studies or animal models, that 
typical human exposures lead to relevant cancer outcomes 
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Four out of the six systematic reviews and meta-analyses on positive health effects of 
breastfeeding described in chapter 6 studied outcomes related to cognitive development (van 
Rossum, 2005; WHO, 2007; Hornell, 2013; WHO, 2013). All four reviews found a positive 
impact of breastfeeding on child neurodevelopment, van Rossum et al. concluding with there 
being probable evidence of improved intellectual and motor development. However, socio-
economic factors, parental intelligence and HOME score are vital confounding factors. 
Taking these factors into account, Hörnell et al. concluded that there is a probable evidence 
that breastfeeding is beneficial for IQ and developmental scores of children, i.e. increasing 
scores with increasing duration (Hornell et al., 2013). 
WHO (2013) found an increase in test scores both in the pooled analysis of all studies, as well 
as in the high-quality studies included. They concluded that there is a strong evidence of 
causal effect of breastfeeding on increased IQ, although the magnitude of this effect seems to 
be modest (WHO, 2013). 
In the PROBIT Study from Belarus, at 6.5 years of age, the intervention group had higher 
means on all of the Wechsler Abbreviated Scales of Intelligence measures (section 6.1.2). 
Teachers' academic ratings were significantly higher in the intervention group for both 
reading and writing. When pooling their data and treating them as an observational study, 
there was still a higher IQ in the children breastfed for 6 vs 3 months, but the difference did 
not reach statistical significance.  
The biological plausibility for an association between breastmilk and neurodevelopment is 
connected to specific breastmilk constituents which may offer developmental advantages. 
They include long-chain polyunsaturated fatty acids (LCPUFA) and particularly DHA (see 
section 3.4). Isaacs et al. reported that breastfeeding was positively related to brain volume 
and – among male subjects – increased amounts of white matter was also related to 
breastfeeding (cited in WHO, 2013), thus suggesting that breastmilk promotes structural 
changes in the brain. In a recent publication from Canada, exclusive breastfeeding was 
associated with the brain’s cortical thickness – in addition to replicating the association 
between breastfeeding and general intelligence (Kafouri et al., 2013). 
As described in section 3.4.4, breastmilk influences the gut microbiota differently from infant 
formula, and this may also be relevant for neurodevelopment. 
However, the suggested biological mechanisms must be considered as hypotheses; none of 
the suggestions are so far supported by unequivocal evidence. 
VKM concludes that the evidence is convincing for a positive effect of breastmilk on 
neurodevelopment. The optimal length of exclusive and partial breastfeeding associated 
with the positive effect remains to be settled. 
 
10.2.1.2 Immune response-associated diseases 
Infections 
A reduced risk of lower respiratory tract infections, especially the severe ones, as well as of 
gastroenteritis and otitis media in breastfed versus non-breastfed children is well documented 
(Agostoni et al., 2009; Ip et al., 2009; van Rossum et al., 2005). The reduced risk is 
demonstrated both when comparing exclusive with partial breastfeeding or formula feeding 
and when comparing different lengths of exclusive or partial breastfeeding with formula 
feeding.  
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In the recent systematic literature review by Hörnell et al. (2013) it is concluded that the 
evidence is convincing that breastfeeding protects infants in industrialised countries against 
overall infections, acute otitis media and gastrointestinal and respiratory tract infections. The 
magnitude of the effect varies depending on the specific outcome and the exclusiveness of 
breastfeeding (Hornell et al., 2013). 
The biological plausibility for the protective effect of breastmilk on infectious diseases is 
strong (see section 3.4). 
All the reviews agree that the protection from infections lasts as long as the child is breastfed. 
The large Generation R study found that exclusive breastfeeding for 4 months and partial 
breastfeeding thereafter reduced the risk significantly up to 1 year of age (Duijts et al., 2010). 
It is unclear whether the effects last beyond the partly breastfeeding period. 
VKM concludes that the evidence is convincing for a protective effect of breastmilk on 
infections, at least as long as the child is exclusively or partly breastfed.  
 
Asthma and wheezing, allergies and atopic dermatitis 
The studies on immune-assosiated diseases show heterogeneous results. Both for asthma, 
allergies and atopc dermatitis (see section 6.3), the review by van Rossum concluded that 
there is probable evidence, while Hörnell et al. concluded that there is limited evidence for a 
protective effect and no conclusion can be given.  
In the PROBIT Study a reduced prevalence of atopic eczema was found at 1 year when 
treating the data as an RCT study. No differences in allergy incidence were observed between 
the intervention and control groups when the children were 6.5 years old irrespective of how 
they handled the data statistically (section 6.1.2). The results may indicate that the protective 
effect is strongest in early life. It must be kept in mind, though, that all children in the 
PROBIT study were breastfed initially.  
The immunoregulatory properties of breastmilk form a strong biological plausibility for a 
positive impact of breastmilk on immune response-associated diseases. 
As described in detail in section 3.4, numerous components of breastmilk not only possess 
innate and adaptive defence properties, but may also aid the nursed infant’s immune 
development, including generation of immunological tolerance with appropriately controlled 
inflammatory reactions. 
VKM is aware of the challenges connected to diagnosis of immune response-associated 
diseases and that this may vary between studies. VKM is also aware that the heterogenicity of 
results may be related to the differences in breastfeeding length reported between studies. An 
explanation might be that there is an unknown, but optimal length of breastfeeding in relation 
to immune response-associated diseases, after which the impact of breastfeeding fades.  
VKM concludes that the evidence is limited, and no conclusion can be given for a 
protective effect of breastmilk on asthma, wheezing, allergies and atopic dermatitis. 
 
Type 1 diabetes  
As pointed out in chapter 6, available evidence suggests that breastfeeding may reduce the 
risk of type 1 diabetes mellitus. Ip et al. concluded that the risk of developing type 1 diabetes 
is significantly reduced in breastfed infants, van Rossum et al. (2005) indicated “possible 
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evidence” for a protective effect from breastfeeding, while Hörnell et al. (2013) indicated 
“probable evidence”.  
Type 1 diabetes is characterised by a selective loss of insulin-producing B cells in the 
pancreatic islets in genetically susceptible individuals. Evidence suggests that B cell 
autoimmunity may be induced early in life. The biological plausibility for an association 
between breastfeeding and type 1 diabetes may be due to breastmilk per se or to the 
associated delayed introduction of gluten and/or cow’s milk protein (see section 6.2.3).  
Furthermore, the positive effect of breastmilk has been suggested to be based on the fact that 
breastmilk strengthens the child's immune system. Several anti-microbial substances in 
human milk may protect the child from for instance enterovirus infections, and as a 
consequence from B cell autoimmunity, which progressively can lead to the development of 
type 1 diabetes. Another possible protective mechanism is the more rapid decrease in gut 
permeability that breastfed children exhibit compared to children who are formula fed during 
the first months of life. Conversely, the early introduction to cow's milk proteins may increase 
intestinal permeability, cause inflammation of the intestinal mucosae, and deregulate the 
immune response to cow's milk protein (Patelarou et al., 2012). 
VKM concludes that the evidence is probable for a protective effect of breastmilk on risk 
of type 1 diabetes. The optimal length of exclusive and partial breastfeeding associated 
with the reduced risk remains to be settled. 
 
Crohn’s disease and ulcerative colitis 
Crohn’s disease is included in the reviews by van Rossum et al. (2005) and Hörnell et al. 
(2013). The first concluded that there is “possible evidence” for a protective effect of 
breastmilk while the latter concluded that the evidence is “probable”. As to ulcerative colitis, 
van Rossum et al. concluded that the evidence is insufficient and Hörnell et al. concluded that 
the evidence for a protective effect from breastfeeding is “probable”.  
The suggested biological plausibility for an association between breastmilk and inflammatory 
bowel disease may be attributed to the immunomodulatory properties of human milk. Also, 
breastmilk oligosaccharides supporting the growth of beneficial intestinal microorganisms 
might be of importance (Klement et al., 2004). 
VKM concludes that the evidence is limited suggestive for a protective effect of 
breastmilk on risk of Crohn’s disease and ulcerative colitis.  
 
Coeliac disease 
Coeliac disease was reviewed by Hörnell et al. (2013) and the conclusion was that there was 
“probable evidence” for breastfeeding as a protective factor for coeliac disease, or at least for 
delaying its clinical presentation. SACN COT (2011) stated that the evidence currently available 
is not strong enough to make specific recommendations about the appropriate timing of 
introduction of gluten. 
The biological plausibility for an association between coeliac disease and breastmilk may be 
linked to the presence of immunomodulating factors in breastmilk, influencing tolerance to 
gluten antigen.  
VKM concludes that the evidence is limited suggestive for a protective effect of 
breastmilk on risk of coeliac disease. 
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10.2.1.3 Growth, overweight and obesity 
All the systematic reviews and meta-analyses on positive health effects of breastmilk, 
described in chapter 6, have studied overweight and obesity, and they all conclude that 
breastmilk reduces the risk of overweight and obesity in childhood. In the systematic 
literature review by Hörnell et al. (not including the 2013 PROBIT Study on overweight 
(Martin et al., 2013)) it is concluded that growth in infancy (length and height) varied only a 
little between those exclusively breastfed for 4 months or 6 months. Nonetheless, it is 
concluded that there is probable evidence that exclusive breastfeeding for more than 4 months 
is associated with slower weight gain during later infancy compared with those exclusively 
breastfed for less than 4 months. The evidence is convincing that longer duration of exclusive 
or any breastfeeding is associated with a protective effect against overweight and obesity in 
childhood and adolescence. With regard to the association with overweight/obesity in 
adulthood, due to a scarcity of studies, it is judged that the evidence is limited suggestive for a 
protective effect of breastfeeding (Hornell et al., 2013). 
The latest WHO review stated that a significant reduction in body weight in children was 
found both in the pooled analyses of all studies (24% reduction) as well as in the high quality 
studies (12% reduction). The protective effect was especially notable in childhood and 
through the teens till the age of 19. The report concluded that breastfeeding may provide some 
protection against overweight and obesity, but residual confounding cannot be ruled out 
(WHO, 2013). 
The PROBIT Study found no difference in risk of overweight and obesity between the 
different breastfeeding groups at the ages of 6.5 and 11 years, irrespective of how they 
organised their data (i.e. using the RCT design or observational design, see 6.1.2) and 
irrespective of length of exclusive breastfeeding. However, again it must be kept in mind that 
all PROBIT children were breastfed initially. 
As to biological plausibility, several mechanisms have been proposed for a protective effect 
of breastfeeding against overweight and obesity, although they must be considered to be 
hypotheses as none of the suggestions are so far supported by unequivocal evidence. 
Increased protein intake in early infancy has been suggested to be an important risk factor for 
later overweight and obesity – and knowing that infant formula in general has higher protein 
content than breastmilk (Nommsen-Rivers and Dewey, 2009) – this could contribute to some 
of the differences found in growth between breastfed and formula fed children. A high-protein 
diet stimulates insulin-like growth factor 1 (IGF-1) and insulin release in infancy, factors 
involved in growth the first years of life (Rzehak et al., 2013; Socha et al., 2011). Another 
path to explain the differences in risk between formula fed and breastfed infants goes by the 
gut microbiota. Type of feeding (breastmilk or infant formula) plays important roles in 
determining the microbiota composition, see section 3.4.4 and Morelli et al., 2008 (Morelli, 
2008).  
Yet another hypothesis to explain differences in risk of overweight between breastfed and 
formula fed children goes by the infant's ability to self-regulate intake: there is evidence that 
infants who are bottle-fed in early infancy, irrespective of the content being formula or 
expressed breastmilk, are more likely to empty the bottle. This tendency to finish a portion 
seems to continue into later childhood (Li et al., 2008; Li et al., 2010; Li et al., 2012). This 
implies a higher caloric intake and may explain the increased risk. 
VKM concludes that the evidence is convincing for a protective effect of breastfeeding 
on risk of overweight and obesity in childhood and adolescence. The optimal length of 
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exclusive and partial breastfeeding associated with the reduction in risk remains to be 
settled. 
 
10.2.1.4 Type 2 diabetes 
As to type 2 diabetes, Ip et al. (2007) and SACN (2011) indicated a protective effect from 
breastmilk, while Hörnell et al. (2013) concluded that there is a “probable” reduced risk. 
WHO (2013) concluded that further studies are needed. Few studies have investigated 
breastmilk in relationship to risk of type 2 diabetes in adults. 
The biological plausibility for an association between breastmilk and type 2 diabetes may be 
the presence of long-chain polyunsaturated fatty acids (LCPUFAs) in breastmilk. Breastmilk 
increases the amount of these fatty acids in skeletal muscle membrane, which is inversely 
related to fasting blood glucose. Differences in insulin secretion represent another possible 
mechanism; the concentration of insulin in formula fed infants is higher than in breastfed, and 
may lead to failure of the B cells, and subsequently type 2 diabetes. Also, since obesity is an 
important determinant of type 2 diabetes, a protective effect of breastfeeding on obesity may 
represent another explanation (WHO, 2013).  
VKM concludes that the evidence is probable for a protective effect of breastmilk on risk 
of type 2 diabetes. The optimal length of exclusive and partial breastfeeding associated 
with the reduction in risk remains to be settled. 
 
10.2.1.5 Childhood cancer 
As described in section 6.2.5, some studies suggest a reduced incidence of some cancers 
among breastfed individuals. Ip et al. (2007) and SACN (2011) indicated that there is a 
reduced risk, while van Rossum et al. (2005) and Hörnell et al. (2013) concluded that the 
evidence is limited suggestive. 
One possible biological plausibility for an association between breastmilk and malignancies 
may be the presence of substances with antitumor activity, like HAMLET formations 
(described in section 3.4.1). 
VKM concludes that the evidence is limited suggestive for a protective effect of 
breastmilk on risk of childhood cancer. 
 
10.2.1.6 Sudden infant death syndrome (SIDS) 
Breastfeeding appears to be associated with a reduced risk for SIDS. Ip et al. (2007) indicated 
that there is a reduced risk, while van Rossum et al. (2005) concluded that the evidence is 
“insufficient”. A later meta-analysis published in 2011 (Hauck et al.), concluded that 
breastfeeding is protective and the effect is stronger when breastfeeding is exclusive. 
SIDS may have several causes, airway infection being one predisposing factor. Breastfed 
children seem to have a different sleeping pattern with lower arousal thresholds than formula 
fed infants, which may provide one mechanism for protection against SIDS. 
VKM concludes that the evidence is limited suggestive for a protective effect of 
breastmilk on risk of sudden infant death syndrome. 
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10.2.1.7 Cardiovascular diseases 
All reviews included in the present assessment agreed that there is no convincing evidence 
that breastfeeding influences cardiovascular morbidity and mortality.  
VKM concludes that the evidence is limited and no conclusion can be given for a 
protective effect of breastmilk on risk of cardiovascular diseases. 
 
10.2.1.8 High blood pressure 
WHO (2007) and SACN (2011) concluded that blood pressure later in life is reduced (systolic 
and diastolic) in breastfed children. Van Rossum et al. (2005) indicated “convincing 
evidence” while Hörnell et al. (2013) indicated “probable evidence”. The WHO (2013) 
systematic review found a small protective effect of breastfeeding against increased systolic, 
but not diastolic blood pressure. The effect on systolic blood pressure was especially 
pronounced through childhood until the age of 19. 
The suggested biological plausibility for an association between breastmilk and blood 
pressure is related to differences in sodium content between formula and breastmilk. This 
might be a mechanism for programming of later blood pressure, but evidence for such a 
mechanism is scarce. Different long-chain polyunsaturated fatty acids are present in 
breastmilk which until recently were not present in formula. As these are important structural 
components of the vascular endothelium, they may partly explain an eventual favourable 
effect of human milk on later blood pressure (WHO, 2013). 
VKM concludes that the evidence is probable for a protective effect of breastmilk on 
later risk of high blood pressure. The optimal length of exclusive and partial 
breastfeeding associated with the reduced risk remains to be settled. 
 
10.2.1.9 Serum cholesterol 
Long-term reduction in serum cholesterol is included in the review from WHO (2007) which 
reported a reduced mean difference in serum cholesterol between breastfed and non-breastfed 
which lasts into adulthood. Also SACN (2011) indicated reduced serum cholesterol from 
breastmilk and Hörnell et al. (2013) concluded that there is a “probable” reduction. A 
significant reduction in serum cholesterol among adults was not found in the updated 
systematic review from WHO (2013). 
VKM concludes that the evidence is limited and no conclusion can be given for an 
association between breastmilk and reduced serum cholesterol. 
 
10.2.2 Summary grading of evidence, positive health effects 
Table 10.1 summarises the results from the systematic reviews and meta-analyses of the 
positive health effects associated with consumption of breastmilk, and includes an evaluation 
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Table 10.1: Summary of the strength of evidence in children for positive health effects associated with 
consumption of breastmilk. The Table is identical to Table 6.1 apart from the addition of the column with 
conclusions from VKM to the very right. 
Main results 
in infants 











 MD 4.9 
(2.97; 6.92)a 
- - - Probable   MD 3.45 
(1.92; 
4.98)a 








- - Probable 
evidence  
- - - No conclusion 
Otitis media -  Convincing 
evidence  
- Convincing  - Convincing  
Gastrointestin
al infections 
-  Convincing 
evidence  
- Convincing  - Convincing  * 
Respiratory 
infections 
- - Possible 
evidence  





-  - -  - Convincing * 
Atopic disease - - Probable 
evidence  
- Limited, no 
conclusion 




-  Eczema, 
Probable 
evidence  
- Limited, no 
conclusion 





-  Probable 
evidence  
- Limited, no 
conclusion 
- Limited, no 
conclusion 
Wheezing - - Probable 
evidence  
- Limited, no 
conclusion 
- Limited, no 
conclusion 




 Convincing   OR 0.76 
(0.71; 
0.81)c 














Probable  - Probable  
Type 2 
diabetes 
 OR 0.63 
(0.45; 0.89)c 










- Limited,  
suggestive  
SIDS -  Insufficient 
evidence 




- Not clear No evidence No 
evidence2 




- - Possible 
evidence  
- Probable   - Limited,  
suggestive 
Ulcerative - - Insufficient - Probable  - Limited,  
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aMean difference (MD) and 95% confidence intervals by meta-analysis comparing breastfed vs. not-breastfed subjects in 
different studies. 
bMean difference (MD) and 95% confidence intervals by meta-analysis comparing breastfed vs. not-breastfed subjects in 
different studies, restricted to studies considered high quality 
cOdds ratio (OR) and 95% confidence intervals by meta-analysis comparing breastfed vs. not-breastfed subjects in different 
studies. 
dOdds ratio (OR) and 95% confidence intervals by meta-analysis comparing breastfed vs. not-breastfed subjects in different 
studies, restricted to studies considered high quality. 
1Reduced risk for acute lymphoblastic leukemia, Hodgkin’s disease and neuroblastoma. 
2SACN 2011 has looked into cardiovascular mortality whereas the others have reported morbidity. 
- (=Not investigated). 
MD: Mean difference. 
*Including results from Duijts et al., 2010. 




10.2.3 Grading of evidence – negative health effects 
To comply with the terms of reference, the assessment of risks is based on findings from a 
full-scale systematic literature search, see section 7.1. To assess the relevance and quality of 
included studies, a rating system based on the NNR5 AMSTAR was applied, modified for our 
purposes, see Appendix 2. The quality assessment resulted in no studies in category A, while 
24 studies qualified for category B. The category C-studies were not considered further.  
A short paragraph on biological plausibility will be given if the grade of evidence is 
convincing or probable or otherwise relevant. As stated in the introduction to section 10.2, the 
papers which follow have investigated possible negative health effects of breastmilk with 
focus on substances in breastmilk, and not breastmilk as such. Our grading of the evidence 
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thus has similarities to a hazard characterisation, i.e. how well it is documented that 
environmental contaminants in breastmilk are a cause of concern.  
 
10.2.3.1 Neurodevelopment 
PCBs are the most extensively investigated POPs with regard to possible negative effects on 
neurodevelopment. Also dioxins, DDE and HCB have been investigated. Since these 
substances generally show high correlation in breastmilk, are all fat-soluble, and since no 
causative associations can be deduced from the cohort studies, VKM has pooled the studies 
on PCBs, dioxins, DDT/DDE and HCB when grading the evidence, whereas mercury is 
addressed separately. 
The biological rationale for a detrimental effect of POPs on neurodevelopment is described in 
chapter 5. 
Eight of the cohorts included in the present benefit and risk assessment (published in 16 
papers, 14 including POPs and two including mercury) have looked particularly on breastmilk 
exposure to contaminants and risk of impaired neurodevelopment. The most consistently used 
tests are the Bayley Scales of Infant Development up till 2 years of age, and the McCarthy 
Scales of Children’s Abilities in the 4 to 7-year olds. The Kaufman Assessment Battery for 
Children was used on 4-year olds in two cohorts and a follow-up at 6 years in one cohort. The 
same tests have been administered at similar ages in several of the studies. No association 
between neurodevelopment (cognitive or motor abilities) and postnatal exposure to POPs was 
found in three cohorts (eleven out of 15 papers, see Table 7.14).  
A positive effect of breastmilk was however noted in several of the studies (see section 7.2.4).  
In three papers from three cohorts, various negative associations with PCB exposure were 
reported. In the Dutch cohort (summarised in section 7.3), indications of a negative impact of 
contaminants on neurodevelopment were transient (observed at 7 months but not at 18 
months, Bayley Scales of Infant Development) and not found at later follow-up when 
assessing developmental milestones and intelligence (Kaufman Assessment Battery, 
McCarthy Scales). In the German cohort, no associations between postnatal PCB exposure 
and development at 7, 18 and 30 months (Bayley Scales of Infant Development) were seen, 
but at 42 months, there was association with decreased intelligence scores assessed by the 
Kaufman Assessment Battery. In a later follow-up at 6 years of age, the negative effect of 
postnatal PCB exposure was no longer significant.  
The last study (the Canadian Inuit cohort), using a PBPK model to estimate exposure, 
assessed development (Bayley Scales of Infant Development) at 11 months of age and found 
that activity level, measured by non-elicited activity, was best predicted by postnatal 
exposure, with the strongest association obtained for simulated PCB levels during the fourth 
month of life, indicating this as a sensitive period in neurodevelopment. No follow-up has 
been published, and only exclusive breastfeeding was used in the exposure model.  
Investigations of Hg in breastmilk and neurodevelopment is limited to two papers from one 
cohort from the Faroe Islands and showed a positive association between exposure via 
breastmilk and milestone development, in spite of substantially higher contaminant 
concentrations (PCBs, DDE and Hg) in the breastmilk. Studies from this cohort have however 
clearly indicated that children are more susceptible to prenatal methyl-Hg exposure than to 
postnatal exposure via breastmilk. 
The biological plausibility for the neurotoxicity of POPs such as dioxins and dl-PCBs, non-dl-
PCBs and DDT is well documented, but is less clear for HCB (section 5.2). 
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The transient negative associations in the Dutch cohort did not show a dose-response 
relationship. In the German cohort, the effect was shown by linear regression analyses, 
implying an underlying dose-response relationship. In the Canadian Inuit cohort there 
appeared to be a dose-response between the simulated exposure (unadjusted for confounders) 
at 4 months and the outcome.  
Mean serum PCB-levels were approximately 1.4-fold higher in the German cohort than in the 
Dutch and Canadian cohorts. The cohorts reporting no effects had levels in the same range as 
the Dutch, with the exception of the INMA mainland cohorts, which had substantially lower 
exposure, and in the same range as in Norway.  
Two studies considered the possibility of postnatal critical windows and estimated serum 
concentrations in infants. However, only one of the studies (the Canadian Inuit cohort) had 
findings indicating an effect of POPs in breastmilk – the other study (the INMA mainland 
cohort) had no findings. As explained above, the contaminant exposure level was much lower 
in the INMA mainland cohort than in the Canadian cohort, possibly explaining why no effect 
was observed. 
The above summary of findings shows that in four out of seven cohorts, no association 
between POPs in breastmilk and neurodevelopment was found. In two cohorts, the association 
was transient, as an association was found at low age, but was no longer significant at later 
follow-up. The last study used PBPK modelling and found an association in 11-month old 
infants, but follow-up data have not been published. These overall results led the VKM 
committee into discussions of how to grade the evidence in a hazard characterisation context. 
It was discussed if the results qualified for a conclusion of “substantial effect on risk 
unlikely”. However, there is a biological rationale for POPs having harmful effects on 
neurodevelopment (described in section 5.2), this effect has been confirmed in animal studies, 
and there was a transient dose-response relationship of effect up to a certain point in time in 
two of the studies. Thus the evidence does not qualify for this conclusion. 
VKM concludes that the evidence is limited suggestive for a negative effect from POPs in 
breastmilk on neurodevelopment. The concentration of POPs in breastmilk, combined 
with the length of exclusive and partial breastfeeding associated with the transient 
negative effects, remains to be settled. As to mercury, this compound was only 
investigated in one cohort and VKM concludes that the evidence for an effect of 
exposure from breastmilk is limited and no conclusion can be given. 
 
10.2.3.2 Immune response-associated diseases (thymus weight, vaccine antibody titer, middle 
ear infections, asthma and wheezing) 
Associations between contaminants in breastmilk and later immune response-associated 
parameters have been studied in four cohorts published in five papers (Table 7.15). Widely 
different outcome measures associated with function of the immune system were investigated 
in the five included studies (thymus weight, vaccine antibody titer, prevalence of middle ear 
infections, asthma and wheezing), and they are not directly comparable.  
In the Faroe Islands cohort 3, Grandjean et al. (2010) found that an apparent association 
between breastfeeding duration and increased serum IgE in children was weakened and no 
longer significant after adjustment for the concomitant PCB exposure. A history of asthma or 
atopic dermatitis was not associated with the duration of breastfeeding. The results indicate 
that PCBs in breastmilk may cause an IgE increase in children and thus interact with 
beneficial effects from breastfeeding (Grandjean et al., 2010).  
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Also, in the Faroe 3 cohort there was an inverse association between PCB exposure and 
vaccine antibody concentrations at 7 years, indicating that the contaminants reduce the 
efficacy of vaccines (Heilmann et al., 2010). In the Dutch cohort, there was no association 
between postnatal PCB and dioxin exposure and vaccine antibody titer to mumps, measles 
and rubella. The Dutch study found an increase in middle ear infection, but in the same 
children reduced prevalence of allergic disease with increasing PCB and dioxin exposure in 
the children at age 4. The INMA (Menorca) cohort found no association with asthma and 
wheezing and postnatal exposure to DDE/DDT. The Slovakian cohort had thymus size as 
endpoint and found a small but significant decrease in thymus weight between highly and 
moderately PCB exposed when the child was 6 months but not at 16 months. 
The mean serum PCB-153 level was more than twice as high in the Faroe 3 cohort as in the 
Dutch, Slovakian and the INMA (Menorca) cohorts. The Menorca cohort addressed 
DDE/DDT (not PCBs), and the mean level of cord serum DDE was twice as high as those of 
the Faroe 3 cohort. 
Biological plausibility for immunological effects of PCB and PCDD/PCDF include 
morphological changes in organs related to the immune system, as well as functional 
impairment of humoral- and cell-mediated immune responses. Reduced lipopolysaccharide- 
induced proliferative response in splenocytes, reduced antibody secretion and impaired 
neutrophil function are associated with the ndl-PCBs as these effects seem to be independent 
of the Ah receptor. Examples of Ah receptor-mediated adverse effects of dioxins and dl-PCBs 
seem to be disruption of the endothelial barrier function, activation of oxidative stress-
sensitive signalling pathways, and induction of proinflammatory events (EFSA, 2005a). 
Immune response-associated disorders are probably most likely to occur in a sensitive 
perinatal or postnatal window of development (section 10.3.1).  
VKM concludes that the evidence is limited and no conclusion can be given for a 
negative effect from POPs in breastmilk on thymus weight, vaccine antibody titer, 
middle ear infections, asthma and wheezing in children.  
 
10.2.3.3 Growth and weight 
Associations between POPs in breastmilk and later growth and development have been 
studied in three cohorts published in four papers, see Table 7.16. Two of the cohorts (the 
North Carolina and Michigan cohorts) found no associations between PCB exposure from 
breastmilk and child height or weight development, while the Faroe 2 cohort study noted a 
somewhat lower weight and height in 18-month old children with increasing PCB exposure. 
However, as pointed out earlier, a slightly reduced growth in breastfed versus formula fed 
children is often observed, and may not solely be ascribed to contaminant exposure even 
though PCB exposure is higher in breastfed than formula fed children (Nommsen-Rivers and 
Dewey, 2009). The North Carolina cohort also investigated pesticide exposure from 
breastmilk and growth and found no associations. In addition, one study in the Canadian 
cohort investigated associations between PCBs and HCB exposure from breastmilk and 
thyroid-related parameters (which again can affect growth), and found no associations.  
The time point for assessing effect on growth and sexual maturation varied between the 
studies as illustrated in Table 7.16, but the outcome measurement, height and weight, were the 
same in three of the four studies, and thus there is comparability of the outcome between the 
studies.  
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The Michigan cohort had mean PCB-153 level 1.5-fold that of the North Carolina cohort, and 
the mean PCB-153 level was in the same range in the Canadian cohort. The Faroe 2 cohort 
had higher PCB-exposure, and the mean PCB-153 was more than 5-fold that of the North 
Carolina cohort. 
In animal experiments, the biological plausibility for an association between a number of 
environmental contaminants and increased risk of overweight and obesity have been 
suggested, especially within the group of chemicals with endocrine activity. Such compounds 
(e.g. PCBs, DDT, phthalates, BPA etc.), are environmental contaminants that can mimic or 
block hormonal actions by activation or repression of e.g. estrogenic, androgenic and thyroid 
hormone receptors or changing homeostasis by altering metabolism of hormones. Several of 
these compounds may modulate lipid metabolism and adipogenesis, contributing to obesity 
initiation and/or exacerbation. It has been hypothesized that obesogenic chemicals provided 
by breastmilk may contribute to increased risk of overweight and obesity later in life 
(Janesick and Blumberg, 2011).  
VKM concludes that the evidence is limited and no conclusion can be given for an 
association between POPs in breastmilk and weight or height in children. 
  
10.2.3.4 Thyroid parameters 
Only one of the included studies investigated thyroid parameters as outcome, and no 
association was found between PCBs or HCB in breastmilk and thyroid hormones. 
VKM concludes that the evidence is limited and no conclusion can be given for an 
association between POPs in breastmilk and parameters related to thyroid hormones. 
 
10.2.4 Summary grading of evidence, negative health effects 
Table 10.2 summarises the results from the literature review of the contaminants in 
breastmilk, and includes an evaluation of the strength of evidence from VKM. Findings of a 
positive association between breastmilk and health outcome in the cohorts where negative 
health effets were investigated are not included in Table 10.2, but are described in section 
7.2.4. 
 
Table 10.2: Summary of the strength of evidence for an association between children's health outcomes 
and suggestive contaminant exposure through breastmilk.  
Outcome Exposure Number of 
participants* 
(cohorts) 
Association/effect Number of  













Adverse effect (3, thereof  
2 with transient effects)  
NS (11)  
 
6 rated B+1 
8 rated B2 
Limited, 
suggestive 
Neurodevelopment Hg 1022 (1, Faroe 1) Adverse effect (0) 
NS (2)  
 
2 rated B3 Limited, no 
conclusion 
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Outcome Exposure Number of 
participants* 
(cohorts) 
Association/effect Number of  






PCBs, dioxins,  
DDE, DDT 




Adverse effect (4) 
NS (1)  
 
1 rated B+4 





PCBs, DDE 1353 (3, Faroe 2, 
Michigan, North 
Carolina) 
Adverse effect (1)  
NS (2) 
 




PCBs, HCB 204 (1, Canada) Adverse effect (0) 
NS (1)  
 
1 rated B7 Limited, no 
conclusion 
*Participants at inclusion. For participants at follow-up, see Summary Tables. 
1Gascon et al., 2013; Vreugdenhil et al., 2002 (1); Vreugdenhil et al., 2002 (2); Patandin et al., 1999; Lanting et al., 1998; 
Koopman-Essebom et al., 1996. 
2Forns et al., 2012; Verner et al., 2010; Winneke, et al., 2005; Walkowiak et al., 2001; Huisman et al., 1995; Gladen&Rogan, 
1991; Rogan&Gladen, 1991; Jacobsen et al., 1990. 
3Jensen et al., 2005; Grandjean et al., 1995. 
4Weisglas-Kuperus et al., 2000. 
5Jusko et al., 2012, Grandjean et al., 2010, Heilmann et al., 2010, Sunyer et al., 2006. 
6Grandjean et al., 2003; Gladen et al., 2000; 11Jacobsen et al., 1990. 
7Dallaire et al., 2009. 
NS=no significant association. 
 
 
 Additional considerations 10.3
The literature grading (sections in 10.2) will form the basis of the benefit and risk assessment 
(in section 10.4). Several additional considerations have to be brought into the discussion to 
comply with the mandate, i.e. “…to evaluate the benefits and potential risks related to 
breastmilk based on Norwegian data on prevalence of breastfeeding and concentrations of 
environmental contaminants in breastmilk”. These additional considerations will be presented 
here. 
 
10.3.1 Timing of exposure – critical windows of susceptibility and prenatal versus 
postnatal exposure 
A number of the papers evaluated for risk of negative health effects found assiciations with 
prenatal exposure to contaminants which were not observed postnatally (Tables 7.5-7.13). It 
is now widely accepted that the timing of chemical exposures to the developing organism may 
be of critical importance for the health outcome (Brown et al., 2008; Selevan et al., 2000). An 
impaired outcome may become manifest during the particular life stage of exposure or at later 
life stages. The most critical period of development is recognised to be during organogenesis 
and organ development. The rapid growth of the foetus implicates high activity in cellular 
processes which needs to be tightly regulated. At this stage there is also immature capacity to 
handle and detoxify xenobiotics and limited capacity of homeostatic regulation. Hence, the 
unborn foetus is generally recognised as the most vulnerable being in the population 
regarding adverse effects from exposure to environmental contaminants or other xenobiotics 
such as drugs.  
The development of organs and physiological functions, including biotransformation and 
elimination of xenobitics, in many cases extends into the neonatal and postnatal period and 
early childhood. Consequently, these periods are also regarded as life stages where 
susceptibility to chemicals may be increased. Especially the nervous- and immune system 
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undergo substantial development after birth, and have been assumed to be sensitive to 
chemical exposures also in the postnatal period. It is currently not known whether the nervous 
system is as sensitive to chemicals postnatally as it is prenatally, or whether there are 
particular sensitive time periods in infancy. In the absence of such knowledge, a conservative 
approach would be to assume that the infant is as sensitive as the foetus. It would also be a 
conservative approach to assume that children, as long as they are growing and developing, 
are more sensitive than adults. In toxicological risk assessments the higher sensitivity at 
certain life stages, such as the fetal period, infancy and childhood, is taken into consideration 
by application of uncertainty factors44 to account for differences in toxicokinetics and 
toxicodynamics between population groups (Brown et al., 2008).  
It has been questioned whether the substantial exposure to some lipid-soluble contaminants 
from breastmilk, which may result in a temporary several fold increase in body burden of the 
contaminant in infants compared with that at birth (see section 5.2.5), has been adequately 
taken into consideration in risk assessments of such substances. The included studies in this 
benefit and risk assessment have separate measures of pre- and postnatal exposure and 
associations with the health outcomes. Effects from prenatal exposure can be assessed by e.g. 
investigating association between infant and/or maternal exposure levels at birth and health 
outcomes later in life. However, if postnatal exposure is also of importance, it may influence 
the associations with prenatal exposure. The postnatal exposure via breastmilk is determined 
by the maternal level/breastmilk concentration and duration and degree of breastfeeding, but 
associations between postnatal exposure and health outcome can be influenced by prenatal 
exposure. Although such influence can be adjusted for in statistical analyses, residual 
influence cannot be ruled out. However, focusing on studies separating pre-and postnatal 
exposure measures was in view of VKM the best approach available for this benefit and risk 
assessment. 
 
10.3.2 Exposure in Norway  
Breastmilk consumption in Norwegian infants – comparison with exposure levels in papers 
investigating positive health effects from breastmilk 
Chapter 2 describes in detail the data available on breastfeeding prevalence, degree and 
duration in Norway. The Figures 2.3-2.5,, which compare rates of breastfeeding between 
European countries, illustrate what has been stated many times in this report: that 
breastfeeding duration in Norway is exceptially long. The breastfeeding prevalence is 
confirmed by nationally representative surveys showing that 80% of mothers breastfeed at 6 
months and 46% still breastfeed at when the child is 12 months old.  
The two most recent systematic reviews for positive health effects of breastmilk include 
studies with different durations and exclusivity of breastfeeding. The length of breastfeeding 
in the studies included in these reviews varying from zero months to 1 year. Few studies 
treated breastfeeding duration as a continuous or ordinal variable with several categories, thus 
allowing dose-response analyses. Breastfeeding degree (exclusive, predominant or partial) has 
rarely been assessed. Thus a direct comparison of breastmilk consumption in Norway with the 
degree and duration of breastfeeding in the systematic reviews is not possible.  
 
                                                 
44Uncertainty factors (also called assessment factors) have been used to account for uncertainty in the 
extrapolation of the data derived from animals to humans, and to account for variations among humans. Usually, 
a default factor of 10 is used for extrapolation from animals to humans and a factor of 10 is used for variation 
among humans (100 altogether). 
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Exposure of contaminants from breastmilk in Norwegian infants – comparison with exposure 
levels in papers investigating negative health effects from contaminants in breastmilk 
Possible negative effects from contaminants in breastmilk observed in the included cohorts 
are assumed to be related to exposure levels, which are determined by contaminant 
concentrations in the breastmilk and breastfeeding duration. In this chapter exposure levels in 
the included cohort are therefore compared with current exposure levels in Norway.  
The present-day exposures to PCB-153, dioxins and dl-PCBs, DDE and HCB in breastfed 
infants in Norway are described in chapter 8.There are two main differences between the 
included cohorts and present-day Norwegian conditions: 
a) Present-day mean concentrations of contaminants in Norway (breastmilk PCB-153 39 
ng/L and DDE 50 ng/L) are substantially lower than in all of the included studies 
except one (The INMA mainland cohort) 
b) Norwegian women continue to partial breastfeeding longer (mean duration 10.3 
months) than women in the included cohorts, except in the Faroe Island and possibly 
in the Canadian cohorts 
 
Contaminants concentration in breastmilk: All but one of the included cohorts had mothers 
(and consequently breastmilk) with substantially higher mean contaminant concentrations 
than the present-day levels in Norway. Based on the comparison of the maternal PCB-153 
levels (see Table 7.3), the maternal body concentration of PCBs in the Faroe Islands cohorts 
was 9 to 12-fold higher than the present-day Norwegian. The Slovakian, German, Dutch, 
Michigan, Canadian (Inuit) and the INMA (Menorca) cohorts had about 3 to 4 times higher 
mean maternal levels than the present levels in Norway, whereas the mean contaminant levels 
in the North Carolina cohort were more than twice the levels of today’s exposure in Norway. 
The INMA mainland sub-cohorts had, however, maternal PCB levels comparable to the 
present-day Norwegian levels.  
The DDE levels were more than 10 times higher in the Faroese cohorts and in the INMA sub-
cohort from Menorca than the present mean level in Norway (Table 7.3). The INMA 
mainland sub-cohorts had maternal DDE level more than 2.5-fold the Norwegian level.  
The maternal mercury level in the Faroe Island cohorts was substantially higher than in 
Norway (Table 7.3). 
Duration of breastfeeding: In the Faroe Islands cohorts the rate of breastfeeding was high 
and duration was longer than in most of the other cohorts. As an example, in the Faroe 2 
cohort, the mean exclusive breastfeeding duration was 3.5 months and the total mean duration 
of partial breastfeeding was 7.8 months. As many as 18.2% were exclusively breastfed for 6 
months. In Norway, 9% are exclusively breastfed for 6 months, mean duration of any 
breastfeeding is 10.3 months45, and 46% are still breastfed at 12 months. Also in the Canadian 
cohort the mean length of exclusive breastfeeding was long (156 days, corresponding to 5.1 
months). However, no information on duration of partial breastfeeding was included in this 
cohort, and since only exclusive breastfeeding was fed into the pharmacokinetic model used 
in the study, this may represent an underestimation of the real exposure. 
In the Michigan cohort mean duration of any breastfeeding was 30 weeks, and in the INMA 
cohorts the mean duration of exclusive breastfeeding was 3.8 months and partly breastfeeding 
6.1 months.  
                                                 
45 Based on calculations by VKM on data from Småbarnskost 2007. 
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The duration of breastfeeding in the North Carolina cohort was reported in four intervals: 
short (0-9 weeks), medium (10-19 weeks), long (20 weeks) and very long (weaning after 49 
weeks) in the Dutch cohort in three intervals zero, short (6-16 weeks) or long (>16 weeks), 
and also in the German cohort in three intervals, short (2 weeks), medium (>2 weeks to 4 
months) and long (>4 months). Based on the reported intervals it appears that mean or median 
breastfeeding duration in these cohorts was shorter than in Norway. The Slovakian cohort did 
not report (although they recorded), length of breastfeeding duration, and could thus not be 
compared with the breastfeeding duration in Norway.  
Body burden: The amount of POPs in the body is related to possible negative effects of these 
compounds. In a breastfed infant this amount (body burden or body concentration) increases 
throughout the nursing period, however, it increases more during the first 4 to 6 months of 
breastfeeding than in the period 6 to 12 months (section 5.2.5). Since breastfeeding duration 
in the Faroe Islands cohorts was in the same range as the current Norwegian practice, while 
the breastmilk PCB levels were higher, the mean PCB concentration in the infant body was 
probably substantially higher in the infants in all age groups in the Faroese cohorts than in 
Norway at present. A similar situation was probably the case in the Canadian cohort since 
they had a long duration of exclusive breastfeeding, and assuming that partial breastfeeding 
continued equally long in the Canadian cohort as in the Faroese cohorts and in Norway.  
The generally longer duration of breastfeeding in Norway compared with the other included 
cohorts from Michigan, Germany, Spain, the Netherlands and North Carolina, combined with 
the higher PCB levels in the mothers in these cohorts (giving higher levels in infants at birth 
and higher levels in breastmilk), imply that the body concentrations were higher in infants in 
these cohorts than in present day Norwegian children the first few months after birth. The 
mean body concentration in Norwegian infants will generally not reach similar peak body 
concentrations as infants in the included cohorts, even with a substantially longer 
breastfeeding period. Provided that the body concentration is approximately doubled by 4 
months of breastfeeding, and the mean POP levels in the cohorts are more than 2-fold the 
Norwegian (generally 3 to 4-fold), it takes approximately 5 months of breastfeeding before 
Norwegian infants reach similar accumulated body concentration as the infants in the 
included cohorts had at birth. Even after 2 years of breastfeeding, the mean accumulated body 
concentration in Norwegian infants will not reach a concentration similar to the peak 
concentration in the included cohorts. This is illustrated in Figure 10.2 The cumulative 
amount per kg body weight on top of the body concentration at birth, which is displayed as a 
function of breastfeeding duration, is an approximation of the body concentration during the 
breastfeeding period. Infants in the INMA mainland sub-cohorts, might on the other hand 
experience lower PCB body concentrations than Norwegian infants at the end of the nursing 
period, because PCB levels in the INMA-mainland cohort mothers were similar to the 
Norwegian, but the breastfeeding duration was shorter. 
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Figure 10.2: Scenarios of estimated body concentration (cumulative amount per kg body weigth received 
by the infant on top of the body concentration at birth) of dioxins and dl-PCBs in breastfed infants with 
varying maternal level and with varying duration of breastfeeding. For calculations the mean 
concentration (11 pg TEQ/g fat) of dioxins and dl-PCBs in breastmilk (3.5% fat) in Norway and 2.5 and 3-
fold this level was used. Concentration in the infant’s body at birth was considered similar as in the 
mother, which was calculated from the concentration in breastmilk, 35% fat in the body and bw 70 kg. 
This can be considered as an overestimate in the infant, because the newborn infant has substantially 
lower fat percentage. Infant bw was according to WHO (Table 8.1 in this document). Breastmilk 
consumption was according to Table 2.2 in this document for exclusive breastfeeding and 500 ml/day for 
partially breastfeeding. This volume for partially breastfeeding is considered an overestimate (see section 
8.1). Weaning was estimated to occur over two months, 250 ml/day weaning month one and 125 ml/day 
weaning month two. 
 
Based on the discussion above, it can be concluded that the total PCB exposure in the 
included cohorts was generally substantially higher than in Norway, even with a longer 
breastfeeding duration in Norway. In this rough estimate of body concentration (cumulative 
amount per kg body weight received by the infant on top of body concentration at birth) in 
order to compare exposure in infants in Norway with infants in the included cohorts, it has not 
been taken into account that the concentration of contaminants in breastmilk decreases during 
the nursing period (section 5.2.5) and thus represents an overestimation of the situation 
among breastfed infants. Another factor that has not been taken into consideration which 
affects the serum concentration of contaminants in infants is the change in fat percentage in 
infants from birth to childhood.  
The highest body concentration in Norwegian infants is reached later in infancy than in the 
cohorts from Michigan, Germany, Spain, the Netherlands and North Carolina because the 
breastfeeding period is longer in Norway. As mentioned in section 10.3.1, it is not known if 
infants are equally sensitive to contaminant exposure in the period they reach highest body 
concentration (around weaning) as in the prenatal or early postnatal period. Assuming equal 
sensitivity is a conservative approach, meaning that it overestimates rather than 
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Norwegian contaminant exposure estimates and tolerable intake levels 
The estimated contaminant exposures from breastmilk in Norwegian infants (chapter 8) 
indicate that in all infant age groups the exposure to dioxins and dl-PCBs is substantially 
higher (10 to 30-fold at mean exposure) than the tolerable intake at 14 pg/TEQ/kg bw/week 
(sections 5.2.1 and 8.5).  
Exceeding the tolerable intake in infants does not necessarily imply that the concentration in 
the infant body reaches a level of concern, and therefore the tolerable intakes of dioxins and 
dl-PCBs are not directly applicable for infants (explained in section 5.2.5). The tolerable 
intake of dioxins and dl-PCBs has been set to ensure that the contaminant concentration in the 
mother (the maternal whole body concentration, expressed per kg body weight) is below the 
highest concentration that is considered safe to the foetus. This is the body concentration 
associated with intake similar to the tolerable intake. Due to the rapid growth of the the infant 
a dilution of contaminants takes place with a slower increase in body concentration.  
The dietary intake of dioxins and dl-PCBs, as recently estimated in the MoBa cohort is below 
the TWI46 for more than 97% of the participating Norwegian pregnant women (Caspersen et 
al., 2013). The median, 95-percentile, 97-percentile and 99-percentile weekly exposure to 
dioxins and dl-PCBs in MoBa was 3.9, 9.9 and 18.5 pg TEQ/kg body weight, respectively 
(Caspersen et al., 2013). This indicates a low risk associated with prenatal exposure among 
infants in Norway.  
There is no established tolerable intake level of PCB-153 or sum6 PCBs. A PTDI at 20 ng/kg 
bw/day for all 209 PCB congeners was proposed at the “2nd PCB workshop” in Brno (Czech 
Republic, May 2002) and has been used in France, the Netherlands, and Norway as a 
guideline value (AFSSA, 2007; Baars et al., 2001; VKM, 2008). This value was based on 
maternal body burden and postnatal neurodevelopmental and immune effects in children, and 
corresponds to 10 ng PCB-6/kg body weight per day. The BMDL-calculations are based on 
the Michigan cohort (Jacobson and Jacobson, 2002) and the Faroese cohort 1 (Grandjean et 
al., 2003), and thus exposure from breastmilk is to some extent already taken into account in 
the PTDI for total PCBs. Based on dietary intake from the Norwegian MoBa cohort 
(Caspersen et al., 2013), the median and 95-percentile dietary intake of PCB6 was 2.58 and 
8.31 ng/kg bw/day, respectively, and thus below 10 ng PCB-6/kg body weight per day. 
However, the 97.5-percentile intake was 15.48 and the 99-percentile intake was 26.22 ng/kg 
bw/day, indicating that less than 5% of the Norwegian infants may have PCB exposure higher 
than the PCB-6 intake corresponding to the PTDI suggested for total PCB. 
For sum DDT, the provisional tolerable daily intake (PTDI) is 0.01 mg/kg bw (10000 ng/kg 
bw/day). Depending on infant age, there is a margin of 33 and 130 between mean daily intake 
of DDE in breastfed infants and the PTDI. The PTDI is 15-fold higher than the 95-percentile 
exposure for 1-month old infants. Since p.p’-DDE is the major constituent of sum DDT, 
calculating exposure to sum DDT would not have affected this margin substantially. 
The estimated HCB exposure from breastmilk was in all infant age groups lower than the 
health based guidance value of 170 ng/kg bw/day suggested by WHO. 
 
10.3.3 Breastmilk versus infant formula 
Infant formula contains all the nutrients a child needs to grow and develop (described in 
chapter 4). However, infant formula contains none of the enzymes (e.g. lipase, lysozyme) that 
                                                 
46The TWI for dioxins and dl-PCBs is 14 pg TEQ/kg body weight/week. 
Norwegian Scientific Committee for Food Safety (VKM) 10-003-final  
2 
 





Helle Margrete Meltzer (chair) 
Per Brandtzæg 
Helle Knutsen 
Beate Fossum Løland 
Jon Øyvind Odland 
Janneche Utne Skåre 
Liv Elin Torheim 
Norwegian Scientific Committee for Food Safety (VKM) 10-003-final  
201 
 
makes breastmilk more digestible, no immune-boosting substances like immunoglobulins, 
hormones and growth factors, formerly no DHA (this has been added recently) or cholesterol 
important for brain development. Furthermore, infant formula has lower bioavailability of 
minerals, to mention some of the main differences. With all the recent knowledge 
accumulating as to the impact of the gut microbiome for health, it has become apparent that 
the carbohydrate profile of breastmilk has advantages over infant formula also in this respect 
(Sela and Mills, 2010). 
Infant formula also contains contaminants, although with a somewhat different profile and 
with lower levels of the POPs than in breastmilk. As indicated in sections 5.3 and 5.4, infant 
formula may contain both process-generated substances like acrylamide, PAHs, 3-MCPD and 
furans, and substances migrating from food contact materials like BPA and phthalates. The 
latter substances are also present in breastmilk, but possibly at lower concentrations. Infant 
formula has been found to have somewhat higher concentration of lead than breastmilk. There 
are indications that the daily intakes of manganese and molybdenum are much higher from 
infant formulas than from breastmilk, but eventual implications are unknown. Thus we 
provide the infant with unwanted substances irrespective of feeding path. 
Possible outbreaks from microbiological hazards in the infant formula itself or due to 
contaminated water are an issue in developing countries, but no such outbreaks have been 
registered in Norway.  
The main difference between the unwanted substances provided by breastmilk and those in 
infant formula is that the contaminants with higher levels in breastmilk are more persistent, 
meaning they have a longer half-life and accumulate in the fat compartments of the body, 
while most of the unwanted substances dominating in infant formula have a shorter half-life 
and do not accumulate to the same degree. The net impact on child health of the unwanted 
substances in infant formula is not known. 
 
10.3.4 Other pollutants not found in the literature search  
Although most studies have focused on one pollutant (or pollutant group) and one outcome at 
a time, in reality, the contaminant profile of breastmilk mirrors the concentration in the 
mother’s body. VKM takes the standpoint that one measured contaminant in breastmilk may 
be used as a marker of most of those not measured, since they are characterised by being 
mobilised through the physiological production of breastmilk. Thus the combined effect of 
multiple contaminants in breastmilk is in reality being studied, although the number of 
analysed components may be limited. 
This argumentation also applies to the many studies on positive health effects of breastmilk 
included in chapter 6. Hidden behind all the positive findings there also lies a mixture of 
contaminants in unknown doses. 
Some recent studies not addressing breastmilk directly, point to fluorinated compounds in 
particular, as contaminants where postnatal exposure from breastmilk may be of significance 
(see section 7.2.5). 
 
 Benefit and risk assessment of breastmilk, discussion by health 10.4
outcome 
The aim of the following sections is to bring all information presented in previous chapters 
and sections into a balanced discussion of benefits and risks associated with breastfeeding and 
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health outcomes, with special emphasis on the impact of duration of breastfeeding. It is 
important to bring the methodological challenges into the benefit and risk assessment (see 
chapter 9), because even well-designed studies are subject to methodological limitations that 
are unavoidable in observational research.  
The sections are organised according to health outcomes, starting with those outcomes that 
have been studied both from a benefit and risk point of view; i.e. neurodevelopment, immune 
response-associated diseases and growth/overweight/obesity.  
VKM is aware of the many methodological challenges connected to interpretation of results 
from epidemiological observational studies (chapter 9). All studies included in the present 
assessment were graded B, implying that they had some limitations. However, if outcome 
measurements are comparable and all point in the same direction, we comply with the 
established guidelines that a conclusion can be drawn.  
 
10.4.1 Neurodevelopment – benefit and risk assessment 
A child’s cognitive development is considered a sensitive endpoint for development of the 
nervous system. Studies of cognitive development in children focus on information 
processing, conceptual resources, perceptual skill, language learning and other aspects of 
brain development. Standard IQ tests or school grades are two of many ways to score 
development (types of tests used are described in Appendix 7). Early life influence on the 
nervous system can affect cognitive and motoric skills later in life. 
Motor development and cognitive development may be fundamentally interrelated and 
display equally protracted developmental timetables. When cognitive development is 
perturbed, as in a neurodevelopmental disorder, motor development is often adversely 
affected as well (Diamond, 2000).  
Neurodevelopmental deviations like reduced IQ, distractibility, anti-social behaviour and 
inattention have been subject to a number of the included studies both on the benefit and risk 
side. The neurodevelopmental outcomes related to breastmilk consumption in these studies 
are probably within the normal variation of what is expected for cognitive development. 
Instead of prevalence data on disorders connected to severe aberrant cognitive development, 
such as ADHD, autism spectre disorders, mental retardation, etc., the impact of altered IQ 
distribution is presented below, since it is one of the neurodevelopmental markers most often 
measured. 
 
IQ distribution as a marker of cognitive development 
Figure 10.3 illustrates that a five point gain or loss in IQ might not affect an individual’s life-
quality, but may be of importance at the population level, by increasing the proportion of 
people having mild disabilities, and decreasing the proportion of specially gifted people, or 
vice versa. 
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Figure 10.3: Impact of a five point change in IQ in a population. Source: Schmidt, 2013. 
 
Weighing the evidence, benefit and risk assessment of breastmilk versus risk of impaired 
cognitive development 
Grading the scientific evidence on the benefit side (section 10.2.1 and Table 10.2.1), VKM 
concluded that the evidence is convincing for a positive effect of breastmilk on 
neurodevelopment. The optimal length of exclusive and partial breastfeeding associated with 
the positive effect remains to be settled. 
Grading of the scientific evidence on the risk side (section 10.2.3), VKM concluded that the 
evidence is limited suggestive for a negative effect from POPs in breastmilk on 
neurodevelopment. The length of exclusive and partial breastfeeding associated with the 
transient negative effect remains to be settled.  
For mercury, the evidence is limited and no conclusion can be given. 
The grading of the scientific evidence for negative health effects from POPs in breastmilk on 
neurodevelopment was based on seven cohorts, with findings in three cohorts (Dutch, German 
and Canadian cohorts). The findings were transient in the Dutch and German cohorts. 
The rough estimates of body concentration of specific POPs in infants in Norway and in 
infants from cohorts with higher mean POP levels indicate that Norwegian children generally 
will not reach similar body concentrations as infants in the Canadian, German and Dutch 
cohorts (section 10.3.2). Furthermore, the infants in the Dutch and German cohorts had peak 
body concentrations earlier in life than Norwegian infants. Whereas it is known that the 
unborn child is especially sensitive to substances that can affect neurodevelopment, it is not 
known if there are equally sensitive postnatal periods. Assuming equal sensitivity is a 
conservative approach which most likely overestimates the risk when the highest body 
concentration (i.e. concentration in blood) is reached as late in infancy as 12 months. 
A specific confounder challenge for interpretation of studies on neurodevelopment is the lack 
of HOME score measurements. Where it had been included, several of the papers came to the 
conclusion that a stimulating home environment, which was also associated with higher rate 
of breastfeeding, outbalanced an eventual negative effect of contaminants in breastmilk. 
HOME score measurements were used in 7 of the 14 papers investigating associations 
between POP’s in breastmilk and neurodevelopment, including the two papers which reported 
transient findings (the Dutch and German cohorts). 
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The outcomes investigated within the category negative health effects from POPs in 
breastmilk and neurodevelopment used a number of different tests (Appendix 7). 
Furthermore, the timepoint of investigation varied from some weeks to teenage years. The 
same tests have, however, been administered at similar ages in several of the studies. 
Several of the studies investigating associations between contaminants in breastmilk and 
neurodevelopment (in particular in the Dutch and Faroese cohorts) found an overall beneficial 
effect of breastmilk per se, implying that the beneficial effect was negatively confounded by 
dioxins and dl-PCBs in breastmilk. This indicates that possible negative effects from the 
contaminants may be camuflaged by beneficial effects of breastmilk itself. 
Taking the present-day levels of contaminants in breastmilk and the long duration of 
breastfeeding (12 months) in Norway into account, the following conclusion is drawn: 
VKM concludes that the benefits of breastmilk clearly outweigh the possible risk of 
impaired neurodevelopment from contaminants in breastmilk. It is still not fully known 
whether contaminants in breastmilk may confound the positive effect of breastmilk per 
se, i.e. whether breastmilk would be even more beneficial for neurodevelopment if the 
levels of contaminants were lower.  
 
10.4.2 Immune response-associated diseases – benefit and risk assessment 
Immune response-associated diseases include among others infections, food allergy, atopic 
dermatitis/eczema, allergic rhinitis and allergic asthma. Infancy is a time of increased disease 
susceptibility and severity, and ear infections, gastroenteritis and respiratory tract infections 
are quite common.  
The typical progression of allergic diseases is often referred to as the allergic or atopic march, 
and is initiated by food allergy, with or without associated atopic dermatitis/eczema in infancy 
or early childhood, followed by allergic asthma and/or allergic rhinitis later in childhood as 
sensitization with IgE antibodies develops. Reliable and comparable prevalence data on 
infectious diseases in infancy and other immune response-associated diseases are scarce, so 
the data below should be considered as suggestive.  
In the work with this benefit and risk assessment it has been challenging to find comparable 
endpoints within the category of “immune response-associated diseases”. VKM is aware that 
allocating studies into such a broad category has limitations when benefits and risks are to be 
compared.  
As there were other health outcomes categorized under the “immune response-associated 
disease umbrella” in this report, such as type 1 diabetes, coeliac disease and ulcerative colitis 
and Crohn’s disease, with total lack of comparability with outcomes investigated for in the 
contaminant papers, these will be assessed in section 10.4.4.  
 
Prevalence of infections, food allergy, atopic dermatitis/eczema, allergic asthma and allergic 
rhinitis in infancy and childhood 
A high proportion of infants will experience gastrointestinal or lower respiratory tract 
infections within their first year of life. Prevalence is difficult to estimate as only a proportion 
of the patients will visit a doctor or other health personnel. There are also wide variations in 
prevalence rates for acute otitis media from different studies because of varying diagnostic 
criteria and selection of patients. In a study from 2010, episodes of acute otitis media 
confirmed by a doctor are reported to be 28.6% at 1 year of age. 
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The prevalences of food allergy, atopic dermatitis/eczema, allergic asthma and allergic rhinitis 
in infancy and childhood are challenging to determine – reported rates vary from country to 
country and study to study. As with infections, prevalence is difficult to estimate as only a 
proportion of the patients will visit a doctor or other health personnel.  
 
Weighing the evidence, benefit and risk assessment of breastmilk versus risk of infections, 
food allergy, atopic dermatitis/eczema, allergic asthma and allergic rhinitis in infancy  
Grading the evidence on the benefit side, VKM concluded that the evidence is convincing for 
a protective effect of breastmilk on infections, at least as long as the child is breastfed (section 
10.2.1 and Table 10.1).  
VKM concluded that the evidence is limited and inconclusive for a protective effect of 
breastmilk on asthma and wheezing, allergies and atopic dermatitis. 
Grading the evidence on the risk side, VKM concluded that the evidence is limited and 
inconclusive for a negative effect from POPs in breastmilk on thymus weight, vaccine 
antibody titer, middle ear infections, asthma and wheezing.  
The grading of the scientific evidence for negative health effects from POPs in breastmilk on 
immune response-associated diseases was based on four cohorts, with findings of increased 
risk in three cohorts (Faroe Island 3, Dutch and Slovakian cohorts). 
The Faroe 3 cohort had approximately 9-fold higher concentrations of PCBs than the present-
day Norwegian levels (Table 7.3). The Slovakian and Dutch cohorts had about 3 to 4 times 
higher mean maternal levels than the present levels in Norway. In the INMA (Menorca) 
cohort DDE was addressed, and the mean levels were 100-fold higher than in Norway. 
The rough estimates of body concentration of specific POPs in infants in Norway and in 
infants from cohorts with higher mean POP levels indicate that Norwegian children generally 
will not reach similar body concentrations as infants in the Faroese, Slovakian47 and Dutch 
cohorts (section 10.3.2). Furthermore, the infants in the Dutch cohort probably had peak body 
concentration earlier in life than Norwegian infants. No comparison with the Slovakian cohort 
could be performed, since breastfeeding duration was not given. 
In the risk assessment of other immune response-associated diseases than infections, a major 
challenge was the heterogeneity within each main group of outcomes, e.g. immunologically 
or allergy related diseases, where all five papers included in reality measured widely different 
outcomes, and different parameters of similar outcomes. 
Four of the five studies investigating association between POPs in breastmilk and 
immunological parameters also found an association between prenatal contaminant exposure 
and immune response-associated diseases. The nervous- and immune systems undergo 
substantial development after birth, and have been assumed to be sensitive to chemical 
exposures also in the postnatal period. In the absence of knowledge, a conservative approach 
would be to assume that the infant is as sensitive as the foetus. 
In two of the four studies reporting negative associations between POPs in breastmilk and 
immune response-associated diseases, the negative associations were counteracted by 
breastfeeding. In one paper from the Faroe Island 3 cohort it was shown that an apparent 
                                                 
47No direct comparison with the Slovakian cohort could be performed, since breastfeeding duration was not 
given. However, since the mean level was 3 to 4-fold the Norwegian, it can be assumed that with a common 
breastfeeding duration as in e.g. Germany, the body concentration in infants was substantially higher than in 
Norway. 
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association between breastfeeding duration and increased serum IgE in children was 
weakened and no longer significant after adjustment for the concomitant PCB exposure. In a 
paper from the Dutch cohort, breastfeeding duration counteracted the increased odds ratio for 
middle ear infection. It is not known whether POPs in breastmilk may confound the positive 
effect of breastmilk per se, i.e. whether breastmilk would be even more beneficial for the 
immunodevelopment if the levels of contaminants were lower. 
Taking the present-day levels of contaminants in breastmilk and the long duration of 
breastfeeding (12 months) in Norway into account, the following conclusion is drawn : 
VKM concludes that the benefits of breastmilk in terms of defence against infections 
clearly outweigh the possible risk of reduced resistance to infections from contaminants 
in breastmilk, at least as long as the child is breastfed. 
No conclusion can be drawn on other immune response-associated diseases due to 
inconclusive results on the benefit side and few and disperse studies on the risk side. 
 
10.4.3 Growth, overweight and obesity – benefit and risk assessment 
In adults, raised body mass index (BMI) is a major risk factor for cardiovascular diseases, 
diabetes, musculoskeletal disorders and some cancers (endometrial, breast, and colon). 
Childhood obesity is associated with a higher risk of adult obesity, disability in adulthood and 
shortened life span (WHO fact sheet accessed July 2013). 
The influence of early life factors on later body weight and metabolic diseases has generated 
increasing interest in recent years (Shamir et al., 2013). There is evidence that obesity risk 
may begin early in life, during pregnancy or in early childhood and that rapid weight gain, 




In Norway, approximately 20% of adult men and 17% of adult women were considered to be 
obese in 2005. 
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Data from 2012 show that approximately 16% of Norwegian 8-year olds are overweight or 
obese. Figure 10.4 shows that 3.5% of these were obese and 12.3% were overweight (Source: 
Fact sheet from the Norwegian Institute of Public Health48). Overweight, but not obesity, was 
more prevalent among girls than boys in this age group. 
 
Weighing the evidence, benefit and risk assessment of breastmilk versus risk of impaired 
growth, overweight and obesity 
Grading the evidence on the benefit side, VKM concludes that the evidence is convincing for 
a protective effect of breastmilk on risk of overweight and obesity in childhood. The optimal 
length of exclusive and partial breastfeeding associated with the reduction in risk remains to 
be settled, although there are indications that exclusive breastfeeding for more than 4 months 
is associated with slower weight gain during later infancy compared with those exclusively 
breastfed for less than 4 months. 
Grading the evidence on the risk side, VKM concludes that the evidence is limited and 
inconclusive for an association between POPs in breastmilk and altered weight or height in 
children. 
The grading of the scientific evidence for negative health effects from POPs in breastmilk on 
growth and weight was based on three cohorts, with negative findings in one, pointing 
towards reduced (and not increased) weight with increasing PCB exposure (Faroe Island 2). 
Infants in the Faroese cohorts are expected to have a substantially higher level of 
contaminants in blood both at birth as well as early and late in the nursing period than 
Norwegian infants. 
Taking the present-day levels of contaminants in breastmilk and the long duration of 
breastfeeding (12 months) in Norway into account, the following conclusion is drawn: 
VKM concludes that the reduced risk of overweight and obesity associated with 
breastfeeding clearly outweighs the possible risk presented by contaminants in 
breastmilk.  
 
10.4.4 Other health outcomes – benefit and risk assessment 
Table 6.1 summarises most of the reported beneficial health effects of breastfeeding from six 
systematic reviews and meta-analyses. The following health outcomes have only been studied 
from a benefit point of view: Coeliac disease, type 1 and 2 diabetes, childhood cancer, Sudden 
Infant Death Syndrome, cardiovascular diseases and its risk markers (high blood pressure and 
serum cholesterol), Crohn’s disease and ulcerative colitis. 
As these outcomes only have been studied from a benefit side they do not fulfill the criteria 
for being included in the benefit risk assessment; common health outcomes was to be the 
comparison metrics (see section 10.1). However, when approaching the issue of benefits and 
risks of breastmilk in a broader perspective, looking beyond the strict criteria set up by 
international bodies like EU, it is important to have all these other health outcomes in mind.  
Adding to this comes all the aspects of breastfeeding omitted in this report and stated in 
section 1.1, e.g. the many positive psychological aspects of breastfeeding both for mother and 
child, or the positive impact of breastfeeding on maternal physical health. 
                                                 
48http://www.fhi.no/eway/default.aspx?pid=239&trg=List_6212&Main_6157=6263:0:25,6306&MainContent_6
263=6464:0:25,6308&List_6212=6218:0:25,6320:1:0:0:::0:0.  
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Type 1 diabetes, type 2 diabetes and high blood pressure 
VKM concluded that the evidence is probable for a protective effect of breastmilk on risk of 
type 1 diabetes, type 2 diabetes and high blood pressure. The optimal length of exclusive and 
partial breastfeeding associated with the protective effect on reduced risk remains to be 
settled. 
 
Crohn’s disease, ulcerative colitis, coeliac disease, childhood cancer and sudden infant death 
syndrom 
VKM concluded that the evidence is limited suggestive for a protective effect of breastmilk 
on risk of Crohn’s disease, ulcerative colitis, coeliac disease, childhood cancer and sudden 
infant death syndrom.  
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11 Conclusions: benefit and risk assessment of breastmilk 
and infant health in Norway 
In the wake of intermittent scientific and public concern about contaminants in breastmilk, a 
debate has arisen among experts. Although the experts agree that breastfeeding is beneficial, 
there are discussions about the advisable length of breastfeeding. As a basis for future advice 
on these issues the Norwegian Scientific Committee set out to perform a benefit and risk 
assessment of the health impact of breastmilk on infant health in Norway. The Committee 
concludes as follows. 
 
Breastfeeding in Norway 
• Norwegian women characteristically have a long duration of partial breastfeeding: 
80% breastfeed till the child is 6 months of age and 46% still breastfeed when the 
child is 12 months old. 
 
Nutrients and immunological components in breastmilk and infant formula 
• Breastmilk is physiologically tailored to meet the needs of a full-term newborn. 
Provided that the nutritional needs of the mother are met during pregnancy and 
breastfeeding, breastmilk meets all the nutritional requirements of the infant in the 
first months of life, with the exception of vitamin D. Breastmilk also contains a 
number of specialised components, including factors with anti-microbial and anti-
inflammatory properties as well as constituents stimulating the maturation of the 
infant’s immune system. 
• Infant formula covers all the established nutritional needs necessary for normal infant 
growth and development, but lacks the many additional protective and immune-
maturing substances present in breastmilk. 
 
Positive health effects of breastmilk 
• Both exclusive and partial breastfeeding have health benefits for the infant that extend 
into childhood and, possibly, adolescence and adulthood. 
• The evidence is convincing that breastfeeding protects against infections.  
• The evidence is convincing that breastfeeding has a protective effect against later risk 
of overweight and obesity.  
• The evidence is convincing that breastmilk enhances neurodevelopment.  
• The evidence is probable that breastfeeding has a risk-reducing effect on type 1 and 
type 2 diabetes and high blood pressure.  
The meta-analyses and systematic reviews included in the benefit assessment did not allow 
for conclusions regarding the optimal length of exclusive and partial breastfeeding which 
secures the positive health effects. 
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Contaminants in breastmilk and infant formula 
• Persistent contaminants have accumulated in the environment and are biomagnified in 
the food chain and therefore present in our bodies. The concentrations in breastmilk 
reflect the amounts accumulated in the mother. 
• A prolonged national and international effort has been made to reduce emissions of 
environmental contaminants, and breastmilk levels of most contaminants discussed in 
this assessment have been steadily declining for the past thirty years, in some cases by 
as much as 90%. Concentrations of contaminants in Norwegian breastmilk have been 
lowered substantially as a result. 
• The contaminants examined in this assessment are those which have actually been 
studied in human breastmilk in relation to infant and child health. These are PCBs, 
dioxins, DDT/DDE, HCB and mercury. In the statement on human breastmilk below, 
the term “contaminants” refers to these substances. Current levels of environmental 
contaminants in Norwegian breastmilk are considerably lower than in most of the 
cohorts used to characterise the potential negative impact on infant health of these 
contaminants. 
• Infant formula also contains contaminants, although these have a somewhat different 
profile. Infant formula contains lower concentrations of the classical environmental 
contaminants than breastmilk, but higher concentrations of other unwanted substances. 
Infants are exposed to contaminants irrespective of feeding path, whether breastmilk 
or formula. 
• Microbial contamination of infant formula may be of concern as this may cause 
diarrhoea and, in severe cases, bacteraemia and meningitis. Cronobacter spp. 
(formerly Enterobacter sakazakii), is a rare cause of invasive infection with a high 
death rate among newborn infants. Possible outbreaks due to microbiological hazards 
in infant formula or contaminated water are issues in developing countries, but no 
such outbreaks have been registered in Norway.  
 
Negative health effects from contaminants in breastmilk 
• The studies on potential negative health effects of contaminants in breastmilk in this 
report are based on 24 papers from 10 cohorts conducted in seven different countries 
(USA, Canada, Faroe Isles, Spain, Germany, the Netherlands and Slovakia). No such 
data on impact on infant and child health of exposure to contaminants via breastmilk 
was available from Norway. 
• In four out of seven cohorts, no associations were found between neurodevelopment 
and postnatal exposure to PCB, dioxins, DDT/DDE and HCB in breastmilk. 
Associations with contaminants were found in three cohorts, although they were not 
found to persist over time. VKM concludes that there is limited suggestive evidence 
for a negative effect from contaminants in breastmilk (at the level in these cohorts) on 
neurodevelopment.  
• There were too few papers on postnatal exposure to contaminants and growth or 
immune response-associated diseases to allow conclusions to be drawn.  
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Exposure to contaminants in breastmilk in Norway compared with exposure in the cohorts 
included in the risk part of the present report 
• The mere presence of environmental contaminants in breastmilk does not necessarily 
imply that breastfed infant run a significant risk of adverse health effects; the degree 
of accumulation in the infant’s body must be taken into consideration.  
The estimated cumulative amounts of contaminants received by infants (per kg of body 
weight) are an approximation of the accumulated level. In the included cohorts these were 
generally substantially higher than the corresponding amounts currently obtained in Norway, 
whether seen prenatally, early postnatally or at 1 year of age. Even with a breastfeeding 
duration of 2 years, the cumulative amounts of contaminants in present-day Norwegian 
infants do not reach similar peak levels as infants in the included cohorts. Further, the highest 
cumulative amount per kg body weight in present-day Norwegian infants is reached later in 
infancy than in infants in the cohorts used for characterisation of possible negative health 
impact. 
 
Benefit and risk assessment 
Taking the present-day levels of contaminants in breastmilk and the long duration of 
breastfeeding (12 months) in Norway into account, VKM concludes that:  
• The benefits of breastmilk clearly outweigh the possible risk of impaired 
neurodevelopment from contaminants in breastmilk.  
• The benefits of breastmilk in terms of defence against infections clearly outweigh the 
possible risk of reduced resistance to infections from contaminants in breastmilk, at 
least as long as the child is breastfed. 
• The reduced risk of overweight and obesity associated with breastfeeding clearly 
outweighs the possible risk presented by contaminants in breastmilk. 
• As regards the beneficial effects of breastmilk on risk of type 1 and type 2 diabetes 
and high blood pressure, the evidence suggests a probable beneficial effect later in 
life. There are no studies investigating these health outcomes in relation to 
contaminants in breastmilk. 
• No conclusion can be drawn on other immune response-associated diseases due to 
inconclusive results on the benefit side and few and disperse studies on the risk side. 
  
Following a comprehensive assessment of scientific literature on the positive health 
effects of breastmilk and concentrations in breastmilk of compounds representing 
possible health hazards, and given current knowledge about concentrations of 
contaminants in Norwegian breastmilk and breastfeeding duration in Norway, VKM 
concludes that the benefits associated with breastmilk clearly outweigh the risk 
presented by current levels of contaminants in breastmilk. This conclusion is not 
affected by whether a child is exclusively or partially breastfed up to the age of 6 months 
and partially breastfed up to 12 months of age. 
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12 Data gaps 
The basis for being able to use observational epidemiological studies to reach convincing 
conclusions is that there is evidence from at least two independent and well-designed studies. 
In general, a major challenge in the present benefit risk assessment was a lack of comparable 
exposures and health outcomes.  
 
 There is a need for studies which describe breastfeeding extent (exclusive or partial) 
and duration in detail and in similar manners. 
 There is a need for a research program which includes several cohorts and measure 
health outcomes in the same manner. 
 There is a need for long-term studies, i.e. studies investigating benefits of breastmilk 
and possible risks of contaminants in breastmilk in children breastfed for up till 12 
months or more.  
 Especially if negative effects are found, there is a need for follow-up studies of the 
children to investigate if the effects are transient. 
 Hitherto, there are scarce data on breastmilk concentrations of POPs other than 
dioxins, PCBs, DDT/DDE and HCB. There is a need to know more about the 
concentrations of other persistent pollutants, especially those encompassed by the 
Stockholm convention, like PFOS/PFOA and brominated compounds. 
 There is a need for more knowledge about unwanted substances with a short half-life, 
like acrylamide and phenols, both in breastmilk and in infant formula.  
 The methodology of PBPK modelling should be refined further. There are knowledge 
gaps as to sensitive windows of exposure after birth where PBPK modelling would 
bring the field further. 
 There is a lack of good data on infant and child body composition, not least fat mass. 
Such data are needed for advanced PBPK modelling. 
 With better understanding of the toxicokinetics of contaminants in infants and 
children, TWI or similar tolerable intakes could be refined. 
 Some contaminants may have effects which become apparent decades after exposure.  
Long-term studies are therefore warranted. 
 Methodology for separating prenatal versus postnatal exposure needs to be further 
refined.  
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Appendix 1: Tables of excluded studies 
Articles were excluded if they did not allow for a clear separation between prenatal and 
postnatal exposure or if they included premature which were not separated in the statistical 
analyses or if they did not seem relevant for Nordic background levels. 
 
Appendix 1, Table 1: Excluded studies, PCBs, dioxins and PBDEs 
 Reference 
 
1 Blanck HM, Marcus M, Rubin C, Tolbert PE, Hertzberg VS, Henderson AK, Zhang RH. (2002). Growth in girls 
exposed in utero and postnatally to polybrominated biphenyls and polychlorinated biphenyls. Epidemiology, 13(2), 
205-210. 
2 Chao HR, Tsou TC, Huang HL, Chang-Chien GP. (2011). Levels of breast milk PBDEs from southern Taiwan and 
their potential impact on neurodevelopment. Pediatr Res, 70(6), 596-600. 
3 Eggesbo M, Thomsen C, Jorgensen JV, Becher G, Odland JO, Longnecker MP. (2011). Associations between 
brominated flame retardants in human milk and thyroid-stimulating hormone (TSH) in neonates. Environ Res, 
111(6), 737-743. 
4 Heilmann C, Grandjean P, Weihe P, Nielsen F, Budtz-Jorgensen E. (2006). Reduced antibody responses to 
vaccinations in children exposed to polychlorinated biphenyls. PLoS Med, 3(8), e311. 
5 Hertz-Picciotto I, Bergman A, Fangstrom B, Rose M, Krakowiak P, Pessah I, Hansen R, Bennett DH. (2011). 
Polybrominated diphenyl ethers in relation to autism and developmental delay: a case-control study. Environ Health, 
10(1), 1. 
6 Holdke B, Karmaus W, Kruse H. (1998). [Body burden of polychlorinated biphenyl compounds in whole blood of 7-
10-year-old children in the area of a hazardous waste incineration facility]. Gesundheitswesen, 60(8-9), 505-512. 
7 Horvathova M, Jahnova E, Palkovicova L, Trnovec T, Hertz-Picciotto I. (2011). The kinetics of cell surface receptor 
expression in children perinatally exposed to polychlorinated biphenyls. J Immunotoxicol, 8(4), 367-380. 
8 Jackson LW, Lynch CD, Kostyniak PJ, McGuinness BM, Louis GM. (2010). Prenatal and postnatal exposure to 
polychlorinated biphenyls and child size at 24 months of age. Reprod Toxicol, 29(1), 25-31. 
9 Jacobson JL, Jacobson SW. (2002). Breast-feeding and gender as moderators of teratogenic effects on cognitive 
development. Neurotoxicol Teratol, 24(3), 349-358. 
10 Kim S, Choi K, Ji K, Seo J, Kho Y, Park J, Kim S, Park S, Hwang I, Jeon J, Yang H, Giesy JP. (2011). Trans-
placental transfer of thirteen perfluorinated compounds and relations with fetal thyroid hormones. Environ Sci 
Technol, 45(17), 7465-7472. 
11 Leijs, M. M., Koppe, J. G., Olie, K., van Aalderen, W. M., de, V. P., ten Tusscher, G. W. (2009) Effects of dioxins, 
PCBs, and PBDEs on immunology and hematology in adolescents. Environ.Sci.Technol., 43, (20) 7946-7951. 
12 Madia, F., Giordano, G., Fattori, V., Vitalone, A., Branchi, I., Capone, F. et al. (2004) Differential in vitro 
neurotoxicity of the flame retardant PBDE-99 and of the PCB Aroclor 1254 in human astrocytoma cells. 
Toxicol.Lett., 154, (1-2) 11-21. 
13 Nishijo M, Tawara K, Nakagawa H, Honda R, Kido T, Nishijo H, Saito S. (2008). 2,3,7,8-Tetrachlorodibenzo-p-
dioxin in maternal breast milk and newborn head circumference. J Expo Sci Environ Epidemiol, 18(3), 246-251. 
14 Park JS, She J, Holden A, Sharp M, Gephart R, Souders-Mason G, Zhang V, Chow J, Leslie B, Hooper K. (2011). 
High postnatal exposures to polybrominated diphenyl ethers (PBDEs) and polychlorinated biphenyls (PCBs) via 
breast milk in California: does BDE-209 transfer to breast milk? Environ Sci Technol, 45(10), 4579-4585. 
15 Patandin S, Weisglas-Kuperus N, de Ridder MA, Koopman-Esseboom C, van Staveren WA, van der Paauw CG, 
Sauer PJ. (1997). Plasma polychlorinated biphenyl levels in Dutch preschool children either breast-fed or formula-fed 
during infancy. Am J Public Health, 87(10), 1711-1714. 
16 Pluim HJ, de Vijlder JJ, Olie K, Kok JH, Vulsma T, van Tijn DA, van der Slikke JW, Koppe JG. (1993). Effects of 
pre- and postnatal exposure to chlorinated dioxins and furans on human neonatal thyroid hormone concentrations. 
Environ Health Perspect, 101(6), 504-508. 
17 Pluim HJ, de Vijlder JJ, Olie K et al. (1993) Effects of pre- and postnatal exposure to chlorinated dioxins and furans 
on human neonatal thyroid hormone concentrations. Environ Health Perspect 101, 504-508. 
18 Pluim HJ, de Vijlder JJ, Olie K, Kok JH, Vulsma T, van Tijn DA, van der Slikke JW, Koppe JG. (1993). Effects of 
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pre- and postnatal exposure to chlorinated dioxins and furans on human neonatal thyroid hormone concentrations. 
Environ Health Perspect, 101(6), 504-508. 
19 Sandberg DE, Vena JE, Meyer-Bahlburg HFL, Beehler G, Swanson M, Weiner J (2001), Endocrine disruptors and 
children's sex-dimorphic behaviour. APMIS, 109: S506–S507.  
20 Sunyer J, Basagana X, Gonzalez JR, Julvez J, Guerra S, Bustamante M, de CR, Anto JM, Torrent M. (2010). Early 
life environment, neurodevelopment and the interrelation with atopy. Environ Res, 110(7), 733-738. 
21 Teufel M (1992) [PCB exposure of children in East and West Germany]. Klin Padiatr 204, 348-354. 
22 Winneke G, Bucholski A, Heinzow B, Kramer U, Schmidt E, Walkowiak J, Wiener JA, Steingruber HJ. (1998). 
Developmental neurotoxicity of polychlorinated biphenyls (PCBS): cognitive and psychomotor functions in 7-month 
old children. Toxicol Lett, 102-103, 423-428. 
23 Winneke G, Walkowiak J, Lilienthal H. (2002). PCB-induced neurodevelopmental toxicity in human infants and its 
potential mediation by endocrine dysfunction. Toxicology, 181-182, 161-165. 
 
Appendix 1, Table 2: Excluded studies, heavy metals (Hg and Pb) 
 Reference 
 
1 Afeiche M, Peterson KE, Sanchez BN, Cantonwine D, Lamadrid-Figueroa H, Schnaas L, Ettinger AS, Hernandez-
Avila M, Hu H, Tellez-Rojo MM. (2011). Prenatal lead exposure and weight of 0- to 5-year-old children in Mexico 
city. Environ Health Perspect, 119(10), 1436-1441. 
2 Dorea JG, Bezerra VL, Fajon V, Horvat M. (2011). Speciation of methyl- and ethyl-mercury in hair of breastfed 
infants acutely exposed to thimerosal-containing vaccines. Clin Chim Acta, 412(17-18), 1563-1566. 
3 Dorea JG, Marques RC, Isejima C. (2012). Neurodevelopment of Amazonian infants: antenatal and postnatal 
exposure to methyl- and ethylmercury. J Biomed Biotechnol, 2012, 132876. 
4 Grandjean P, Budtz-Jorgensen E, Steuerwald U, Heinzow B, Needham LL, Jorgensen PJ, Weihe P. (2003). 
Attenuated growth of breast-fed children exposed to increased concentrations of methylmercury and polychlorinated 
biphenyls. FASEB J, 17(6), 699-701. 
5 Baghurst PA, McMichael AJ, Wigg NR, Vimpani GV, Robertson EF, Roberts RJ, Tong SL. (1992). Environmental 
exposure to lead and children's intelligence at the age of seven years. The Port Pirie Cohort Study. N Engl J Med, 
327(18), 1279-1284. 
6 Counter SA, Buchanan LH, Ortega F, Amarasiriwardena C, Hu H. (2000). Environmental lead contamination and 
pediatric lead intoxication in an Andean Ecuadorian village. Int J Occup Environ Health, 6(3), 169-176. 
7 Jedrychowski W, Perera F, Jankowski J, Mrozek-Budzyn D, Mroz E, Flak E, Edwards S, Skarupa A, Lisowska-
Miszczyk I. (2009). Gender specific differences in neurodevelopmental effects of prenatal exposure to very low-lead 
levels: the prospective cohort study in three-year olds. Early Hum Dev, 85(8), 503-510. 
8 Miyake Y, Tanaka K, Yasutake A, Sasaki S, Hirota Y. (2011). Lack of association of mercury with risk of wheeze 
and eczema in Japanese children: the Osaka Maternal and Child Health Study. Environ Res, 111(8), 1180-1184. 
9 Sanin LH, Gonzalez-Cossio T, Romieu I, Peterson KE, Ruiz S, Palazuelos E, Hernandez-Avila M, Hu H. (2001). 
Effect of maternal lead burden on infant weight and weight gain at one month of age among breastfed infants. 
Pediatrics, 107(5), 1016-1023. 
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Appendix 1, Table 3: Excluded studies, pesticides 
 Reference 
 
1 Carrizo D, Grimalt JO, Ribas-Fito N, Sunyer J, Torrent M. (2006). Physical-chemical and maternal determinants of 
the accumulation of organochlorine compounds in four-year-old children. Environ Sci Technol, 40(5), 1420-1426. 
2 Carrizo D, Grimalt JO, Ribas-Fito N, Sunyer J, Torrent M. (2007). Influence of breastfeeding in the accumulation of 
polybromodiphenyl ethers during the first years of child growth. Environ Sci Technol, 41(14), 4907-4912. 
3 Eriksson P, Talts U. (2000). Neonatal exposure to neurotoxic pesticides increases adult susceptibility: a review of 
current findings. Neurotoxicology, 21(1-2), 37-47. 
4 Grimalt JO, Carrizo D, Gari M, Font-Ribera L, Ribas-Fito N, Torrent M, Sunyer J. (2010). An evaluation of the 
sexual differences in the accumulation of organochlorine compounds in children at birth and at the age of 4 years. 
Environ Res, 110(3), 244-250. 
5 Hardell L, Lindstrom G, van BB. (2002). Is DDT exposure during fetal period and breast-feeding associated with 
neurological impairment? Environ Res, 88(3), 141-144. 
6 Lackmann GM, Schaller KH, Angerer J. (2004). Organochlorine compounds in breast-fed vs. bottle-fed infants: 
preliminary results at six weeks of age. Sci Total Environ, 329(1-3), 289-293. 
7 Link B, Gabrio T, Zollner I, Piechotowski I, Kouros B. (2007). Sentinel health department project in Baden-
Wuerttemberg (Germany)--a useful tool for monitoring children's health and environment. Int J Hyg Environ Health, 
210(3-4), 351-355. 
8 Mariussen E, Fonnum F. (2006). Neurochemical targets and behavioral effects of organohalogen compounds: an 
update. Crit Rev Toxicol, 36(3), 253-289. 
9 Miyake Y, Tanaka K, Yasutake A, Sasaki S, Hirota Y. (2011). Lack of association of mercury with risk of wheeze 
and eczema in Japanese children: the Osaka Maternal and Child Health Study. Environ Res, 111(8), 1180-1184. 
10 Nagayama J, Tsuji H, Iida T, Nakagawa R, Matsueda T, Hirakawa H, Yanagawa T, Fukushige J, Watanabe T. 
(2007). Immunologic effects of perinatal exposure to dioxins, PCBs and organochlorine pesticides in Japanese 
infants. Chemosphere, 67(9), S393-S398 
11 Noakes PS, Taylor P, Wilkinson S, Prescott SL. (2006). The relationship between persistent organic pollutants in 
maternal and neonatal tissues and immune responses to allergens: A novel exploratory study. Chemosphere, 63(8), 
1304-1311. 
12 Pohl HR, Tylenda CA. (2000). Breast-feeding exposure of infants to selected pesticides: a public health viewpoint. 
Toxicol Ind Health, 16(2), 65-77. 
13 Sunyer J, Basagana X, Gonzalez JR, Julvez J, Guerra S, Bustamante M, de CR, Anto JM, Torrent M. (2010). Early 
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Appendix 3: Tables of included studies 
Appendix 3, Table 1: Included studies with PCBs, dioxins 
 References Quality 
assessment 
1 Dallaire R, Muckle G, Dewailly E, Jacobson SW, Jacobson JL, Sandanger TM, Sandau CD, 
Ayotte P. (2009). Thyroid hormone levels of pregnant inuit women and their infants exposed to 
environmental contaminants. Environ Health Perspect, 117(6), 1014-1020. 
B 
2 Forns J, Torrent M, Garcia-Esteban R, Grellier J, Gascon M, Julvez J, Guxens M, Grimalt JO, 
Sunyer J. (2012). Prenatal exposure to polychlorinated biphenyls and child neuropsychological 
development in 4-year-olds: an analysis per congener and specific cognitive domain. Sci Total 
Environ, 432, 338-343. 
B 
3 Gascon M, Verner MA, Guxens M, Grimalt JO, Forns J, Ibarluzea J, Lertxundi N, Ballester F, 
Llop S, Haddad S, Sunyer J, Vrijheid M. (2013). Evaluating the neurotoxic effects of lactational 
exposure to persistent organic pollutants (POPs) in Spanish children. Neurotoxicology, 34, 9-15. 
B+ 
4 Gladen BC, Ragan NB, Rogan WJ. (2000). Pubertal growth and development and prenatal and 
lactational exposure to polychlorinated biphenyls and dichlorodiphenyl dichloroethene. J Pediatr, 
136(4), 490-496. 
B 
5 Gladen BC, Rogan WJ. (1991). Effects of perinatal polychlorinated biphenyls and 
dichlorodiphenyl dichloroethene on later development. J Pediatr, 119(1 Pt 1), 58-63. 
B 
6 Grandjean P, Poulsen LK, Heilmann C, Steuerwald U, Weihe P. (2010). Allergy and sensitization 
during childhood associated with prenatal and lactational exposure to marine pollutants. Environ 
Health Perspect, 118(10), 1429-1433. 
B 
7 Grandjean P, Budtz-Jorgensen E, Steuerwald U, Heinzow B, Needham LL, Jorgensen PJ, Weihe P. 
(2003). Attenuated growth of breast-fed children exposed to increased concentrations of 
methylmercury and polychlorinated biphenyls. FASEB J, 17(6), 699-701. 
B 
8 Heilmann C, Budtz-Jorgensen E, Nielsen F, Heinzow B, Weihe P, Grandjean P. (2010). Serum 
concentrations of antibodies against vaccine toxoids in children exposed perinatally to 
immunotoxicants. Environ Health Perspect, 118(10), 1434-1438. 
B 
9 Huisman M, Koopman-Esseboom C, Lanting CI, van der Paauw CG, Tuinstra LG, Fidler V, 
Weisglas-Kuperus N, Sauer PJ, Boersma ER, Touwen BC. (1995). Neurological condition in 18-
month-old children perinatally exposed to polychlorinated biphenyls and dioxins. Early Hum Dev, 
43(2), 165-176. 
B 
10 Jacobson JL, Jacobson SW, Humphrey HE. (1990). Effects of exposure to PCBs and related 
compounds on growth and activity in children. Neurotoxicol Teratol, 12(4), 319-326. 
B 
11 Jusko TA, Sonneborn D, Palkovicova L, Kocan A, Drobna B, Trnovec T, Hertz-Picciotto I.(2012). 
Pre- and postnatal polychlorinated biphenyl concentrations and longitudinal measures of thymus 
volume in infants. Environ Health Perspect, 120(4), 595-600. 
B 
12 Koopman-Esseboom C, Weisglas-Kuperus N, de Ridder MA, van der Paauw CG, Tuinstra LG, 
Sauer PJ. (1996). Effects of polychlorinated biphenyl/dioxin exposure and feeding type on infants' 
mental and psychomotor development. Pediatrics, 97(5), 700-706. 
B+ 
13 Lanting CI, Patandin S, Fidler V, Weisglas-Kuperus N, Sauer PJ, Boersma ER, Touwen BC. 
(1998). Neurological condition in 42-month-old children in relation to pre- and postnatal exposure 
to polychlorinated biphenyls and dioxins. Early Hum Dev, 50(3), 283-292. 
B+ 
14 Patandin S, Lanting CI, Mulder PG, Boersma ER, Sauer PJ, Weisglas-Kuperus N. (1999). Effects 
of environmental exposure to polychlorinated biphenyls and dioxins on cognitive abilities in Dutch 
children at 42 months of age. J Pediatr, 134(1), 33-41. 
B+ 
15 Rogan WJ, Gladen BC. (1991). PCBs, DDE, and child development at 18 and 24 months. Ann 
Epidemiol, 1(5), 407-413. 
B 
16 Verner MA, Plusquellec P, Muckle G, Ayotte P, Dewailly E, Jacobson SW, Jacobson JL, 
Charbonneau M, Haddad S. (2010). Alteration of infant attention and activity by polychlorinated 
biphenyls: unravelling critical windows of susceptibility using physiologically based 
pharmacokinetic modeling. Neurotoxicology, 31(5), 424-431. 
B 
17 Vreugdenhil HJ, Slijper FM, Mulder PG, Weisglas-Kuperus N. (2002). Effects of perinatal B+ 
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 Reference Reason for C 
14 Pan IJ, Daniels JL, Herring AH, Rogan WJ, Siega-Riz AM, Goldman 
BD, Sjodin A. (2010). Lactational exposure to polychlorinated 
biphenyls, dichlorodiphenyltrichloroethane, and 
dichlorodiphenyldichloroethylene and infant growth: an analysis of 
the Pregnancy, Infection, and Nutrition Babies Study. Paediatr 
Perinat Epidemiol, 24(3), 262-271. 
Does not try to discern pre and postnatal 
effects. Little variation in exposure, all 
breastfed long. 
15 Pan IJ, Daniels JL, Goldman BD, Herring AH, Siega-Riz AM, 
Rogan WJ. (2009). Lactational exposure to polychlorinated 
biphenyls, dichlorodiphenyltrichloroethane, and 
dichlorodiphenyldichloroethylene and infant neurodevelopment: an 
analysis of the pregnancy, infection, and nutrition babies study. 
Environ Health Perspect, 117(3), 488-494. 
Relevant, but study designed for other purpose. 
Does not try to discern pre and postnatal 
effects, and does not include non-breastfed. 
16 Ribas-Fito N, Julvez J, Torrent M, Grimalt JO, Sunyer J. (2007). 
Beneficial effects of breastfeeding on cognition regardless of DDT 
concentrations at birth. Am J Epidemiol, 166(10), 1198-1202. 
Lacks important cofounders. 
17 Ribas-Fito N, Cardo E, Sala M, Eulalia de MM, Mazon C, Verdu A, 
Kogevinas M, Grimalt JO, Sunyer J. (2003). Breastfeeding, exposure 
to organochlorine compounds, and neurodevelopment in infants. 
Pediatrics, 111(5 Pt 1), e580-e585. 
Postnatal results not assessed. 
18 Schell LM, Gallo MV, Ravenscroft J, DeCaprio AP. (2009). 
Persistent organic pollutants and anti-thyroid peroxidase levels in 
Akwes sne M hawk young adults. Environ Res, 109(1), 86-92. 
Cannot be used for assessing effects of 
postnatal exposure. 
19 Schell LM, Gallo MV, Denham M, Ravenscroft J, DeCaprio AP, 
Carpenter DO. (2008). Relationship of thyroid hormone levels to 
levels of polychlorinated biphenyls, l ad, p,p'- DDE, and other 
toxicants in Akwesasne M hawk youth. Environ Health Perspect, 
116(6), 806-813. 
Cannot be used for assessing effects of 
postnatal exposure. 
20 Torres-Sanchez L, Schnaas L, Cebrian ME, Hernandez MC, 
Val ci  EO, Garcia Hernandez RM, Lop z-Carrillo L. (2009). 
Prenatal dichlorodiphenyldich oroethyl ne (DDE) exposure and
neurodevelopment: a follow-up from 12 to 30 months of age. 
Neurotoxicology, 30(6), 1162-1165. 
Too scarce breastfeeding data. No information 
about breastfeeding length or exclusive or 
partial breastfeeding.  
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 References Quality 
assessment 
exposure to PCBs and dioxins on play behavior in Dutch children at school age. Environ Health 
Perspect, 110(10), A593-A598. 
18 Vreugdenhil HJ, Lanting CI, Mulder PG, Boersma ER, Weisglas-Kuperus N. (2002). Effects of 
prenatal PCB and dioxin background exposure on cognitive and motor abilities in Dutch children 
at school age. J Pediatr, 140(1), 48-56. 
B+ 
19 Walkowiak J, Wiener JA, Fastabend A, Heinzow B, Kramer U, Schmidt E, Steingruber HJ, 
Wundram S, Winneke G. (2001). Environmental exposure to polychlorinated biphenyls and 
quality of the home environment: effects on psychodevelopment in early childhood. Lancet, 
358(9293), 1602-1607. 
B 
20 Weisglas-Kuperus N, Patandin S, Berbers GA, Sas TC, Mulder PG, Sauer PJ, Hooijkaas H. 
(2000). Immunologic effects of background exposure to polychlorinated biphenyls and dioxins in 
Dutch preschool children. Environ Health Perspect, 108(12), 1203-1207. 
B+ 
21 Winneke G, Kramer U, Sucker K, Walkowiak J, Fastabend A, Heinzow B, Steingruber HJ. (2005). 
PCB-related neurodevelopmental deficit may be transient: follow-up of a cohort at 6 years of age. 
Environ Toxicol Pharmacol, 19(3), 701-706. 
B 
 
Appendix 3, Table 2: Included studies with heavy metals (only Hg) 
 References, Hg Quality 
assessment 
1 Grandjean P, Weihe P, White RF. (1995). Milestone development in infants exposed to 
methylmercury from human milk. Neurotoxicology, 16(1), 27-33. 
B 
2 Jensen TK, Grandjean P, Jorgensen EB, White RF, Debes F, Weihe P. (2005). Effects of breast 
feeding on neuropsychological development in a community with methylmercury exposure from 
seafood. J Expo Anal Environ Epidemiol, 15(5), 423-430. 
B 
 
Appendix 3, Table 3: Included studies with pesticides 
 Reference Quality 
assessment 
1 Dallaire R, Muckle G, Dewailly E, Jacobson SW, Jacobson JL, Sandanger TM, Sandau CD, Ayotte P. 
(2009). Thyroid hormone levels of pregnant inuit women and their infants exposed to environmental 
contaminants. Environ Health Perspect, 117(6), 1014-1020. 
B 
2 Gascon M, Verner MA, Guxens M, Grimalt JO, Forns J, Ibarluzea J, Lertxundi N, Ballester F, Llop 
S, Haddad S, Sunyer J, Vrijheid M. (2013). Evaluating the neurotoxic effects of lactational exposure 
to persistent organic pollutants (POPs) in Spanish children. Neurotoxicology, 34, 9-15. 
B+ 
3 Gladen BC, Ragan NB, Rogan WJ. (2000). Pubertal growth and development and prenatal and 
lactational exposure to polychlorinated biphenyls and dichlorodiphenyl dichloroethene. J Pediatr, 
136(4), 490-496. 
B 
4 Gladen BC, Rogan WJ. (1991). Effects of perinatal polychlorinated biphenyls and dichlorodiphenyl 
dichloroethene on later development. J Pediatr, 119(1 Pt 1), 58-63. 
B 
5 Rogan WJ, Gladen BC. (1991). PCBs, DDE, and child development at 18 and 24 months. Ann 
Epidemiol, 1(5), 407-413. 
B 
6 Sunyer J, Torrent M, Garcia-Esteban R, Ribas-Fito N, Carrizo D, Romieu I, Anto JM, Grimalt JO. 
(2006). Early exposure to dichlorodiphenyldichloroethylene, breastfeeding and asthma at age six. 
Clin Exp Allergy, 36(10), 1236-1241. 
B 
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Appendix 4: List of studies categorised as C 
 Reference Reason for C 
1 Chen Z, Robison L, Giller R, Krailo M, Davis M, Davies S, Shu XO. 
(2006). Environmental exposure to residential pesticides, chemicals, 
dusts, fumes, and metals, and risk of childhood germ cell tumors. Int 
J Hyg Environ Health, 209(1), 31-40. 
The exposure is only anamnestic, not measured 
levels of contaminants in blood or milk. 
2 Darnerud PO, Lignell S, Glynn A, Aune M, Tornkvist A, Stridsberg 
M. (2010). POP levels in breast milk and maternal serum and thyroid 
hormone levels in mother-child pairs from Uppsala, Sweden. 
Environ Int, 36(2), 180-187. 
Not possible to discern pre- and postnatal 
exposure. 
3 Dewailly E, Ayotte P, Bruneau S, Gingras S, Belles-Isles M, Roy R. 
(2000). Susceptibility to infections and immune status in Inuit infants 
exposed to organochlorines. Environ Health Perspect, 108(3), 205-
211. 
Missing relevant breastfeeding data. No 
stratification full/partial breastfeeding. 
4 Glynn A, Thuvander A, Aune M, Johannisson A, Darnerud PO, 
Ronquist G, Cnattingius S. (2008). Immune cell counts and risks of 
respiratory infections among infants exposed pre- and postnatally to 
organochlorine compounds: a prospective study. Environ Health, 7, 
62. 
Not possible to discern pre- and postnatal 
exposure. 
5 Kaneko H, Matsui E, Shinoda S, Kawamoto N, Nakamura Y, Uehara 
R, Matsuura N, Morita M, Tada H, Kondo N. (2006). Effects of 
dioxins on the quantitative levels of immune components in infants. 
Toxicol Ind Health, 22(3), 131-136. 
Low relevance, due to inadequacies in the 
descriptions of groups, and no exposure 
characteristics of the formula fed group. 
6 Karmaus W, Davis S, Chen Q, Kuehr J, Kruse H. (2003). Atopic 
manifestations, breast-feeding protection and the adverse effect of 
DDE. Paediatr Perinat Epidemiol, 17(2), 212-220. 
Too scarce breastfeeding history.  
7 Karmaus W, Kuehr J, Kruse H. (2001). Infections and atopic 
disorders in childhood and organochlorine exposure. Arch Environ 
Health, 56(6), 485-492. 
Breastfeeding anamnesis insufficiently 
described. 
8 Marques RC, Dorea JG, Bernardi JV, Bastos WR, Malm O. (2009). 
Prenatal and postnatal mercury exposure, breastfeeding and 
neurodevelopment during the first 5 years. Cogn Behav Neurol, 
22(2), 134-141. 
Not possible to separate pre- and postnatal 
effects. Hg in vaccines was the focus of the 
article. No control group 
9 Marques RC, Dorea JG, Bernardi JV, Bastos WR, Malm O. (2008). 
Maternal fish consumption in the nutrition transition of the Amazon 
Basin: growth of exclusively breastfed infants during the first 5 
years. Ann Hum Biol, 35(4), 363-377. 
Not possible to discern pre- and postnatal 
exposure. Hg from fish the focus of attention. 
No control group. 
10 Marques RC, Garrofe DJ, Rodrigues BW, de Freitas RM, de Freitas 
FM, Malm O. (2007). Maternal mercury exposure and neuro-motor 
development in breastfed infants from Porto Velho (Amazon), 
Brazil. Int J Hyg Environ Health, 210(1), 51-60. 
All were exclusively breastfed. Not possible to 
separate pre- and postnatal effects. No control 
group. 
11 Matsuura N, Uchiyama T, Tada H, Nakamura Y, Kondo N, Morita 
M, Fukushi M. (2001). Effects of dioxins and polychlorinated 
biphenyls (PCBs) on thyroid function in infants born in Japan--the 
second report from research on environmental health. Chemosphere, 
45(8), 1167-1171. 
Low relevance, due to inadequacies in the 
descriptions of groups, and no exposure 
characteristics of the formula fed group. 
12 Matsuura N, Uchiyama T, Tada H, Nakamura Y, Kondo N, Morita 
M, Fukushi M. (2001). Effects of dioxins and polychlorinated 
biphenyls (PCBs) on thyroid function in infants born in Japan--the 
second report from research on environmental health. Chemosphere, 
45(8), 1167-1171. 
Low relevance, due to inadequacies in the 
descriptions of groups, and no exposure 
characteristics of the formula fed group. 
13 Nagayama J, Okamura K, Iida T, Hirakawa H, Matsueda T, Tsuji H, 
Hasegawa M, Sato K, Ma HY, Yanagawa T, Igarashi H, Fukushige 
J, Watanabe T. (1998). Postnatal exposure to chlorinated dioxins and 
related chemicals on thyroid hormone status in Japanese breast-fed 
infants. Chemosphere, 37(9-12), 1789-1793. 
Of low relevance, since N is low. Insufficient 
description of the study group. 
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 Reference Reason for C 
14 Pan IJ, Daniels JL, Herring AH, Rogan WJ, Siega-Riz AM, Goldman 
BD, Sjodin A. (2010). Lactational exposure to polychlorinated 
biphenyls, dichlorodiphenyltrichloroethane, and 
dichlorodiphenyldichloroethylene and infant growth: an analysis of 
the Pregnancy, Infection, a  Nutrition Babies Study. Paediatr 
Perinat Epidemiol, 24(3), 262-271. 
Does not try to discern pre and postnatal 
effects. Little variation in exposure, all 
breastfed long. 
15 P n IJ, Daniels JL, Goldman BD, Herring AH, Siega-Riz AM, 
Rogan WJ. (2009). Lactational exposure to polychlorinated 
biphenyls, dichlorodip enyltrichloroethane, and 
dichlorodiphenyldichloroethylene and infant neurodevelopment: an 
analysis of the pregnancy, infection, and nutrition babies study. 
Environ Health Perspect, 117(3), 488-494. 
Relevant, but study designed for other purpose. 
Does not try to discern pre and postnatal 
effects, and does not include non-breastfed. 
16 Ribas-Fit  N, Julvez J, Torrent M, Grimalt JO, Sunyer J. (2007). 
Beneficial effects of breastfeeding on cognition regardless of DDT 
concentrations at birth. Am J Epidemiol, 166(10), 1198-1202. 
Lacks important cofounders. 
17 ibas-Fito N, Cardo E, Sala M, Eulalia de MM, Mazon C, Verdu A, 
Kogevinas M, Grimalt JO, Su yer J. (2003). Breastfeeding, exposure 
to organochlorine compounds, and neurodevelopment in infants. 
Pediatrics, 111(5 Pt 1), e580-e585. 
Postnatal results not assessed. 
18 Schell LM, Gallo MV, Ravenscroft J, DeCaprio AP. (2009). 
Persistent organic pollutants and anti-thyroid peroxidase levels in 
Akwesas e Mohawk young adults. Enviro  Res, 109(1), 86-92. 
Cannot be used for assessing effects of 
postnatal exposure. 
19 Schell LM, Gallo MV, Denham M, Ravenscroft J, DeCaprio AP, 
Carpenter DO. (2008). Relationship of thyroid hormone levels to 
levels of polychlorinated biphenyls, lead, p,p'- DDE, and oth r 
toxicants in Akwesasne Mohawk youth. Environ Health Perspect, 
116(6), 806-813. 
Cannot be used for assessing effects of 
p stnatal exposure. 
20 Torres-Sanchez L, Schnaas L, Cebrian ME, Hernandez MC, 
Valencia EO, Garcia Hernandez RM, Lopez-Carrillo L. (2009). 
Prenatal dichlorodiphenyldichloroethylene (DDE) exposure and 
neurodevelopment: a follow-up from 12 to 30 months of age. 
Neurotoxicology, 30(6), 1162-1165. 
Too scarce breastfeeding data. No information 
about breastfeeding length or exclusive or 
partial breastfeeding.  
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 Reference Reason for C 
14 Pan IJ, Daniels JL, Herring AH, Rogan WJ, Siega-Riz AM, Goldman 
BD, Sjodin A. (2010). Lactational exposure to polychlorinated 
biphenyls, dichlorodiphenyltrichloroethane, and 
dichlorodiphenyldichloroethylene and infant growth: an analysis of 
the Pregnancy, Infection, and Nutrition Babies Study. Paediatr 
Perinat Epidemiol, 24(3), 262-271. 
Does not try to discern pre and postnatal 
effects. Little variation in exposure, all 
breastfed long. 
15 Pan IJ, Daniels JL, Goldman BD, Herring AH, Siega-Riz AM, 
Rogan WJ. (2009). Lactational exposure to polychlorinated 
biphenyls, dichlorodiphenyltrichloroethane, and 
dichlorodiphenyldichloroethylene and infant neurodevelopment: an 
analysis of the pregnancy, infection, and nutrition babies study. 
Environ Health Perspect, 117(3), 488-494. 
Relevant, but study designed for other purpose. 
Does not try to discern pre and postnatal 
effects, and does not include non-breastfed. 
16 Ribas-Fito N, Julvez J, Torrent M, Grimalt JO, Sunyer J. (2007). 
Beneficial effects of breastfeeding on cognition regardless of DDT 
concentrations at birth. Am J Epidemiol, 166(10), 1198-1202. 
Lacks important cofounders. 
17 Ribas-Fito N, Cardo E, Sala M, Eulalia de MM, Mazon C, Verdu A, 
Kogevinas M, Grimalt JO, Sunyer J. (2003). Breastfeeding, exposure 
to organochlorine compounds, and neurodevelopment in infants. 
Pediatrics, 111(5 Pt 1), e580-e585. 
Postnatal results not assessed. 
18 Schell LM, Gallo MV, Ravenscroft J, DeCaprio AP. (2009). 
Persistent organic pollutants and anti-thyroid peroxidase levels in 
Akwesasne Mohawk young adults. Environ Res, 109(1), 86-92. 
Cannot be used for assessing effects of 
postnatal exposure. 
19 Schell LM, Gallo MV, Denham M, Ravenscroft J, DeCaprio AP, 
Carpenter DO. (2008). Relationship of thyroid hormone levels to 
levels of polychlorinated biphenyls, lead, p,p'- DDE, and other 
toxicants in Akwesasne Mohawk youth. Environ Health Perspect, 
116(6), 806-813. 
Cannot be used for assessing effects of 
postnatal exposure. 
20 Torres-Sanchez L, Schnaas L, Cebrian ME, Hernandez MC, 
Valencia EO, Garcia Hernandez RM, Lopez-Carrillo L. (2009). 
Prenatal dichlorodiphenyldichloroethylene (DDE) exposure and 
neurodevelopment: a follow-up from 12 to 30 months of age. 
Neurotoxicology, 30(6), 1162-1165. 
Too scarce breastfeeding data. No information 
about breastfeeding length or exclusive or 
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Appendix 6: Literature search on contaminants in infant formula 
Database: Embase <1980 to 2012 Week 04>, Ovid MEDLINE(R) In-Process & Other Non-
Indexed Citations, Ovid MEDLINE(R) Daily and Ovid MEDLINE(R) <1946 to Present> 
Search Strategy: 
-------------------------------------------------------------------------------- 
1     infant formula*.ti,ab,sh. (7860) 
2     baby formula*.ti,ab,sh. (93) 
3     infant fed*.ti,ab,sh. (121)  
4     milk based formula*.ti,ab,sh. (599) 
5     milkbased formula*.ti,ab,sh. (3) 
6     artificial formula*.ti,ab,sh. (143) 
7     artificial milk.ti,sh,ab. (7675) 
8     bottle milk.ti,ab,sh. (35) 
9     bottlefed.ti,ab,sh. (83) 
10     bottle fed.ti,ab,sh. (1584) 
11     breast milk substitut*.ti,ab,sh. (429) 
12     breastmilk substitut*.ti,ab,sh. (112) 
13     formula feeding.ti,ab,sh. (1733) 
14     1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10 or 11 or 12 or 13 (16549) 
15     pesticide*.ti,ab,sh. (76504) 
16     persistant organic pollutant*.ti,ab,sh. (11) 
17     persistent organic pollutant*.ti,ab,sh. (3283) 
18     environmental pollutant*.ti,ab,sh. (27769) 
19     environmental exposur*.ti,ab,sh. (120777) 
20     environmental contaminant*.ti,ab,sh. (6449) 
21     dioxin*.ti,ab,sh. (26360) 
22     polychlorinated biphenyl*.ti,ab,sh. (31688) 
23     pcb*.ti,ab,sh. (27899) 
24     pollutant*.ti,ab,sh. (70642) 
25     metals, heavy.sh. (11548) 
26     heavy metal*.ti,ab,sh. (53545) 
27     mercury.ti,ab,sh. (70506) 
28     lead.sh. (65775) 
29     cadmium*.ti,ab,sh. (80445) 
30     pfos.ti,ab,sh. (1920) 
31     perfluorooctane sulfonate*.ti,ab,sh. (1000) 
32     perfluorooctanesulfonic acid*.ti,ab,sh. (703) 
33     pfoa.ti,ab,sh. (1751) 
34     perfluorooctanoic acid*.ti,ab,sh. (1599) 
35     pfc.ti,ab,sh. (12802) 
36     perfluoro compound*.ti,ab,sh. (1828) 
37     perfluorinated acid*.ti,ab,sh. (170) 
38     brominated flame retardant*.ti,ab,sh. (1223) 
39     flame retardant*.ti,ab,sh. (4121) 
40     ddt.ti,ab,sh. (17850) 
41     chlorphenotane*.ti,ab,sh. (10341) 
42     "1,1 dichloro 2,2 bis(4 chlorophenyl)ethylene".sh. (3205) 
43     dde.ti,ab,sh. (7137) 
44     dichlorodiphenyl dichloroethylene.ti,ab,sh. (1645) 
45     15 or 16 or 17 or 18 or 19 or 20 or 21 or 22 or 23 or 24 or 25 or 26 or 27 or 28 or 29 or 30 or 31 or 32 or 33 or 34 or 35 or 36 or 37 or 
38 or 39 or 40 or 41 or 42 or 43 or 44 (528118) 
46     child growth.ti,ab,sh. (8367) 
47     child development.ti,ab,sh. (67095) 
48     infant growth.ti,ab,sh. (1410) 
49     infant development.ti,ab,sh. (3050) 
50     language development.ti,ab,sh. (19032) 
51     child* language.ti,ab,sh. (3925) 
52     preschool child*.ti,ab,sh. (446941) 
53     child, preschool.sh. (682538) 
54     cognitive development*.ti,ab,sh. (8434) 
55     cognition.ti,ab,sh. (201496) 
56     cognitive defect*.ti,ab,sh. (72656) 
57     cognitive disorder*.ti,ab,sh. (4570) 
58     child* intelligence.ti,ab,sh. (449) 
59     nerve cell differentiation.ti,ab,sh. (19521) 
60     neurodevelopment*.ti,ab,sh. (23036) 
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61     immune system*.ti,ab,sh. (153455) 
62     allerg*.ti,ab,sh. (333017) 
63     sensiti?ation.ti,ab,sh. (88052) 
64     hypersensitiv*.ti,ab,sh. (177785) 
65     child behavio?r.ti,ab,sh. (47063) 
66     behavio?r* disorder*.ti,ab,sh. (46573) 
67     sexual* m tur*.ti,ab,sh. (24713) 
68     thyroid.ti,ab,sh. (251098) 
69     infection*.ti,ab,sh. (1908429) 
70     autism*.ti,ab,sh. (38834) 
71     infantile autism*.ti,ab,sh. (3129) 
72     autistic disorder*.ti,ab,sh. (15380) 
73     attention deficit disorder*.ti,ab,sh. (45891) 
74     adhd*.ti,ab,sh. (24161) 
75     childhood mental disorder*.ti,ab,sh. (62) 
76     adolescen* mental disorder*.ti,ab,sh. (164) 
77     intellectual impair*.ti,ab,sh. (7210) 
78     intellectual disabilit*.ti,ab,sh. (50815) 
79     cognitive impair*.ti,ab,sh. (52266) 
80     cognitive disabilit*.ti,ab,sh. (1066) 
81     obesity*.ti,ab,sh. (359732) 
82     obese*.ti,ab,sh. (133795) 
83     overweight*.ti,ab,sh. (63788) 
84     weight gain.ti,ab,sh. (110098) 
85     cancer*.ti,ab,sh. (2391609) 
86     46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 or 56 or 57 or 58 or 59 or 60 or 61 or 62 or 63 or 64 or 65 or 66 or 67 or 68 or 
69 or 70 or 71 or 72 or 73 or 74 or 75 or 76 or 77 or 78 or 79 or 80 or 81 or 82 or 83 or 84 or 85 (6843057) 
87     14 and 45 and 86 (154) 
88     prematurity.ti,ab,sh. (75988) 
89     premature infant*.ti,ab,sh. (29230) 
90     premature child*.ti,ab,sh. (1133) 
91     infant, premature.sh. (36498) 
92     88 or 89 or 90 or 91 (117783) 
93     87 not 92 (152) 
94     limit 93 to humans (132) 
95     limit 94 to yr="1990 -Current" (130) 
96     remove duplicates from 95 (104) 
97     limit 96 to (danish or english or german or norwegian or swedish) (99) 
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61     immune system*.ti,ab,sh. (153455) 
62     allerg*.ti,ab,sh. (333017) 
63     sensiti?ation.ti,ab,sh. (88052) 
64     hypersensitiv*.ti,ab,sh. (177785) 
65     child behavio?r.ti,ab,sh. (47063) 
66     behavio?r* disorder*.ti,ab,sh. (46573) 
67     sexual* matur*.ti,ab,sh. (24713) 
68     thyroid.ti,ab,sh. (251098) 
69     infection*.ti,ab,sh. (1908429) 
70     autism*.ti,ab,sh. (38834) 
71     infantile autism*.ti,ab,sh. (3129) 
72     autistic disorder*.ti,ab,sh. (15380) 
73     attention deficit disorder*.ti,ab,sh. (45891) 
74     adhd*.ti,ab,sh. (24161) 
75     childhood mental disorder*.ti,ab,sh. (62) 
76     adolescen* mental disorder*.ti,ab,sh. (164) 
77     intellectual impair*.ti,ab,sh. (7210) 
78     intellectual disabilit*.ti,ab,sh. (50815) 
79     cognitive impair*.ti,ab,sh. (52266) 
80     cognitive disabilit*.ti,ab,sh. (1066) 
81     obesity*.ti,ab,sh. (359732) 
82     obese*.ti,ab,sh. (133795) 
83     overweight*.ti,ab,sh. (63788) 
84     weight gain.ti,ab,sh. (110098) 
85     cancer*.ti,ab,sh. (2391609) 
86     46 or 47 or 48 or 49 or 50 or 51 or 52 or 53 or 54 or 55 or 56 or 57 or 58 or 59 or 60 or 61 or 62 or 63 or 64 or 65 or 66 or 67 or 68 or 
69 or 70 or 71 or 72 or 73 or 74 or 75 or 76 or 77 or 78 or 79 or 80 or 81 or 82 or 83 or 84 or 85 (6843057) 
87     14 and 45 and 86 (154) 
88     prematurity.ti,ab,sh. (75988) 
89     premature infant*.ti,ab,sh. (29230) 
90     premature child*.ti,ab,sh. (1133) 
91     infant, premature.sh. (36498) 
92     88 or 89 or 90 or 91 (117783) 
93     87 not 92 (152) 
94     limit 93 to humans (132) 
95     limit 94 to yr="1990 -Current" (130) 
96     remove duplicates from 95 (104) 
97     limit 96 to (danish or english or german or norwegian or swedish) (99) 
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Appendix 7: Tests for neurodevelopment and home environment 
Bayley Scales of Infant Development 
The Bayley Scales of Infant Development Second edition (BSID-II) is a standard series of 
measurements originally developed by psychologist Nancy Bayley and used primarily to 
assess the mental, motor and behavioural development of infant and preschool children. The 
BSID-II is the most important and most widely used developmental assessment test. One of 
its primary uses is to evaluate infants suspected of delay or atypical development to determine 
eligibility for services and to track progress over time. Children at risk for developmental 
disability are those born prematurely or with low birth weight or with major congenital 
anomaly, delayed milestones, or other risk factors. The Bayley Scales are also preferred as a 
tool in developmental research.  
The BSID-II is a developmental test, not an intelligence test, and thus assesses different 
abiliteis present at different ages. US norms have been developed for 17 age groups between 
the ages of one month and 3.5 years (42 months), with 50 boys and 50 girls in each age group. 
There are three scales: mental scale, motor scale and a 30-item behavior rating scale (BRS). 
The mental scale provides an index score of general cognitive development (i.e., the Mental 
Development Index, MDI). The motor scale provides an index of overall motor development 
(i.e., Psychomotor Development Index, PDI). From these two scales, four “facet” scores can 
be derived: Cognitive, Language, Motor and Personal/Social. These are intended for 
identifying relative strengths and weaknesses. The BRS provides a qualitative assessment of 
behavior reflecting three main factors: Orientation/Engagement, Emotional Regulation, and 
Motor Quality. The BRS is considered a critical aspect of the BSID-II because an infant’s 
state (including engagement, arousal level, and motivation at the time of testing) may 
substantially influence the Mental and Motor scores. 
The BSID-II takes between 45 - 60 minutes to administer. Raw scores of successfully 
completed items are converted to scale scores and to composite scores. These scores are used 
to determine the child's performance compared with norms taken from typically developing 
children of their age (in months). The assessment is often used in conjunction with the Social-
Emotional Adaptive Behavior Questionnaire. Completed by the parent or caregiver, this 
questionnaire establishes the range of adaptive behaviors that the child can currently achieve 
and enables comparison with age norms. 
Reference: Strauss, E., Sherman, E.M.S., & Spreen, O. 2006. A compendium of neuropsychological tests. 
Administration, norms, and commentary. 3rd ed. New York: Oxford University Press. 
 
Home Inventory and the Bradley scale  
The Home Observation for Measurement of the Environment (HOME) Inventory is designed 
to measure the quality and quantity of stimulation and support available to a child in the home 
environment. It is a descriptive profile which yields a systematic assessment of the caring 
environment in which the child is reared. The focus is on the child in the home environment, 
the child as an active recipient of inputs from objects, events, and transactions occurring in 
connection with the family surroundings. It is intended to be used by practitioners, as well as 
researchers, and ideally it should be combined with information from individual assessments 
of the child in a context of a multimodal assessment procedure. 
The HOME involves an hour long semi-structured interview in the home with the main 
caregiver and child to collect information about the nature and variety of the child’s day-to-
day experiences and the parenting capacity of the caregivers and to explore a range of other 
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aspects of the child’s world and the life of the family. The HOME has been shown to be a 
good predictor of outcomes for children 
The HOME Inventory was developed in the 1960’s and has been used with large numbers of 
children in a variety of different contexts around the world. It is therefore a well-established 
and tested tool for undertaking a standardised assessment of a child’s home environment.  
There are four HOME inventories for children aged 0-3, 3-6, 6-10 and 10-14 years. There are 
additional disability adapted inventories for a range of disabled children and for child care 
contexts. Each inventory contains a group of scales to assess different aspects of the child’s 
environment. Each scale contains a number of items that are scored according to a glossary. 
The HOME therefore provides a framework for practitioners to assess all aspects of the home 
environment, including parenting, which directly impact on the child.  
The HOME Inventory has been used successfully in research and in practice. It is easy to 
administer and score and has sound psychometric properties. Even though it requires special 
training, it is straightforward to complete and to score and at the same time the whole 
procedure is not threatening to the family. The combination of interview and direct 
observation allows for an assessment of the caring environment along with a more detailed 
assessment of individual children. However one of the most serious restrictions of this 
inventory is the lack of a standardised procedure for administration. Another limitation comes 
from the measurement scale itself. The choice of a binary scale makes it easier for the 
interviewer to score but it deprives the researcher or the practitioner of more subtle 
information needed to make informed judgements. 
Reference: Totsika, V. & Sylva, K., 2004. Child and Adolescent Mental Health Volume 9, No. 1, pp. 25-35 
http://www.familieschildrenchildcare.org/fccc_static_PDFs/Sylva_2004.pdf. 
 
McCarthy Scales of Children's Abilities (MSCA)  
The McCarthy Scales of Children's Abilities (MSCA) is a psychological test given to young 
children. The MSCA was created by Dorothea McCarthy in 1972. The MSCA was intended 
to measure children from ages 2 to 8. It includes 18 subtests that yield a General Cognitive 
Index and scores for verbal, perceptual-performance, quantitative, motor, and memory scales. 
The test materials are appealing to children, but considerably older normative data set makes 
this a limited instrument in comparison to more currently normed measures that were 
developed for, or extend into, the same age range. Thus, it is no longer advisable to administer 
the MSCA.  
Reference: Baron, I. S. (2004). Neuropsychological evaluation of the child. New York: Oxford University Press. 
 
Kaufman Assessment Battery for Children (K-ABC) 
The Kaufman Assessment Battery for Children (K-ABC) is an instrument for assessing 
intellectual skills and cognitive development in children aged from 2 years 6 months to 12 
years 5 months. The test was developed by Alan S. Kaufman and Nadeen L. Kaufman in 1983 
and revised in 2004. The battery has been normed on 2000 children in the US with equal 
representation of boys and girls for each of 20 age groups. The K-ABC utilizes two 
component processes according to principal factor analysis, simultaneous and sequential 
processing. It is based on Luria’s theory of simultaneous and successive information 
processing. These define intelligence in terms of the child’s problem solving and processing 
styles. Seven subtests are used to measure simultaneous processing, while three subtests are 
included in assessment of sequential processing. There are also six achievement subtests, and 
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a nonverbal scale with six subtests to aid in assessment of cultural or linguistic minorities and 
handicapped children. 
A short form of the K-ABC includes the subtests Hand Movements (reproducing hand-
movement sequences), Word Order (serial recall of words), Triangles (puzzle assembly), and 
Matrix Analogies (identification of principles of similarity). This form gives an estimated 
mental processing composite (MPC), with good to excellent reliabilities with the full version 
and has been used extensively. 
Thus, the K-ABC gives special attention to certain emerging testing needs, such as use with 
handicapped groups, application to problems of learning disabilities, and appropriateness for 
cultural and linguistic minorities. The authors rightly caution, however, that success in 
meeting these special needs must be judged through practical use over time. They also point 
out that the K-ABC should not be regarded as “the complete test battery”; like any other test, 
it should be supplemented and corroborated by other instruments to meet individual needs, 
such as the Stanford-Binet, Wechsler Intelligence Scale for Children, or other 
neuropsychological tests. The K-ABC has been translated, adapted and standardized in more 
than 15 countries. 
Reference: Baron, I. S. (2004). Neuropsychological evaluation of the child. New York: Oxford University Press. 
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Appendix 8: Information on materials used in infant feeding (baby) bottles 
and teats after the BPA ban, including possible migration of such 
chemicals, received from EU countries 
VKM asked various EU countries for information about the materials used in, and possible 
migration of, chemicals from infant feeding (baby) bottles and teats after the BPA ban. 
Information about chemical contaminants in infant formula was also requested. The 
information received are summarised here. 
Answers were received from Cyprus, Finland, Germany, Iceland, The Slovak Republic, 
Sweden, and United Kingdom, and are very much appreciated.  
According to information from Germany, polycarbonates based on other bisphenols are not 
used for baby bottles. UK reported that they did not have any information on the use or intent 
to use bisphenol F (BPF), bisphenol B (BPB) or bisphenol S (BPS) as substitutes for BPA, but 
that they were aware that such substitutes are being/were investigated by British industry. The 
Slovak republic reported that of 36 baby bottles controlled in 2009-2011 the content of BPA 
was not detectable in any samples (detection limit was 0.02 mg/kg), and that they plan to 
monitor also BPF and BFS within their official control of baby bottles in 2012. 
The results of a study on the analytical identification and quantification of migration of 
chemicals from plastics in baby bottles found in the European Union market made of 
materials that are now present as substitutes for polycarbonate (PC) were reported by 
(Simoneau et al., 2012). A total of 449 baby bottles with a focus on first age or sets of bottles 
were purchased from 26 European Union countries, Canada, Switzerland and the USA. From 
this collection, which contained several duplicates, a total of 277 baby bottles were analysed. 
The materials included different types of plastic such as polycarbonate (PC), polyamide (PA), 
polyethersulphone (PES), polypropylene (PP), but also silicone, and from the United States a 
co-polyester marketed under the trade name TritanTM. The bottles were subjected to the 
conventional migration test for hot fill conditions, i.e. 2 h at 70ºC. The simulant used was that 
specified in European Union legislation (2007/19/EC) for milk, i.e. 50% ethanol. The 
migration solutions in general showed a low release of substances. Results showed that bottles 
made of PP and silicones showed a greater number of substances in the migration solutions 
and in greater quantity. Chemicals from PP included alkanes, which could be found in >65% 
of the bottles at levels up to 3500 mg/kg; and benzene derivatives in 17% of the baby bottles 
and found at levels up to 113 mg/kg. Some substances were found on a regular basis such as 
plasticisers, esters and antioxidants (e.g. tris(2,4-di-tert-butylphenyl)phosphate, known as 
Irgafos 168. Some substances found were not included in the Community positive list, which 
means that those should not be found even in the first migration. Such substances included 
2,6-di-isopropylnaphthalene (DIPN), found in 4% of the bottles at levels up to 25 mg/kg, 2,4-
di-tert-butyl phenol (in 90% of the bottles at levels up 400 mg/kg). Moreover, BPA was 
detected and quantified in baby bottles made of PA, but limited to one brand and model 
specific (but labelled BPA free). Results for baby bottles made of silicone also indicated the 
presence of components, e.g. potentially coming from inks (benzophenone, DIPN), which 
could come for example from the presence of instruction leaflets in the bottles). In the case of 
silicone, phthalates were also found in relevant concentrations, with levels for diisobutyl 
phthalate (DiBP) and dibutyl phthalate (DBP) from the first migration test of 50-150 mg/kg 
and diethylhexyl phthalate (DEHP) at levels 25-50 mg/kg. 
Other countries also reported the same materials found in baby bottles. United Kingdom 
reported that a market leading UK brand of baby bottles (manufactured in England) were 
made of either PES or PP. Cyprus reported that from samples of baby bottles analysed in 
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2011, the materials were mainly found to be PC and PP, while one sample was made of PES. 
The Slovak republic reported that in 2011 PC, PP and a few bottles made of TritanTM 
coplyester or polyester were found on their market. 
The teats used on the feeding bottles are also a potential source of contaminants to the infants. 
Germany reported that to their knowledge teats for baby bottles are made of natural rubber 
latex or silicone, and that in both cases plasticizers are not used. Bundesinstitut für 
Risikobewertung (BfR) in Germany gives recommendations for silicone elastomers (silicone 
rubbers) as well as natural and synthetic rubber used in food contact. Cyprus also reported 
that latex (kaoutsouk) and silicone were used in teats, and that they had no information 
regarding potential use of plasticizers in these materials. They also stated that there are 
possible migrations of N-nitrosamines and N-nitrosatable compounds (Directive 93/11/EEC) 
from teats made of kaoutsouk. UK reported that commonly teats produced in UK are made of 
silicone, and are advertised as “BPA free” and “100% silicone” or “food grade silicone”, and 
that they are the preferred teat for wide-necked baby bottles, whereas latex teats are also 
available in UK for traditional style bottles. They further reported that they did not have any 
information on any plastic materials used for teats, however, if used they would be covered by 
the requirements of Regulation 1935/2004 and Regulation 10/2011. The restrictions on the 
use of certain plasticizers and epoxidised soybean oil (ESBO) would preclude their use in the 
UK for such items. They further stated that with established silicone and latex alternatives it 
appears unlikely that plastic teats would be available even in small numbers. 
Commission Directive 93/11/EEC of 15 March 1993 concerning the release of the N-
nitrosamines and N-nitrosatable substances from elastomer or rubber teats and soothers. 
Regarding other contaminants than BPA in baby bottles and teats, UK stated that advertising 
materials in the UK occasionally mention that baby care materials are free from phthalates 
and polyvinyl chloride (PVC) as well as PBA, however, the use of either is not a recognised 
issue in UK. No concerns have been raised by the public or industry as to other materials in 
baby bottles than BPA. 
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